https://www.enets.org/ https://www.enets.org/nextgen-single-page-2023.html https://www.enets.org/nextgen-single-page-2022.html https://www.enets.org/mission-statement.html https://www.enets.org/membership.html https://www.enets.org/free-membership-for-new-young-enets-members-in-2025.html https://www.enets.org/abstract-library.html https://www.enets.org/history-to-date.html https://www.enets.org/enets-executive-committee.html https://www.enets.org/advisory-board.html https://www.enets.org/general-assembly.html https://www.enets.org/by-laws.html https://www.enets.org/honorary-members.html https://www.enets.org/enets-news.html https://www.enets.org/in-memoriam.html https://www.enets.org/people.html https://www.enets.org/honorary-member.html https://www.enets.org/coe.html https://www.enets.org/list-of-coes.html https://www.enets.org/map-of-coes.html https://www.enets.org/coe-programme.html https://www.enets.org/patients-satisfaction-survey.html https://www.enets.org/new-intl-policy-for-extra-eu-coes-2023.html https://www.enets.org/enets-database.html https://www.enets.org/organisational-structure.html https://www.enets.org/participation.html https://www.enets.org/scientific-db-projects.html https://www.enets.org/database-project.html https://www.enets.org/call-for-study-proposals.html https://www.enets.org/db-faqs.html https://www.enets.org/enets-database-concept1.html https://www.enets.org/enets-database-concept2.html https://www.enets.org/enets-database-concept3.html https://www.enets.org/enets-database-concept4.html https://www.enets.org/enets-database-concept5.html https://www.enets.org/enets-studies.html https://www.enets.org/enets-study.html https://www.enets.org/grants-and-awards.html https://www.enets.org/grant.html https://www.enets.org/grants-and-awards-winner.html https://www.enets.org/archive-grant-and-award-winners.html https://www.enets.org/publications.html https://www.enets.org/guidelines.html https://www.enets.org/consensus-papers.html https://www.enets.org/task-force-publications.html https://www.enets.org/database-publications.html https://www.enets.org/standardised-reports.html https://www.enets.org/endorsed-publications.html https://www.enets.org/journal-of-neuroendocrinology-jne.html https://www.enets.org/jne-impact-factor.html https://www.enets.org/education.html https://www.enets.org/webinars.html https://www.enets.org/chd-webinar-july-2023.html https://www.enets.org/webinar-archive.html https://www.enets.org/webinar.html https://www.enets.org/net-cancer-awareness-day.html https://www.enets.org/net-cancer-awareness-day-webinar-2021.html https://www.enets.org/net-cancer-awareness-day-webinar-2022.html https://www.enets.org/net-cancer-awareness-day-webinar-2023.html https://www.enets.org/ebnenm.html https://www.enets.org/ebnen.html https://www.enets.org/board-governance.html https://www.enets.org/ebnenm-fellows.html https://www.enets.org/information-for-trainees.html https://www.enets.org/information-for-training-institutions.html https://www.enets.org/information-for-trainers.html https://www.enets.org/resources-and-templates.html https://www.enets.org/ebnenm-exams.html https://www.enets.org/faqs-on-ebnen.html https://www.enets.org/uems.html https://www.enets.org/podcasts.html https://www.enets.org/enets-task-forces.html https://www.enets.org/women-in-net.html https://www.enets.org/y-nets.html https://www.enets.org/nurses-and-dietitians.html https://www.enets.org/patients.html https://www.enets.org/scan-2025.html https://www.enets.org/think-nens-educational-programme-for-primary-care-physicians.html https://www.enets.org/y-nets-member.html https://www.enets.org/newsletter-anmeldeformular.html https://www.enets.org/support-us.html https://www.enets.org/newsletters.html https://www.enets.org/contact.html https://www.enets.org/legal-notice.html https://www.enets.org/privacy-policy.html https://www.enets.org/partners.html https://www.enets.org/startseite-test.html https://www.enets.org/abstract/case-management-of-metastatic-carcinoid-of-the-foregut-midgut-and-hindgut-the-relevance-of-ki-67-prognostication.html https://www.enets.org/abstract/plasma-chromogranin-a-response-to-octreotide-test-prognostic-value-for-clinical-outcome-in-endocrine-digestive-tumors.html https://www.enets.org/abstract/chromogranin-a-as-a-predictor-of-progression-regression-or-stable-disease-in-ileo-cecal-midgut-carcinoid-tumors.html https://www.enets.org/abstract/neoadjuvant-peptide-receptor-radionuclide-therapy-for-an-inoperable-neuroendocrine-pancreatic-carcinoma.html https://www.enets.org/abstract/radioguided-surgery-in-net-first-impression-with-ga-68-labeled-somatostatin-analogues.html https://www.enets.org/abstract/gastroduodenal-ulceration-associated-with-radioembolization-for-the-treatment-of-liver-malignancies-a-newly-observed-complication-institutional-experience-and-review-of-the-literature.html https://www.enets.org/abstract/endoglin-as-indicator-of-metastatic-neuroendocrine-tumors-of-the-pancreas.html https://www.enets.org/abstract/diagnostic-efficacy-of-the-secretin-stimulation-test-for-the-zollinger-ellison-syndrome-an-intra-individual-comparison-using-different-dosages-in-patients-and-controls.html https://www.enets.org/abstract/long-acting-release-octreotide-induce-complete-response-in-type-1-gastric-carcinoid-tumors.html https://www.enets.org/abstract/antitumor-activity-of-pasireotide-som230-alone-and-in-combination-with-everolimus-rad001-in-du-145-human-prostate-cancer-model.html https://www.enets.org/abstract/paraneoplastic-antigen-ma2-pnma2-auto-antibodies-as-biomarkers-for-early-small-intestine-neuroendocrine-tumors-detection.html https://www.enets.org/abstract/peptide-receptor-radioligand-therapy-prrt-is-an-effective-treatment-for-the-long-term-stabilization-of-malignant-gastrinomas.html https://www.enets.org/abstract/a-case-illustrative-of-phenotypic-heterogeneity-and-challenges-in-the-management-of-paraganglioma.html https://www.enets.org/abstract/developing-a-customized-database-for-net-in-a-developing-country.html https://www.enets.org/abstract/predictors-of-response-to-radio-embolization-therasphere-treatment-of-neuro-endocrine-liver-metastasis.html https://www.enets.org/abstract/molecular-imaging-of-gastroenteropancreatic-neuroendocrine-tumours-with-ga-68-dotanoc-pet-ct-and-correlation-with-an-immunhistochemical-quantification-of-somatostatin-receptors-using-novel-monoclonal-and-polyclonal-antibodies.html https://www.enets.org/abstract/combined-treatment-of-rapidly-progressing-neuroendocrine-tumors-by-transcatheter-arterial-chemoembolisation-of-the-liver-and-peptide-receptor-radiotherapy-is-save-and-effective-report-of-thirty-consecutive-patients.html https://www.enets.org/abstract/prognostic-clinicopathologic-factors-in-longitudinally-followed-patients-with-metastatic-small-bowel-carcinoid.html https://www.enets.org/abstract/serum-chromogranin-a-correlation-with-tumor-burden-in-metastatic-small-bowel-carcinoid-patients.html https://www.enets.org/abstract/diffuse-idiopathic-pulmonary-neuroendocrine-cell-hyperplasia.html https://www.enets.org/abstract/patterns-and-predictors-of-failure-after-curative-resections-of-pancreatic-endocrine-carcinoma.html https://www.enets.org/abstract/pancreatic-cystic-endocrine-tumors-a-different-morphological-entity-associated-with-a-less-aggressive-behavior.html https://www.enets.org/abstract/survival-of-neuroendocrine-tumour-patients-in-newcastle-nhs-foundation-trust.html https://www.enets.org/abstract/plasma-chromogranin-a-cga-and-urinary-5-hydroxy-indoleacetic-acid-5-hiaa-use-in-monitoring-somatostatin-analogue-ssa-therapy-at-newcastle-nhs-foundation-trust.html https://www.enets.org/abstract/primary-hyperparathyroidism-in-patients-with-gastric-carcinoid-tumors-type-1-an-unusual-coexistence.html https://www.enets.org/abstract/a-monocentric-analysis-of-patients-with-pulmonary-neuroendocrine-tumors-over-15-years-long-term-survival-and-life-quality-dependent-from-histological-subtypes-and-surgical-management.html https://www.enets.org/abstract/gastric-gist-with-synchronous-neuroendocrine-tumor-of-the-pancreas-case-report-and-literature-review.html https://www.enets.org/abstract/expression-of-mtor-signaling-pathway-and-effects-of-mtor-inhibitors-on-its-pathway-in-human-neuroendocrine-tumors.html https://www.enets.org/abstract/specialist-dietetic-input-and-nutritional-outcomes-in-neuroendocrine-tumour-patients.html https://www.enets.org/abstract/clinical-and-prognostic-implications-of-the-genetic-diagnosis-of-hereditary-net-syndromes-in-asymptomatic-patients.html https://www.enets.org/abstract/immunohisochemical-evaluation-of-emt-regulators-e-and-n-cadherin-in-neuroendocrine-tumors-of-the-gastro-entero-pancreativ-system.html https://www.enets.org/abstract/chemotherapy-in-the-treatment-of-progressive-undifferentiated-neuroendocrine-carcinomas-a-single-center-experience.html https://www.enets.org/abstract/relationship-between-neuroendocrine-tumor-related-symptoms-and-rand-36-health-related-quality-of-life-scores.html https://www.enets.org/abstract/somatostatin-analogue-therapy-and-rand-36-health-related-quality-of-life-scores-in-patients-with-neuroendocrine-tumors.html https://www.enets.org/abstract/neuroendocrine-tumor-disease-state-and-rand-36-health-related-quality-of-life-scores.html https://www.enets.org/abstract/neuroendocrine-markers-are-expressed-in-human-mammary-glands.html https://www.enets.org/abstract/plasma-ccn2-connective-tissue-growth-factor-is-associated-with-right-ventricular-dysfunction-in-patients-with-neuroendocrine-tumors.html https://www.enets.org/abstract/preliminary-report-of-the-use-of-everolimus-in-a-patient-with-progressive-medullary-thyroid-carcinoma.html https://www.enets.org/abstract/twenty-year-experience-in-diagnosis-and-treatment-of-insulinoma-in-burdenko-surgery-clinic-moscow-medical-academy-russia.html https://www.enets.org/abstract/clinical-morphology-correlation-in-diagnostics-and-evaluating-surgery-results-of-pancreatic-insulinoma-and-nesidiobastosis.html https://www.enets.org/abstract/epidemiology-of-the-neuroendocrine-tumors-diagnosed-in-cardarelli-hospital-a-retrospective-single-institution-analysis-of-274-cases.html https://www.enets.org/abstract/the-rise-and-fall-of-chromogranin-a-as-an-indicator-for-net.html https://www.enets.org/abstract/the-clinical-challenge-of-patients-with-a-thoracic-or-neck-neuroendocrine-tumor-a-retrospective-analysis-from-a-single-irish-institution.html https://www.enets.org/abstract/metronomic-combination-therapy-including-temozolamide-bevacizumab-and-somatostatin-analogue-for-the-treatment-of-malignant-gastroenteropancreatic-neuroendocrine-tumors.html https://www.enets.org/abstract/somatostatinreceptor-scintigraphy-with-tc-99m-tektrotyd-in-patients-with-neuroendocrine-tumors-correlation-with-immunohistochemistry.html https://www.enets.org/abstract/clinical-and-demographic-characteristics-in-patients-newly-diagnosed-with-neuroendocrine-tumors-net.html https://www.enets.org/abstract/surgical-approaches-in-84-patients-with-insulinomas-in-multiple-endocrine-neoplasia-type-1-men-1.html https://www.enets.org/abstract/incidence-and-clinical-significance-of-adrenal-masses-in-patients-with-gastrenteropancreatic-neuroendocrine-tumors.html https://www.enets.org/abstract/multiple-tumors-in-patients-with-pancreatic-neuroendocrine-tumours-morphological-and-immunohistochemical-characteristics.html https://www.enets.org/abstract/genome-wide-dna-methylation-profiling-of-pancreatic-neuroendocrine-tumors-identifies-distinct-methylation-profiles-and-differentially-methylated-gene-promoter-regions-associated-with-low-medium-and-high-grade-tumors.html https://www.enets.org/abstract/sustained-response-to-anti-igfr-1r-monoclonal-antibody-combined-with-docetaxel-in-a-patient-with-metastatic-adrenocortical-carcinoma.html https://www.enets.org/abstract/deletions-of-11q21-q25-are-associated-with-atypical-lung-carcinoids-and-a-poor-clinical-outcome.html https://www.enets.org/abstract/adrenocortical-cancer-a-therapeutic-approach-with-everolimus-rad001.html https://www.enets.org/abstract/interest-of-combined-chromogranin-a-and-pancreatic-polypeptide-for-diagnosis-and-follow-up-of-gastroenteropancreatic-endocrine-carcinoma.html https://www.enets.org/abstract/serum-chromogranin-a-as-tumor-marker-in-neuroendocrine-tumors.html https://www.enets.org/abstract/frequent-biological-association-of-merkel-cell-polyomavirus-with-merkel-cell-carcinomas.html https://www.enets.org/abstract/the-validity-of-ki-67-as-a-prognostic-indicator-in-patients-with-appendiceal-carcinoid-tumor.html https://www.enets.org/abstract/treatment-of-unresectable-neuroendocrine-liver-tumors-with-y-90-microsphere.html https://www.enets.org/abstract/reduced-expression-of-p27-and-the-occurrence-of-cpg-island-methylator-phenotype-in-insulinomas.html https://www.enets.org/abstract/first-experience-of-laparoscopic-treatment-of-organic-hyperinsulinism.html https://www.enets.org/abstract/non-functioning-pancreatic-endocrine-tumors-diagnostic-criteria-and-surgical-treatment.html https://www.enets.org/abstract/carcinoid-and-carcinoid-syndrome-analysis-of-110-cases-from-a-single-insitute.html https://www.enets.org/abstract/role-of-contrast-enhanced-ultrasonography-in-the-differential-diagnosis-of-the-pancreatic-and-hepatic-lesions.html https://www.enets.org/abstract/angiogenesis-markers-after-hepatic-artery-embolization-of-liver-metastases-in-patients-with-neuroendocrine-tumors.html https://www.enets.org/abstract/the-diagnostic-and-prognostic-value-of-elevated-progrp-levels-in-well-and-moderately-differentiated-neuroendocrine-tumors.html https://www.enets.org/abstract/ptov-1-overexpression-in-neuroendocrine-tumors-a-new-molecular-marker.html https://www.enets.org/abstract/metastatic-growth-hormone-secreting-pituitary-carcinoma-treated-with-peptide-receptor-radionuclide-therapy.html https://www.enets.org/abstract/gastroenteropancreatic-neuroendocrine-tumors-gep-nets-our-experience-in-a-multidisciplinary-team-in-a-university-hospital.html https://www.enets.org/abstract/a-case-of-insulinoma-successfully-treated-by-means-of-long-acting-somatostatin-analogue.html https://www.enets.org/abstract/surgical-treatment-of-duodenopancreatic-neuroendocrine-tumors-pnets-in-patients-with-multiple-endocrine-neoplasia-type-1-men-1-a-dutch-consensus-statement.html https://www.enets.org/abstract/rare-association-between-pancreatic-insulinoma-and-graves-s-disease-fortune-or-misfortuner.html https://www.enets.org/abstract/structure-of-complications-in-acromegalic-patients-at-a-single-institute.html https://www.enets.org/abstract/alterations-of-e-cadherin-beta-catenin-and-caveolin-1-expression-in-gastroenteropancreatic-neuroendocrine-tumors.html https://www.enets.org/abstract/epcam-expression-and-detection-of-circulating-tumor-cells-in-neuroendocrine-tumors.html https://www.enets.org/abstract/hyperplasia-adenoma-sequence-in-pituitary-carcinogenesis-new-insight-into-the-role-of-aip-gene.html https://www.enets.org/abstract/the-prognostic-value-of-fdg-pet-scan-in-neuroendocrine-tumors-a-retrospective-analysis-of-46-patients-treated-in-one-center.html https://www.enets.org/abstract/endoscopic-ultrasound-of-66-insulinomas.html https://www.enets.org/abstract/expression-of-components-of-the-mtor-pathway-in-gastroenteropancreatic-neuroendocrine-tumors.html https://www.enets.org/abstract/the-role-of-ki-67-in-the-prognosis-and-management-of-neuroendocrine-net-patients-in-a-multdisciplinary-cancer-center.html https://www.enets.org/abstract/long-term-follow-up-analysis-of-lung-carcinoid-tumors-retrospective-monoinstitutional-evaluation.html https://www.enets.org/abstract/gene-mutations-and-hypoxia-inducible-factor-hif-1-expression-as-prognostic-predictive-factors-in-pheochromocytomas-paragangliomas-p-p.html https://www.enets.org/abstract/mammalian-target-of-rapamycin-mtor-expression-analysis-and-therapeutic-approach-in-lung-and-gastroenteropancreatic-poorly-differentiated-endocrine-carcinoma-pdec.html https://www.enets.org/abstract/chronic-complications-of-peptide-receptor-radionuclide-therapy-prrt-a-single-center-experience.html https://www.enets.org/abstract/presentation-and-outcome-of-pancreaticoduodenal-tumors-in-multiple-endocrine-neoplasia-type-1-men-1-syndrome.html https://www.enets.org/abstract/from-hormone-dependent-solid-breast-carcinoma-to-primary-neuroendocrine-carcinoma-a-case-report.html https://www.enets.org/abstract/myocardial-motion-abnormalities-in-patients-with-carcinoid-disease-without-overt-carcinoid-heart-disease.html https://www.enets.org/abstract/a-pilot-study-using-biochemical-markers-to-predict-acrcinoid-heart-disease-in-patients-with-carcinoid-disease.html https://www.enets.org/abstract/gastroenteropancreatic-neuroendocrine-tumors-single-institution-clinicopathological-study.html https://www.enets.org/abstract/results-of-the-gastroenteropancreatic-nets-spanish-registry-in-the-2001-2010-period.html https://www.enets.org/abstract/everolimus-rad001-induces-tumor-response-in-patients-with-medullary-thyroid-cancer-an-in-vivo-and-in-vitro-study.html https://www.enets.org/abstract/transarterial-chemoebolization-tace-of-liver-metastases-derived-from-neuroendocrine-tumors-is-an-effective-treatment-only-in-patients-with-low-or-mediate-hepatic-tumor-burden.html https://www.enets.org/abstract/slug-represents-an-important-regulator-of-e-cadherin-expression-in-neuroendocrine-tumor-cells-of-the-pancreas.html https://www.enets.org/abstract/atypical-lung-carcinoid-tumor-metastatic-to-endocrine-glands-and-bone-marrow.html https://www.enets.org/abstract/chromogranin-a-is-a-sensitive-marker-for-detection-of-recurrence-in-neuroendocrine-tumors.html https://www.enets.org/abstract/prolonged-cell-survival-in-xenografts-from-human-digestive-endocrine-tumors.html https://www.enets.org/abstract/downstaging-of-a-gastroenteropancreatic-neuroendocrine-tumor-after-combination-therapy-of-temozolomide-bevacizumab-and-long-acting-somatostatin-analogs.html https://www.enets.org/abstract/68ga-dota-tate-pet-ct-comparison-with-99mtc-hynic-toc-spect-ct-in-the-assessment-of-the-extent-of-the-disease-in-patients-with-malignant-endocrine-tumors-our-experience-preliminary-results.html https://www.enets.org/abstract/transarterial-chemoembolization-tace-of-liver-metastasis-from-pancreatic-well-differentiated-endocrine-carcinoma.html https://www.enets.org/abstract/synchronous-appendiceal-neuroendocrine-carcinoma-and-mucinous-cystadenocarcinoma-a-case-report.html https://www.enets.org/abstract/gastrointestinal-motility-in-patients-with-neuroendocrine-tumors.html https://www.enets.org/abstract/valproic-acid-induces-apoptosis-mediated-cell-death-of-the-ileal-carcinoid-cell-line-got1.html https://www.enets.org/abstract/somatostatin-receptors-1-5-expression-in-a-large-series-of-well-differentiated-neuroendocrine-tumors.html https://www.enets.org/abstract/serotonin-synthesis-inhibitors-a-novel-approach-for-managing-gastrointestinal-symptoms-in-carcinoid-syndrome.html https://www.enets.org/abstract/molecular-genetic-findings-in-gastric-carcinoid-suggest-possible-neurofibromin-ras-pathway-involvement-in-carcinoid-pathogenesis.html https://www.enets.org/abstract/management-and-outcomes-of-malignant-paragangliomas-and-phaeochromocytomas.html https://www.enets.org/abstract/ectopic-hormone-secreting-phaeochromocytoma-a-francophone-observational-study.html https://www.enets.org/abstract/assessment-of-the-proliferation-marker-ki-67-by-endoscopic-ultrasound-guided-fine-needle-aspiration-eus-fna-in-pancreatic-endocrine-tumors-a-comparative-analysis-with-histology-of-the-surgical-specimen.html https://www.enets.org/abstract/sunitinib-for-the-treatment-of-advanced-progressive-pancreatic-neuroendocrine-tumors.html https://www.enets.org/abstract/multidisciplinary-reference-centers-the-need-for-combined-expertise-in-the-diagnosis-and-treatment-of-neuroendocrine-tumors.html https://www.enets.org/abstract/grade-according-to-ki-67-or-mitotic-count-in-gastroenteropancreatic-neuroendocrine-tumors.html https://www.enets.org/abstract/lanreotide-autogel-for-malignant-carcinoid-syndrome-an-8-year-experience.html https://www.enets.org/abstract/efficacy-and-safety-results-from-a-phase-ii-study-of-pasireotide-som230-in-the-treatment-of-patients-with-metastatic-nets-refractory-or-resistant-to-octreotide-lar.html https://www.enets.org/abstract/correlation-of-ki-67-proliferative-index-with-pathological-features-and-outcome-in-pancreatic-endocrine-tumors.html https://www.enets.org/abstract/effectiveness-of-transarterial-embolization-of-liver-neuroendocrine-metastases.html https://www.enets.org/abstract/gastrointestinal-neuroendocrine-tumors-tumor-characteristics-and-long-term-clinical-outcome-in-the-german-net-registry.html https://www.enets.org/abstract/the-importance-of-endoscopic-ultrasound-in-detecting-recurrent-gastrinoma-in-a-case-of-men-1.html https://www.enets.org/abstract/prevalence-severity-and-clinical-outcome-of-malnutrition-in-gastroenteropancreatic-neuroendocrine-tumors.html https://www.enets.org/abstract/extensive-multitasking-surgery-for-advanced-neuroendocrine-tumors-is-safe-and-effective.html https://www.enets.org/abstract/the-use-of-f-18-fdg-pet-for-patients-with-neuroendocrine-tumors.html https://www.enets.org/abstract/association-of-carcinoid-with-noncarcinoid-neoplasms.html https://www.enets.org/abstract/serotonin-expression-in-gastric-neuroendocrine-tumors-and-in-foci-of-endocrine-cell-hyperplasia.html https://www.enets.org/abstract/incidence-of-second-primary-tumors-in-patients-with-neuroendocrine-tumors.html https://www.enets.org/abstract/the-role-of-18f-dopa-pet-in-a-case-of-malignant-pheochromcytoma.html https://www.enets.org/abstract/association-of-somatostatin-receptor-2-immunohistochemical-expression-with-111in-dtpa-octreotide-scintigraphy-and-68ga-dotatoc-pet-ct-in-neuroendocrine-tumors.html https://www.enets.org/abstract/oxaliplatin-based-chemotherapy-in-patients-with-advanced-neuroendocrine-carcinoma-an-italian-retrospective-multicenter-analysis.html https://www.enets.org/abstract/paragangliomas-a-series-of-five-cases.html https://www.enets.org/abstract/recurrence-characteristics-in-resected-pulmonary-typical-and-atypical-carcinoids.html https://www.enets.org/abstract/near-complete-regression-of-liver-metastatic-lesions-in-a-patient-with-advanced-pancreatic-gastrinoma-in-response-to-somatostatin-analogue-therapy-following-cytoreductive-surgery.html https://www.enets.org/abstract/giant-adrenal-tumor-a-case-report.html https://www.enets.org/abstract/rationale-for-combining-mtor-with-other-targeted-agents-in-the-treatment-of-neuroendocrine-tumors.html https://www.enets.org/abstract/validation-of-a-new-assay-that-uses-2-monoclonal-antibodies-to-measure-intact-and-fragmented-plasma-cga-levels.html https://www.enets.org/abstract/antibody-formation-against-somatostatin-analogues-with-altered-biodistribution-and-dosimetry-a-case-with-implications-for-prrt.html https://www.enets.org/abstract/long-term-disease-stabilization-in-a-patient-with-advanced-pancreatic-neuroendocrine-tumor-treated-with-combined-everolimus-and-octreotide-lar-after-prior-failure-of-cytotoxic-therapy.html https://www.enets.org/abstract/toxicity-response-and-survival-analyses-of-peptide-receptor-radionuclide-therapy-prrt-in-treatment-refractory-metastatic-thyroid-cancer-using-yttrium-90-and-lutetium-177-labeled-somatostatin-analogs.html https://www.enets.org/abstract/multiple-endocrine-neoplasia-type-1-men-1-hadassah-hebrew-university-medical-center-experience.html https://www.enets.org/abstract/progression-free-survival-pfs-as-a-primary-endpoint-for-clinical-studies-in-advanced-neuroendocrine-tumors-nets.html https://www.enets.org/abstract/detection-of-cardiac-metastases-in-patients-with-neuroendocrine-tumors-comparison-of-ga-68-dota-sms-r-pet-ct-cardiac-mri-ct-scan-and-2d-echocardiography.html https://www.enets.org/abstract/the-role-of-t-type-calcium-channels-in-medullary-thyroid-carcinoma-mtc-t-type-calcium-channel-blockers-inhibit-hormone-secretion-and-induce-apoptotic-cell-death-in-a-human-mtc-cell-line.html https://www.enets.org/abstract/low-dose-multiple-cycle-ld-mt-peptide-receptor-radionuclide-therapy-a-new-concept-for-the-treatment-of-well-differentiated-metastatic-neuroendocrine-tumors.html https://www.enets.org/abstract/different-sites-of-rare-metastases-in-neuroendocrine-tumor-patients-detected-by-ga-68-somatostatin-receptor-pet-ct.html https://www.enets.org/abstract/clinical-value-of-mri-dwi-and-gd-eob-dtpa-to-assess-liver-involvement-in-patients-with-advanced-gastroenteropancreatic-neuroendocrine-tumors-gep-nets.html https://www.enets.org/abstract/laparoscopic-vs-open-resection-of-pancreatic-endocrine-neoplasms-a-review.html https://www.enets.org/abstract/localization-of-sporadic-neuroendocrine-tumors-by-gene-expression-analysis-of-their-metastases.html https://www.enets.org/abstract/neuroendocrine-tumors-imaging-abdominal-complications.html https://www.enets.org/abstract/radio-guided-surgery-in-neuroendocrine-tumours-using-68ga-labeled-somatostatin-analogs-r-a-pilot-study.html https://www.enets.org/abstract/swiss-neuroendocrine-tumor-swissnet-registry-results-after-30-months.html https://www.enets.org/abstract/transcription-factor-signature-in-pancreatic-and-duodenal-neuroendocrine-neoplasms.html https://www.enets.org/abstract/temozolomide-in-metastatic-bronchial-carcinoids.html https://www.enets.org/abstract/loss-of-expression-of-the-dna-mismatch-repair-proteins-mlh1-and-msh2-is-rare-in-pancreatic-and-small-intestinal-neuroendocrine-tumors.html https://www.enets.org/abstract/the-immunohistochemical-ihc-expression-and-prognostic-value-of-er-pr-and-her2-neu-in-pancreatic-and-small-intestinal-neuroendocrine-tumors.html https://www.enets.org/abstract/dissociation-between-iodine-131-meta-iodobenzylguanidine-mibg-scintigraphy-and-radiolabeled-octreotide-in-the-localization-and-management-of-sporadic-malignant-pheochromocytoma-an-impact-on-management.html https://www.enets.org/abstract/treatment-with-177lutetium-dota-tyr3-octreotate-in-patients-with-neuroendocrine-tumors.html https://www.enets.org/abstract/a-variant-pancreatic-insulinoma-in-men1-syndrome-characterized-by-normoglycemia-normoinsulinemia-but-abnormal-c-peptide-and-abnormal-proinsulin-levels.html https://www.enets.org/abstract/microvessel-density-and-prognosis-of-gastroenteropancreatic-neuroendocrine-tumors-gep-nets.html https://www.enets.org/abstract/ki-67-mib-1-proliferative-activity-and-beta-catenin-immunoexpression-in-liver-metastases-of-gastroenteropancreatic-neuroendocrine-tumors.html https://www.enets.org/abstract/immunhistochemical-expression-of-somatostatin-receptors-in-gastroenteropancreatic-neuroendocrine-tumors-using-irs-and-her2-scoring-scheme.html https://www.enets.org/abstract/somatostatin-analogues-as-a-therapeutic-option-in-a-series-of-91-patients-with-gastric-carcinoids.html https://www.enets.org/abstract/czech-neuroendocrine-registry-first-results.html https://www.enets.org/abstract/occurrence-of-other-primary-malignancies-in-patients-with-endocrine-tumors-of-the-digestive-tract-and-pancreas.html https://www.enets.org/abstract/carcinoid.html https://www.enets.org/abstract/matrix-metalloproteinases-mmps-and-tissue-inhibitors-of-matrix-metalloproteinases-tmips-in-gep-net-patients-r-a-potential-prognostic-biomarkers-for-metastases.html https://www.enets.org/abstract/complete-remission-in-a-patient-with-metastatic-type-1-gastric-carcinoid-gca1-treated-with-a-long-acting-somatostatin-analogue.html https://www.enets.org/abstract/immunohistochemical-analysis-of-epithelial-mesenchymal-transition-markers-in-neuroendocrine-tumors-of-the-lung.html https://www.enets.org/abstract/successfull-endoscopic-ultrasound-guided-alcoholic-ablation-of-insulinoma.html https://www.enets.org/abstract/paraneoplastic-antigen-ma2-autoantibodies-as-specific-blood-biomarkers-for-detection-of-early-recurrence-of-small-intestine-neuroendocrine-tumors.html https://www.enets.org/abstract/pancreatic-neuroendocrine-tumors-experience-of-endocrinology-department-of-the-university-hospital-of-coimbra.html https://www.enets.org/abstract/umb-4-as-new-monoclonal-somatostatin-receptor-antibody-correlation-of-immunostaining-with-molecular-imaging-using-somatostatin-receptor-pet-ct.html https://www.enets.org/abstract/efficacy-and-safety-of-the-combination-streptozotocin-5-fu-in-endocrine-pancreatic-tumors-a-retrospective-study.html https://www.enets.org/abstract/surgical-treatment-of-non-functioning-neuroendocrine-tumors-of-the-pancreas.html https://www.enets.org/abstract/novel-insights-in-octreotide-effects-on-human-neuroendocrine-cell-line-cndt2-5.html https://www.enets.org/abstract/magnetic-resonance-imaging-mri-v-endoscopic-ultrasonography-eus-for-the-detection-of-10-mm-pancreatic-tumors-in-multiple-endocrine-neoplasia-type-1-men1-a-gte-study.html https://www.enets.org/abstract/genome-wide-microrna-expression-in-small-intestine-neuroendocrine-tumors-rmidgut-carcinoidsr-upregulation-of-mirna-182-mirna-183-and-downregulation-of-mirna-215.html https://www.enets.org/abstract/comparison-of-18f-dopa-68ga-somatostatin-analogues-and-18f-fdg-pet-ct-in-patients-with-recurrent-medullary-thyroid-carcinoma.html https://www.enets.org/abstract/extreme-obesity-due-to-insulinoma-within-multiple-endocrine-neoplasia-men-1-syndrome.html https://www.enets.org/abstract/liver-and-liver-pancreastransplantation-in-the-two-stage-treatment-of-liver-metastasized-neuroendocrine-tumors-of-the-pancreas-about-three-cases.html https://www.enets.org/abstract/a-proteomic-approach-identifies-novel-proteins-involved-in-invasion-mechanisms-in-enteroendocrine-carcinomas.html https://www.enets.org/abstract/integrated-genome-wide-dna-methylation-and-mrna-expression-analysis-of-pancreatic-nets-identifies-differential-activation-of-the-hypoxia-inducible-factor-hif-pathway-between-low-and-intermediate-grade-tumors.html https://www.enets.org/abstract/diverging-incidence-and-survival-trends-for-neuroendocrine-tumors-due-to-histological-grade.html https://www.enets.org/abstract/a-randomized-cross-over-study-in-patients-with-neuroendocrine-tumors-nets-to-assess-patient-preference-of-lanreotide-autogel-given-by-either-self-partner-or-healthcare-professional.html https://www.enets.org/abstract/clinical-characteristics-of-the-5-160-patients-included-in-the-french-database-of-the-french-endocrine-tumor-group-gte.html https://www.enets.org/abstract/phase-ii-study-of-sunitinib-following-hepatic-transarterial-embolization-for-metastatic-neuroendocrine-tumors.html https://www.enets.org/abstract/reduced-men1-gene-expression-in-pulmonary-carcinoids-is-associated-with-metastatic-disease.html https://www.enets.org/abstract/distinct-cut-off-values-of-ki-67-index-for-net-grading-in-a-large-german-multicentrer-cohort.html https://www.enets.org/abstract/comparison-of-the-ajcc-and-enets-staging-classifications-for-neuroendocrine-tumors-of-the-pancreas.html https://www.enets.org/abstract/nurse-evaluation-of-long-acting-somatostatin-analogue-injection-devices-a-quantitative-study.html https://www.enets.org/abstract/patients-treated-for-well-differentiated-neuroendocrine-tumors-a-study-to-evaluate-the-ratio-of-patients-lost-to-follow-up.html https://www.enets.org/abstract/risk-of-metastatic-spread-in-patients-with-early-stage-surgically-resected-pancreatic-neuroendocrine-tumors.html https://www.enets.org/abstract/survival-analyses-of-pancreatic-neuroendocrine-tumors-contrasting-institutional-databases-with-population-based-registries.html https://www.enets.org/abstract/predictive-factors-of-tumor-control-in-patients-with-well-differentiated-digestive-endocrine-carcinomas-wdec-treated-with-lanreotide.html https://www.enets.org/abstract/the-global-mtor-inhibitor-torin1-is-more-effective-than-the-mtorc1-inhibitor-everolimus-alone-or-in-combination-with-histone-deacetylases-inhibitors-in-suppressing-neuroendocrine-tumors-cell-proliferation.html https://www.enets.org/abstract/diagnostic-algorithm-of-pancreatic-neuroendocrine-tumors.html https://www.enets.org/abstract/results-of-resection-and-predictors-of-outcome-of-pancreatic-neuroendocrine-tumors.html https://www.enets.org/abstract/management-of-patients-with-multiple-pancreatic-tumors.html https://www.enets.org/abstract/primary-renal-somatostatinoma-with-hepatic-metastases.html https://www.enets.org/abstract/new-imaging-modalities-in-the-diagnosis-of-phaeochromocytoma.html https://www.enets.org/abstract/insulin-like-growth-factor-1-receptor-igf-1r-and-its-inhibition-in-non-functioning-neuroendocrine-tumors.html https://www.enets.org/abstract/long-term-follow-up-of-tissue-valve-prostheses-in-carcinoid-heart-disease.html https://www.enets.org/abstract/chromogranin-a-as-a-predictor-of-progression-regression-or-stable-disease-in-ileo-cecal-neuroendocrine-tumors.html https://www.enets.org/abstract/prognostic-factors-and-survival-in-481-patients-with-pancreatic-and-peripancreatic-endocrine-tumors-results-from-the-national-cancer-registry-of-spain-rgetne.html https://www.enets.org/abstract/afinitor-uk-particular-patient-supplies-for-advanced-neuroendocrine-tumors-nets.html https://www.enets.org/abstract/robot-assisted-distal-pancreatectomy-for-insulinoma-a-case-report.html https://www.enets.org/abstract/very-long-term-follow-up-5-years-of-renal-function-of-neuroendocrine-tumor-patients-treated-with-five-or-more-cycles-of-peptide-receptor-radionuclide-therapy-prrnt.html https://www.enets.org/abstract/clinical-case-of-acth-secreting-thymic-carcinoma-with-multiple-metastases-to-the-brain-ovary-and-skin.html https://www.enets.org/abstract/peptide-receptor-radionuclide-therapy-prrnt-in-patients-with-metastasized-neuroendocrine-tumor-having-single-or-non-functional-kidney-is-it-safer.html https://www.enets.org/abstract/ck-19-expression-in-pancreatic-neuroendocrine-tumors-as-negative-prognostic-factor-and-a-risk-factor-for-metastases.html https://www.enets.org/abstract/glycodelin-expression-in-pancreatic-neuroendocrine-and-solid-pseudopapillary-tumors-as-in-important-factor-of-favorable-disease-prognosis.html https://www.enets.org/abstract/one-year-response-to-everolimus-in-a-case-of-advanced-pancreatic-net.html https://www.enets.org/abstract/ga-68-sms-r-pet-ct-in-the-detection-of-unknown-primary-neuroendocrine-tumor-single-centre-result-in-124-patients.html https://www.enets.org/abstract/morbidity-and-mortality-associated-with-desmoplasia-in-midgut-neuroendocrine-tumors-nets.html https://www.enets.org/abstract/challenges-in-the-management-of-vipoma-patients.html https://www.enets.org/abstract/expression-of-somatostatin-receptors-and-dopamine-2-receptor-in-lung-carcinoids-as-a-possible-biotherapy-target.html https://www.enets.org/abstract/sdhb-loss-predicts-malignancy-in-pheochromocytomas-sympathethic-paragangliomas-but-not-through-hypoxia-signalling.html https://www.enets.org/abstract/carcinoid-metastases-to-the-breast-more-common-than-previously-thought-a-presentation-of-13-cases.html https://www.enets.org/abstract/difficulties-in-differential-diagnostics-of-neuroendocrine-tumors.html https://www.enets.org/abstract/management-of-insulinomas-perioperative-and-long-term-outcomes-following-enucleations-and-pancreatic-resections-in-198-patients.html https://www.enets.org/abstract/circulating-tumor-cells-ctcs-correlate-with-overall-survival-in-neuroendocrine-tumors-nets.html https://www.enets.org/abstract/ki-67-is-a-better-prognostic-marker-than-mitotic-count-in-neuroendocrine-tumors.html https://www.enets.org/abstract/y90-dotatate-in-gastroenteropancreatic-neuroendocrine-tumors-gep-nets-survival-following-different-indications-for-treatment.html https://www.enets.org/abstract/description-and-treatment-of-gep-nets-in-a-spanish-hospital-during-10-years.html https://www.enets.org/abstract/treatment-of-pancreatic-neuroendocrine-neoplasms-data-from-a-prospective-observational-multicenter-study.html https://www.enets.org/abstract/the-carcinoid-syndrome-caused-by-retroperitoneal-carcinoid-tumors.html https://www.enets.org/abstract/evaluation-of-the-association-between-serotonin-and-bone-mineral-density-in-patients-with-neuroendocrine-tumors.html https://www.enets.org/abstract/doxorubicin-etoposide-and-cisplatin-as-first-line-treatment-in-advanced-adrenocortical-carcinoma.html https://www.enets.org/abstract/diagnosis-and-management-of-thymic-neuroendocrine-tumors-a-case-series-review.html https://www.enets.org/abstract/risk-of-cardiovascular-events-cv-in-patients-newly-diagnosed-with-neuroendocrine-tumors-net.html https://www.enets.org/abstract/risk-of-hepatic-and-gastrointestinal-gi-events-in-patients-newly-diagnosed-with-neuroendocrine-tumors-net.html https://www.enets.org/abstract/recognizing-carcinoid-heart-disease-and-timing-of-cardiac-and-abdominal-procedures.html https://www.enets.org/abstract/changes-on-chromosome-18-are-involved-in-sporadic-and-familial-ileal-carcinoid-tumor-development.html https://www.enets.org/abstract/chronic-atrophic-gastritis-associated-with-hyperparathyroidism-a-prospective-study.html https://www.enets.org/abstract/alterations-of-timp-3-gene-in-insulinomas-and-its-significance.html https://www.enets.org/abstract/a-novel-pkcssii-inhibitor-induces-antiproliferative-effects-in-human-pancreatic-neuroendocrine-tumor-cells.html https://www.enets.org/abstract/everolimus-reduces-cell-viability-in-selected-human-medullary-thyroid-carcinoma-primary-cultures.html https://www.enets.org/abstract/plasma-somatostatin-gastrin-ratio-improves-the-diagnosis-of-gastrinoma.html https://www.enets.org/abstract/temozolomide-as-2-3-line-treatment-of-patients-with-poorly-differentiated-neuroendocrine-carcinomas.html https://www.enets.org/abstract/expression-of-igf-mtor-pathway-components-in-human-pheochromocytomas-and-in-vitro-inhibition-of-pc12-rat-pheochromocytoma-cell-growth-by-mtor-inhibitors.html https://www.enets.org/abstract/insulinoma-a-rare-tumorr.html https://www.enets.org/abstract/a-novel-missense-mutation-of-the-tmem127-gene-that-leads-to-pheochromocytoma-phenotype.html https://www.enets.org/abstract/plasma-chromogranin-a-in-patients-with-men-i-and-pancreatic-endocrine-tumors.html https://www.enets.org/abstract/the-succinate-dehydrogenase-genetic-testing-in-patients-with-extra-adrenal-paragangliomas-the-portuguese-cancer-center-lisboa-experience.html https://www.enets.org/abstract/an-unexpected-diagnosis.html https://www.enets.org/abstract/the-use-of-guar-gum-in-the-medical-management-of-hyperinsulinaemic-hypoglycaemia.html https://www.enets.org/abstract/mammalian-target-of-rapamycin-pathway-activation-is-associated-with-ret-mutation-status-in-medullary-thyroid-carcinoma.html https://www.enets.org/abstract/metastatic-gastrinoma-co-secreting-pthrp-and-acth.html https://www.enets.org/abstract/coexistence-of-a-somatostatin-producing-carcinoma-of-duodenum-and-a-jejuna-gastrointestinal-stromal-tumor-gist-in-a-patient-with-von-recklinghausenrs-disease.html https://www.enets.org/abstract/sorafenib-and-bevacizumab-combination-targeted-therapy-in-advanced-neuroendocrine-tumor-a-phase-ii-study-of-the-spanish-neuroendocrine-tumor-group-getne0801.html https://www.enets.org/abstract/biochemical-markers-in-diagnosis-and-monitoring-of-neuroendocrine-tumors.html https://www.enets.org/abstract/characteristics-of-patients-with-well-differentiated-metastatic-lung-neuroendocrine-tumors.html https://www.enets.org/abstract/primary-lymph-node-gastrinoma-a-genuine-entityr-two-case-reports-and-a-review-of-the-literature.html https://www.enets.org/abstract/a-case-of-primary-hepatic-carcinoid-tumor-misdiagnosed-as-hepatocellular-carcinoma-hcc.html https://www.enets.org/abstract/aberrant-expression-of-fsh-receptor-in-pancreatic-neuroendocrine-tumors.html https://www.enets.org/abstract/lutetium-177-dotatate-therapy-in-the-management-of-neuroendocrine-tumors.html https://www.enets.org/abstract/an-observational-registry-collecting-data-on-gastroenteropancreatic-neuroendocrine-tumor-patients-gep-net-registry-in-the-middle-east-and-asia.html https://www.enets.org/abstract/gallium-68-dotatate-pet-ct-frequently-changes-patient-management-or-staging-when-compared-with-indium-111-octreotide-in-the-assessment-of-neuroendocrine-tumors.html https://www.enets.org/abstract/peptide-receptor-radiotherapy-as-a-potential-tool-of-neoadjuvant-therapy-in-patients-with-inoperable-neuroendocrine-tumors-nets.html https://www.enets.org/abstract/early-detection-of-gastric-gist-tumor-in-a-patient-with-rectal-neuroendocrine-cancer-r-a-case-report.html https://www.enets.org/abstract/99mtc-labelled-glp-1-scintigraphy-with-use-of-lys40-ahx-hynic-99mtc-edda-nh2-exendin-4-in-the-diagnosis-of-insulinoma.html https://www.enets.org/abstract/chromogranin-b-is-a-prognostic-marker-in-nets.html https://www.enets.org/abstract/unusual-behavior-of-gastric-carcinoid-type-1.html https://www.enets.org/abstract/tumor-size-correlates-with-malignancy-in-non-functioning-pancreatic-endocrine-tumor.html https://www.enets.org/abstract/hepatic-arterial-embolization-v-chemoembolization-in-patients-with-liver-metastases-of-digestive-neuroendocrine-tumors.html https://www.enets.org/abstract/clinical-and-immunohistochemical-evaluation-of-medullary-thyroid-cancer-mtc-and-c-cell-hyperplasia-cch.html https://www.enets.org/abstract/association-between-time-to-disease-progression-endpoints-and-overall-survival-in-patients-with-neuroendocrine-tumors.html https://www.enets.org/abstract/medical-and-peptide-receptor-radionuclide-therapy-prrt-with-somatostatin-analogues-ssa-in-well-and-moderately-differentiated-neuroendocrine-tumors.html https://www.enets.org/abstract/monoclonal-antibodies-against-the-human-somatostatin-receptor-subtypes-1-5-characterization-and-immunohistochemical-application-in-gastrointestinal-neuroendocrine-tumors.html https://www.enets.org/abstract/pancreatic-metastases-from-bronchopulmonary-atypical-carcinoid-an-uncommon-tumor-spreading-to-a-rare-location.html https://www.enets.org/abstract/hepatic-neuroendocrine-tumor-metastasis-proliferation-is-hepatocyte-regulated-via-a-5ht7-mediated-induction-of-an-igf-1-and-hgf-feedback-loop-mediated-by-camp-pka-independent-pakt-and-pcreb.html https://www.enets.org/abstract/risk-stratification-using-octreotide-test-for-patients-with-gastroenteropancreatic-neuroendocrine-tumors-results-of-prospective-validation-of-the-test.html https://www.enets.org/abstract/the-risk-of-metachronous-cancers-in-patients-with-small-intestinal-carcinoid-tumors.html https://www.enets.org/abstract/prognostic-features-in-patients-with-metastatic-neuroendocrine-tumor-undergoing-y-90-embolization.html https://www.enets.org/abstract/goblet-cell-carcinoid-tumors-a-retrospective-study-of-clinical-presentation-and-survival.html https://www.enets.org/abstract/the-utility-of-alpha-internexin-as-a-predictive-tissue-biomarker-for-proliferation-in-gastrointestinal-and-pancreatic-neuroendocrine-tumors.html https://www.enets.org/abstract/relationship-between-dose-and-molecular-response-after-peptide-receptor-radionuclide-therapy-prrnt-in-neuroendocrine-tumors-preliminary-results.html https://www.enets.org/abstract/treatment-and-prognosis-of-patients-with-poorly-differentiated-neuroendocrine-tumors.html https://www.enets.org/abstract/evidence-for-the-role-of-mir196a-in-regulating-small-intestinal-neuroendocrine-tumor-proliferation-and-metastasis-via-hox-akt-pathway-activation.html https://www.enets.org/abstract/effect-of-somatostatin-analogues-in-the-control-of-tumor-growth-in-patients-with-metastatic-lung-carcinoid-tumors.html https://www.enets.org/abstract/clinical-effect-of-temozolomide-based-chemotherapy-in-poorly-differentiated-endocrine-carcinoma-pdec-after-progression-on-first-line-chemotherapy.html https://www.enets.org/abstract/the-impact-of-68ga-dotatoc-pet-ct-on-the-multimodal-management-of-patients-with-neuroendocrine-tumors.html https://www.enets.org/abstract/utilization-of-gene-network-graph-topology-with-inference-relevance-analysis-delineates-g-protein-coupled-receptor-pathways-and-creb-targets-in-small-intestinal-neuroendocrine-neoplasia.html https://www.enets.org/abstract/paraganglioma-gallium-68-dototate-pet-ct-scanning-a-useful-addition-to-mibg-scanning-in-metastatic-disease.html https://www.enets.org/abstract/the-seer-as-a-prophet-epidemiological-analysis-as-a-harbinger-of-evolving-priorities-in-gastroenteropancreatic-neuroendocrine-neoplasia.html https://www.enets.org/abstract/expression-of-egfr-and-igf-pathway-genes-in-insulinomas.html https://www.enets.org/abstract/predictors-of-clinical-response-to-everolimus-in-patients-with-well-differentiated-metastatic-pancreatic-nets.html https://www.enets.org/abstract/role-of-vegfr-2-p53-p53r2-and-ki-67-expression-in-metastatic-carcinoid-cancer.html https://www.enets.org/abstract/effect-of-mtor-inhibitor-and-octreotide-lar-on-the-vascularization-of-hepatic-metastases-of-non-pancreatic-nets-preliminary-semi-quantitative-dynamic-mri-assessment.html https://www.enets.org/abstract/efficacy-and-safety-of-everolimus-in-japanese-patients-with-advanced-pancreatic-neuroendocrine-tumors-pnet-japanese-subgroup-analysis-of-radiant-3.html https://www.enets.org/abstract/well-differentiated-pancreatic-neuroendocrine-tumor-of-uncertain-behavior-a-case-report.html https://www.enets.org/abstract/effect-of-everolimus-octreotide-lar-treatment-on-5-hydroxyindoleacetic-acid-levels-in-patients-with-advanced-neuroendocrine-tumors-phase-iii-radiant-2-study-results.html https://www.enets.org/abstract/long-term-survival-and-quality-of-life-in-patients-with-ileum-net-a-single-center-experience.html https://www.enets.org/abstract/long-term-results-and-life-quality-in-patients-with-pancreatic-neuroendocrine-tumors-at-munich-university-grosshadern.html https://www.enets.org/abstract/report-of-two-first-degree-relatives-with-appendix-carcinoid-and-review-of-the-literature.html https://www.enets.org/abstract/differential-protein-expression-in-small-intestinal-carcinoids-and-liver-metastases.html https://www.enets.org/abstract/four-years-follow-up-in-a-case-of-gastric-neuroendocrine-carcinoma.html https://www.enets.org/abstract/impact-of-baseline-ki-67-index-and-other-baseline-characteristics-on-outcome-in-a-study-of-sunitinib-su-for-the-treatment-of-advanced-progressive-pancreatic-neuroendocrine-tumor-net.html https://www.enets.org/abstract/sporadic-hypercalcitoninemia-thyroid-medullary-carcinoma-autoimmune-thyroiditis-or-glp-1-agonistsr-effectr.html https://www.enets.org/abstract/everolimus-octreotide-lar-v-placebo-octreotide-lar-in-patients-with-advanced-net-results-of-a-randomized-double-blind-placebo-controlled-multicenter-phase-3-trial-radiant-2.html https://www.enets.org/abstract/dosimetry-with-111in-octreotide-and-coinfusion-of-amino-acids-in-the-prediction-of-nephrotoxicity-in-neuroendocrine-tumors-after-prrt-with-90y-dotatoc.html https://www.enets.org/abstract/overall-survival-os-analysis-of-sunitinib-su-after-adjustment-for-crossover-co-in-patients-with-pancreatic-neuroendocrine-tumors-net.html https://www.enets.org/abstract/pancreatic-endocrine-tumors-tnm-staging-and-who-grading-relation-with-prognosis.html https://www.enets.org/abstract/focal-nesidioblastosis-in-an-adult.html https://www.enets.org/abstract/aggressive-somatostatinoma-with-associated-pheocromocytoma-in-a-neurofibromatosis-patient.html https://www.enets.org/abstract/role-of-chromogranin-a-and-neuron-specific-enolase-biomarkers-in-progression-free-survival-pfs-with-everolimus-eve-v-placebo-pb-in-patients-with-advanced-pancreatic-neuroendocrine-tumors-pnet-phase-iii-radiant-3-results.html https://www.enets.org/abstract/pcr-assessment-of-carcinoid-lymph-node-metastasis-cga-transcript-outperforms-immunostaining-tyramide-signal-amplification-and-h-e-and-significantly-upstages-disease.html https://www.enets.org/abstract/cell-cycle-phase-expression-profile-guided-selection-of-proliferative-markers-for-well-differentiated-small-intestinal-neuroendocrine-neoplasms.html https://www.enets.org/abstract/management-of-multiple-endocrine-neoplasia-type-1-in-patients-with-pancreatic-neuroendocrine-tumors.html https://www.enets.org/abstract/gastrointestinal-stromal-tumor-gist-of-the-esophagus-in-a-patient-with-men-1-and-related-pancreatic-gastrinoma.html https://www.enets.org/abstract/rad001-and-octreotide-lar-as-first-line-treatment-of-well-differentiated-neuroendocrine-tumors-an-i-t-m-o-italian-trials-in-medical-oncology-group-study.html https://www.enets.org/abstract/comparison-of-68ga-somatostatin-analogues-18f-dopa-and-18f-fdg-pet-ct-in-patients-with-recurrent-medullary-thyroid-carcinoma.html https://www.enets.org/abstract/predictive-factors-of-tumor-control-in-patients-with-well-differentiated-digestive-endocrine-carcinomas-wdec-treated-with-lanreotide.html https://www.enets.org/abstract/pattern-and-clinical-predictors-of-lymph-node-involvement-in-neuroendocrine-neoplasms-of-the-pancreas.html https://www.enets.org/abstract/risk-stratification-using-octreotide-test-for-patients-with-gastro-entero-pancreatic-neuroendocrine-tumors-results-of-prospective-validation-of-the-test.html https://www.enets.org/abstract/microrna-signatures-as-novel-biomarkers-in-small-intestine-neuroendocrine-tumors.html https://www.enets.org/abstract/activin-a-in-carcinoid-heart-disease-a-possible-role-in-diagnosis-and-pathogenesis.html https://www.enets.org/abstract/alternative-splicing-and-differential-gene-expression-in-pancreatic-nets.html https://www.enets.org/abstract/enhanced-combined-177lu-dotatate-and-90y-dotatate-treatment-of-patients-with-metastatic-neuroendocrine-tumors-refractory-to-conventional-therapy-an-ongoing-study.html https://www.enets.org/abstract/expression-of-uch-l1-in-pancreatic-endocrine-tumors-and-its-clinical-significance.html https://www.enets.org/abstract/high-resolution-epi-genomic-analysis-comparing-pulmonary-carcinoids-with-a-favorable-and-a-poor-disease-outcome.html https://www.enets.org/abstract/rats-heterozygous-for-the-menx-associated-p27-mutation-develop-a-men-phenotype.html https://www.enets.org/abstract/succinate-dehydrogenase-sdh-complex-expression-in-pancreatic-endocrine-tumours-pets.html https://www.enets.org/abstract/clinicopathological-characteristics-are-capable-of-predicting-long-term-outcome-of-gastrointestinal-neuroendocrine-tumours-in-germany.html https://www.enets.org/abstract/platinum-based-chemotherapy-in-patients-with-advanced-neuroendocrine-carcinomas-an-italian-retrospective-multicenter-analysis.html https://www.enets.org/abstract/fdopa-pet-ct-has-a-significant-clinical-impact-on-the-management-of-patients-with-neuroendocrine-tumors.html https://www.enets.org/abstract/next-generation-sequencing-is-a-cost-effective-and-time-saving-method-in-clinical-genetic-screening-of-patients-with-pheochromocytomas.html https://www.enets.org/abstract/the-role-of-image-and-chromogranin-a-level-at-diagnosis-a-portuguese-review-of-19-patients.html https://www.enets.org/abstract/carcinoid-tumor-of-common-bile-duct-cbd-misdiagnosed-as-cholangiocarcinoma.html https://www.enets.org/abstract/postoperative-complications-after-previous-peptide-receptor-radionuclide-therapy.html https://www.enets.org/abstract/a-retrospective-analysis-of-neuroendocrine-tumors-nets-in-west-azarbaijan-of-iran.html https://www.enets.org/abstract/hyperammonemic-encephalopathy-in-neuroendocrine-tumor-resolved-through-liver-embolization-a-case-report.html https://www.enets.org/abstract/how-long-to-continue-surveillance-in-patients-following-rcurative-resectionr-of-primary-small-bowel-tumorsr.html https://www.enets.org/abstract/resection-of-primary-tumor-improves-survival-in-small-bowel-neuroendocrine-tumors-a-single-center-experience.html https://www.enets.org/abstract/survival-and-cause-of-death-in-patients-with-small-bowel-neuroendocrine-tumors.html https://www.enets.org/abstract/does-tnm-staging-classification-predict-survival-in-patients-with-small-bowel-neuroendocrine-tumorsr.html https://www.enets.org/abstract/laparoscopic-surgery-of-pancreatic-endocrine-tumors-is-there-a-benefitr.html https://www.enets.org/abstract/diagnosis-and-management-of-insulinomas-in-a-tertiary-referral-center-a-10-year-review.html https://www.enets.org/abstract/ovarian-primary-neuroendocrine-tumor-combined-with-a-monodermal-teratoma-a-case-report.html https://www.enets.org/abstract/invaded-moderately-differentiated-neuroendocrine-carcinoma-of-larynx.html https://www.enets.org/abstract/everolimus-and-octreotide-lar-in-neuroendocrine-tumors-an-i-t-m-o-italian-trials-in-medical-oncology-group-study.html https://www.enets.org/abstract/a-pilot-study-on-the-immunohistochemical-expression-of-chromogranin-and-or-synaptophysin-in-moderate-to-poorly-differentiated-gastroenteropancreatic-carcinomas.html https://www.enets.org/abstract/treatment-of-small-bowel-neuroendocrine-tumor-nets-a-single-center-s-experience.html https://www.enets.org/abstract/a-prospective-evaluation-of-the-effects-of-chronic-proton-pump-inhibitor-use-on-plasma-biomarker-levels-in-humans.html https://www.enets.org/abstract/combined-blockade-of-several-signalling-pathways-shows-marked-anti-tumor-potential-in-two-novel-mouse-phaeochromocytoma-cell-lines.html https://www.enets.org/abstract/czech-neuroendocrine-tumor-registry-28-months-results.html https://www.enets.org/abstract/an-increasing-incidence-of-gep-nets-in-chengdu-city-with-a-population-of-14-million-in-china.html https://www.enets.org/abstract/clinical-case-of-a-man-with-acth-ectopic-syndrome-and-autosomal-dominant-polycystic-disease.html https://www.enets.org/abstract/a-67-year-old-woman-with-a-carcinoid-tumor-of-the-coccyx-with-liver-metastases.html https://www.enets.org/abstract/tumor-response-assessment-to-treatment-with-177lu-dota0-tyr3-octreotate-in-patients-with-gastroenteropancreatic-neuroendocrine-tumors-differential-response-of-bone-versus-soft-tissue-lesions.html https://www.enets.org/abstract/efficacy-of-telotristat-etiprate-in-refractory-carcinoid-syndrome-results-of-a-randomized-placebo-controlled-multicenter-study.html https://www.enets.org/abstract/outcomes-of-peptide-receptor-radionuclide-therapy-prrt-in-north-american-cohort-of-patients-with-metastatic-well-differentiated-neuroendocrine-tumors-mnets.html https://www.enets.org/abstract/telotristat-etiprate-produces-clinical-and-biochemical-responses-in-patients-with-symptomatic-carcinoid-syndrome-preliminary-results-of-an-ongoing-phase-2-multicenter-open-label-serial-ascending-european-study.html https://www.enets.org/abstract/swiss-neuroendocrine-tumor-swissnet-registry-update-after-three-years.html https://www.enets.org/abstract/ileal-gep-nen-in-mother-and-son-r-option-for-familial-disease.html https://www.enets.org/abstract/malignant-carotid-body-tumors-cbts-clinical-presentation-investigations-and-their-management.html https://www.enets.org/abstract/challenges-in-the-management-of-a-disseminated-malignant-abdominal-paragangliom-mpgl.html https://www.enets.org/abstract/status-of-dna-repair-and-cell-proliferation-markers-in-high-grade-neuroendocrine-carcinoma-of-the-uterine-cervix-cnec-compared-to-small-cell-carcinoma-of-the-lung-sclc.html https://www.enets.org/abstract/single-center-treatment-outcomes-in-patients-pts-with-high-grade-neuroendocrine-carcinoma-of-the-uterine-cervix-cnec.html https://www.enets.org/abstract/insulinomas-in-children.html https://www.enets.org/abstract/b-lymphocyte-stimulator-in-neuroendocrine-tumors-correlation-with-disease-behavior.html https://www.enets.org/abstract/eus-fna-for-pancreatic-neuroendocrine-tumors-a-single-referral-centre-experience.html https://www.enets.org/abstract/yf476-a-gastrin-receptor-antagonist-causes-regression-of-tumors-and-normalizes-serum-chromogranin-a-in-patients-with-type-1-gastric-carcinoids.html https://www.enets.org/abstract/co-existing-type-1-gastric-neuroendocrine-tumors-nets-and-adenocarcinoma-in-autoimmune-associated-atrophic-gastritis.html https://www.enets.org/abstract/expression-of-cocaine-and-amphetamine-regulated-transcript-is-associated-with-worse-survival-in-small-bowel-carcinoid-tumors.html https://www.enets.org/abstract/activation-of-cdk4-cyclind-d1-and-the-associated-attenuation-of-rb-function-in-pancreatic-neuroendocrine-tumors-pan-nets.html https://www.enets.org/abstract/pancreatic-neuroendocrine-tumors-retrospective-analysis-of-44-cases.html https://www.enets.org/abstract/efficacy-of-peptide-receptor-radionuclide-therapy-treatment-with-177ludotatate-in-advanced-well-differentiated-pancreatic-neuroendocrine-tumors.html https://www.enets.org/abstract/single-institutional-series-of-neuroendocrine-tumors-managed-in-the-australian-capital-territory.html https://www.enets.org/abstract/expression-of-uch-l1-in-pets-and-its-implications.html https://www.enets.org/abstract/pattern-and-clinical-predictors-of-lymph-node-involvement-in-pancreatic-neuroendocrine-tumors-pannets.html https://www.enets.org/abstract/bevacizumab-plus-octreotide-and-metronomic-capecitabine-in-patients-with-metastatic-well-to-moderately-differentiated-neuroendocrine-tumors-the-xelbevoct-multicenter-phase-ii-study.html https://www.enets.org/abstract/a-rare-case-of-cushing-syndrome-caused-by-an-ectopic-acth-secreting-pancreatic-neuroendocrine-tumor-in-a-patient-with-von-hipple-lindau-disease.html https://www.enets.org/abstract/ck19-expression-in-arth-producing-extrapituitary-neuroendocrine-neoplasms-is-a-negative-prognostic-factor.html https://www.enets.org/abstract/chromogranin-a-cga-in-the-diagnosis-and-monitoring-of-patients-with-gastroenteropancreatic-gep-neuroendocrine-tumors-net-a-single-institution-experience.html https://www.enets.org/abstract/morphological-characteristics-of-pancreatic-tumors-in-children-and-young-patients.html https://www.enets.org/abstract/surgical-treatment-of-organic-hyperinsulinism.html https://www.enets.org/abstract/pelvic-carcinoid-tumor-recurrence-treated-by-laparosocopic-ultrasonography-guided-laparoscopic-resection.html https://www.enets.org/abstract/the-somatostatin-analogue-octreotide-inhibits-growth-of-neuroendocrine-tumor-cells-by-triggering-janus-faced-proteins.html https://www.enets.org/abstract/case-report-a-rare-cause-of-retroperitoneal-fibrosis-responding-to-steroids.html https://www.enets.org/abstract/role-of-micrornas-in-small-intestine-neuroendocrine-tumors.html https://www.enets.org/abstract/successful-treatment-with-everolimus-of-functioning-liver-metastases-from-a-pancreatic-insulinoma.html https://www.enets.org/abstract/an-esophageal-gastrointestinal-stromal-tumor-gist-in-a-patient-with-men-1-related-pancreatic-gastrinoma.html https://www.enets.org/abstract/gastric-carcinoids-prevalence-in-europe-and-usa-and-rationale-for-treatment-with-yf476-a-gastrin-receptor-antagonist.html https://www.enets.org/abstract/clinical-manifestations-of-patients-with-pancreatic-ss-cells-hyperplasia.html https://www.enets.org/abstract/bronchial-carcinoid-response-to-mtor-inhibitors-depends-on-mtor-expression-levels.html https://www.enets.org/abstract/mtor-inhibitors-hamper-cell-viability-in-selected-human-medullary-thyroid-carcinoma-primary-cultures.html https://www.enets.org/abstract/everolimus-controlled-resistant-hypoglycemia-in-malignant-insulinoma.html https://www.enets.org/abstract/ten-years-of-gastroenteropancreatic-neuroendocrine-tumors-gep-nets-evolution-of-classification-and-correlation-with-follow-up-in-50-patients.html https://www.enets.org/abstract/clinical-and-prognostic-features-of-rectal-neuroendocrine-tumors.html https://www.enets.org/abstract/treatment-survival-and-prognostic-markers-in-patients-with-thymic-carcinoids-a-clinicopathologic-study-of-28-cases.html https://www.enets.org/abstract/olfactory-receptor-51e1-is-a-novel-potential-tissue-biomarker-for-the-diagnosis-and-prognosis-of-small-intestine-neuroendocrine-tumors.html https://www.enets.org/abstract/role-of-somatostatin-analogues-in-the-management-of-merkel-cell-carcinoma-a-case-report.html https://www.enets.org/abstract/mtor-expression-in-primary-pancreatic-neuroendocrine-tumors-and-their-metastases.html https://www.enets.org/abstract/chromogranin-a-cga-and-pancreastatin-pcst-as-predictors-of-peptide-receptor-radionuclide-therapy-prrt-outcomes-in-patients-with-metastatic-well-differentiated-neuroendocrine-tumors-mnets.html https://www.enets.org/abstract/the-first-neuroendocrine-tumor-methylome-using-methylation-specific-immunoprecipitation-followed-by-second-generation-sequencing-r-medip-seq.html https://www.enets.org/abstract/tie-2-and-angiopoietin-2-plasma-levels-as-new-diagnostic-markers-for-patients-with-neuroendocrine-tumors-data-from-one-clinical-center.html https://www.enets.org/abstract/low-diagnostic-accuracy-of-tumor-markers-for-the-annual-screening-of-pancreatic-neuroendocrine-tumors-in-men-1-patients.html https://www.enets.org/abstract/neuroendocrine-carcinoma-nec-and-composite-exocrine-neuroendocrine-carcinoma-cenec-of-the-stomach-a-clinicopathological-review-of-58-cases.html https://www.enets.org/abstract/gallium-68-dotatate-pet-ct-assessment-of-patients-pts-with-gastroenteropancreatic-neuroendocrine-tumors-gep-nets-first-experience-in-a-multidisciplinary-team-in-argentina-argentum-group.html https://www.enets.org/abstract/comparison-of-prognostic-capacity-for-overall-survival-os-and-disease-free-survival-dfs-of-neuroendocrine-tumors-nets-classifications-2010-who-tnm-staging-enets-and-ajcc.html https://www.enets.org/abstract/comparative-expression-analysis-of-somatostatin-receptor-subtypes-in-human-neuroendocrine-tumors-using-two-sets-of-new-monoclonal-antibodies.html https://www.enets.org/abstract/somscan-towards-a-ga-68-labeled-pan-somatostatin-pet-imaging-probe-based-on-som230-pasireotide.html https://www.enets.org/abstract/comparison-of-the-automated-chromogranin-a-assay-using-kryptor-instrumentation-with-the-manual-irma-assay-of-cisbio.html https://www.enets.org/abstract/effective-treatment-of-a-metastatic-thymic-neuroendocrine-tumor-with-capecitabine-and-temozolomide-a-case-report.html https://www.enets.org/abstract/peptide-receptor-radionuclide-therapy-for-neuroendocrine-tumors-in-germany-first-results-of-a-multiinstitutional-cancer-registry.html https://www.enets.org/abstract/symptomatic-control-of-neuroendocrine-tumors-with-everolimus.html https://www.enets.org/abstract/clinical-and-psychometric-validation-of-the-disease-specific-questionnaire-module-eortc-qlq-ginet21-in-assessing-quality-of-life-of-patients-with-neuroendocrine-tumors.html https://www.enets.org/abstract/activation-of-hedgehog-pathway-in-neuroendocrine-tumor.html https://www.enets.org/abstract/depression-and-carcinoid-syndrome-is-there-any-relationshipr-a-cross-sectional-study.html https://www.enets.org/abstract/assessment-of-quality-of-life-coping-strategies-and-beliefs-in-net-patients.html https://www.enets.org/abstract/comparison-of-transarterial-liver-directed-therapies-ldt-for-low-grade-metastatic-neuroendocrine-tumors-mnets.html https://www.enets.org/abstract/octreotide-long-acting-releasetherapy-for-patients-with-functional-and-metastatic-gastroenteropancreatic-neuroendocrine-tumors-a-retrospective-analysis-in-chang-gung-memorial-hospital.html https://www.enets.org/abstract/differential-claudin-1-gene-expression-in-neural-crest-derived-tumors-of-common-embryological-origin.html https://www.enets.org/abstract/treatment-of-unresectable-metastatic-gep-nets-data-from-a-prospective-observational-unicentric-study.html https://www.enets.org/abstract/the-good-the-bad-the-unexpected.html https://www.enets.org/abstract/genome-wide-expression-profiling-reveals-downregulation-of-otp-and-cd44-and-upregulation-of-ret-as-indicators-of-poor-prognosis-in-lung-carcinoids.html https://www.enets.org/abstract/primary-neuroendocrine-tumor-of-the-parathyroid.html https://www.enets.org/abstract/management-of-an-advanced-pancreatic-neuroendocrine-tumor.html https://www.enets.org/abstract/hif-1a-determines-the-metastatic-potential-of-the-gep-net-cell-line-bon-1.html https://www.enets.org/abstract/thoracic-and-gastroenteropancreatic-gep-neuroendocrine-tumors-nets-and-ectopic-adrenocorticotropin-acth-syndrome-eas.html https://www.enets.org/abstract/mir-129-5p-and-let-7-are-down-regulated-in-carcinoid-tumors.html https://www.enets.org/abstract/cost-effectiveness-of-sunitinib-in-patients-with-advanced-or-metastatic-pancreatic-neuroendocrine-tumors-in-portugal.html https://www.enets.org/abstract/overall-survival-of-well-differentiated-neuroendocrine-tumors-evaluated-by-f-18-fdg-pet.html https://www.enets.org/abstract/alterations-of-global-and-gene-specific-dna-methylation-in-midgut-carcinoids.html https://www.enets.org/abstract/detection-of-liver-metastases-and-prognostic-value-of-functional-and-anatomical-imaging-in-patients-with-neuroendocrine-tumors.html https://www.enets.org/abstract/succinate-dehydrogenase-sdhb-a-new-marker-of-malignancy-in-midgut-carcinoidsr.html https://www.enets.org/abstract/difficulties-in-diagnosis-and-management-of-neuroendocrine-tumors-of-the-head-and-neck-a-case-report.html https://www.enets.org/abstract/methylguanine-dna-methyl-transferase-mgmt-expression-predicts-response-to-temozolamide-in-patients-with-digestive-neuroendocrine-tumors-nets.html https://www.enets.org/abstract/glucagon-like-peptide-1-receptor-glp-1r-imaging-for-the-preoperative-localization-of-benign-insulinomas-in-30-patients.html https://www.enets.org/abstract/right-hemicolectomy-in-the-treatment-of-patients-with-appendiceal-neuroendocrine-tumors-does-size-matterr.html https://www.enets.org/abstract/efficacy-and-safety-of-everolimus-in-metastatic-gastroenteropancreatic-neuroendocrine-tumors.html https://www.enets.org/abstract/immunohistochemical-ihc-overexpression-of-succinate-dehydrogenase-sdhb-as-prognostic-factor-in-sporadic-pheochromocytomas-paragangliomas-p-p.html https://www.enets.org/abstract/quality-of-life-in-patients-with-neuroendocrine-tumors-a-cross-sectional-study.html https://www.enets.org/abstract/well-differentiated-neuroendocrine-tumors-wdnets-and-carcinoid-syndrome-cs-a-retrospective-analysis-of-110-patients-from-istituto-nazionale-tumori-milano.html https://www.enets.org/abstract/efficacy-of-everolimus-in-patients-with-metastatic-insulinomas-and-refractory-hypoglycemia-for-the-french-group-of-endocrine-tumors-gte-renaten.html https://www.enets.org/abstract/diagnostic-accuracy-of-gallium-68-somatostatin-receptor-positron-emission-tomography-in-patients-with-thoracic-and-gastroenteropancreatic-neuroendocrine-tumors-a-meta-analysis.html https://www.enets.org/abstract/laparoscopic-surgery-of-pancreatic-neuroendocrine-tumors-results-from-a-tertiary-care-institution.html https://www.enets.org/abstract/benefit-of-octreotide-lar-in-patients-with-neuroendocrine-midgut-tumors-who-previously-progressed-on-placebo-therapy-two-cases-from-the-promid-study.html https://www.enets.org/abstract/validation-of-chromogranin-a-assays-in-patients-with-neuroendocrine-tumors.html https://www.enets.org/abstract/cux1-mediates-progression-of-neuroendocrine-tumors.html https://www.enets.org/abstract/goblet-cell-appendiceal-neuroendocrine-tumors-diagnosis-recurrence-rates-treatment-and-survival-a-series-of-37-patients.html https://www.enets.org/abstract/effect-of-open-label-everolimus-after-disease-progression-in-patients-with-advanced-neuroendocrine-tumors-a-radiant-2-analysis.html https://www.enets.org/abstract/international-survey-for-the-use-of-biomarkers-and-molecular-imaging-in-neuroendocrine-tumors-net-what-we-are-using-in-daily-practice.html https://www.enets.org/abstract/should-primary-hyperparathyroidism-at-age-below-40-years-always-lead-to-search-for-men-1-despite-presence-of-other-plausible-explanationsr.html https://www.enets.org/abstract/pasireotide-and-octreotide-lar-was-an-effective-combination-in-a-patient-with-small-intestinal-net-with-hypokalemia-and-a-high-level-of-vip.html https://www.enets.org/abstract/diagnostic-features-and-management-outcomes-in-bronchopulmonary-neuroendocrine-tumors-a-clinical-study-of-116-patients.html https://www.enets.org/abstract/risk-factors-for-sporadic-pancreatic-neuroendocrine-tumors-pnets-updated-results-from-a-single-center-case-control-study.html https://www.enets.org/abstract/progression-free-survival-by-prior-somatostatin-analog-use-and-primary-tumor-site-and-updated-safety-results-in-patients-with-advanced-neuroendocrine-tumors-and-a-history-of-carcinoid-syndrome-a-radiant-2-analysis.html https://www.enets.org/abstract/metastatic-pancreatic-neuroendocrine-carcinoma-does-aggressive-surgical-intervention-improve-outcomer.html https://www.enets.org/abstract/limitations-of-chromogranin-a-in-clinical-practice.html https://www.enets.org/abstract/effect-of-everolimus-on-pharmacokinetics-of-octreotide-lar-in-patients-with-advanced-neuroendocrine-tumors-a-radiant-2-analysis.html https://www.enets.org/abstract/duodenal-carcinoid-tumors-are-associated-with-increased-survival-and-earlier-detection-when-compared-with-jejunal-or-ileal-carcinoids-a-population-based-study.html https://www.enets.org/abstract/folfox-regimen-for-clinically-aggressive-neuroendocrine-tumors-about-one-case.html https://www.enets.org/abstract/bifunctional-shrnaimpdx-1-therapy-prevents-hypoglycemic-death-from-insulinoma-in-mice.html https://www.enets.org/abstract/long-term-stable-disease-with-everolimus-in-a-patient-with-advanced-pancreatic-neuroendocrine-tumor-enrolled-in-radiant-1.html https://www.enets.org/abstract/metastatic-neuroendocrine-carcinoma-mnets.html https://www.enets.org/abstract/update-on-the-observational-gastroenteropancreatic-neuroendocrine-tumors-gepnet-registry-an-international-collaboration.html https://www.enets.org/abstract/paraneoplastic-neurological-syndrome-in-a-patient-with-a-pancreatic-well-differentiated-endocrine-tumor.html https://www.enets.org/abstract/are-all-metastatic-grade-3-who-2010-neuroendocrine-carcinoma-poorly-differentiatedr.html https://www.enets.org/abstract/differential-expression-of-markers-in-a-midgut-carcinoid-tissue-microarray.html https://www.enets.org/abstract/activation-of-egfr-and-c-met-signaling-pathways-in-well-differentiated-neuroendocrine-tumors-of-the-small-intestine.html https://www.enets.org/abstract/salivary-free-catecholamines-metabolites-in-pheochromocytoma.html https://www.enets.org/abstract/intrapancreatic-accessory-spleen-ipas-misdiagnosed-as-nonfunctioning-pancreatic-neuroendocrine-tumor-pnet-a-case-report-and-characterization-of-a-syndrome-based-on-systematic-review-of-the-literature.html https://www.enets.org/abstract/epidemiology-of-neuroendocrine-tumors-in-france-the-pronet-study.html https://www.enets.org/abstract/correlation-between-mtor-pathway-and-clinical-outcomes-in-patients-with-well-differentiated-neuroendocrine-tumors-treated-with-everolimus.html https://www.enets.org/abstract/cost-effectiveness-of-sunitinib-in-patients-pts-with-advanced-or-metastatic-pancreatic-neuroendocrine-tumors-pnet-in-the-netherlands.html https://www.enets.org/abstract/neuroendocrine-carcinomas-nec-of-the-pancreas-a-land-of-hoper.html https://www.enets.org/abstract/evaluation-of-68ga-dota-tate-and-68ga-dota-lan-pet-ct-in-somatostatin-exopressing-organs-and-tumors.html https://www.enets.org/abstract/initial-experience-of-biological-stability-and-image-timing-of-ga-68-dotanoc-in-somatostatin-receptor-sstr-expressing-organ-and-tumor.html https://www.enets.org/abstract/ck19-and-kit-immunostaining-is-a-useful-adjunct-to-ki-67-based-grading-of-pancreatic-net-a-study-on-matched-cytological-and-histological-samples.html https://www.enets.org/abstract/effectiveness-of-transarterial-embolization-in-neuroendocrine-tumors.html https://www.enets.org/abstract/left-pancreatectomy-for-neuroendocrine-pancreatic-tumors.html https://www.enets.org/abstract/cachexia-in-pancreatic-neuroendocrine-tumors-a-comparison-with-pancreatic-adenocarcinoma.html https://www.enets.org/abstract/effects-of-transarterial-chemoembolization-of-liver-metastases-from-neuroendocrine-tumors-on-clinical-outcome.html https://www.enets.org/abstract/metastatic-midgut-carcinoid-tumors-20-years-experience-in-a-single-center.html https://www.enets.org/abstract/sunitinib-in-a-men-1-patient-with-small-cell-neuroendocrine-tumor-of-the-thymus.html https://www.enets.org/abstract/pancreatic-neuroendocrine-tumors-associated-with-mesenchimal-neoplasms-of-the-gi-tract.html https://www.enets.org/abstract/association-between-activin-a-nt-pro-bnp-in-carcinoid-heart-disease-and-intestinal-desmoplasia-in-patients-with-metastatic-midgut-and-pelvic-net.html https://www.enets.org/abstract/pheochromocytoma-molecular-analysis-after-maternal-transmission-of-sdhd-mutation-elucidates-mechanism-of-parent-of-origin-effect.html https://www.enets.org/abstract/trans-arterial-embolization-tae-is-the-best-locoregional-treatment-option-for-patients-with-liver-metastases-from-neuroendocrine-tumors.html https://www.enets.org/abstract/alternative-splicing-and-differential-gene-expression-in-pancreatic-nets.html https://www.enets.org/abstract/liver-transplantation-for-metastatic-neuroendocrine-tumor-a-case-series-and-proposed-selection-criteria.html https://www.enets.org/abstract/long-term-outcomes-in-50-consecutive-patients-with-neuroendocrine-tumors-of-the-pancreas.html https://www.enets.org/abstract/effect-of-the-combined-administration-of-mtor-inhibitor-and-dopamine-or-somatostatin-analogues-in-a-human-bronchial-neuroendocrine-cell-line.html https://www.enets.org/abstract/gastric-neuroendocrine-tumor-type-1-associated-with-autoimmune-polyglandular-syndrome-type-3b-a-case-report.html https://www.enets.org/abstract/effect-of-dacarbazine-chemotherapy-in-well-differentiated-neuroendocrine-tumors.html https://www.enets.org/abstract/epidemology-of-neuroendocrine-tumors-in-ontario-a-15-year-population-based-study.html https://www.enets.org/abstract/orexins-exert-a-pro-apoptotic-effect-on-neuroendocrine-tumors-nets-in-an-ex-vivo-culture-model-of-tissue-slices.html https://www.enets.org/abstract/survival-of-patients-with-neuroendocrine-cancers-in-ontario-over-the-last-15-years.html https://www.enets.org/abstract/cost-utility-of-sunitinib-su-for-treatment-of-advanced-or-metastatic-pancreatic-neuroendocrine-tumors-pnet-in-scotland-and-wales.html https://www.enets.org/abstract/patterns-of-care-of-neuroendocrine-cancer-in-ontario-health-services-delivery.html https://www.enets.org/abstract/diagnositc-and-prognostic-role-of-68ga-dotatate-pet-in-patients-with-neuroendocrine-tumors.html https://www.enets.org/abstract/contrast-enhanced-ultrasound-ceus-is-a-helpful-tool-to-predict-the-effectiveness-of-somatostatin-analogues-in-patients-with-liver-metastases-from-neuroendocrine-tumors.html https://www.enets.org/abstract/establishment-of-a-multidisciplinary-tumor-board-for-patients-with-neuroendocrine-neoplasms.html https://www.enets.org/abstract/endoscopic-ultrasound-guided-fine-needle-tissue-acquisition-eus-fnta-using-a-19-g-needle-for-histological-grading-of-pancreatic-endocrine-tumors-pets-a-prospective-study.html https://www.enets.org/abstract/second-primary-tumor-in-patients-with-gastroenteropancreatic-neuroendocrine-tumors-gepnets-data-from-a-retrospective-observational-unicentric-study.html https://www.enets.org/abstract/a-case-of-acth-secreting-bronchial-carcinoid.html https://www.enets.org/abstract/treatment-of-malignant-neuroendocrine-tumors-of-the-hepatopancreatododenal-region.html https://www.enets.org/abstract/insulin-autoimmune-syndrome-mimicking-insulinoma-a-challenging-diagnosis.html https://www.enets.org/abstract/hypoglycemic-syndrome-in-30-patients.html https://www.enets.org/abstract/long-acting-somatostatin-analogues-are-highly-effective-in-patients-with-early-stage-men-1-related-well-differentiated-neuroendocrine-tumors.html https://www.enets.org/abstract/predictors-of-survival-following-y90-dotatoc-dotatate-therapy.html https://www.enets.org/abstract/outcomes-after-liver-resection-and-multidisciplinary-management-of-gastroenteropancreatic-neuroendocrine-tumor-liver-metastases.html https://www.enets.org/abstract/neuroendocrine-and-ductal-breast-cancer-coexistence-an-unusual-case-report.html https://www.enets.org/abstract/analysis-of-the-ajcc-enets-staging-classification-for-midgut-neuroendocrine-tumors.html https://www.enets.org/abstract/unresectable-mesenteric-midgut-nets-are-they-a-unique-prognostic-categoryr.html https://www.enets.org/abstract/the-role-of-chemotherapy-in-the-management-of-gastroenteropancreatic-neuroendocrine-tumors-gep-nets-the-large-experience-of-the-spanish-national-tumor-registry-rgetne.html https://www.enets.org/abstract/manecs-among-colorectal-signet-ring-cell-carcinomas.html https://www.enets.org/abstract/the-bone-scintigram-in-patients-with-neuroendocrine-tumors-a-series-of-12-cases.html https://www.enets.org/abstract/determinants-of-long-term-outcome-for-rectal-nets-from-a-large-german-multicentre-cohort.html https://www.enets.org/abstract/expression-of-chromosome-18-related-tumor-suppressor-proteins-in-ileal-neuroendocrine-tumors.html https://www.enets.org/abstract/role-of-ga-68-somatostatin-receptor-pet-ct-in-the-assessment-of-response-to-radiofrequency-ablation-in-hepatic-metastases-of-neuroendocrine-tumors.html https://www.enets.org/abstract/genetic-alterations-in-glucagon-cell-adenomatosis.html https://www.enets.org/abstract/proliferative-activity-is-not-associated-with-tumor-aggressiveness-in-ileal-neuroendocrine-tumors.html https://www.enets.org/abstract/a-case-report-of-a-patient-with-metastatic-cervical-paraganglioma-responding-to-the-tyrosine-kinase-inhibitor-sunitinib.html https://www.enets.org/abstract/efficacy-of-combined-peptide-receptor-radionuclide-therapy-and-radiofrequency-ablation-for-the-management-of-hepatic-metastases-of-neuroendocrine-tumors.html https://www.enets.org/abstract/efficacy-of-everolimus-and-tolerability-with-long-term-use.html https://www.enets.org/abstract/lack-of-accuracy-of-circulating-chromogranin-a-in-the-preoperative-diagnosis-of-lung-neuroendocrine-tumors.html https://www.enets.org/abstract/lymph-nodal-merkel-cell-carcinoma-mcc-in-the-absence-of-primary-tumor-regression-of-the-primary-or-lymph-nodal-primitivityr-report-of-a-series-with-favorable-prognostic-behavior.html https://www.enets.org/abstract/safety-and-efficacy-of-peptide-receptor-radionuclide-therapy-after-liver-transplantation-in-metastatic-neuroendocrine-tumors.html https://www.enets.org/abstract/does-the-enets-tnm-staging-criteria-predict-survival-in-patients-with-small-bowel-neuroendocrine-tumoursr.html https://www.enets.org/abstract/diagnostic-performance-of-dual-tracer-pet-ct-in-staging-neuroendocrine-tumors-of-the-lung.html https://www.enets.org/abstract/loss-of-succinate-dehydrogenase-sdhb-expression-in-midgut-carcinoids-as-prognostic-factor-a-new-marker-of-personalized-cancer-medicine-in-neuroendocrine-tumorsr.html https://www.enets.org/abstract/comparison-of-biomarkers-in-predicting-presence-and-severity-of-carcinoid-heart-disease-in-patients-with-metastatic-mid-gut-neuroendocrine-tumours.html https://www.enets.org/abstract/olfactory-receptor-51e1-is-a-potential-novel-tissue-biomarker-for-the-diagnosis-and-prognosis-of-small-intestine-neuroendocrine-tumors.html https://www.enets.org/abstract/ki-67-heterogeneity-in-gastro-entero-pancreatic-neuroendocrine-tumors.html https://www.enets.org/abstract/global-microrna-profiling-of-small-intestine-neuroendocrine-tumors-si-nets-and-establishment-of-a-method-to-study-serum-microrna-expression-from-the-same-tumors.html https://www.enets.org/abstract/a-single-center-open-label-phase-ii-proof-of-concept-study-with-pasireotide-lar-in-patients-with-progressive-medullary-thyroid-cancer-mtc-preliminary-data.html https://www.enets.org/abstract/first-in-vitro-study-of-human-gastroenteropancreatic-neuroendocrine-tumors-comparative-effect-of-octreotide-pasireotide-and-everolimus.html https://www.enets.org/abstract/correlation-of-tumor-absorbed-doses-of-177lu-dota-tate-treatment-with-pre-therapeutic-ga68-dota-tate-pet-ct-uptake-in-neuroendocrine-tumors.html https://www.enets.org/abstract/pancreatic-neuroendocrine-tumors-and-diffusion-weighted-mri-a-better-tool-for-detectionr.html https://www.enets.org/abstract/imaging-of-metastatic-recurrent-paragangliomas-and-pheochromocytomas-with-ga-68-dotatate-pet-ct.html https://www.enets.org/abstract/pancreastatin-a-predictive-neuroendocrine-tumor-marker.html https://www.enets.org/abstract/expression-of-pten-and-mtor-in-pancreatic-neuroendocrine-tumors-and-their-clinical-significance.html https://www.enets.org/abstract/the-combination-of-ck19-and-kit-is-a-potential-predictor-for-clinical-behaviors-and-postoperative-outcomes-in-resectable-pancreatic-neuroendocrine-tumors.html https://www.enets.org/abstract/neurokinin-a-levels-predict-survival-in-patients-with-well-differentiated-small-bowel-neuroendocrine-tumors.html https://www.enets.org/abstract/a-single-fasting-plasma-5-hiaa-value-correlates-with-24-hour-urinary-5-hiaa-values-and-other-biomarkers-in-midgut-neuroendocrine-tumors-nets.html https://www.enets.org/abstract/is-deep-enucleation-of-small-pancreatic-tumors-justifiedr.html https://www.enets.org/abstract/primary-hepatic-neuroendocrine-carcinomas-treated-with-a-combination-of-cisplatin-and-etoposide-as-first-line-chemotherapy-two-case-reports.html https://www.enets.org/abstract/pulmonary-neuroendocrine-tumors-long-term-survival-after-resection-and-prognostic-factors.html https://www.enets.org/abstract/rectal-neuroendocrine-tumors-long-term-survival-after-resection-and-prognostic-factors.html https://www.enets.org/abstract/neuroendocrine-neoplasms-epidemiological-trends-in-queensland-australia.html https://www.enets.org/abstract/chromogranin-a-is-a-sensitive-marker-of-progression-or-regression.html https://www.enets.org/abstract/antitumoral-effect-of-everolimus-in-preclinical-models-of-poorly-differentiated-neuroendocrine-carcinomas.html https://www.enets.org/abstract/role-of-semaphorins-and-their-signaling-pathway-in-the-progression-of-gastroenteropancreatic-neuroendocrine-tumors-gep-nets.html https://www.enets.org/abstract/expression-of-netrin-1-and-its-receptors-in-pnets.html https://www.enets.org/abstract/laparoscopic-resection-of-primary-midgut-carcinoid-tumors.html https://www.enets.org/abstract/goblet-cell-carcinoma-of-the-appendix-acute-v-chronic-presentations.html https://www.enets.org/abstract/is-octreotide-benefitial-in-patients-with-metastatic-gastroenteropancreatic-gep-and-hepatobiliary-neuroendocrine-carcinoma-nec-r.html https://www.enets.org/abstract/clinicopathological-analysis-in-119-cases-of-rectal-neuroendocrine-tumors.html https://www.enets.org/abstract/effectiveness-of-prrt-for-nets-in-germany-an-analysis-of-450-patients.html https://www.enets.org/abstract/gep-net-in-2012-from-chinese-peoplers-libration-army-general-hospital.html https://www.enets.org/abstract/serotonin-in-blood-assessment-of-its-origin-by-concomitant-determination-of-r-thromboglobulin-platelets-and-chromogranin-a-enterochromaffin-cells.html https://www.enets.org/abstract/preclinical-evaluation-of-novel-combinations-of-177-lutetium-octreotate-with-molecular-targeted-agents-in-neuroendocrine-tumor-models.html https://www.enets.org/abstract/the-effect-of-patient-and-doctors-delay-in-patients-with-neuroendocrine-tumors.html https://www.enets.org/abstract/gastrinoma-and-neurofibromatosis-type-2-is-there-an-associationr.html https://www.enets.org/abstract/assessment-of-dna-double-strand-breaks-in-blood-lymphocytes-after-whole-body-radiation-exposure-in-patients-with-neuroendocrine-tumors-undergoing-177lu-octreotate-therapy.html https://www.enets.org/abstract/incidence-and-geographic-distribution-of-gastroenteropancreatic-gep-neuroendocrine-tumors-nets-a-systematic-review-of-the-literature.html https://www.enets.org/abstract/angiogenic-characteristics-of-radiological-hypervascular-liver-tumors-net-hepatocellular-carcinoma-and-hypovascular-colorectal-liver-metastases-and-their-microenvironment.html https://www.enets.org/abstract/diagnostic-accuracy-of-f-18-dopa-pet-or-pet-ct-in-neuroendocrine-tumors-a-meta-analysis.html https://www.enets.org/abstract/multicenter-retrospective-analysis-of-systemic-chemotherapy-for-advanced-poorly-differentiated-neuroendocrine-carcinoma-of-digestive-system.html https://www.enets.org/abstract/occurrence-of-type-1-gastric-carcinoid-in-patients-with-autoimmune-chronic-atrophic-gastritis.html https://www.enets.org/abstract/evaluation-of-mucin-and-neuroendocrine-expression-in-diffuse-gastric-cancer-with-signet-ring-cell-morphology.html https://www.enets.org/abstract/measurement-of-serum-chromogranin-a-level-in-56-patients-with-neuroendocrine-tumors-using-immunoradiometric-assay.html https://www.enets.org/abstract/identification-of-new-gpcr-targets-in-net-cell-lines-using-ligand-screening.html https://www.enets.org/abstract/preliminary-results-of-a-nationwide-survey-of-pancreatic-neuroendocrine-tumors-in-von-hippelrlindau-disease-in-japan.html https://www.enets.org/abstract/pancreatic-neuroendocrine-tumors-two-different-tnm-staging-systems.html https://www.enets.org/abstract/sequential-chemo-radiation-therapy-for-locally-advanced-neuroendocrine-carcinoma-of-head-and-neck.html https://www.enets.org/abstract/targeting-chaperone-activity-and-chaperone-expression-in-human-gep-net-cells-can-repress-their-proliferation-and-sensitize-them-to-chemotherapy.html https://www.enets.org/abstract/pancreatic-polypeptide-cell-hyperplasia-associated-with-nonfunctioning-pancreatic-neuroendocrine-tumor-a-case-report.html https://www.enets.org/abstract/genotype-r-phenotype-correlations-and-timing-of-prophylactic-thyroidectomy-in-patients-with-familial-medullary-thyroid-carcinoma.html https://www.enets.org/abstract/strategy-of-combining-liver-directed-local-treatment-with-systemic-treatment-in-patients-with-liver-metastasis-of-neuroendocrine-tumor.html https://www.enets.org/abstract/clinical-and-prognostic-features-of-neuroendocrine-tumor-of-unknown-primary-site.html https://www.enets.org/abstract/merkel-cell-carcinoma-in-a-nine-year-old-girl.html https://www.enets.org/abstract/neuroendocrine-tumors-of-the-gastrointestinal-tract-with-second-primary-malignancy.html https://www.enets.org/abstract/illness-perceptions-risk-perception-and-worry-in-patients-with-inherited-paragangliomas.html https://www.enets.org/abstract/prognostic-factors-affecting-outcome-in-patients-with-liver-resection-of-neuroendocrine-hepatic-metastasis.html https://www.enets.org/abstract/clinical-features-and-treatment-of-gep-nets-in-a-spanish-hospital-through-8-years.html https://www.enets.org/abstract/chomogranin-a-nse-and-5-hydroxyindolacetic-acid-measurements-in-malignant-carcinoids.html https://www.enets.org/abstract/metastatic-gastroenteropancreatic-neuroendocrine-tumors-gep-nets-management-in-a-spanish-university-hospital.html https://www.enets.org/abstract/correlation-between-chromogranin-a-and-recist-in-neuroendocrine-tumorsr-treatment.html https://www.enets.org/abstract/phase-ii-study-of-pazopanib-monotherapy-in-metastatic-gastroenteropancreatic-neuroendocrine-tumors.html https://www.enets.org/abstract/diffuse-expression-of-osteopontin-endostatin-and-angiopoietin-1-in-neuroendocrine-neoplasm-tissues.html https://www.enets.org/abstract/loss-of-succinate-dehydrogenase-sdhb-in-midgut-carcinoids-as-prognostic-factor-a-new-marker-of-personalized-cancer-medicine-in-neuroendocrine-tumorsr.html https://www.enets.org/abstract/immunohistochemical-ihc-and-cytogenetic-approach-for-improving-diagnosis-and-therapy-of-ewing-sarcoma-es-ppnet-arising-in-the-ileocecal-region.html https://www.enets.org/abstract/reducing-the-risk-of-tuberculosis-reactivation-when-administering-everolimus-for-a-pancreatic-neuroendocrine-tumor-a-case-report.html https://www.enets.org/abstract/mammalian-target-of-rapamycin-mtor-expression-analysis-and-therapeutic-approach-in-primitive-t-and-metastatic-m-ileal-neuroendocrine-tumors-int.html https://www.enets.org/abstract/poorly-differentiated-rectal-neuroendocrine-tumors-a-report-of-three-cases.html https://www.enets.org/abstract/incidental-diagnosis-as-prognostic-factor-in-different-tumor-stages-of-non-functioning-pancreatic-endocrine-tumors.html https://www.enets.org/abstract/additional-value-of-new-molecular-imaging-tracers-in-the-detection-of-recurrent-residual-disease-in-patients-with-neuroendocrine-tumors.html https://www.enets.org/abstract/neuroendocrine-neoplasms-in-childhood-and-adolescents.html https://www.enets.org/abstract/interobserver-variability-of-pulmonary-carcinoids.html https://www.enets.org/abstract/identification-of-signaling-pathways-involved-in-lung-carcinoid-progression-using-gene-expression-profiling.html https://www.enets.org/abstract/enucleation-of-pancreatic-neuroendocrine-neoplasms-combined-with-pre-operative-wirsung-stenting-intra-operative-ultrasounds-and-absorbable-fibrin-sealant-patch-application.html https://www.enets.org/abstract/diagnosis-and-work-up-of-72-consecutive-patients-with-neuroendocrine-neoplasms-at-a-swiss-tertiary-referral-center.html https://www.enets.org/abstract/correlation-of-monoclonal-and-polyclonal-somatostatin-receptor-sstr-5-antibodies-in-pancreatic-neuroendocrine-tumors.html https://www.enets.org/abstract/somatic-mutations-in-h-ras-in-sporadic-pheochromocytoma-and-paraganglioma-identified-by-exome-sequencing.html https://www.enets.org/abstract/everolimus-in-patients-with-previously-treated-metastatic-neuroendocrine-tumors-nets.html https://www.enets.org/abstract/incidence-of-nets-according-to-the-data-of-cancer-registry-of-russian-cancer-research-center-rcrc.html https://www.enets.org/abstract/telotristat-etiprate-produces-clinical-and-biochemical-responses-in-patients-with-carcinoid-syndrome-results-of-a-phase-2-multicenter-open-label-serial-ascending-study.html https://www.enets.org/abstract/sequlae-and-survivorship-in-neuroendocrine-patients-treated-with-131i-mibg.html https://www.enets.org/abstract/comparing-chinese-pancreatic-neuroendocrine-tumors-with-americans-their-clinicopathological-features-and-prognosis.html https://www.enets.org/abstract/natural-course-and-survival-of-thymic-and-bronchopulmonary-neuroendocrine-tumors-are-different-for-male-and-female-men-1-patients.html https://www.enets.org/abstract/neoadjuvant-treatment-of-nonfunctioning-pancreatic-neuroendocrine-tumors-with-177lu-dota0-tyr3-octreotate.html https://www.enets.org/abstract/ability-of-tumor-markers-for-predicting-future-metastatic-disease-in-men-1-patients-with-a-pancreatic-neuroendocrine-tumor.html https://www.enets.org/abstract/comparison-of-response-evaluation-in-patients-with-gastroenteropancreatic-and-thoracic-neuroendocrine-tumors-after-treatment-with-177lu-dota0-tyr3-octreotate.html https://www.enets.org/abstract/analysis-of-the-undifferentiated-neuroendocrine-carcinomas-grade-3-from-the-czech-neuroendocrine-registry.html https://www.enets.org/abstract/incidence-of-second-malignancy-in-patients-with-neuroendocrine-tumors-nets-of-the-ileum-and-colon-mgc.html https://www.enets.org/abstract/the-relationship-between-the-ki-67-protein-and-igf-related-genes-in-gastroenteropancreatic-neuroendocrine-tumor-patients-with-normal-and-elevated-serum-chromogranin-a.html https://www.enets.org/abstract/comparison-of-the-utility-of-biochemical-markers-in-predicting-the-presence-and-severity-of-carcinoid-heart-disease.html https://www.enets.org/abstract/affinity-proteomic-plasma-analysis-of-human-well-differentiated-small-intestinal-neuroendocrine-tumors.html https://www.enets.org/abstract/men-1-difficulties-in-diagnosis-and-therapeutic-dilemmas.html https://www.enets.org/abstract/serum-mirna-expression-in-small-intestine-neuroendocrine-tumors-and-biological-function-of-mir-196a-in-neuroendocrine-tumor-cells.html https://www.enets.org/abstract/olfactory-receptor-51e1-is-a-potential-novel-target-for-diagnosis-and-treatment-of-somatostatin-receptor-negative-lung-carcinoid-patients.html https://www.enets.org/abstract/gene-silencing-by-promoter-hypermethylation-in-si-nets.html https://www.enets.org/abstract/care-of-net-patients-at-the-skaane-university-hospital-lund-university-sweden-a-model-for-the-multidisciplinary-approach-to-the-diagnosis-and-treatment-of-net.html https://www.enets.org/abstract/management-of-patients-with-neuroendocrine-tumors-case-presentations-including-long-term-open-label-pasireotide.html https://www.enets.org/abstract/malignant-pheocromocytoma-rare-aggressive-but-easily-neglected.html https://www.enets.org/abstract/role-of-egf-pathway-in-regulating-bronchial-carcinoid-cell-proliferation.html https://www.enets.org/abstract/the-use-of-capsule-endoscopy-for-assessment-of-neuroendocrine-tumors-of-unknown-primary-tumor-location.html https://www.enets.org/abstract/neuroendocrine-tumors-searching-for-new-prognostic-biomarkers.html https://www.enets.org/abstract/liver-resection-experience-for-metastatic-small-bowel-nets-a-single-center-experience.html https://www.enets.org/abstract/clinical-characteristics-and-survival-of-neuroendocrine-tumors-of-unknown-primary.html https://www.enets.org/abstract/a-small-mixed-adenocarcinoma-and-neuroendocrine-tumor-of-the-duodenum-with-multiple-liver-metastases.html https://www.enets.org/abstract/hepatic-arterial-embolization-for-gastroenteropancreatic-net-liver-metastases.html https://www.enets.org/abstract/does-small-mean-benignr-not-for-the-who-2010-classification-of-gastrointestinal-neuroendocrine-tumors-nets-a-case-report-of-a-small-rectal-neuroendocrine-neoplasm-nen-with-distant-metastatic-spread.html https://www.enets.org/abstract/immunohistochemical-expression-of-somatostatin-receptors-1-2-3-and-5-types-ssr-in-functioning-and-non-functioning-gastroenteropancreatic-neuroendocrine-tumors.html https://www.enets.org/abstract/primary-lymph-node-gastrinoma-or-metastatic-gastrinoma-with-unidentified-primary-tumor-siter.html https://www.enets.org/abstract/pancreatic-focal-alpha-cell-hyperplasia-with-hyperglucagonaemia-without-the-glucagonoma-syndrome.html https://www.enets.org/abstract/prognostic-factors-and-survival-in-well-differentiated-pancreatic-neuroendocrine-tumors.html https://www.enets.org/abstract/histopathological-reporting-of-neuroendocrine-tumors-a-4-year-tertiary-referral-centre-experience.html https://www.enets.org/abstract/platinum-based-chemotherapy-for-the-treatment-of-high-grade-gastrointestinal-and-unknown-primary-neuroendocrine-neoplasms.html https://www.enets.org/abstract/pancreatic-angiography-with-selective-intra-arterial-calcium-stimulation-for-the-localization-of-insulinomas-a-case-report.html https://www.enets.org/abstract/downgrading-due-to-ki-67-index-assessment-with-image-analysis.html https://www.enets.org/abstract/grading-net-mitosis-and-ki-67-conditio-sine-qua-nonr.html https://www.enets.org/abstract/feasability-of-a-dosimetry-guided-therapy-planning-for-peptide-receptor-radionuclide-therapy-with-177lu-dota-octreotate.html https://www.enets.org/abstract/ethanol-ablation-in-an-81-year-old-patient-with-pancreatic-neuroendocrine-tumor-islet-cell-tumor-and-severe-hypoglycemia-r-a-case-study.html https://www.enets.org/abstract/comparative-expression-analysis-of-chromosome-18-related-mirnas-in-ileal-net-with-and-without-chr18-loss.html https://www.enets.org/abstract/high-expression-of-mammalian-target-of-rapamycin-mtor-in-nf1-related-periampullary-neuroendocrine-tumors.html https://www.enets.org/abstract/observational-study-of-patients-with-gastroenteropancreatic-and-bronchial-neuroendocrine-tumors-in-argentina-results-from-the-large-database-of-a-multidisciplinary-group-clinical-multicenter-study.html https://www.enets.org/abstract/cutaneous-merkel-cell-carcinoma-treatment-our-experience.html https://www.enets.org/abstract/carbohydrate-metabolism-disorders-in-patients-with-pancreas-neuroendocrine-tumors-pnet-based-on-patients-from-department-of-endocrinology-in-2009-2011.html https://www.enets.org/abstract/a-multi-center-retrospective-evaluation-of-neuroendocrine-tumors-anatolian-society-of-medical-oncology-group-study.html https://www.enets.org/abstract/is-there-a-therapeutic-impact-of-segmental-portal-hypertension-on-advanced-pancreatic-neuroendocrine-tumorsr.html https://www.enets.org/abstract/neuroendocrine-carcinoma-surgery-of-peritoneal-metastasis.html https://www.enets.org/abstract/sunitinib-in-pancreatic-neuroendocrine-tumors.html https://www.enets.org/abstract/temozolomide-and-capecitabine-an-effective-combination-in-metastasic-g2-nets.html https://www.enets.org/abstract/characterization-of-elderly-patients-r70-years-with-neuroendocrine-tumors-nets.html https://www.enets.org/abstract/risk-of-recurrence-in-patients-with-neuroendocrine-tumors-after-r0-resection.html https://www.enets.org/abstract/a-retrospective-analysis-of-safety-and-efficacy-of-everolimus-in-gastroenteropancreatic-neuroendocrine-tumor-gep-net-patients-that-showed-progression-after-prrt.html https://www.enets.org/abstract/non-functioning-pancreatic-neuroendocrine-tumors-pnet-association-with-prediabetes-diabetes.html https://www.enets.org/abstract/oxalipatin-based-chemotherapy-for-grade-3-neuroendocrine-carcinoma-after-failure-of-platinum-based-chemotherapy.html https://www.enets.org/abstract/neuroendocrine-tumors-of-the-rectum-experience-in-argentina.html https://www.enets.org/abstract/adrenal-metastases-and-neuroendocrine-breast-carcinoma-in-a-men-1-patient.html https://www.enets.org/abstract/a-pancreatic-metastasis-from-carcinoid-midgut-tumor.html https://www.enets.org/abstract/forty-five-years-of-experience-in-a-single-center-for-surgical-treatment-of-pancreatic-insulinoma.html https://www.enets.org/abstract/mixed-exocrine-endocrine-pancreatic-tumors.html https://www.enets.org/abstract/small-cell-carcinoma-of-the-gallbladder-case-report-and-review-of-literature.html https://www.enets.org/abstract/primary-carcinoid-tumors-of-the-pancreas.html https://www.enets.org/abstract/isolation-and-whole-genome-amplification-of-single-circulating-tumor-cells-in-neuroendocrine-tumors-a-pilot-study.html https://www.enets.org/abstract/the-calcium-metabolism-disturbances-40-patients-with-neuroendocrine-tumors-a-cross-sectional-study.html https://www.enets.org/abstract/contrast-enhanced-ultrasonography-ceus-reliably-predicts-tumor-progression-in-pancreatic-neuroendocrine-tumors.html https://www.enets.org/abstract/contrast-enhanced-ultrasonography-ceus-predicts-the-effectiveness-of-anti-angiogenic-therapies-in-patients-with-liver-metastases-from-neuroendocrine-tumors.html https://www.enets.org/abstract/expression-and-phosphorilation-of-mtor-pathway-and-antitumor-activity-of-mtor-inhibitors-in-neuroendocrine-tumors.html https://www.enets.org/abstract/serum-levels-of-chromogranin-a-were-not-elevated-in-patients-with-insulinomas.html https://www.enets.org/abstract/networking-the-first-three-years-of-the-world-net-cancer-awareness-day-alliance.html https://www.enets.org/abstract/neuroendocrine-neoplasms-of-the-ampulla-of-vater-clinicopathological-analysis-of-nine-cases.html https://www.enets.org/abstract/loss-of-chromosome-18-in-neuroendocrine-tumors-of-the-midgut.html https://www.enets.org/abstract/gastroenteropancreatic-gep-neuroendocrine-tumors-epidemiology-and-clinical-retrospective-study-from-a-tertiary-care-center-in-north-india.html https://www.enets.org/abstract/impact-of-prior-chemotherapy-ct-and-somatostatin-analogues-ssas-on-clinical-outcome-in-well-differentiated-pancreatic-neuroendocrine-tumors-pwdnets-before-treatment-of-everolimus-ev.html https://www.enets.org/abstract/analysis-of-predictive-markers-of-response-to-chemotherapy-in-microdissected-components-of-mixed-neuroendocrine-non-neuroendocrine-carcinomas.html https://www.enets.org/abstract/non-functioning-neuroendocrine-pancreatic-neoplasia-as-an-incidental-findingrsurgeryr.html https://www.enets.org/abstract/efficacy-of-somatostatin-analogues-ssas-in-patients-with-neuroendocrine-tumors-nets-according-to-the-2010-who-classification-of-net-a-multicentric-study.html https://www.enets.org/abstract/the-bone-metastasis-phenotype-in-patients-diagnosed-with-neuroendocrine-tumors.html https://www.enets.org/abstract/impact-of-ki-67-proliferative-index-on-survival-in-patients-with-typical-and-atypical-pulmonary-carcinoids.html https://www.enets.org/abstract/interferon-alpha-in-the-management-of-metastatic-neuroendocrine-tumors-a-retrospective-study-in-37-patients.html https://www.enets.org/abstract/aspirin-inhibits-cell-viability-and-mtor-signalling-in-neuroendocrine-tumor-cells.html https://www.enets.org/abstract/heterotopic-pancreatic-tissue-located-in-the-subserosa-of-the-jejunum-a-case-report.html https://www.enets.org/abstract/lanreotide-activity-and-synergy-in-combination-with-targeted-agents-in-gastrointestinal-neuroendocrine-tumors-gi-net-ex-vivo-analysis-of-programmed-cell-death-eva-pcd-in-gi-nets-isolated-from-patients-with-advanced-disease.html https://www.enets.org/abstract/evaluation-of-relevant-factors-of-prognosis-among-a-large-german-multi-centric-cohortrresults-from-the-german-net-registry.html https://www.enets.org/abstract/in-vitro-anticancer-effect-of-metformin-on-neuroendocrine-tumor-cells.html https://www.enets.org/abstract/bio-differentiating-and-antiangiogenic-therapy-with-gastroenteropancreatic-patients-with-neuroendocrine-tumors-gep-nets.html https://www.enets.org/abstract/surgery-after-peptide-receptor-radionuclide-therapy-prrt-for-patients-with-neuroendocrine-tumors-nets-with-metastatic-abdominal-localizations.html https://www.enets.org/abstract/aspirin-delays-the-development-progression-of-neuroendocrine-pancreatic-neoplasms-and-prolongs-survival-in-a-transgenic-mouse-model-of-islet-cell-tumors.html https://www.enets.org/abstract/a-single-center-open-label-phase-ii-proof-of-concept-study-with-pasireotide-lar-in-patients-with-progressive-medullary-thyroid-cancer-mtc-preliminary-data.html https://www.enets.org/abstract/o6-methylguanine-dna-methyltransferase-deficiency-in-neuroendocrine-tumors-and-correlation-with-response-to-alkylating-agents-temozolomide-streptozotocin-dacarbazine.html https://www.enets.org/abstract/natural-history-of-atypical-carcinoid-of-lung-after-surgery.html https://www.enets.org/abstract/management-of-metastatic-nonfunctional-pancreatic-neuroendocrine-tumor.html https://www.enets.org/abstract/natural-history-of-resectable-large-cell-neuroendocrine-carcinoma-of-the-lung.html https://www.enets.org/abstract/first-in-vitro-study-of-human-gastroenteropancreatic-neuroendocrine-tumors-comparative-effect-of-octreotide-pasireotide-and-everolimus.html https://www.enets.org/abstract/effect-of-dacarbazine-chemotherapy-in-well-differentiated-neuroendocrine-tumors.html https://www.enets.org/abstract/surgical-treatment-of-pancreatic-neuroendocrine-tumors.html https://www.enets.org/abstract/evaluation-of-vegf-vegfr-1-2-3-and-endocan-esm-1-expression-in-gastroenteropancreatic-neuroendocrine-tumors-and-correlation-with-ki-67-labeling-and-prognosis.html https://www.enets.org/abstract/circulating-endothelial-cells-in-neuroendocrine-tumors.html https://www.enets.org/abstract/cardiac-metastases-in-neuroendocrine-tumors-diagnosis-management-and-outcomes.html https://www.enets.org/abstract/inter-and-intra-observers-reproducibility-of-mri-for-the-measurement-of-net-liver-metastases.html https://www.enets.org/abstract/intraoperative-gamma-probe-detection-of-metastatic-medullary-thyroid-carcinoma-mtc-with-111in-pentetreotide.html https://www.enets.org/abstract/use-of-molecular-imaging-to-differentiate-neuroendocrine-tumors-from-other-synchronous-primary-cancers-a-case-series.html https://www.enets.org/abstract/long-term-follow-up-of-men-1-patients-with-non-operated-small-2-cm-non-functional-neuroendocrine-tumor-of-the-pancreas-nf-pet.html https://www.enets.org/abstract/endoscopic-therapy-with-argon-plasma-coagulation-for-multiple-type-1-gastric-carcinoid-tumors.html https://www.enets.org/abstract/the-experience-of-a-multidisciplinary-tumor-board-for-patients-with-neuroendocrine-neoplasms.html https://www.enets.org/abstract/everolimus-treatment-in-a-series-of-patients-with-advanced-neuroendocrine-tumors.html https://www.enets.org/abstract/aggressive-surgery-for-pancreatic-neuroendocrine-tumors.html https://www.enets.org/abstract/pancreatic-net-tumors-presenting-with-hypercalcitonemia.html https://www.enets.org/abstract/long-term-haematological-and-renal-toxicity-of-90yttrium-dota-octreotate-in-the-treatment-of-advanced-neuroendocrine-tumors-nets.html https://www.enets.org/abstract/surgicial-management-of-gastroenteropancreatic-neuroendocrine-tumors-early-and-long-term-results.html https://www.enets.org/abstract/the-axon-guidance-molecules-slit2-and-robo-control-motility-and-growth-of-pancreatic-neuroendocrine-tumor-cells.html https://www.enets.org/abstract/liver-metastases-in-a-patient-with-g1-gastric-carcinoid.html https://www.enets.org/abstract/role-of-molecular-imaging-using-ga-68-somatostatin-receptor-pet-ct-in-predicting-survival-after-peptide-receptor-radionuclide-therapy-of-neuroendocrine-neoplasms.html https://www.enets.org/abstract/thymosin-r4-as-putative-marker-in-neuroendocrine-tumors.html https://www.enets.org/abstract/the-grading-of-pnens-in-men-1-syndrome-consequences-for-tumor-progression-and-surgical-strategyr.html https://www.enets.org/abstract/whole-exome-sequence-of-bon-1-and-qgp-1-two-human-pancreatic-neuroendocrine-tumor-cell-lines-reveals-homozygous-loss-of-function-mutations-in-tp53-hrnr-and-cyfip2.html https://www.enets.org/abstract/goblet-cell-carcinoids-characteristics-of-a-danish-cohort-of-85-patients.html https://www.enets.org/abstract/laparoscopic-surgery-of-functioning-neuroendocrine-tumors-of-pancreas.html https://www.enets.org/abstract/results-of-pancreatic-surgery-for-neuroendocrine-tumors-single-center-experience-with-no-perioperative-mortality.html https://www.enets.org/abstract/epigenetic-regulation-of-endogenous-somatostatin-expression-in-neuroendocrine-tumors.html https://www.enets.org/abstract/effect-of-mean-absorbed-renal-dose-on-the-renal-function-after-peptide-receptor-radionuclide-therapy.html https://www.enets.org/abstract/appendix-well-differentiated-neuroendocrine-tumors-a-wdnets-at-a-large-tertiary-center-clinical-pathological-features-and-long-term-follow-up-evaluation.html https://www.enets.org/abstract/a-comparison-of-three-chromogranin-a-assays-in-patients-with-neuroendocrine-tumors.html https://www.enets.org/abstract/incidence-and-survival-of-patients-with-small-intestinal-neuroendocrine-tumors-in-a-danish-net-center.html https://www.enets.org/abstract/efficacy-of-transarterial-chemoembolization-of-liver-metastases-from-neuroendocrine-tumors.html https://www.enets.org/abstract/a-novel-animal-model-for-medullary-thyroid-carcinoma.html https://www.enets.org/abstract/ovriectomy.html https://www.enets.org/abstract/cerebellar-and-hypothalamic-regulation-of-vestibular-compensation-after-unilateral-labyrinthectomy-in-rat.html https://www.enets.org/abstract/quantification-of-somatostatin-receptor-subtypes-using-in-vivo-pet-ct-data-ex-vivo-conventional-immunohistochemistry-and-automated-digitized-analysis-by-definiens-xd-image-software.html https://www.enets.org/abstract/phase-ii-clinical-trial-of-pasireotide-lar-in-patients-with-metastatic-neuroendocrine-tumors.html https://www.enets.org/abstract/experience-of-a-single-italian-center-with-net-patients.html https://www.enets.org/abstract/efficacy-of-octreotide-lar-oct-in-patients-pts-with-advanced-neuroendocrine-tumors-net-a-subgroup-analysis-of-phase-iii-radiant-2-study-with-updated-overall-survival-os.html https://www.enets.org/abstract/somatostatin-analogues-for-preventing-carcinoid-crisis.html https://www.enets.org/abstract/ganglioneuroma-of-retroperitoean.html https://www.enets.org/abstract/neuroendocrine-functions-and-labyrinthectomy.html https://www.enets.org/abstract/action-of-the-hypothalamic-proline-rich-peptide-during-vestibular-compensation-following-unilateral-labyrinthectomy.html https://www.enets.org/abstract/somatostatin-analogues-for-carcinoid-syndrome.html https://www.enets.org/abstract/normal-gastrointestinal-neuroendocrine-cells-lack-e-cadherin.html https://www.enets.org/abstract/metastatic-type-1-gastric-carcinoid-a-real-threat-or-just-a-mythr.html https://www.enets.org/abstract/analysis-of-somatostatin-receptor-2a-sstr2a-immunohistochemistry-rt-qpcr-and-in-vivo-pet-ct-data-in-patients-with-pancreatic-neuroendocrine-neoplasm.html https://www.enets.org/abstract/the-plasma-chromogranin-a-level-predicts-survival-and-tumor-response-in-patients-with-gastroenteropancreatic-neuroendocrine-tumors.html https://www.enets.org/abstract/clinically-detected-gastroenteropancreatic-neuroendocrine-tumors-are-on-the-rise-epidemiological-changes-in-germany.html https://www.enets.org/abstract/long-term-prognosis-of-pancreatic-neuroendocrine-tumors-in-von-hippel-lindau-disease.html https://www.enets.org/abstract/microrna-expression-in-serum-of-small-intestine-neuroendocrine-tumor-patients-and-mir-196a-biological-function-in-neuroendocrine-tumor-cells.html https://www.enets.org/abstract/characteristics-and-determinants-of-long-term-outcome-for-resectable-sporadic-non-functional-pancreatic-neuroendocrine-tumors-nf-pnets-updated-16-year-experience-from-two-large-chinese-centers.html https://www.enets.org/abstract/serum-chromogranin-a-is-a-predictor-for-liver-metastatic-tumor-burden-and-therapeutic-response-in-advanced-non-functional-pancreatic-neuroendocrine-tumors.html https://www.enets.org/abstract/pancreatic-neuroendocrine-tumor-presenting-in-pregnancy-with-severe-hypercalcemia.html https://www.enets.org/abstract/comparison-of-manual-and-automatic-methods-of-ki-67-proliferation-index-for-neuroendocrine-tumors-the-development-and-validation-of-a-novel-digital-pathology-tool-ki-67counter.html https://www.enets.org/abstract/chromogranin-a-is-a-useful-marker-in-japanese-patients-with-pancreatic-neuroendocrine-tumors.html https://www.enets.org/abstract/the-effect-of-autophagy-inhibitors-alone-or-in-combination-with-mtor-inhibitors-in-a-neuroendocrine-tumor-cell-model.html https://www.enets.org/abstract/resection-at-diagnosis-of-the-primary-pancreatic-neuroendocrine-tumor-in-patients-with-unresectable-liver-metastases-a-possible-new-approach-for-a-multimodal-treatment.html https://www.enets.org/abstract/surgery-after-peptide-receptor-radionuclide-therapy-prrt-in-patients-with-gastroenteropancreatic-neuroendocrine-tumors-gep-nets.html https://www.enets.org/abstract/treatment-with-somatostatin-analogs-of-recurrent-type-i-gastric-carcinoid-in-patients-with-autoimmune-chronic-atrophic-gastritis.html https://www.enets.org/abstract/immunohistochemical-and-genomic-evidence-for-the-expression-of-somatostatin-receptors-1-5-and-dopamine-receptor-2-in-lung-carcinoids.html https://www.enets.org/abstract/actg2-inhibits-growth-and-is-epigenetically-repressed-in-small-intestinal-neuroendocrine-tumors.html https://www.enets.org/abstract/incidence-of-secondary-neoplasia-in-patients-with-neuroendocrine-tumor-an-analysis-of-the-swissnet-database.html https://www.enets.org/abstract/hepatic-metastases-of-gastroenteropancreatic-neuroendocrine-tumors-a-17-year-single-center-prospective-study.html https://www.enets.org/abstract/association-between-tumor-expression-of-vegfa-vegfr1-flt1-vegfr2-kdr-and-clinical-outcomes-in-neuroendocrine-tumors.html https://www.enets.org/abstract/metachronous-functioning-syndromes-in-sporadic-pancreatic-neuroendocrine-tumors-pnet.html https://www.enets.org/abstract/brain-metastases-in-neuroendocrine-tumor-patients-frequency-and-outcome.html https://www.enets.org/abstract/correlation-of-serum-chromogranin-a-change-with-radiographic-response-in-patients-with-non-functioning-advanced-neuroendocrine-tumors.html https://www.enets.org/abstract/neuroendocrine-tumors-of-the-pancreas-grade-2-with-ki-67-index-more-than-5-and-with-expression-cytokeratin-19-are-the-risk-group-of-rapid-progression.html https://www.enets.org/abstract/challenging-in-predicting-response-in-treatment-of-neuroendocrine-pancreatic-tumors-nutritional-factors.html https://www.enets.org/abstract/on-the-benign-side-of-malignancy-how-neuroendocrine-tumors-are-experienced-by-patients-and-their-family-carers.html https://www.enets.org/abstract/the-predictive-value-of-gastrin-levels-for-the-diagnosis-of-gastric-enterochromaffin-like-cells-hyperplasia-in-patients-with-hashimotors-thyroiditis.html https://www.enets.org/abstract/overall-survival-os-as-a-function-of-the-number-of-therapeutic-lines-in-patients-with-well-differentiated-pancreatic-neuroendocrine-tumors-wdpnet.html https://www.enets.org/abstract/the-role-of-plasma-chromogranin-a-as-assessment-of-treatment-response-in-grade-1-3-non-functioning-gastroenteropancreatic-gep-neuroendocrine-tumors.html https://www.enets.org/abstract/the-chemokine-receptor-cxcr4-r-differential-expression-in-bronchopulmonary-neuroendocrine-neoplasms.html https://www.enets.org/abstract/nuclear-imaging-in-intermediate-grade-neuroendocrine-tumors.html https://www.enets.org/abstract/surgical-management-of-the-patients-with-liver-metastases-of-pancreatic-neuroendocrine-tumors.html https://www.enets.org/abstract/grade-increases-in-gastroenteropancreatic-neuroendocrine-tumor-metastases-compared-to-the-primary-tumor.html https://www.enets.org/abstract/does-biopsy-reliably-identify-grade-in-gastroenteropancreatic-neuroendocrine-tumorsr.html https://www.enets.org/abstract/succinate-dehydrogenase-subunit-b-sdhb-immunohistochemistry-should-not-replace-clinical-genetic-testing-for-sdhx-mutations-in-patients-with-pheochromocytoma-and-paraganglioma.html https://www.enets.org/abstract/complete-mesenterial-venous-obstruction-r-a-clinical-syndrome-unique-to-neuroendocrine-neoplasms-of-the-small-bowel.html https://www.enets.org/abstract/clinical-impact-of-everolimus-cumulative-dose-on-pancreatic-neuroendocrine-tumors-pnets-outcome.html https://www.enets.org/abstract/quality-of-life-in-neuroendocrine-tumor-patients-compared-to-the-general-population.html https://www.enets.org/abstract/o6-methylguanine-dna-methyltransferase-mgmt-expression-and-ki-67-index-predict-response-to-temozolomide-in-patients-with-well-differentiated-pancreatic-neuroendocrine-tumors-wdpnet.html https://www.enets.org/abstract/lymph-node-involvement-to-predict-survival-in-pulmonary-neuroendocrine-tumors-r-a-single-center-experience.html https://www.enets.org/abstract/variation-between-chromogranin-a-assays-in-the-diagnosis-of-gastric-carcinoid-type-1.html https://www.enets.org/abstract/ki-67-index-as-a-biomarker-of-response-to-cytotoxic-chemotherapy.html https://www.enets.org/abstract/effects-of-sunitinib-in-combination-with-octreotide-lar-for-patients-with-advanced-pancreatic-neuroendocrine-tumor-which-failed-sunitinib-or-octreotide-lar-alone.html https://www.enets.org/abstract/incidental-pathological-finding-of-pancreatic-non-functioning-neuroendocrine-tumors.html https://www.enets.org/abstract/zollinger-ellison-syndrome-the-esophageal-stricture-as-a-rare-and-severe-complication.html https://www.enets.org/abstract/patient-reported-symptom-experiences-following-participation-in-a-study-of-telotristat-etiprate-for-patients-with-neuroendocrine-tumors-and-diarrhea-not-adequately-controlled-on-octreotide.html https://www.enets.org/abstract/expression-of-igf-mtor-pathway-components-in-human-pheochromocytomas-and-in-vitro-inhibition-of-pc12-rat-pheochromocytoma-cell-growth-by-mtor-inhibitors-alone-and-in-combination-with-the-dual-igfi-r-ins-r-antagonist-osi-906.html https://www.enets.org/abstract/molecular-imaging-of-somatostatin-receptors-with-68ga-dotatoc-pet-in-patients-with-meningioma.html https://www.enets.org/abstract/5-fu-based-chemotherapy-in-pancreatic-neuroendocrine-neoplasms-predictive-and-prognostic-markers-for-treatment-und-survival.html https://www.enets.org/abstract/paraneoplastic-encephalitis-in-a-patient-with-exceptionally-long-survival-despite-a-hepatic-metastatic-neuroendocrine-rectum-neoplasm.html https://www.enets.org/abstract/scoping-study-on-quality-of-life-ql-in-patients-pts-with-neuroendoncrine-tumors-net-of-the-digestive-tract-in-argentina-preliminary-results.html https://www.enets.org/abstract/extrapulmonary-small-cell-neuroendocrine-carcinoma-of-the-colon-in-an-18-year-old-girl.html https://www.enets.org/abstract/daxx-and-atrx-loss-defines-chromosomal-instability-and-poor-outcome-in-pancreatic-net.html https://www.enets.org/abstract/video-capsule-endoscopy-as-a-tool-to-detect-small-bowel-neuroendocrine-tumors.html https://www.enets.org/abstract/metastatic-pancreatic-neuroendocrine-tumors-with-ectopic-cushing-syndrome-could-everolimus-be-a-safe-therapeutic-optionr.html https://www.enets.org/abstract/pancreatic-neuroendocrine-tumors-pnets-role-of-endoscopic-ultrasound-fine-needle-aspiration-eus-fna-and-accuracy-of-ki-67-measurement-on-cytological-specimens.html https://www.enets.org/abstract/expression-and-prognostic-role-of-cxcr4-cxcl12-cxcr7-and-mtor-pathways-in-neuroendocrine-tumors-nets.html https://www.enets.org/abstract/targeted-next-generation-sequencing-in-the-screening-for-familial-neuroendocrine-tumor-syndromes-a-tool-for-personalized-medicine.html https://www.enets.org/abstract/the-role-of-chromogranin-a-as-a-predictor-of-radiological-disease-progression-in-midgut-and-pancreatic-neuroendocrine-tumors.html https://www.enets.org/abstract/assessment-of-neuroendocrine-tumors-heterogeneity-with-combination-of-molecular-imaging-studies.html https://www.enets.org/abstract/diagnostic-and-outcome-differences-between-sporadic-and-familial-cases-of-medullary-thyroid-cancer-a-retrospective-cohort-study.html https://www.enets.org/abstract/diagnostic-and-outcome-differences-between-sporadic-and-familial-cases-of-pheochromocytoma-and-paraganglioma-a-retrospective-cohort-study.html https://www.enets.org/abstract/plasma-chromogranin-b-as-a-marker-of-tumor-burden-and-radiological-progression-in-neuroendocrine-tumors.html https://www.enets.org/abstract/mixed-adenoneuroendocrine-carcinoma-manecs-a-rare-and-challenging-subgroup-of-neuroendocrine-neoplasia.html https://www.enets.org/abstract/role-of-68ga-dotatate-pet-tc-68ga-pet-ct-for-the-management-of-patients-with-neuroendrocrine-tumors-nets-impact-in-therapeutic-decisions-of-our-clinical-practice.html https://www.enets.org/abstract/phase-1-expansion-study-of-an-oral-torc1-torc2-kinase-inhibitor-cc-223-in-non-pancreatic-neuroendocrine-tumors-net.html https://www.enets.org/abstract/telotristat-etiprate-te-in-a-cohort-of-carcinoid-heart-disease-patients-in-two-phase-2-trials.html https://www.enets.org/abstract/success-with-lutetium-177-dotatate-therapy-in-cushingrs-syndrome-caused-by-functional-pancreatic-neuroendocrine-tumor-pnet-with-ectopic-adrenocorticotropic-hormone-acth-secretion-refractory-to-concomitant-everolimus-pasireotide-and-metyrapone.html https://www.enets.org/abstract/urinary-5-hydroxyindoleacetic-acid-in-serotonin-producing-neuroendocrine-tumors-correlation-with-disease-features-and-patients-survival.html https://www.enets.org/abstract/the-analysis-of-immunohistochemistry-staining-neuronspecific-enolase-nse-level-and-somatostatin-receptor-scintigraphy-of-gastroenteropancreatic-neuroendocrine-neoplasm-cases.html https://www.enets.org/abstract/the-pan-trk-inhibitor-gnf5837-inhibits-cell-viability-and-akt-and-mapk-signaling-in-human-neuroendocrine-got1-tumor-cells.html https://www.enets.org/abstract/incidence-and-prevalence-of-neuroendocrine-tumors-nets-of-the-ileum-and-colon-excluding-appendiceal-nets-in-northern-ireland-ni-over-a-25-year-period-1988-2012.html https://www.enets.org/abstract/immunohistochemical-and-qrt-pcr-based-evaluation-of-somatostatin-receptor-1-to-5-expression-in-92-patients-with-bronchopulmonary-neuroendocrine-neoplasms.html https://www.enets.org/abstract/evidence-of-improved-survival-when-patients-are-referred-on-to-a-specialist-net-clinic-with-multidisciplinary-team-management.html https://www.enets.org/abstract/the-assessment-of-proliferation-in-bp-nen-entities-based-on-the-three-proliferation-markers-ki-67-top2a-and-racgap1.html https://www.enets.org/abstract/novel-succinate-dehydrogenase-subunit-b-intronic-mutation-in-an-australian-kindred-with-variable-clinical-and-imaging-phenotype-necessitating-different-treatment-modalities-including-131-i-mibg-and-177-lutetium-dotatate.html https://www.enets.org/abstract/web-based-tailored-information-and-support-for-patients-with-a-neuroendocrine-tumor.html https://www.enets.org/abstract/gene-expression-characterization-of-gastroenteropancreatic-neuroendocrine-tumors-gepnets-gastrointestinal-and-pancreatic-nets-ginets-and-pnets-and-their-correlation-with-clinical-factors-and-tumor-behavior.html https://www.enets.org/abstract/primary-hepatic-neuroendocrine-tumors-four-familial-case-series-with-review-of-literature.html https://www.enets.org/abstract/simultanenous-duplicate-malignant-disease-adenocarcinoma-of-the-colon-and-disseminated-neuroendocrine-tumor.html https://www.enets.org/abstract/the-role-of-combined-68ga-dotatoc-and-18f-fdg-pet-ct-in-patients-with-pancreatic-neuroendocrine-tumors.html https://www.enets.org/abstract/expression-patterns-of-cellular-retinoic-acid-binding-protein-i-in-neuroendocrine-tumors-of-the-lung-a-pilot-immunohistochemical-study.html https://www.enets.org/abstract/detection-limitation-of-occult-net-using-gallium-68-dotatoc-scan-plus-fdg-pet.html https://www.enets.org/abstract/capecitabine-cp-and-somatostatine-analog-ssa-suitable-treatment-for-progressing-g1-g2-neuroendocrine-tumors-wd-net.html https://www.enets.org/abstract/delayed-haematological-toxicity-in-patients-treated-with-177lu-octreotate-peptide-receptor-radiotherapy-prrt-for-metastatic-neuroendocrine-tumors-nets.html https://www.enets.org/abstract/prognostic-validity-of-the-who-2010-tnm-staging-and-grading-criteria-for-pancreatic-neuroendocrine-tumors.html https://www.enets.org/abstract/metastatic-g1-g2-neuroendocrine-tumors-wdnet-treated-with-sequences-of-different-somatostatine-analogs-ssa-lanreotide-lar-la-octreotide-lar-oc-a-single-center-experience.html https://www.enets.org/abstract/sunitinib-in-gastroeneteropancreatic-neuroendocrine-tumor-gep-net-after-failure-of-previous-treatments-including-everolimus-a-series-of-five-clinical-cases.html https://www.enets.org/abstract/the-role-of-primary-resection-and-hepatic-resection-in-the-management-of-metastatic-pancreatic-neuroendocrine-tumors-with-irresectable-liver-metastases.html https://www.enets.org/abstract/the-effects-of-camp-in-different-neuroendocrine-tumorous-cells-the-role-of-epac-and-pka-in-cell-proliferation-and-cell-adhesion.html https://www.enets.org/abstract/determination-of-a-prognostic-classification-system-in-metastatic-grade-1-and-2-pancreatic-neuroendocrine-tumors-pnets.html https://www.enets.org/abstract/grading-of-metastases-in-digestive-neuroendocrine-tumors-net-interest-for-clinical-managementr.html https://www.enets.org/abstract/a-molecular-multi-transcript-gene-blood-signature-significantly-outperforms-chromogranin-a-cga-in-the-detection-of-gut-neuroendocrine-tumors-nets.html https://www.enets.org/abstract/evaluation-of-tumor-response-to-targeted-therapies-in-precision-cut-slices-of-human-pancreatic-neuroendocrine-tumors.html https://www.enets.org/abstract/evaluation-of-the-clinical-utility-of-plasma-biomarkers-in-diagnosis-of-neuroendocrine-tumors.html https://www.enets.org/abstract/renal-effects-of-streptozocin-preliminary-results-of-the-streptotox-study.html https://www.enets.org/abstract/impact-of-long-acting-octreotide-in-patients-with-early-stage-men1-related-duodeno-pancreatic-neuroendocrine-tumors.html https://www.enets.org/abstract/chemotherapy-for-advanced-neuroendocrine-tumors-nets-patient-selection-should-be-independent-of-primary-tumor-site.html https://www.enets.org/abstract/health-related-quality-of-life-hrqol-in-patients-pts-with-advanced-neuroendocrine-tumors-net-treated-with-everolimus-eve-results-from-an-open-label-phase-iiib-multicenter-expanded-access-program-eap.html https://www.enets.org/abstract/role-of-metformin-on-recurrence-free-survival-rfs-in-neuroendocrine-tumors-net.html https://www.enets.org/abstract/cancer-associated-fibroblasts-in-neuroendocrine-neoplasms-a-role-in-cancer-progression.html https://www.enets.org/abstract/secondary-hormonal-syndromes-in-patients-with-sporadic-neuroendocrine-tumors.html https://www.enets.org/abstract/the-neuroendocrine-tumor-in-choroid-an-unusual-metastatic-location-clinical-case-report.html https://www.enets.org/abstract/role-of-epithelial-to-mesenchymal-transition-markers-in-predicting-bone-and-visceral-metastases-from-nets.html https://www.enets.org/abstract/association-between-dose-of-octreotide-and-tumor-control-in-gastroenteropancreatic-neuroendocrine-tumors.html https://www.enets.org/abstract/experience-of-temozolomide-mono-and-combination-therapy-in-advanced-neuroendocrine-tumors-nets-in-russia.html https://www.enets.org/abstract/immunohistochemical-expression-of-connective-tissue-growth-factor-and-insulin-like-growth-factor-1-in-lung-carcinoids.html https://www.enets.org/abstract/serial-89zr-bevacizumab-pet-in-patients-with-neuroendocrine-tumors-before-and-on-everolimus-treatment.html https://www.enets.org/abstract/a-pcr-based-multigene-transcript-analysis-blood-test-outperforms-chromogranin-a-in-the-detection-of-gastrointestinal-and-pancreatic-neuroendocrine-tumors-and-is-unaffected-by-ppi-use-or-hypertension.html https://www.enets.org/abstract/french-cohort-of-familial-midgut-carcinoid-tumors.html https://www.enets.org/abstract/thyroid-disturbances-in-neuroendocrine-tumors-a-romanian-retrospective-study.html https://www.enets.org/abstract/pet-10-study-efficacy-of-platin-etoposide-combination-in-well-differentiated-pancreatic-neuroendocrine-tumors-with-ki-67-r-10.html https://www.enets.org/abstract/the-second-non-metastatic-tumor-in-romanian-patients-with-nets.html https://www.enets.org/abstract/hyperinsulinemic-hypoglycemia-by-an-ovarian-germ-cell-tumor.html https://www.enets.org/abstract/effect-of-combined-treatment-with-mtor-inhibitors-mtori-and-dopamine-agonists-on-cell-proliferation-in-a-human-typical-lung-carcinoid-cell-line.html https://www.enets.org/abstract/high-grade-g3-neuroendocrine-neoplasms-should-be-further-classified-according-to-morphological-differentiation.html https://www.enets.org/abstract/combined-therapy-with-rad001-e-bez235-overcomes-resistance-of-pet-cells-to-mtor-inhibition.html https://www.enets.org/abstract/comparison-of-the-novel-cell-detector-method-with-cell-search-technology-in-the-isolation-of-circulating-tumor-cells-in-neuroendocrine-tumors.html https://www.enets.org/abstract/a-case-report-of-a-pancreatic-neuroendocrine-tumor-pnet-with-high-levels-of-5-hiaa-in-urine.html https://www.enets.org/abstract/somatostatin-analogs-ssa-in-patients-with-diffuse-idiopathic-pulmonary-neuroendocrine-cell-hyperplasia-a-case-series.html https://www.enets.org/abstract/negative-urinary-fractionated-metanephrines-and-elevated-urinary-vanillylmandelic-acid-in-a-patient-with-a-sympathetic-paravesical-paraganglioma.html https://www.enets.org/abstract/transarterial-chemo-embolization-for-patients-with-liver-metastasis-of-neuroendocrine-tumors.html https://www.enets.org/abstract/laparoscopic-antrectomy-a-safe-and-definitive-treatment-in-managing-type-1-gastric-carcinoids.html https://www.enets.org/abstract/clinical-analysis-of-245-patients-with-gep-nets-a-single-institution-analysis-2002r2013-in-south-china.html https://www.enets.org/abstract/prognostic-role-of-smoking-in-gastroenteropancreatic-neuroendocrine-tumors-gep-net.html https://www.enets.org/abstract/distinct-expression-of-splicing-variants-of-the-human-men1-multiple-endocrine-neoplasia-type-1-gene-in-various-pituitary-adenomas.html https://www.enets.org/abstract/a-case-of-adrenal-pheochromocytoma-rupture-treated-with-transarterial-embolization-tae.html https://www.enets.org/abstract/hematological-toxicity-of-combined-lutetium-177-octreotate-radiopeptide-chemotherapy-of-gastroenteropancreatic-neuroendocrine-tumors-followed-long-term.html https://www.enets.org/abstract/the-cytotoxic-effect-of-sunitinib-on-human-bronchial-carcinoid-cell-lines-and-primary-cultures-is-counteracted-by-egf-and-igf-1-but-not-by-vegf.html https://www.enets.org/abstract/neuroendocrine-tumors-of-the-appendix-a-study-of-presentation-investigation-and-management.html https://www.enets.org/abstract/a-three-tier-grading-system-based-on-ki-67-index-mitotic-count-and-necrosis-with-cut-offs-specifically-generated-for-lung-neuroendocrine-tumors-is-prognostically-effective-and-accurate.html https://www.enets.org/abstract/promoter-hypermethylation-at-rassf1-is-a-feature-of-small-intestinal-neuroendocrine-tumors.html https://www.enets.org/abstract/real-world-study-on-everolimus-in-advanced-progressive-neuroendocrine-tumors.html https://www.enets.org/abstract/clinical-characteristics-of-144-patients-pts-included-in-a-multidisciplinary-group-with-well-differentiated-gastroenteropancreatic-neuroendocrine-tumors-gep-nets-g2-who-2010-grupo-argentum.html https://www.enets.org/abstract/large-cell-neuroendocrine-carcinoma-of-the-gallbladder-a-case-report-and-literature-review.html https://www.enets.org/abstract/comparison-of-radiolableled-somatostatin-analogues-and-131-i-mibg-treatment-for-the-management-of-patients-with-metastatic-progressive-phaeochromocytomas-and-paragangliomas.html https://www.enets.org/abstract/ileal-neuroendocrine-well-differentiated-tumors-prognostic-factors-with-focus-on-loss-of-succinate-dehydrogenase-sdhb-expression.html https://www.enets.org/abstract/ssa-therapy-for-patients-with-bronchial-carcinoids-bc-in-the-community-setting.html https://www.enets.org/abstract/pheochromocytoma-and-paraganglioma-in-pediatric-age.html https://www.enets.org/abstract/interference-of-nutrient-oxygen-availability-with-mtor-activation-and-inhibition-in-lung-carcinoids-a-tissue-and-cellular-study.html https://www.enets.org/abstract/immunohistochemical-staining-of-catecholamine-synthesizing-enzymes-in-head-and-neck-paraganglioma-tissue.html https://www.enets.org/abstract/clinicopathological-characteristics-of-colorectal-neuroendocrine-tumor-in-chinese-patients.html https://www.enets.org/abstract/an-analysis-of-toxicity-after-peptide-receptor-radionuclide-therapy-prrt-in-807-patients-determination-of-the-limited-predictive-role-of-clinical-factors.html https://www.enets.org/abstract/outcome-of-malignant-insulinomas-mi-in-the-community-setting.html https://www.enets.org/abstract/symnet-a-study-of-patient-reported-outcomes-pros-associated-with-lanreotide-autogel-lan-for-the-control-of-carcinoid-syndrome-cs-symptoms-in-gastroenteropancreatic-neuroendocrine-tumor-gep-net-patients-pts.html https://www.enets.org/abstract/non-functional-pancreatic-neuroendocrine-tumors-pnets-with-transformation-to-insulinoma-an-esoteric-presentation-of-a-rare-disease.html https://www.enets.org/abstract/comparison-of-diagnostic-methods-in-the-evaluation-of-pancreatic-and-duodenal-gastrinomas.html https://www.enets.org/abstract/specific-microrna-profiles-are-associated-with-pathological-features-in-lung-carcinoids.html https://www.enets.org/abstract/usefulness-of-the-who-classification-and-of-the-enets-tnm-staging-system-to-predict-prognosis-in-patients-with-rectal-nens.html https://www.enets.org/abstract/treatment-practices-in-european-centers-with-interest-in-neuroendocrine-carcinomas-and-high-grade-g3-neuroendocrine-tumors.html https://www.enets.org/abstract/outcome-predictors-of-gastrinomas-the-role-of-enets-staging-grading-and-interdisciplinary-treatment.html https://www.enets.org/abstract/hypoglycemic-syndrome-recurrence-after-surgical-removal-of-a-pancreatic-neuroendocrine-adenoma.html https://www.enets.org/abstract/nets-in-a-hospital-registry-at-a-russian-cancer-centre.html https://www.enets.org/abstract/gastroenteropancreatic-neuroendocrine-neoplasms-the-experience-of-an-oncology-center.html https://www.enets.org/abstract/heterogeneity-in-the-ki-67-index-of-neuroendocrine-tumors.html https://www.enets.org/abstract/cyclin-d1-levels-are-involved-in-the-resistance-to-m-tor-inhibitors-in-human-bronchial-carcinoids.html https://www.enets.org/abstract/from-e-l-i-o-s-educational-learning-investigational-observational-study-an-initial-update-on-neuroendocrine-tumors-nets-in-the-southern-italy.html https://www.enets.org/abstract/ewing-sarcoma-a-dangerous-pitfall-for-poorly-differentiated-neuroendocrine-carcinoma-pdec-in-ileum.html https://www.enets.org/abstract/metabonomic-profiling-a-novel-approach-in-neuroendocrine-neoplasias.html https://www.enets.org/abstract/evaluation-of-lysyl-oxidase-like-2-loxl2-expression-by-immunohistochemistry-ihc-in-gastroenteropancreatic-neuroendocrine-tumors-gep-net-a-retrospective-analysis-and-comparison-with-pten.html https://www.enets.org/abstract/correlation-between-genomic-imbalances-cell-proliferation-and-tumor-size-in-sporadic-pancreatic-neuroendocrine-tumors.html https://www.enets.org/abstract/an-early-rare-men1-phenotype.html https://www.enets.org/abstract/identification-of-hypoxia-induced-epigenetic-changes-in-the-development-of-pancreatic-neuroendocrine-tumors.html https://www.enets.org/abstract/progression-free-survival-pfs-and-tumor-growth-with-lanreotide-autogel-lan-in-patients-pts-with-enteropancreatic-nets-results-from-clarinet-a-randomized-double-blind-placebo-pbo-controlled-study.html https://www.enets.org/abstract/well-differentiated-pancreatic-neuroendocrine-tumors-prognostic-significance-of-pathological-parameters.html https://www.enets.org/abstract/anti-tumor-efficacy-of-somatostatin-analogues-ssas-in-patients-with-neuroendocrine-tumors-nets-according-to-ki-67-score-a-multicentric-study-from-elios-educational-learning-investigational-observational-study.html https://www.enets.org/abstract/toward-a-preoperative-classification-of-mesenteric-lymph-node-metastases-for-better-selection-of-carcinoid-tumors-before-radical-surgery.html https://www.enets.org/abstract/topotecan-in-pretreated-metastatic-neuroendocrine-carcinoma.html https://www.enets.org/abstract/electron-microscopy-of-pancreatic-beta-cell-neuroendocrine-tumors-nets-in-multiple-endocrine-neoplasia-type-1-men1-knockout-mice-reveal-an-adenomatous-phenotype-with-depletion-of-insulin-granules-and-increased-mitochondrial-content.html https://www.enets.org/abstract/upregulation-of-somatostatin-receptor-type-2-expression-in-neuroendocrine-tumors-by-epigenetic-modulation.html https://www.enets.org/abstract/inducing-understanding-and-overcoming-resistance-to-everolimus-in-pancreatic-neuroendocrine-tumors.html https://www.enets.org/abstract/prognostic-value-of-somatostatin-receptor-scintigraphy-on-high-grade-neuroendocrine-neoplasms-and-impact-on-the-treatment-decision-of-intermediate-grade-neuroendocrine-neoplasms.html https://www.enets.org/abstract/characteristics-and-treatments-of-patients-with-g3-gastroenteropancreatic-neuroendocrine-tumors-g3-net-and-neuroendocrine-carcinoma-nec-a-european-multicenter-retrospective-study.html https://www.enets.org/abstract/elect-a-phase-3-study-of-efficacy-and-safety-of-lanreotide-autogel-lan-treatment-for-carcinoid-syndrome-cs-in-patients-pts-with-gastroenteropancreatic-neuroendocrine-tumors-gep-nets.html https://www.enets.org/abstract/parathyroid-hormone-related-peptide-pthrp-secretion-by-metastatic-gastroenteropancreatic-neuroendocrine-tumors-gep-net-clinical-features-diagnosis-management-and-long-term-follow-up.html https://www.enets.org/abstract/rectal-neuroendocrine-tumors-a-review-of-clinical-outcomes.html https://www.enets.org/abstract/vipomas-report-of-three-cases-in-ten-years.html https://www.enets.org/abstract/superior-mesenteric-vein-stenting-for-management-of-complications-of-mesenteric-desmoplasia-in-midgut-neuroendocrine-tumors.html https://www.enets.org/abstract/periampulary-and-pancreatic-neuroendocrine-neoplasms-with-duodenal-stromal-gastrointestinal-tumors-in-patients-with-type-1-neurofibromatosis-two-case-reports.html https://www.enets.org/abstract/expression-of-the-truncated-somatostatin-receptor-variant-sstr5tmd4-in-medullary-thyroid-carcinoma.html https://www.enets.org/abstract/evaluation-of-the-added-value-of-diffusion-weighted-imaging-to-conventional-mri-in-pancreatic-neuroendocrine-tumors-and-comparison-with-68ga-dotanoc-pet-ct.html https://www.enets.org/abstract/vimentin-and-e-cadherin-expression-in-primary-neuroendocrine-tumors-by-grade.html https://www.enets.org/abstract/ahcc-extract-which-potentially-can-attenuate-immunological-toxicity-in-patients-with-neuroendocrine-tumors-after-treatment-with-the-radioisotope-preparation-90y-dota-tate-an-initial-report.html https://www.enets.org/abstract/prolonged-progression-free-survival-with-extended-cycle-streptozotozin-5-fu-chemotherapy-in-patients-with-metastatic-pancreatic-neuroendocrine-tumors.html https://www.enets.org/abstract/primary-neuroendocrine-tumor-of-extrahepatic-bile-duct.html https://www.enets.org/abstract/phase-1-and-phase-2-clinical-trials-investigating-targets-against-the-molecular-hallmarks-of-gastroenteropancreatic-neuroendocrine-tumors.html https://www.enets.org/abstract/analysis-of-somatostatin-receptors-expression-in-neuroendocrine-tumors.html https://www.enets.org/abstract/predictive-biomarkers-of-response-in-patients-with-extrapulmonary-neuroendocrine-tumors-epnet-treated-with-platin-based-chemotherapy.html https://www.enets.org/abstract/neuroendocrine-tumor-of-the-appendix-in-pregnancy.html https://www.enets.org/abstract/good-clinical-response-to-a-somatostatin-analog-in-a-patient-with-metastatic-glucagonoma-and-necrolytic-migratory-erythema-5-year-follow-up.html https://www.enets.org/abstract/comparison-of-different-diagnostic-methods-for-the-assessment-of-progression-in-patients-with-neuroendocrine-tumors-net.html https://www.enets.org/abstract/intra-and-interobserver-reproducibility-of-ct-and-mri-for-measurement-of-liver-metastasis-as-a-basis-of-recist-evaluation-in-patients-with-neuroendocrine-tumors.html https://www.enets.org/abstract/tumor-perfusion-changes-during-everolimus-e-treatment-preliminary-results-from-perfusion-ct-p-ct-study.html https://www.enets.org/abstract/e-l-i-o-s-educational-learning-investigational-observational-study-an-initial-update-on-neuroendocrine-tumors-nets-in-the-southern-italy.html https://www.enets.org/abstract/forkheadbox-proteins-as-novel-drug-targets-in-gastroenteropancreatic-neuroendocrine-tumor-disease-inhibition-of-foxm1-exerts-antiproliferative-effects-in-gep-nen-cell-lines.html https://www.enets.org/abstract/retrospective-study-of-mibg-therapy-for-phaeochromocytoma-ph-and-paraganglioma-pg-the-christie-experience.html https://www.enets.org/abstract/signalling-pathways-in-bronchial-neuroendocrine-tumor-disease-and-its-translation-to-innovative-targets-the-new-kid-on-the-block.html https://www.enets.org/abstract/prognostic-value-of-histophathological-features-of-pancreatic-neuroendocrine-tumors.html https://www.enets.org/abstract/role-of-somatostain-receptor-scintigraphy-with-spect-ct-in-diagnosis-staging-and-follow-up-of-patients-with-neuroendocrine-tumors-nets.html https://www.enets.org/abstract/the-use-of-endoluminal-stents-to-overcome-vascular-obstruction-arising-from-mesenteric-and-retroperitoneal-neuroendocrine-metastases.html https://www.enets.org/abstract/normal-tissue-perfusion-changes-during-everolimus-treatment-preliminary-results-from-a-functional-vascular-study.html https://www.enets.org/abstract/stz-based-chemotherapy-is-associated-with-durable-response-rate-in-pancreatic-net-as-1st-or-2nd-line-treatment.html https://www.enets.org/abstract/streptozotocin-based-chemotherapy-is-still-alive-in-patients-with-neuroendocrine-neoplasms-predictive-and-prognostic-markers-for-treatment-und-survival.html https://www.enets.org/abstract/soluble-vcam-1-and-its-relation-to-clinical-staging-and-histological-grading-in-neuroendocrine-neoplasms-nens.html https://www.enets.org/abstract/predictive-factors-for-progression-free-survival-pfs-in-patients-with-advanced-pancreatic-neuroendocrine-tumors-pnet-treated-with-sunitinib.html https://www.enets.org/abstract/efficacy-of-lanreotide-autogel-in-men1-related-gastrinoma-a-case-series.html https://www.enets.org/abstract/evaluation-of-vegf-and-endocan-esm-1-expression-in-pnets-and-correlation-with-ki-67-and-prognosis.html https://www.enets.org/abstract/sunitinib-induced-hypocalcaemia-during-treatment-of-pancreatic-neuroendocrine-tumors-pnets.html https://www.enets.org/abstract/pancreatic-neuroendocrine-tumors-experience-in-a-spanish-reference-center.html https://www.enets.org/abstract/adrenal-tumors-in-patients-with-pancreatic-neuroendocrine-tumors.html https://www.enets.org/abstract/the-natural-history-of-an-apparently-aggressive-gastric-neuroendocrine-neoplasm-type-1.html https://www.enets.org/abstract/transarterial-chemoembolization-for-unresectable-liver-neuroendocrine-metastases.html https://www.enets.org/abstract/peptide-receptor-radionuclide-therapy-for-progressive-and-metastatic-neuroendocrine-tumors-analysis-of-efficacy-in-1000-patients-from-a-single-center.html https://www.enets.org/abstract/recurrent-carcinoid-valvulopathy-after-bioprosthetic-valve-surgery.html https://www.enets.org/abstract/streptozotocin-5-fluorouracil-stz-5fu-chemotherapy-in-g1-g2-pancreatic-neuroendocrine-tumors-pnets-single-institution-experience.html https://www.enets.org/abstract/minimally-invasive-surgery-for-pancreatic-neuroendocrine-tumors-why-notr.html https://www.enets.org/abstract/evaluation-of-patients-pts-with-neuroendocrine-tumors-at-first-cardiological-consultation-with-echocardiographic-echo-method-argentum-group.html https://www.enets.org/abstract/systemic-therapy-in-advanced-gastroenteropancreatic-neuroendocrine-tumors-gep-net-and-ki-index-5-10.html https://www.enets.org/abstract/chromogranin-a-cga-in-pheochromocytoma-and-in-multiple-endocrine-neoplasia-type-1.html https://www.enets.org/abstract/a-comparative-study-among-several-imaging-methods-for-the-detection-of-primary-and-metastatic-sites-of-gep-nets.html https://www.enets.org/abstract/clinico-biological-and-histological-predictive-factors-and-markers-of-response-to-everolimus-in-neuroendocrine-tumors.html https://www.enets.org/abstract/androgens-regulate-smad-ubiquitination-regulatory-factor-1-expression-and-prostate-cancer-cell-invasion.html https://www.enets.org/abstract/identification-of-novel-and-pathological-feature-of-angiostatic-microvasculature-in-liver-metastatic-pancreatic-neuroendocrine-tumors-and-its-clinical-implication.html https://www.enets.org/abstract/liver-transplantation-for-metastatic-hepatic-neuroendocrine-tumors-of-unknown-origin.html https://www.enets.org/abstract/abrogation-of-autophagy-by-chloroquine-in-neuroendocrine-tumor-cells-treated-with-mtor-inhibitors-induces-apoptosis-while-reduction-of-cell-proliferation-is-due-to-a-chloroquine-autophagy-unrelated-lysosomal-effect.html https://www.enets.org/abstract/co-expression-of-somatostatin-and-cxcr4-receptors-as-targets-for-diagnostics-and-treatment-in-intestinal-neuroendocrine-neoplasms.html https://www.enets.org/abstract/receptor-tyrosine-kinases-inhibition-new-insights-on-therapeutic-implications-of-egfr-and-igf1r-in-human-bronchopulmonary-net.html https://www.enets.org/abstract/tim16-inhibition-decreases-calcitonin-secretion-and-enhances-sensitivity-to-paclitaxel-in-a-human-medullary-thyroid-carcinoma-cells.html https://www.enets.org/abstract/surgical-management-of-carcinoid-valve-disease-mechanical-versus-tissue-valves.html https://www.enets.org/abstract/the-challenge-of-differential-diagnosis-of-solid-pancreatic-lesions-in-von-hippel-lindau-case-report.html https://www.enets.org/abstract/trends-in-neuroendocrine-tumor-in-friuli-venezia-giulia-in-the-last-20-years.html https://www.enets.org/abstract/unresectable-gastrointestinal-neuroendocrine-liver-metastases-treated-by-liver-directed-therapies.html https://www.enets.org/abstract/the-additional-value-of-somatostatin-receptor-scintigraphy-during-preoperative-staging-in-patients-with-non-functioning-pancreatic-neuroendocrine-tumors.html https://www.enets.org/abstract/optimal-surgical-treatment-of-pancreatic-neuroendocrine-tumors.html https://www.enets.org/abstract/recurrent-disease-after-curative-pancreatic-resection-for-patients-with-non-functional-neuroendocrine-tumor-identify-the-high-risk-patient.html https://www.enets.org/abstract/an-intrapatient-comparison-of-99mtc-hynic-toc-with-68ga-dota-tate-for-imaging-abilities-of-gastroenteropancreatic-neuroendocrine-neoplasms.html https://www.enets.org/abstract/appendiceal-goblet-cell-carcinoids-prognostic-factors-and-selection-of-the-most-appropriate-adjuvant-management-in-a-retrospective-series.html https://www.enets.org/abstract/pancreatic-neuroendocrine-tumor-and-ileal-carcinoid-in-acromegaly-pluriglandular-association-in-non-men-1-patient-a-case-report.html https://www.enets.org/abstract/radioembolization-with-90y-labelled-resin-microspheres-in-patients-with-liver-metastases-from-neuroendocrine-tumors.html https://www.enets.org/abstract/neuroendocrine-pancreatic-tumor-associated-with-a-cerebral-neurofibroma-a-case-report.html https://www.enets.org/abstract/long-term-outcomes-of-surgical-management-of-pancreatic-neuroendocrine-tumors-with-synchronous-liver-metastases.html https://www.enets.org/abstract/localisation-of-insulinoma-and-beta-cells-comparison-of-glucagon-like-peptide-1-receptor-glp1-r-spect-ct-pet-ct-and-mri-preliminary-results-of-a-prospective-clinical-study.html https://www.enets.org/abstract/epidemiologic-analysis-of-neuroendocrine-tumors-in-cancer-center-tianjin-china.html https://www.enets.org/abstract/genomic-profiling-of-metastatic-gastroenteropancreatic-neuroendocrine-tumor-gep-net-patients-in-precision-medicine-era.html https://www.enets.org/abstract/fifty-three-year-old-male-with-a-symptomatic-ileocecal-carcinoid-an-individual-follow-up-of-14-yrs-with-5-different-anti-proliferative-therapies.html https://www.enets.org/abstract/transcatheter-arterial-chemoembolization-for-unresectable-metastatic-hepatic-lesions-of-pancreatic-neuroendocrine-tumors.html https://www.enets.org/abstract/united-kingdom-net-patient-survey-quality-of-life-results.html https://www.enets.org/abstract/hypoglycaemia-in-a-patient-with-glucagonoma-coincidence-of-a-glucagonoma-and-insulinoma-in-a-patient-with-multiple-endocrine-neoplasia-type-i.html https://www.enets.org/abstract/development-of-effective-prophylaxis-against-intraoperative-carcinoid-crisis.html https://www.enets.org/abstract/functional-role-of-mir-196a-in-neuroendocrine-tumor-cells.html https://www.enets.org/abstract/the-impact-of-pharmacological-mediated-depletion-of-macrophages-in-pancreatic-neuroendocrine-neoplasms.html https://www.enets.org/abstract/gemox-or-alkylating-agents-in-neuroendocrine-tumorsr-the-help-of-o6-methylguanine-dna-methyltransferase-mgmt-statusr.html https://www.enets.org/abstract/telotristat-etiprate-in-a-subset-of-carcinoid-syndrome-patients-who-have-high-levels-of-urinary-5-hydroxyindoleacetic-acid-and-frequent-flushing.html https://www.enets.org/abstract/gastric-neuroendocrine-neoplasms-and-long-term-proton-pump-inhibitors-need-for-a-revision-of-classificationsr.html https://www.enets.org/abstract/subtype-classification-and-clinicopathological-characteristics-of-78-cases-with-gastric-neuroendocrine-neoplasms.html https://www.enets.org/abstract/pathological-factors-predicting-recurrence-of-the-non-functioning-pancreatic-net-after-resection.html https://www.enets.org/abstract/predictive-factors-for-antiproliferative-activity-of-octreotide-lar-in-advanced-neuroendocrine-tumors.html https://www.enets.org/abstract/the-clinical-oncology-society-of-australia-cosa-signeture-neuroendocrine-tumor-net-registry-of-australia-first-report-of-patient-characteristics-and-patterns-of-care.html https://www.enets.org/abstract/usefulness-of-a-combination-of-a-48-hour-fasting-and-a-glucagon-tolerance-test.html https://www.enets.org/abstract/filamin-a-is-required-for-somatostatin-receptor-2-sst2-stabilization-signaling-and-angiogenesis-regulation-in-gastroenteropancreatic-neuroendocrine-tumors.html https://www.enets.org/abstract/rwait-and-watchr-approach-for-small-pancreatic-neuroendocrine-tumors-pnets-prognosis-and-survival-in-51-consecutive-patients.html https://www.enets.org/abstract/signs-of-carcinoid-heart-disease-on-staging-ct-which-predictors-are-helpfulr.html https://www.enets.org/abstract/somatostatin-responsive-acth-and-precursor-excess-in-a-midgut-mesentery-net.html https://www.enets.org/abstract/ct-imaging-findings-of-gastric-neuroendocrine-neoplasm-according-to-2010-who-classification.html https://www.enets.org/abstract/evaluation-of-the-combination-oxaliplatin-and-5-fluorouracil-or-gemcitabine-in-patients-with-metastatic-lung-carcinoid-tumors.html https://www.enets.org/abstract/high-thyrocalcitonin-serum-level-in-neuroendocrine-tumors-characteristics-prognosis-and-interest-in-follow-upr.html https://www.enets.org/abstract/characterization-and-prognosis-of-patients-with-metastatic-lung-carcinoid-tumors.html https://www.enets.org/abstract/nets-in-hospital-registry-of-russian-cancer-center.html https://www.enets.org/abstract/pancreatic-neuroendocrine-tumors-in-denmark-and-introduction-of-cancer-package-pathways.html https://www.enets.org/abstract/antiproliferative-effect-of-lanreotide-in-low-grade-neuroendocrine-neoplasms-two-case-reports.html https://www.enets.org/abstract/mtor-down-stream-signaling-pattern-may-predict-pnet-response-to-everolimus.html https://www.enets.org/abstract/gastro-entero-pancreatic-mixed-adenoneuroendocrine-tumors-report-of-four-cases.html https://www.enets.org/abstract/functional-imaging-tests-versus-computed-tomography-scan-detection-of-new-metastases-and-clinical-usefulness-in-digestive-neuroendocrine-neoplasms-follow-up.html https://www.enets.org/abstract/role-of-tgf-beta-1-in-regulating-pancreatic-neuroendocrine-tumor-cell-viability.html https://www.enets.org/abstract/p27kip1-is-involved-in-the-resistance-of-human-bronchial-carcinoids-to-m-tor-inhibitors.html https://www.enets.org/abstract/ifnr-versus-ifnr-plus-octreotide-lar-in-treatment-of-nets.html https://www.enets.org/abstract/experience-of-two-european-centers-on-central-pancreatectomy-for-neuroendocrine-tumors-of-the-pancreas.html https://www.enets.org/abstract/38-years-of-experience-in-a-single-centre-on-neuroendocrine-pancreatico-duodenal-tumors-in-multiple-endocrine-neoplasia-type-1-syndrome.html https://www.enets.org/abstract/experience-with-bevacizumab-in-neuroendocrine-tumors.html https://www.enets.org/abstract/efficacy-of-topotecan-in-pretreated-metastatic-neuroendocrine-carcinoma.html https://www.enets.org/abstract/how-manage-multiple-small-bowel-neuroendocrine-tumorsr.html https://www.enets.org/abstract/epigenetic-manipulation-of-the-somatostatin-receptor-type-2-in-neuroendocrine-tumor-cells.html https://www.enets.org/abstract/177lu-dotatate-vs-sequential-177lu-dotatate-and-90y-dotatate-treatment-outcomes-for-prrt-patients-at-the-christie-a-clinical-audit.html https://www.enets.org/abstract/niacin-vitamin-b3-suppletion-in-patients-with-serotonin-producing-neuroendocrine-tumors.html https://www.enets.org/abstract/cyclin-dependent-kinase-inhibitor-2a-cdkn2a-p16-polymorphisms-and-risk-of-pancreatic-neuroendocrine-tumors.html https://www.enets.org/abstract/malignant-insulinoma-in-a-patient-with-diabetes-response-to-treatment-and-a-return-to-insulin-injections.html https://www.enets.org/abstract/first-line-chemotherapy-in-patients-with-metastatic-gastroenteropancreatic-neuroendocrine-carcinoma-gep-nec-a-retrospective-analysis.html https://www.enets.org/abstract/risk-and-protective-factors-for-midgut-carcinoid-tumours-a-case-control-study-of-prospectively-evaluated-patients.html https://www.enets.org/abstract/interlaboratory-variability-of-mib1-staining-in-well-differentiated-pancreatic-neuroendocrine-tumors.html https://www.enets.org/abstract/pre-prrt-uptake-on-68ga-dotatoc-predicts-good-prognosis-in-neuroendocrine-tumors-patients.html https://www.enets.org/abstract/salvage-treatment-with-peptide-receptor-radionuclide-therapy-prrt-in-patients-with-advanced-vipomas-and-severe-verner-morrison-syndrome.html https://www.enets.org/abstract/the-chicken-chorioallantoic-membrane-assay-as-a-preclinical-model-for-the-research-of-rare-gastrointenstinal-neuroendocrine-tumours.html https://www.enets.org/abstract/regression-of-paraneoplastic-optic-neuropathy-associated-with-glucagonoma-after-surgical-resection.html https://www.enets.org/abstract/expression-and-role-of-the-cxcr4-cxcl12-cxcr7-axis-and-crosstalk-with-the-mtor-pathway-in-neuroendocrine-tumors-nets.html https://www.enets.org/abstract/chemotherapy-with-capecitabine-plus-temozolomide-cap-tem-in-patients-with-advanced-neuroendocrine-neoplasms-nens-an-italian-multicenter-retrospective-analysis.html https://www.enets.org/abstract/autophagy-as-a-possible-mechanism-of-resistance-in-pnet-treatment.html https://www.enets.org/abstract/second-primary-malignancies-in-patients-with-neuroendocrine-tumors.html https://www.enets.org/abstract/a-novel-approach-for-a-metastatic-gut-derived-neuroendocrine-tumour-simultaenous-intestinal-and-vascularised-sentinel-forearm-flap-transplantation.html https://www.enets.org/abstract/ct-evaluation-of-gastric-neuroendocrine-neoplasm-based-on-who-2010-classification.html https://www.enets.org/abstract/cancer-stem-cells-in-small-intestine-neuroendocrine-cell-line-p-sts-isolation-and-molecular-characterisation.html https://www.enets.org/abstract/streptozotocin-based-chemotherapy-in-advanced-g2-pancreatic-neuroendocrine-tumors-pnet-efficacy-according-to-ki67-index.html https://www.enets.org/abstract/clinicopathological-features-and-prognostic-factors-of-gastric-neuroendocrine-tumors-a-retrospective-analysis-of-69-cases.html https://www.enets.org/abstract/is-there-an-additional-value-of-somatostatin-receptor-subtype-2a-immunohistochemistry-over-somatostatin-receptor-scintigraphy-in-predicting-gastroenteropancreatic-neuroendocrine-tumor-responser.html https://www.enets.org/abstract/gly388arg-fgfr4-polymorphysm-is-not-predictive-of-everolimus-efficacy-in-gastrointestinal-well-differentiated-neuroendocrine-tumors-net.html https://www.enets.org/abstract/retrospective-comparison-of-chemotherapy-treatment-with-capecitabine-alone-or-fluropirimidine-plus-oxaliplatin-in-advanced-and-pretreated-net.html https://www.enets.org/abstract/epidemiology-and-classification-of-gastroenteropancreatic-neuroendocrine-neoplasms-using-the-who-2010-criteria-a-cohort-study-in-a-defined-norwegian-population.html https://www.enets.org/abstract/clinicopathological-characteristics-and-long-term-survival-analysis-of-pancreatic-neuroendocrine-incidentalomas-an-experience-of-39-cases-from-a-single-chinese-institute.html https://www.enets.org/abstract/clinicopathologic-characteristics-of-gastric-amphicrine-carcinoma-at-a-single-institution.html https://www.enets.org/abstract/correlation-between-the-18f-fdg-uptake-and-pathological-data-in-well-differentiated-digestive-and-pulmonary-neuroendocrine-tumors-net.html https://www.enets.org/abstract/efficacy-of-prrt-in-metastatic-neuroendocrine-tumors-a-retrospective-large-single-institutional-study.html https://www.enets.org/abstract/long-term-follow-up-and-survival-data-in-progressing-advanced-midgut-neuroendocrine-tumors-following-peptide-receptor-radionuclide-therapy.html https://www.enets.org/abstract/zebrafish-as-a-new-in-vivo-model-to-study-angiogenesis-in-neuroendocrine-tumors-net.html https://www.enets.org/abstract/fdg-pet-as-a-prognostic-factor-in-pancreatic-neuroendocrine-tumors-p-net-after-peptide-receptor-radionuclide-therapy-with-177lu-dotatate-lu-prrt.html https://www.enets.org/abstract/expression-and-clinical-significance-of-merkel-cell-polyomavirus-large-t-antigen-in-merkel-cell-carcinoma.html https://www.enets.org/abstract/incidence-of-neuroendocrine-neoplasms-in-norway-a-report-of-16-258-cases-from-1993-through-2010.html https://www.enets.org/abstract/m-torc1-complex-is-significantly-over-activated-in-sdhx-mutated-paragangliomas.html https://www.enets.org/abstract/177lu-dotatate-re-treatment-in-g1-g2-gastro-entero-pancreatic-gep-nets.html https://www.enets.org/abstract/prognosis-of-stage-iv-gastroenteropancreatic-neuroendocrine-tumors-gep-net-according-to-the-who-classification-and-the-primary-tumor-location.html https://www.enets.org/abstract/role-of-cytoreductive-surgery-crs-and-intraoperative-hyperthermicintraperitoneal-chemotherapy-hipec-for-high-grade-neuroendocrine-tumour.html https://www.enets.org/abstract/the-role-of-external-beam-radiotherapy-in-the-management-of-advanced-neuroendocrine-tumors.html https://www.enets.org/abstract/small-bowel-neuroendocrine-tumors-net-relationship-between-radiologic-features-functionality-and-ki-67-classification.html https://www.enets.org/abstract/contrast-harmonic-endoscopic-ultrasonography-ch-eus-is-able-to-predict-aggressivity-in-pancreatic-neuroendocrine-tumors.html https://www.enets.org/abstract/staged-percutaneous-treatment-of-severe-carcinoid-heart-disease-by-transfemoral-pulmonary-valve-replacement-and-novel-vena-cava-valve-implantation.html https://www.enets.org/abstract/role-of-enteroclysis-mdtc-in-the-diagnosis-and-follow-up-of-ileal-neuroendocrine-tumors.html https://www.enets.org/abstract/incremental-benefit-of-preoperative-endoscopic-ultrasound-for-the-detection-of-pancreatic-neuroendocrine-tumors-a-meta-analysis.html https://www.enets.org/abstract/new-hybrid-spect-ct-modality-for-imaging-purposes-in-patients-with-medullary-thyroid-cancer-mtc.html https://www.enets.org/abstract/gastroenteropancreatic-and-thoracic-neuroendocrine-tumors-and-the-ectopic-adrenocorticotropin-syndrome.html https://www.enets.org/abstract/ectopic-cushingrs-syndrome-ecs-in-patients-with-neuroendocrine-neoplasms.html https://www.enets.org/abstract/aggressive-multi-modality-treatment-of-pancreatic-neuroendocrine-tumors-pnets-outcomes-in-patients-with-advanced-disease.html https://www.enets.org/abstract/the-association-between-gastrin-and-glucose-serum-concentration.html https://www.enets.org/abstract/somatostatin-analogues-in-bronchial-neuroendocrine-tumors-symptom-control-and-anti-proliferative-role.html https://www.enets.org/abstract/correlation-of-serum-plasma-chromogranin-a-with-survival-and-disease-features-in-patients-with-gastroenteropancreatic-neuroendocrine-tumors-first-results-in-a-large-database-in-argentina-argentum-group.html https://www.enets.org/abstract/ki67-as-a-prognostic-marker-in-neuroendocrine-tumours-a-systematic-review-of-the-literature-and-quantitative-synthesis-of-5-year-survival-data.html https://www.enets.org/abstract/optimal-clinical-effect-of-sandostatin-lar-treatment-for-gastroenteropancreatic-gep-carcinoid.html https://www.enets.org/abstract/platelet-serotonin-but-not-dopamine-concentrations-are-lower-in-pancreatic-neuroendocrine-tumor-and-renal-cell-carcinoma-patients-compared-to-healthy-individuals.html https://www.enets.org/abstract/gastric-neuroendocrine-neoplasias-outcome-predictors-enets-staging-and-grading-system-and-treatment.html https://www.enets.org/abstract/appendiceal-neuroendocrine-tumor-correlation-between-histopathological-factors.html https://www.enets.org/abstract/prognostic-role-of-diabetes-mellitus-dm-and-metformin-met-therapy-in-patients-pts-with-advanced-g1-g2-neuroendocrine-tumors-nets-treated-with-everolimus-eve.html https://www.enets.org/abstract/selective-internal-radiation-therapy-sirt-radioembolisation-with-90-yttrium-in-patients-with-unresectable-liver-neuroendocrine-metastases-in-a-specialized-center-an-initial-report.html https://www.enets.org/abstract/evaluation-of-features-and-predictors-for-long-term-hematologic-toxicity-in-neuroendocrine-patients-treated-with-peptide-receptor-radionuclide-therapy.html https://www.enets.org/abstract/characterisation-measurement-and-biodistribution-of-an-improved-formulation-of-lu-177-octreotate.html https://www.enets.org/abstract/cardiac-evaluation-as-part-of-the-initial-extension-studies-in-neuroendocrine-tumors-experience-in-a-multidisciplinary-team-argentum-group.html https://www.enets.org/abstract/a-phase-ii-study-of-everolimus-in-patients-with-fdg-pet-positive-intermediate-grade-ki67-3-20-pancreatic-neuroendocrine-tumor.html https://www.enets.org/abstract/mixed-adenoneuroendocrine-carcinomas-manecs-of-the-gastrointestinal-tract-argentum-group.html https://www.enets.org/abstract/exclusive-hotspot-mutation-of-yy1-gene-in-insulinomas-and-extensive-mutation-of-daxx-in-pnets.html https://www.enets.org/abstract/comparative-proteomic-analysis-of-human-insulinoma-and-its-clinical-implications-in-pancreatic-neuroendocrine-tumors.html https://www.enets.org/abstract/comparative-marker-assessment-in-small-cell-lung-cancer-with-good-and-poor-prognosis.html https://www.enets.org/abstract/mitotane-adrenolitic-drug-inhibits-cell-survival-and-function-of-several-pituitary-cytotypes.html https://www.enets.org/abstract/survival-and-predictors-of-death-for-patients-with-bronchopulmonary-carcinoids-in-a-danish-tertiary-net-center.html https://www.enets.org/abstract/discrepancy-between-radiologic-and-pathologic-measurements-in-pancreatic-neuroendocrine-tumors-a-retrospective-study-on-199-patients.html https://www.enets.org/abstract/mtor-pathway-inhibition-sensitizes-insulinoma-cells-to-streptozotocin-induced-apoptosis.html https://www.enets.org/abstract/cowden-syndrome-and-concomitant-pulmonary-neuroendocrine-tumor-a-presentation-of-two-cases.html https://www.enets.org/abstract/simultaneous-large-cell-neuroendocrine-carcinoma-and-adenocarcinoma-of-the-stomach-a-case-report-and-literature-review.html https://www.enets.org/abstract/revalidation-of-qlqc30-and-ginet21-module-in-patients-with-neuroendocrine-tumors-using-online-questionnaire.html https://www.enets.org/abstract/clinical-characteristics-and-treatment-outcome-of-six-advanced-g3-well-differentiated-neuroendocrine-tumors.html https://www.enets.org/abstract/dual-inhibition-of-pi3k-and-mtorc1-c2-by-pki-587-pf-05212384-as-a-promising-therapeutic-option-for-gastroenteropancreatic-neuroendocrine-tumor-disease-and-its-effect-on-akt-signaling.html https://www.enets.org/abstract/investigation-of-the-effects-of-sunitinib-on-pheochromocytoma-and-paraganglioma-primary-cultures.html https://www.enets.org/abstract/long-term-follow-up-of-resected-small-2-cm-asymptomatic-sporadic-non-functioning-pancreatic-neuroendocrine-tumors-correlation-between-type-of-resection-histopathologic-features-and-outcome.html https://www.enets.org/abstract/population-pharmacokinetic-pk-analysis-of-lanreotide-autogel-lan-in-the-treatment-of-patients-pts-with-nets-pooled-analysis-of-four-clinical-trials.html https://www.enets.org/abstract/clinical-and-pathologic-characteristics-of-small-cell-neuroendocrine-carcinoma-of-the-bladder.html https://www.enets.org/abstract/an-isolated-abnormal-chromogranin-b-is-associated-with-pancreato-duodenal-nets-and-the-presence-of-liver-metastases.html https://www.enets.org/abstract/treatment-satisfaction-symptom-control-and-quality-of-life-qol-with-lanreotide-autogel-lan-in-net-patients-with-carcinoid-syndrome-cs-results-from-the-symnet-study.html https://www.enets.org/abstract/a-phase-ii-study-of-axitinib-in-advanced-carcinoid-tumors-preliminary-results.html https://www.enets.org/abstract/a-novel-human-cell-line-from-familial-medullary-thyroid-carcinoma.html https://www.enets.org/abstract/significance-of-ectopic-lymph-node-like-structures-in-neuroendocrine-tumors-of-the-small-bowel.html https://www.enets.org/abstract/epirubicin-loaded-polyphosphazene-a-new-agent-against-small-intestinal-neuroendocrine-tumors-and-medullary-thyroid-carcinomas.html https://www.enets.org/abstract/establishment-of-a-new-human-pancreatic-neuroendocrine-tumour-cell-line.html https://www.enets.org/abstract/a-national-pathology-registration-analysis-of-applied-terminology-in-pulmonary-neuroendocrine-tumors-carcinomas-is-the-who-2004-classification-in-line-with-clinical-practicer.html https://www.enets.org/abstract/lanreotide-autogel-lan-120-mg-in-patients-with-progressive-enteropancreatic-ep-nets-data-from-the-clarinet-open-label-extension-ole-study.html https://www.enets.org/abstract/significance-of-atrx-daxx-expression-and-alternative-lengthening-of-telomeres-in-insulinomas-and-neuroendocrine-tumors-of-small-intestine.html https://www.enets.org/abstract/high-dose-treatment-with-somatostatin-analogs-in-neuroendocrine-tumors.html https://www.enets.org/abstract/antitumor-treatment-with-lanreotide-autogel-120-mg-lan-for-enteropancreatic-ep-net-update-from-the-clarinet-open-label-extension-ole-study.html https://www.enets.org/abstract/european-information-network-on-rare-cancers-rarecarenet.html https://www.enets.org/abstract/blood-gene-transcript-analysis-predicts-68ga-ssa-pet-ct-imaging-in-neuroendocrine-tumors-and-defines-disease-status.html https://www.enets.org/abstract/efficacy-of-lanreotide-versus-follow-up-in-early-stage-duodeno-pancreatic-neuroendocrine-tumors-nets-related-to-multiple-endocrine-neoplasia-type-1-men1-preliminary-data.html https://www.enets.org/abstract/clinical-characteristics-and-overall-survival-of-large-cell-neuroendocrine-carcinoma-lcnec-compared-to-other-subtypes-of-lung-cancer-results-of-a-population-based-registry.html https://www.enets.org/abstract/health-related-quality-of-life-hrqol-with-lanreotide-autogel-lan-120-mg-in-patients-with-enteropancreatic-ep-nets-post-hoc-analyses-from-the-clarinet-study.html https://www.enets.org/abstract/chromogranin-a-cga-and-pfs-outcomes-in-lanreotide-autogel-lan-in-patients-with-metastatic-enteropancreatic-ep-nets-data-from-the-clarinet-study.html https://www.enets.org/abstract/neuroendocrine-gene-transcript-analysis-of-blood-identifies-stable-or-progressive-net-disease-treated-with-somatostatin-analogs.html https://www.enets.org/abstract/cbez235z2401-randomized-phase-ii-study-of-bez235-or-everolimus-eve-in-patients-with-advanced-pancreatic-neuroendocrine-tumors-pnet.html https://www.enets.org/abstract/the-neuron-specific-enolase-assessment-in-patients-with-neuroendocrine-tumors-with-or-without-carcinoid-syndrome.html https://www.enets.org/abstract/role-of-combined-68ga-dotatoc-and-18f-fdg-pet-ct-in-the-diagnostic-workup-of-well-differentiated-pancreas-neuroendocrine-tumors-pannets-a-surgical-series.html https://www.enets.org/abstract/tumor-infiltrating-lymphocytes-and-pd-l1-expression-differ-in-low-and-high-grade-neuroendocrine-tumors.html https://www.enets.org/abstract/clinical-outcome-of-everolimus-treatment-of-advanced-neuroendocrine-neoplasms-rreal-lifer-data-from-the-german-net-register.html https://www.enets.org/abstract/results-of-sunitinib-treatment-of-advanced-neuroendocrine-neoplasms-rreal-lifer-outcome-data-from-the-german-net-register.html https://www.enets.org/abstract/role-of-amplifications-in-the-pik3-akt-mtor-pathway-in-neuroendocrine-tumors-of-the-small-intestine.html https://www.enets.org/abstract/atypical-bronchial-carcinoid-different-therapeutical-approachs.html https://www.enets.org/abstract/clinico-pathologic-and-survival-analysis-of-211-gastroenteropancreatic-g3-neuroendocrine-carcinomas-gep-necs.html https://www.enets.org/abstract/temozolomid-based-therapy-in-gep-and-bronchopulmonary-nen-from-a-multicentric-study-from-germany.html https://www.enets.org/abstract/two-cases-of-ectopic-acth-secreting-neoplasm-of-occult-origin-becoming-overt-after-bilateral-adrenalectomy.html https://www.enets.org/abstract/a-novel-men1-gene-variant-in-a-sporadic-case-of-multiple-endocrine-neoplasia-type-1.html https://www.enets.org/abstract/multidisciplinary-team-mdt-in-neuroendocrine-tumor-net-management-results-from-the-first-global-net-patient-pt-survey-a-collaboration-between-the-international-neuroendocrine-cancer-alliance-inca-and-novartis-pharmaceuticals.html https://www.enets.org/abstract/pancreatic-neuroendocrine-incidentalomas-when-is-surgery-in-the-patientrs-best-interestsr.html https://www.enets.org/abstract/perfusion-changes-in-liver-metastases-lm-from-pancreatic-neuroendocrine-tumors-pannets-during-everolimus-e-treatment-update-of-perfusion-ct-p-ct-study.html https://www.enets.org/abstract/lack-of-efficacy-of-anthracycline-containing-second-line-chemotherapy-in-patients-with-gi-nec-after-cisplatin-based-treatment.html https://www.enets.org/abstract/circulating-gene-transcript-analysis-of-pancreatic-nets.html https://www.enets.org/abstract/everolimus-eve-induced-hyperglycemia-hg-in-patients-pts-with-advanced-g1-g2-neuroendocrine-tumors-nets-clinical-relevance-and-predictive-value.html https://www.enets.org/abstract/initial-experience-with-robot-assisted-distal-pancreatectomy-for-pancreatic-neuroendocrine-neoplasms.html https://www.enets.org/abstract/describing-nens-just-clinical-biologic-features-or-actual-prognostic-factorsr.html https://www.enets.org/abstract/mesenteric-ischemia-due-to-neuroendocrine-tumors-of-the-digestive-tract.html https://www.enets.org/abstract/the-neuroendocrine-tumor-net-patient-pt-perspective-results-from-the-first-global-net-pt-survey-a-collaboration-between-the-international-neuroendocrine-cancer-alliance-inca-and-novartis-pharmaceuticals.html https://www.enets.org/abstract/everolimus-eve-for-advanced-progressive-pancreatic-neuroendocrine-tumors-pnet-final-overall-survival-os-from-a-randomized-double-blind-placebo-pbo-controlled-multicenter-phase-3-radiant-3-study.html https://www.enets.org/abstract/changes-in-neuroendocrine-tumor-microenvironment-with-who-tumor-grading.html https://www.enets.org/abstract/time-to-diagnosis-of-neuroendocrine-tumors-nets-results-from-the-first-global-net-patient-pt-survey-a-collaboration-between-the-international-neuroendocrine-cancer-alliance-inca-and-novartis-pharmaceuticals.html https://www.enets.org/abstract/pancreatic-location-high-proliferation-and-low-p-mtor-expression-levels-are-more-frequent-in-neuroendocrine-tumor-patients-responsive-to-mtor-inhibitors-results-from-a-preliminary-study.html https://www.enets.org/abstract/the-clinical-utility-of-blood-derived-gene-cluster-analysis-of-neuroendocrine-tumors-using-neoplasia-hallmark-criteria.html https://www.enets.org/abstract/a-randomized-open-label-phase-ii-study-of-everolimus-alone-or-in-combination-with-pasireotide-lar-in-advanced-progressive-pancreatic-neuroendocrine-tumors-pnet-cooperate-2-trial.html https://www.enets.org/abstract/everolimus-in-patients-pts-with-advanced-lung-carcinoids-evaluation-of-median-progression-free-survival-pfs-and-median-time-to-first-dose-decrease-or-discontinuation-ddd.html https://www.enets.org/abstract/follow-up-of-r-2-cm-non-functioning-pancreatic-nets-in-patients-with-men1-treated-with-conservative-approach.html https://www.enets.org/abstract/molecular-profiling-of-small-intestinal-neuroendocrine-tumours-sinets.html https://www.enets.org/abstract/measurement-of-blood-gene-transcripts-defines-prrt-therapeutic-efficacy.html https://www.enets.org/abstract/preliminary-results-on-the-diagnosis-of-nets-in-portugal-r-the-cross-sectional-tne-etc-survey.html https://www.enets.org/abstract/ga-68-somatostatin-receptor-pet-ct-in-the-detection-of-insulinoma.html https://www.enets.org/abstract/neuroendocrine-tumor-net-patient-pt-experience-and-disease-burden-results-from-the-first-global-net-pt-survey-a-collaboration-between-the-international-neuroendocrine-cancer-alliance-inca-and-novartis-pharmaceuticals.html https://www.enets.org/abstract/prognostic-role-of-fdg-pet-in-advanced-digestive-neuroendocrine-neoplasms.html https://www.enets.org/abstract/ca-19-9-a-novel-role-in-the-prognosis-of-pancreatic-neuroendocrine-tumors.html https://www.enets.org/abstract/100-cases-of-pancreatic-resections-for-pancreatic-neuroendocrine-tumors-the-royal-free-hospital-experience.html https://www.enets.org/abstract/the-belgian-dnet-registry-a-prospective-national-web-based-registry-of-digestive-neuro-endocrine-tumours-net-status-after-2-years-of-inclusion.html https://www.enets.org/abstract/management-and-clinical-outcome-of-patients-with-men-1-disease-presenting-non-functioning-pancreatic-neuroendocrine-neoplasms-nf-pnen-r-2-cm.html https://www.enets.org/abstract/risk-factors-for-survival-from-neuroendocrine-neoplasia-with-unknown-primary-tumor-site.html https://www.enets.org/abstract/use-of-everolimus-in-a-patient-with-metastatic-bronchial-carcinoid-receiving-hemodialysis.html https://www.enets.org/abstract/histological-classification-of-pancreatic-neuroendocrine-tumours-optimising-the-ki67-system.html https://www.enets.org/abstract/targeted-therapies-as-first-line-option-in-very-advanced-unresectable-pancreatic-neuroendocrine-tumors.html https://www.enets.org/abstract/health-related-quality-of-life-in-patients-after-diagnosis-of-nonfunctioning-asymptomatic-pancreatic-neuroendocrine-neoplasms-pnen-2-cm.html https://www.enets.org/abstract/epidemiological-characteristics-from-a-single-centre-database-cohort-of-1301-neuroendocrine-tumor-patients-is-there-an-association-between-age-and-grade-of-netr.html https://www.enets.org/abstract/neuroendocrine-carcinomas-of-the-prostate.html https://www.enets.org/abstract/everolimus-in-progressive-metastatic-pancreatic-neuroendocrine-tumors-analyses-of-median-progression-free-survival-and-safety-in-the-real-life-setting.html https://www.enets.org/abstract/identification-of-response-predictors-to-temozolomide-based-chemotherapy.html https://www.enets.org/abstract/68-yr-female-with-a-growing-inoperable-myocardial-metastase.html https://www.enets.org/abstract/recist-versus-choi-criteria-response-assesment-in-patients-with-advanced-pancreatic-neuroendocrine-tumor-pnet-treated-with-sunitinib.html https://www.enets.org/abstract/case-report-of-recurrent-vipoma.html https://www.enets.org/abstract/impact-of-vegf-and-vegfr-polymorphisms-on-neuroendocrine-tumors-of-the-gastro-entero-pancreatic-system-gep-net-outcome.html https://www.enets.org/abstract/test-1.html https://www.enets.org/abstract/biodistribution-and-radiation-dosimetry-of-a-novel-18f-fluoroethyl-triazole-tyr3-octreotate-analogue-for-pet-imaging-patients-with-advanced-neuroendocrine-tumours.html https://www.enets.org/abstract/radio-chemotherapy-versus-surgery-in-non-metastatic-ano-rectal-neuroendocrine-carcinoma-a-multicenter-study-by-the-association-des-gastro-enterologues-oncologues.html https://www.enets.org/abstract/a-novel-hereditary-pancreatic-neuroendocrine-tumor-syndrome-associated-with-biallelic-inactivation-of-the-glucagon-receptor.html https://www.enets.org/abstract/nets-in-russian-cancer-center-hospital-registry.html https://www.enets.org/abstract/characterization-and-rescue-of-a-pathogenic-d63n-mutant-human-glucagon-receptor-that-causes-a-pancreatic-neuroendocrine-tumor-syndrome-mahvash-disease.html https://www.enets.org/abstract/a-clinicopathological-study-of-malignant-insulinoma-in-a-contemporary-series.html https://www.enets.org/abstract/expressions-of-ck-19-and-cd117-in-hepatic-metastatic-pancreatic-nonfunctional-neuroendocrine-neoplasms.html https://www.enets.org/abstract/expressions-of-atrx-and-daxx-in-hepatic-metastatic-pancreatic-nonfunctional-neuroendocrine-neoplasms.html https://www.enets.org/abstract/immunohistochemical-expressions-in-hepatic-nonfunctional-neuroendocrine-neoplasms-with-unknown-origins.html https://www.enets.org/abstract/emergency-therapy-for-liver-metastases-from-advanced-vipoma-surgery-or-transarterial-chemoembolization.html https://www.enets.org/abstract/pretherapy-identification-of-patients-at-risk-of-receiving-a-high-renal-dose-undergoing-peptide-receptor-radionuclide-therapy.html https://www.enets.org/abstract/efficacy-and-safety-of-sunitinib-as-long-term-treatment-in-japanese-patients-with-advanced-pancreatic-neuroendocrine-tumors.html https://www.enets.org/abstract/prognostic-factors-for-recurrence-of-sporadic-pancreatic-neuroendocrine-tumors-after-surgical-resection.html https://www.enets.org/abstract/three-cases-of-ectopic-adrenocorticotropic-hormone-syndrome-due-to-medullary-thyroid-carcinoma.html https://www.enets.org/abstract/two-cases-of-parathyroid-cancer-with-pulmonary-metastasis.html https://www.enets.org/abstract/the-impact-of-pd-l1-expression-in-patients-with-metastatic-gep-nets.html https://www.enets.org/abstract/cea-level-radical-surgery-and-cd56-expression-are-prognostic-factors-for-patients-with-locoregional-gastrin-independent-gnet.html https://www.enets.org/abstract/clinicopathological-features-and-prognostic-factors-of-colorectal-neuroendocrine-neoplasms-in-china.html https://www.enets.org/abstract/bone-metastases-in-nen-patients-frequency-clinical-therapeutic-and-prognostic-relevance.html https://www.enets.org/abstract/telotristat-etiprate-appears-to-halt-carcinoid-heart-disease.html https://www.enets.org/abstract/tissue-prognostic-markers-in-pancreatic-neuroendocrine-tumours.html https://www.enets.org/abstract/carcinoid-tumors-presenting-as-appendicitis.html https://www.enets.org/abstract/aranoza-in-the-treatment-of-metastatic-neuroendocrine-tumors-nets-single-institution-experience.html https://www.enets.org/abstract/caregiversr-burden-of-patients-with-neuroendocrine-tumor-and-related-factors.html https://www.enets.org/abstract/long-term-follow-up-of-peptide-receptor-radionuclide-therapy-with-177lu-dotatate-in-advanced-well-differentiated-pancreatic-neuroendocrine-tumors.html https://www.enets.org/abstract/midkine-is-a-new-novel-serum-biomarker-in-small-intestinal-neuroendocrine-tumors-si-nets.html https://www.enets.org/abstract/epidemiology-survival-and-prognosis-of-neuroendocrine-tumors-a-multidisciplinary-single-center-study.html https://www.enets.org/abstract/double-balloon-enteroscopy-in-detecting-small-bowel-neuroendocrine-neoplasms-sb-nens.html https://www.enets.org/abstract/duodenal-neuroendocrine-tumors-r-data-from-a-single-centre.html https://www.enets.org/abstract/peritoneal-metastases-from-gastroenteropancreatic-neuroendocrine-tumors-frequency-treatment-and-prognosis.html https://www.enets.org/abstract/heterotopic-pancreas-mimicking-a-gastrointestinal-neuroendocrine-tumor-a-case-report.html https://www.enets.org/abstract/pharmacokinetic-pk-differences-between-subcutaneous-and-intramuscular-administration-of-lanreotide-results-from-a-phase-i-study.html https://www.enets.org/abstract/gastrointestinal-neuroendocrine-tumors-of-unknown-primary-site-report-from-a-series-at-a-single-institute.html https://www.enets.org/abstract/a-comparative-analysis-of-ki67-index-of-the-high-grade-neuroendocrine-neoplasms-arising-in-the-gastrointestinal-tract-and-the-pancreas.html https://www.enets.org/abstract/subtype-classification-and-clinicopathological-features-of-gastric-neuroendocrine-neoplasms-experiences-in-116-chinese-patients.html https://www.enets.org/abstract/vitamin-d-deficiency-as-a-risk-factor-in-pancreatic-neuroendocrine-neoplasms-report-from-a-series-at-a-single-institute.html https://www.enets.org/abstract/reduced-25-oh-vitamin-d-levels-in-patients-with-chronic-autoimmune-atrophic-gastritis.html https://www.enets.org/abstract/pd-l1-expression-is-associated-with-grade-of-neuroendocrine-tumors.html https://www.enets.org/abstract/how-long-is-the-piece-of-stringr-r-how-patients-negotiate-the-uncertainties-of-a-net-diagnosis.html https://www.enets.org/abstract/the-role-of-68ga-dota-noc-pet-in-evaluating-neuroendocrine-tumors-real-world-experience-from-single-lebanese-institution.html https://www.enets.org/abstract/the-role-of-hepatic-intra-arterial-therapies-in-metastatic-neuroendocrine-tumours-nets-a-specialist-center-experience.html https://www.enets.org/abstract/the-efficacy-and-safety-of-sunitinib-in-heavily-pretreated-patients-with-nets-national-cancer-research-center-experience.html https://www.enets.org/abstract/intra-operative-portal-vein-insulin-assay-combined-with-occlusion-of-the-pancreas-for-complicated-pancreatogenous-hypoglycemia.html https://www.enets.org/abstract/the-application-of-octreotide-in-a-sinet-patient-with-carcinoid-syndrome-carcinoid-heart-disease-and-carcinoid-crisis-a-case-report.html https://www.enets.org/abstract/efficacy-and-safety-of-targeted-agents-for-treatment-of-gastroenteropancreatic-gep-neuroendocrine-tumor-net-single-center-experience.html https://www.enets.org/abstract/temozolomide-based-second-line-chemotherapy-in-patients-with-advanced-bronchopulmonary-neuroendocrine-tumours.html https://www.enets.org/abstract/clinical-value-of-somatostatin-receptor-scintigraphy-in-the-management-of-medullary-thyroid-carcinoma.html https://www.enets.org/abstract/staging-of-neuroendocrine-tumors-value-of-hybrid-imaging-with-111in-pentetreotide.html https://www.enets.org/abstract/role-of-tsc22d1-tgfr-stimulated-clone-22-domain-family-member-1-in-bronchial-carcinoids.html https://www.enets.org/abstract/differential-somatostatin-and-cxcr4-chemokine-receptor-expression-in-primary-gastroenteropancreatic-neuroendocrine-neoplasms-gep-nen-and-their-metastases.html https://www.enets.org/abstract/budget-impact-of-somatostatin-analogs-ssas-as-treatment-for-metastatic-gastroenteropancreatic-neuroendocrine-tumors-mgep-nets-in-us-hospitals.html https://www.enets.org/abstract/analysis-of-18fdg-pet-ct-in-patients-with-gastrointestinal-neuroendocrine-neoplasm.html https://www.enets.org/abstract/prrt-for-malignant-pheochromocytomas-and-paragangliomas-the-singapore-general-hospital-experience.html https://www.enets.org/abstract/the-role-of-ga68-dotatoc-pet-ct-in-routine-screening-of-multiple-endocrine-neoplasia-type-1.html https://www.enets.org/abstract/expression-of-m-tor-pathway-components-in-gastric-neuroendocrine-neoplasms-a-pilot-study.html https://www.enets.org/abstract/systemic-treaments-and-prognostic-factors-in-chinese-patients-with-progressive-advanced-well-differentiated-pancreatic-neuroendocrine-tumors.html https://www.enets.org/abstract/dual-18f-fluorodeoxyglucose-68gallium-dotatate-fdg-dota-pet-predicts-overall-survival-in-neuroendocrine-tumours-net.html https://www.enets.org/abstract/current-trials-in-neuroendocrine-tumours-a-systematic-review.html https://www.enets.org/abstract/blood-based-prognostic-biomarkers-in-neuroendocrine-tumour-a-retrospective-study.html https://www.enets.org/abstract/epigenetic-remodeling-upon-daxx-and-atrx-loss-in-pancreatic-neuro-endocrine-tumors-pnets.html https://www.enets.org/abstract/c-reactive-protein-as-a-new-prognostic-factor-for-overall-survival-in-patients-with-pancreatic-neuroendocrine-neoplasia.html https://www.enets.org/abstract/genes-involved-in-angiogenesis-and-mtor-are-frequently-found-mutated-in-asian-patients-with-pancreatic-neuroendocrine-tumors.html https://www.enets.org/abstract/validation-of-lysyl-oxidase-like-2-loxl2-as-prognostic-marker-for-gastro-entero-pancreatic-neuroendocrine-tumours-gep-net-using-an-independent-cohort.html https://www.enets.org/abstract/value-of-octreoscan-and-18fdg-pet-for-clinical-prognosis-of-patients-with-neuroendocrine-neoplasms.html https://www.enets.org/abstract/men1-associated-thymic-neuroendocrine-tumors-in-oulu-university-hospital-finland.html https://www.enets.org/abstract/neuroendocrine-cancer-patient-experience-survey.html https://www.enets.org/abstract/are-eifs-ingredients-for-neuroendocrine-tumorigenesisr.html https://www.enets.org/abstract/iodinated-exendin-4-shows-improved-pharmacokinetic-in-rat-insulinoma-model.html https://www.enets.org/abstract/expression-of-oncofetal-protein-imp3-in-lymph-node-metastases-of-small-intestine-neuroendocrine-neoplasms-a-new-predictor-of-recurrence.html https://www.enets.org/abstract/somatostatin-receptor-pet-ct-with-radiolabelled-antagonist-is-twice-as-effective-as-the-agonist-for-detecting-liver-metastases-results-of-a-phase-i-ii-study-comparing-68ga-ops202-with-68ga-dotatoc-pet-ct-in-gastro-entero-pancreatic-neuroendocrine-tumor-p.html https://www.enets.org/abstract/detection-within-a-neuroendocrine-tumor-of-high-levels-of-b-lymphocyte-stimulator-blys-correlates-with-a-greater-disease-severity.html https://www.enets.org/abstract/clinical-nurse-specialist-in-net-patients-at-institut-catala-dr-oncologia-ico.html https://www.enets.org/abstract/is-screening-of-young-asymptomatic-men1-patients-necessaryr.html https://www.enets.org/abstract/the-men2b-due-to-de-novo-mutation-m918t-at-algiers.html https://www.enets.org/abstract/pancreatic-neuroendocrine-neoplasms-magnetic-resonance-imaging-features-and-correlation-with-their-histological-grade.html https://www.enets.org/abstract/the-symptoms-experienced-by-small-bowel-and-pancreatic-net-patients-prior-to-diagnosis-do-not-meet-the-criteria-for-a-functional-diarrhoea-ibs-d-diagnosis.html https://www.enets.org/abstract/nt-probnp-is-superior-to-st2-and-galectin-3-cardiac-markers-in-identifying-carcinoid-heart-disease-in-small-bowel-net-patients.html https://www.enets.org/abstract/efficacy-and-safety-of-telotristat-etiprate-in-patients-with-carcinoid-syndrome-not-adequately-controlled-by-somatostatin-analog-therapy-analysis-of-the-ongoing-telestar-extension-period.html https://www.enets.org/abstract/early-evaluation-of-sunitinib-in-treatment-of-advanced-gastroenteropancreatic-neuroendocrine-neoplasms-gep-nens-by-ct-imaging-recist-or-choi-criteriar.html https://www.enets.org/abstract/quality-of-life-qol-and-psycho-social-distress-in-patients-with-neuroendocrine-neoplasias-nen-r-correlation-with-tumor-stage-clinical-status-and-treatment.html https://www.enets.org/abstract/resection-of-the-primary-tumor-prior-to-peptide-receptor-radionuclide-therapy-improves-treatment-response-and-progression-free-survival-in-pancreatic-neuroendocrine-tumors-with-unresectable-liver-metastases.html https://www.enets.org/abstract/o6-methylguanine-dna-methyltransferase-mgmt-deficiency-and-response-to-aranoza-based-therapy-in-patients-with-neuroendocrine-tumors.html https://www.enets.org/abstract/use-of-lanreotide-lar-in-the-case-of-intolerance-of-octreotide-lar-in-patients-well-differentiated-nets.html https://www.enets.org/abstract/netazepide-a-gastrin-cck2-receptor-antagonist-can-eradicate-gastric-neuroendocrine-tumours-in-patients-with-autoimmune-chronic-atrophic-gastritis.html https://www.enets.org/abstract/analysis-of-18fdg-pet-ct-in-patients-with-pancreatic-neuroendocrine-tumor.html https://www.enets.org/abstract/interim-results-on-the-influence-of-lanreotide-on-uptake-of-68ga-dotatate-in-patients-with-metastatic-or-unresectable-net-no-evidence-for-discontinuation-of-lanreotide-before-68ga-dotatate-pet-ct.html https://www.enets.org/abstract/to-evaluate-patientrs-understand-of-the-neuroendocrine-net-multidisciplinary-team-mdt-meeting-process-at-a-enets-centre-of-excellence.html https://www.enets.org/abstract/management-of-controversial-gastroenteropancreatic-gep-neuroendocrine-tumour-net-clinical-situations-cs-with-somatostatin-analogues-ssas-results-of-a-delphi-questionnaire-q-panel-from-the-netpraxis-program.html https://www.enets.org/abstract/reassessment-of-proliferative-activity-at-disease-progression-in-neuroendocrine-neoplasms.html https://www.enets.org/abstract/to-evaluate-how-the-outcome-of-neuroendocrine-tumour-net-multidisciplinary-team-mdt-meeting-decisions-are-conveyed-to-patients-at-a-enets-centre-of-excellence-the-christie-and-how-this-service-can-be-further-improved.html https://www.enets.org/abstract/a-nation-wide-retrospective-epidemiological-study-of-gastroenteropancreatic-neuroendocrine-neoplasms-in-china.html https://www.enets.org/abstract/evaluation-of-the-somatostatin-cxcr4-chemokine-and-endothelin-a-receptor-expression-in-a-large-series-of-paragangliomas.html https://www.enets.org/abstract/resectable-primary-tumor-in-patients-with-pancreatic-neuroendocrine-tumors-located-to-the-body-or-tail-and-unresectable-liver-metastases-does-distal-pancreatectomy-improve-survivalr.html https://www.enets.org/abstract/access-to-care-and-outcomes-for-neuroendocrine-tumors-does-socio-economic-status-matterr-a-population-based-analysis.html https://www.enets.org/abstract/understanding-a-neuroendocrine-tumorsr-impact-on-health-systems-a-population-based-economic-analysis-of-patterns-of-costs.html https://www.enets.org/abstract/sunitinib-su-in-patients-with-advanced-progressive-pancreatic-neuroendocrine-tumors-pnet-final-overall-survival-os-results-from-a-phase-iii-randomized-study-including-adjustment-for-crossover.html https://www.enets.org/abstract/outcomes-of-cytoreductive-surgery-for-well-differentiated-metastatic-neuroendocrine-tumors-in-the-setting-of-extra-hepatic-metastases.html https://www.enets.org/abstract/a-case-series-of-27-primary-ovarian-neuroendocrine-tumors.html https://www.enets.org/abstract/patient-interviews-in-telestar-a-phase-3-study-of-telotristat-etiprate-report-meaningful-improvement-in-carcinoid-syndrome.html https://www.enets.org/abstract/epidemiology-of-nens-and-mirna-224-ldl-c-level-as-an-independent-risk-factor-in-jiangsu-peoplers-hospital.html https://www.enets.org/abstract/safety-and-compliance-of-capecitabine-and-temozolomide-in-patients-with-advanced-neuroendocrine-tumours.html https://www.enets.org/abstract/type-1-gastric-neuroendocrine-tumor-with-sapho-syndrome-effectively-treated-by-octreotidera-case-report.html https://www.enets.org/abstract/identifying-and-prioritising-gaps-in-neuroendocrine-tumour-research-results-of-the-delphi-consensus-project-of-the-commonwealth-neuroendocrine-tumour-research-collaboration-commnets.html https://www.enets.org/abstract/multicenter-retrospective-analysis-of-clinical-and-pathological-features-of-gallbladder-and-extrahepatic-biliary-duct-neuroendocrine-neoplasm.html https://www.enets.org/abstract/development-and-validation-of-nomogram-in-predicting-individualized-postoperative-survival-for-nonfunctional-pancreatic-neuroendocrine-tumors-a-multicenter-retrospective-study.html https://www.enets.org/abstract/evaluation-of-the-therapeutic-approaches-impacting-on-the-survival-of-patients-with-an-advanced-pancreatic-neuroendocrine-tumor.html https://www.enets.org/abstract/targeting-tumor-metabolism-in-nets-a-novel-mechanism-of-action-of-the-somatostatin-analog-lanreotide.html https://www.enets.org/abstract/efficacy-of-lutetium-177-dota-octreotate-peptide-receptor-radionuclide-therapy-in-patients-with-advanced-neuroendocrine-tumours-and-carcinoid-syndrome-refractory-to-somatostatin-analogues.html https://www.enets.org/abstract/clinical-utility-of-epcam-positive-circulating-tumor-cells-in-neuroendocrine-neoplasms-using-the-cellsearch-platform.html https://www.enets.org/abstract/exploring-the-rising-incidence-of-gastroenteropancreatic-neuroendocrine-tumors-according-to-the-data-from-regional-cancer-registry-a-population-based-analysis-of-epidemiology.html https://www.enets.org/abstract/commnets-formation-of-an-international-commonwealth-countries-net-partnership.html https://www.enets.org/abstract/thymic-neuroendocrine-neoplasia-therapy-with-everolimus.html https://www.enets.org/abstract/everolimus-in-pancreatic-neuroendocrine-carcinomas-g3.html https://www.enets.org/abstract/68ga-dotatoc-pet-and-gene-expression-profile-in-patients-with-neuroendocrine-carcinomas.html https://www.enets.org/abstract/the-role-of-interval-ct-scanning-in-patients-undergoing-palliative-chemotherapy-for-metastatic-neuroendocrine-tumours-nets.html https://www.enets.org/abstract/comparison-of-somatostatin-analogue-sa-and-chemotherapy-ct-in-neuroendocrine-tumors-net-patients-with-ki-67-r20.html https://www.enets.org/abstract/the-usefulness-of-assessment-the-serum-concentrations-of-vascular-endothelial-growth-factor-vegf-and-its-soluble-receptor-type-2-vegfr2-in-patients-with-neuroendocrine-neoplasm-nen.html https://www.enets.org/abstract/merkel-cell-carcinoma-of-the-knee-treated-with-somatostatin-analogue-and-radiotherapy-a-case-report.html https://www.enets.org/abstract/pancreatic-neuroendocrine-tumors-experience-of-a-tertiary-care-center.html https://www.enets.org/abstract/metastatic-neuro-endocrine-tumors-epidemiological-characteristics-management-and-prognostics-factors-results-from-an-inter-regional-network-in-france-between-upper-and-lower-normandy.html https://www.enets.org/abstract/evaluation-of-ct-prognostic-factors-of-neuroendocrine-liver-metastasis-treated-with-transcatheter-arterial-embolization.html https://www.enets.org/abstract/evaluation-of-the-concordance-between-the-stage-of-the-disease-and-ki-67-proliferation-index-in-gastroenteropancretic-neuroendocrine-tumors-gep-nets.html https://www.enets.org/abstract/assessment-of-the-growth-rate-of-paragangliomas-related-to-sdhx-gene-mutations-using-computed-tomography.html https://www.enets.org/abstract/18f-fdg-pet-ct-as-a-predictive-tool-for-response-to-chemotherapy-and-everolimus-treatment-in-patientes-with-pancreatic-neuroendocrine-tumour.html https://www.enets.org/abstract/appropriate-indication-of-organ-preserving-surgery-for-pancreatic-neuroendocrine-neoplasm.html https://www.enets.org/abstract/18f-fdg-pet-ct-heterogeneity-in-patients-with-metastatic-well-differentiated-pancreatic-neuroendocrine-tumours.html https://www.enets.org/abstract/gastroenteropancreatic-neuroendocrine-tumors-ten-year-experience-at-instituto-oncologico-nacional-panama-2004-2015.html https://www.enets.org/abstract/the-efficiency-of-sunitinib-in-chinese-patients-with-advanced-well-differentiated-pancreatic-neuroendocrine-tumor.html https://www.enets.org/abstract/folfox-in-neuroendocrine-tumors.html https://www.enets.org/abstract/nephrotoxicity-after-prrt-with-177lu-dota-octreotate.html https://www.enets.org/abstract/capecitabine-and-temozolomide-in-nets-g1-2-the-experience-of-various-hospitals-in-spain.html https://www.enets.org/abstract/ectopic-malignant-insulinoma-with-multiple-liver-metastases-a-case-report.html https://www.enets.org/abstract/favourable-responses-in-patients-with-bulky-neuroendocrine-tumours-net-a-personalised-approach-using-90y-dota-octreotate-sequenced-with-177lu-dota-octreotate-induction-peptide-receptor-chemoradionuclide-therapy-prcrt.html https://www.enets.org/abstract/how-long-should-we-look-up-for-recurrence-after-resection-of-pancreatic-neuroendocrine-tumorsr.html https://www.enets.org/abstract/clinical-epidemiology-study-of-gastric-neuroendocrine-neoplasms-in-china.html https://www.enets.org/abstract/the-difficulties-of-response-assessment-after-peptide-receptor-radionucleotide-therapy-prrt-an-unusual-case-of-symptomatic-pseudoprogression.html https://www.enets.org/abstract/a-single-centres-experience-of-cardiac-metastasis-from-neuroendocrine-tumours-net.html https://www.enets.org/abstract/3-drugs-chemotherapy-regimen-for-g3-pannens-with-ki67-below-55-single-institution-experience.html https://www.enets.org/abstract/the-relation-between-gep-nen-prognosis-re-stratification-and-ki-67-variability-from-a-single-institution-study.html https://www.enets.org/abstract/surgical-management-of-nonfunctioning-pancreatic-neuroendocrine-tumors-2-cm-or-less-in-size-results-from-a-multi-institutional-clinical-analysis-in-china.html https://www.enets.org/abstract/high-grade-gastroenteropancreatic-neuroendocrine-tumors-gep-net-instituto-oncologico-nacional-panama-city-panama-2004-2015.html https://www.enets.org/abstract/versatile-goblet-cell-carcinoma-of-the-appendix-a-case-presentation.html https://www.enets.org/abstract/everolimus-ev-plus-somatostatin-analog-ssa-administered-before-or-after-chemotherapy-ct-or-prrt-in-advanced-g1-g2-neuroendocrine-tumor-net-a-single-center-experience.html https://www.enets.org/abstract/merkel-cell-carcinoma-of-lymph-node-without-skin-primary-can-and-should-be-distinguished-from-others-metastatic-neuroendocrine-carcinoma.html https://www.enets.org/abstract/a-univariate-analysis-of-factors-influencing-survival-in-advanced-pancreatic-neuroendocrine-tumors.html https://www.enets.org/abstract/the-proteasome-inhibitor-bortezomib-is-a-highly-effective-treatment-option-for-gastroenteropancreatic-neuroendocrine-neoplasms-and-sensitizes-to-dna-damaging-therapy-in-vitro.html https://www.enets.org/abstract/capecitabine-temozolomide-in-g3-neuroendocrine-neoplasms.html https://www.enets.org/abstract/collision-tumor-of-the-appendix-mucinous-cystadenoma-and-carcinoid-a-case-report.html https://www.enets.org/abstract/nutritional-status-and-nutritional-risk-in-patients-with-neuroendocrine-tumors.html https://www.enets.org/abstract/epidemiological-factors-at-diagnosis-in-a-large-cohort-of-patients-with-small-bowel-neurondocrine-tumours.html https://www.enets.org/abstract/a-descriptive-cross-sectional-study-of-pain-in-patients-with-neuroendocrine-tumors.html https://www.enets.org/abstract/predictive-factors-for-survival-in-patients-with-advanced-small-bowel-neuroendocrine-tumours.html https://www.enets.org/abstract/role-of-preoperative-computed-tomography-ct-in-diagnostics-and-disease-stage-of-small-bowel-nen-correlation-with-pathology-based-on-ptnm-who-2010-classification.html https://www.enets.org/abstract/mir-196a-is-specifically-regulated-in-fdg-pet-positive-and-negative-small-intestinal-neuroendocrine-tumor-patients-at-late-stage-of-disease.html https://www.enets.org/abstract/everolimus-eve-treatment-for-advanced-g1-g2-neuroendocrine-tumours-nets-in-the-community-setting-clinical-benefit-irrespective-of-previous-therapies.html https://www.enets.org/abstract/non-functioning-adrenal-composite-pheochromocytoma-ganglioneuroma-simultaneous-with-subclinical-cushing-s-syndrome-due-to-contralateral-adrenal-hyperplasia-an-unusual-presentation.html https://www.enets.org/abstract/detection-of-sstr2-and-5-expression-on-circulating-tumour-cells-in-neuroendocrine-tumours.html https://www.enets.org/abstract/efficacy-of-peptide-receptor-radionuclide-therapy-in-patients-with-advanced-bronchial-neuroendocrine-tumours.html https://www.enets.org/abstract/everolimus-eve-safety-profile-in-patients-pts-with-advanced-g1-g2-neuroendocrine-tumours-nets-from-daily-clinical-practice.html https://www.enets.org/abstract/extra-pulmonary-neuroendocrine-carcinomas-a-national-population-based-study.html https://www.enets.org/abstract/long-term-renal-and-haematological-side-effects-in-net-patients-treated-with-lu-177-dotatate.html https://www.enets.org/abstract/a-new-immunohistochemistry-prognostic-score-ips-based-on-mgmt-ndrg-1-and-phlda-3-for-recurrence-and-survival-in-resected-pancreatic-neuroendocrine-tumors-pannet.html https://www.enets.org/abstract/oxaliplatin-based-chemotherapy-in-advanced-neuroendocrine-tumors-clinical-outcomes-and-preliminary-correlation-with-biological-factors.html https://www.enets.org/abstract/cystic-pancreatic-neuroendocrine-tumors-a-clinicopathologic-study-and-long-term-follow-up-after-surgical-resection-in-a-single-institution.html https://www.enets.org/abstract/multidisciplinary-management-and-patient-flow-in-neuroendocrine-tumors-net-consensus-of-a-tertiary-hospital.html https://www.enets.org/abstract/well-differentiated-non-functioning-neuroendocrine-tumours-of-the-pancreas-a-surgical-series-with-clinical-and-pathological-correlations.html https://www.enets.org/abstract/dosimetry-to-estimate-the-effect-of-gelofusine-on-the-renal-absorbed-dose-of-lutetium-177-dota-octreotate.html https://www.enets.org/abstract/pseudotumor-of-thymus-occuring-after-hypercortisolism-recovery-case-report.html https://www.enets.org/abstract/uncinatectomy-rethinking-the-surgical-approach-for-neuroendocrine-and-intraductal-papillary-mucinous-neoplasms-of-the-pancreas.html https://www.enets.org/abstract/factors-affecting-recurrences-of-the-non-functioning-pancreatic-net-after-resection.html https://www.enets.org/abstract/evaluate-the-accuracy-of-pathological-diagnosis-on-biopsy-specimens-from-gastrointestinal-neuroendocrine-tumors.html https://www.enets.org/abstract/cystic-neuroendocrine-tumors-of-the-pancreas-c-pnets-a-single-center-experience.html https://www.enets.org/abstract/expression-of-somatostatin-receptors-in-gastroenteropancreatic-neuroendocrine-neoplasm-and-multicenter-retrospective-clinical-study-of-octreotide-lar-in-the-treatment-of-advanced-gep-net.html https://www.enets.org/abstract/neutrophil-lymphocyte-ratio-predicts-survival-in-pancreatic-neuroendocrine-tumors.html https://www.enets.org/abstract/gastric-neuroendocrine-tumors-experience-in-a-chinese-general-hospital.html https://www.enets.org/abstract/ca19-9-as-a-prognostic-biomarker-in-pancreatic-neuroendocrine-tumors.html https://www.enets.org/abstract/gastric-neuroendocrine-tumors-from-clinicopathologic-to-immunophenotype-features.html https://www.enets.org/abstract/up-regulation-of-the-immunoregulatory-enzyme-indoleamine-2-3-dioxygenase-ido-with-consecutive-tryptophan-depletion-predicts-death-in-patients-with-neuroendocrine-neoplasia.html https://www.enets.org/abstract/efficacy-and-safety-of-everolimus-in-advanced-progressive-nonfunctional-neuroendocrine-tumors-net-of-the-lung-a-subgroup-analysis-of-the-phase-3-radiant-4-study.html https://www.enets.org/abstract/an-unusual-phenotype-of-multiple-endocrine-neoplasia-type-1-with-a-small-intestine-neuroendocrine-tumor-associated-with-large-deletion-of-the-men1-gene.html https://www.enets.org/abstract/sunitinib-in-the-treatment-of-unresectable-or-metastatic-gastroenteropancreatic-neuroendocrine-neoplasm-a-multicenter-retrospective-study-in-china.html https://www.enets.org/abstract/expression-and-clinical-significance-of-alpha-internexin-in-gastroenteropancreatic-neuroendocrine-neoplasm.html https://www.enets.org/abstract/epidemiology-and-treatment-strategy-of-neuroendocrine-neoplasms-in-north-china.html https://www.enets.org/abstract/somatic-variant-detection-in-circulating-cell-free-plasma-dna-of-patients-with-pancreatic-neuroendocrine-tumours.html https://www.enets.org/abstract/second-primary-malignancies-incidence-in-patients-with-neuroendocrine-tumours-r-retrospective-review-of-454-neuroendocrine-tumour-cases.html https://www.enets.org/abstract/clinical-characteristic-and-treatment-options-of-patients-with-g3-gastroenteropancreatic-neuroendocrine-neoplasms-in-china.html https://www.enets.org/abstract/morphological-differentiation-and-ki67-index-are-predictive-of-prognosis-independently-of-the-type-of-therapy-in-gastroenteropancreatic-neuroendocrine-carcinomas-necs.html https://www.enets.org/abstract/clinicopathologic-features-management-and-outcome-of-neuroendocrine-tumors-nets-in-men1-the-verona-multidisciplinary-planet-group.html https://www.enets.org/abstract/distribution-of-t-cell-infiltrate-in-g1-g2-and-g3-nens.html https://www.enets.org/abstract/promoting-high-quality-care-in-clinical-trials-for-patients-with-neuroendocrine-tumors-nets.html https://www.enets.org/abstract/chilean-neuroendocrine-tumours-hospital-registry-initial-data-of-a-latin-america-perspective.html https://www.enets.org/abstract/pancreatic-nens-2-cm-could-represent-a-new-entity-worth-of-further-investigation.html https://www.enets.org/abstract/prognosis-of-stage-iv-sporadic-pancreatic-neuroendocrine-tumors-pnet-tumor-slope-is-prognostic-together-with-tumor-burden-and-grade.html https://www.enets.org/abstract/clinicopathologic-features-treatments-and-survival-of-patients-with-ectopic-cushingrs-syndrome-from-neuroendocrine-tumors-data-from-an-italian-multicenter-study.html https://www.enets.org/abstract/everolimus-in-the-treatment-of-advanced-gastroenteropancreatic-neuroendocrine-neoplasm-a-single-center-retrospective-study-in-china.html https://www.enets.org/abstract/expression-of-mutated-p53-protein-in-gastroenteropancreatic-neuroendocrine-carcinoma-who-g3.html https://www.enets.org/abstract/retreatment-with-peptide-receptor-radionuclide-therapy-effects-on-long-term-survival-renal-and-bone-marrow-toxicity-using-yttrium-90-vs-lutetium-177.html https://www.enets.org/abstract/small-and-large-incidental-non-hyperfunctiong-pancreatic-neuroendocrine-tumors-spectrum-of-magnetic-resonance-imaging-features.html https://www.enets.org/abstract/does-faecal-occult-blood-testing-help-identify-ileo-colonic-nets-in-the-uk-bowel-cancer-screening-programme-bcsp-r.html https://www.enets.org/abstract/whole-exome-sequencing-of-three-families-with-small-intestine-neuroendocrine-tumors.html https://www.enets.org/abstract/cross-talk-between-egfr-and-igf1r-influences-the-response-to-rtk-inhibitors-in-bronchopulmonary-bp-net-cell-lines.html https://www.enets.org/abstract/graph-theoretic-definition-of-neuroendocrine-disease-r-a-tumor-specific-mathematical-toolbox-for-assessing-neoplastic-behaviour.html https://www.enets.org/abstract/a-case-of-multiple-pancreatic-insulinoma-laparoscopically-resected-through-precise-spatial-diagnosis-by-saci-test.html https://www.enets.org/abstract/assocation-between-mirnas-and-hdacs-in-pancreatic-neuroendocrine-tumors.html https://www.enets.org/abstract/delays-in-diagnosing-neuroendocrine-tumours-by-secondary-care-specialities.html https://www.enets.org/abstract/ifit-an-integrative-bioinformatics-platform-for-biomarker-and-target-discovery-a-case-study-in-neuroendocrine-tumors.html https://www.enets.org/abstract/evaluation-of-enets-and-ajcc-staging-systems-for-pancreatic-neuroendocrine-neoplasms-a-multicenter-study-in-china.html https://www.enets.org/abstract/theragnostic-approach-of-gastroenteropancreatic-neuroendocrine-tumors-gep-net-r-the-role-of-nuclear-medicine-nm-in-a-multidisciplinary-team.html https://www.enets.org/abstract/exploring-gastrointestinal-symptoms-and-their-impact-on-quality-of-life-in-patients-with-neuroendocrine-tumours.html https://www.enets.org/abstract/chemotherapy-for-stage-iv-sporadic-pancreatic-neuroendocrine-tumors-pnet-are-partial-responses-to-post-first-line-chemotherapy-predictable-by-response-type-of-first-line-chemotherapyr.html https://www.enets.org/abstract/neuroendocrine-pancreatic-tumors-secreting-calcitonin.html https://www.enets.org/abstract/long-term-outcomes-of-colorectal-neuroendocrine-tumors-a-sub-group-analysis-of-29-g3-cases-according-to-the-2010-who-classification.html https://www.enets.org/abstract/curative-resection-in-digestive-neuroendocrine-neoplasms-recurrence-free-survival-rate-and-definition-of-a-risk-score-for-recurrence.html https://www.enets.org/abstract/tumor-growth-rate-tgr-as-an-indicator-of-antitumor-activity-with-lanreotide-autogel-depot-lan-vs-placebo-pbo-in-intestinal-pancreatic-net-post-hoc-analysis-of-clarinet-data.html https://www.enets.org/abstract/efficacy-of-everolimus-and-somatostatin-analogs-as-single-agents-or-in-combination-in-human-pancreatic-neuroendocrine-tumors-primary-cultures.html https://www.enets.org/abstract/neuroendocrine-tumors-of-the-biliary-tract-a-retrospective-observational-multicenter-study.html https://www.enets.org/abstract/the-role-of-p27-in-pheochromocytoma-development.html https://www.enets.org/abstract/comparison-of-radiological-and-histological-tumor-size-in-pancreatic-neuroendocrine-neoplasm.html https://www.enets.org/abstract/systemic-treatment-sequences-across-europe-for-patients-pts-with-advanced-non-functional-nf-well-differentiated-pancreatic-neuroendocrine-tumours-wd-pnets.html https://www.enets.org/abstract/neuroendocrine-liver-metastasis-a-novel-nomogram-to-predict-patientrs-prognosis-after-liver-resection.html https://www.enets.org/abstract/duodenum-preserving-pancreatic-head-resection-for-neuroendocrine-pancreatic-tumors-of-the-head-of-the-pancreas.html https://www.enets.org/abstract/biomarker-and-target-identification-in-gep-net-from-in-silico-prediction-to-validation-on-patient-tissues.html https://www.enets.org/abstract/neuroendocrine-tumors-of-the-appendix-are-probably-harmless-neoplasms.html https://www.enets.org/abstract/validation-of-a-blood-neuroendocrine-tumor-gene-signature-the-netest-in-a-netherlands-net-cohort.html https://www.enets.org/abstract/minimally-invasive-versus-open-pancreatic-surgery-in-patients-with-multiple-endocrine-neoplasia-type-1.html https://www.enets.org/abstract/neuroendocrine-tumors-in-russia-net-observational-registry-data.html https://www.enets.org/abstract/chemoprevention-with-a-long-acting-somatostatin-analogue-in-a-multiple-endocrine-neoplasia-type-1-men1-knockout-mouse-model-does-delay-the-progression-of-pancreatic-neuroendocrine-neoplasms-pnens.html https://www.enets.org/abstract/the-clinical-utility-of-blood-neuroendocrine-gene-transcript-analysis-the-netest-in-paragangliomas-and-pheochromocytomas.html https://www.enets.org/abstract/even-malignant-appendiceal-neuroendocrine-tumors-exhibit-no-recurrent-chromosomal-alterations.html https://www.enets.org/abstract/do-medical-oncology-services-receive-more-patients-with-neuroendocrine-tumorsr-assessment-of-this-tendency-and-reflections-about-its-aid-complexity.html https://www.enets.org/abstract/prospective-validation-of-prognostic-score-in-high-grade-gastrointestinal-neuroendocrine-carcinomas-gi-necs.html https://www.enets.org/abstract/efficacy-and-tolerance-of-a-simplified-combination-of-streptozotocine-and-epi-adriamycine-in-metastatic-foregut-neuroendocrine-tumor-net-a-pilot-study.html https://www.enets.org/abstract/cdk-inhibitors-as-new-therapeutic-treatment-for-human-bronchial-carcinoids.html https://www.enets.org/abstract/everolimus-for-advanced-progressive-nonfunctional-neuroendocrine-tumors-net-of-the-gastrointestinal-gi-tract-efficacy-and-safety-from-a-radiant-4-subgroup-analysis.html https://www.enets.org/abstract/sequential-everolimus-and-sunitinib-treatment-in-pancreatic-metastatic-well-differentiated-neuroendocrine-tumors-resistant-to-prior-treatments.html https://www.enets.org/abstract/circulating-neuroendocrine-tumor-gene-signature-the-netest-defines-therapy-in-gep-nets.html https://www.enets.org/abstract/safety-and-efficacy-of-pasireotide-lar-pas-in-patients-with-advanced-neuroendocrine-tumors-net-findings-of-a-phase-i-multi-center-open-label-dose-escalation-study.html https://www.enets.org/abstract/efficacy-of-the-combination-of-capecitabine-and-temozolomide-in-patients-with-advanced-pulmonary-carcinoid-tumours.html https://www.enets.org/abstract/analysis-of-oesophageal-neuroendocrine-tumour-outcomes.html https://www.enets.org/abstract/inhibition-of-intestinal-neuroendocrine-tumor-by-a-new-marker-of-normal-neuroendocrine-cells.html https://www.enets.org/abstract/impact-of-prior-chemotherapy-chemo-on-progression-free-survival-pfs-in-patients-pts-with-advanced-nonfunctional-lung-or-gastrointestinal-gi-neuroendocrine-tumors-net-a-secondary-analysis-from-the-phase-3-radiant-4-study.html https://www.enets.org/abstract/impact-of-prior-somatostatin-analogue-ssa-use-on-progression-free-survival-pfs-in-patients-with-advanced-nonfunctional-neuroendocrine-tumors-net-of-lung-or-gastrointestinal-gi-origin-a-secondary-analysis-from-the-radiant-4-study.html https://www.enets.org/abstract/design-of-a-phase-3-international-prospective-randomized-double-blind-placebo-pbo-controlled-study-assessing-efficacy-and-safety-of-lanreotide-autogel-depot-lan-120-mg-in-patients-with-well-differentiated-advanced-typical-and-atypical-lung-nets.html https://www.enets.org/abstract/a-blood-based-multi-transcript-test-the-netest-predicts-and-defines-prrt-efficacy-in-neuroendocrine-tumors.html https://www.enets.org/abstract/somatostatin-analogs-and-mtor-inhibitors-as-radioprotectors-or-radiosensitizers-in-neuroendocrine-tumor-cells.html https://www.enets.org/abstract/the-cdk4-6-inhibitor-palbociclib-induces-anti-proliferative-mechanisms-in-gastroenteropancreatic-neuroendocrine-neoplasms-in-vitro.html https://www.enets.org/abstract/netter-1-phase-iii-in-patients-with-midgut-neuroendocrine-tumors-treated-with-177lu-dotatate-efficacy-and-safety-results.html https://www.enets.org/abstract/men1-syndrome-with-pancreatic-involvement-and-synchronous-lung-adenocarcinoma-a-case-report.html https://www.enets.org/abstract/prognosis-and-treatment-outcomes-of-patients-with-mixed-adenoneuroendocrine-carcinoma-manec.html https://www.enets.org/abstract/men1-related-glucagonomatosis-incidentally-revealed-during-management-of-recurrent-intestinal-obstruction-following-surgery-for-crohnrs-disease.html https://www.enets.org/abstract/type-i-gastric-neuroendocrine-tumors-diagnostics-16-years-of-experience.html https://www.enets.org/abstract/multimodal-endoscopic-diagnostics-of-gastric-type-i-neuroendocrine-tumors.html https://www.enets.org/abstract/number-and-localization-of-positive-lymph-nodes-correlate-with-recurrence-in-nonfunctioning-pancreatic-neuroendocrine-neoplasms-implications-for-surgery-staging-and-surveillance.html https://www.enets.org/abstract/pathomorphology-of-sporadic-medullary-thyroid-carcinoma-r-a-retrospective-analysis-for-a-period-of-10-years.html https://www.enets.org/abstract/multimodal-endoscopic-diagnostics-of-gastric-neuroendocrine-tumors.html https://www.enets.org/abstract/additional-value-for-urinary-5-hydroxyindoleacetic-acid-as-prognostic-marker-in-neuroendocrine-tumorsr.html https://www.enets.org/abstract/significance-of-preoperative-fdg-pet-ct-scan-in-patients-with-pulmonary-carcinoid-tumours.html https://www.enets.org/abstract/gastric-type-i-neuroendocrine-tumors-endoscopic-treatment-options.html https://www.enets.org/abstract/osteotropism-of-nets-role-of-the-sdf1-cxcr4-axis-in-regulating-emt.html https://www.enets.org/abstract/metastatic-disease-in-gastroenteropancreatic-neuroendocrine-cancer-incidence-treatment-and-survival.html https://www.enets.org/abstract/non-secreting-pancreatic-neuroendocrine-tumors-co-esistenting-with-acth-dependent-cushing-disease.html https://www.enets.org/abstract/multiregion-analysis-reveal-evolutionary-patterns-and-a-chromosomal-instability-signature-in-pancreatic-neuroendocrine-tumours.html https://www.enets.org/abstract/is-mtor-pathway-activity-a-good-predictor-for-everolimus-therapyr-a-pilot-study-to-build-up-a-phase-ii-trial-in-pancreatic-neuroendocrine-neoplasias-pnens.html https://www.enets.org/abstract/retrospective-review-of-single-centrers-experience-of-the-side-effects-reported-by-patients-receiving-everolimus-and-the-potential-implications-relating-to-patient-monitoring-and-education.html https://www.enets.org/abstract/therapeutic-strategies-in-patients-with-gastroenteropancreatic-neuroendocrine-neoplasms-gep-nen-results-from-the-national-neuroendocrine-cancer-registry-of-spain-r-getne.html https://www.enets.org/abstract/induction-and-maintenance-regimen-with-peptide-receptor-radionuclide-therapy-prrt-lu-177-dota-tate-lu-177-in-patients-with-advanced-neuroendocrine-tumours-net.html https://www.enets.org/abstract/medullary-thyroid-carcinoma-cell-lines-r-an-update.html https://www.enets.org/abstract/somatostatin-receptor-pet-ct-with-radiolabelled-antagonist-is-twice-as-effective-as-the-agonist-for-detecting-liver-metastases-results-of-a-phase-1-2-study-comparing-68ga-ops202-with-68ga-dotatoc-pet-ct-in-gastroenteropancreatic-net-patients.html https://www.enets.org/abstract/bizarre-neuroendocrine-tumour-presentations.html https://www.enets.org/abstract/epidemiology-pathological-features-and-clinical-outcome-of-gastroenteropancreatic-neuroendocrine-neoplasms-gep-nens-results-from-the-national-neuroendocrine-cancer-registry-of-spain-r-getne.html https://www.enets.org/abstract/chromogranin-a-in-the-follow-up-of-digestive-neuroendocrine-neoplasms-is-it-a-useful-biomarkerr.html https://www.enets.org/abstract/personalized-177lu-octreotate-peptide-receptor-radionuclide-therapy-prrt-allows-a-safe-and-significant-increase-of-radiation-dose-to-neuroendocrine-tumors-nets.html https://www.enets.org/abstract/vipomas-a-rare-entity.html https://www.enets.org/abstract/merkel-cell-carcinoma-r-epidemiology-data-from-the-czech-national-cancer-registry.html https://www.enets.org/abstract/antitumor-efficacy-of-temozolomide-in-patients-with-metastatic-pulmonary-carcinoids.html https://www.enets.org/abstract/safety-of-high-doses-lanreotide-treatment-in-patients-with-progressive-neuroendocrine-tumors-results-from-a-prospective-phase-ii-trial.html https://www.enets.org/abstract/slit-robo-signaling-links-to-ras-activity-to-suppress-metastasis-and-is-associated-with-time-to-progression-in-pancreatic-neuroendocrine-tumors.html https://www.enets.org/abstract/folfox-chemotherapy-efficacy-and-tolerability-in-advanced-digestive-neuroendocrine-neoplasms-nens.html https://www.enets.org/abstract/comparing-real-life-practice-to-established-guidelines-in-the-management-of-gasteroenteropancreatic-neuroendocrine-cancer-patients-a-tertiary-cancer-center-experience.html https://www.enets.org/abstract/selective-inhibition-of-pi3kalpha-byl719-promising-therapeutic-option-for-neuroendocrine-tumorsr.html https://www.enets.org/abstract/is-true-non-secretion-of-chromogranin-a-an-unfavorable-prognostic-factor-in-patients-with-enets-tnm-stage-iv-gastroenteropancreatic-neuroendocrine-tumorsr.html https://www.enets.org/abstract/immunohistochemical-expression-of-estrogen-and-progesterone-receptors-in-neuroendocrine-tumors.html https://www.enets.org/abstract/in-vivo-expression-of-survivin-and-xiap-in-medullary-thyroid-carcimoma.html https://www.enets.org/abstract/o6-methylguanine-dna-methyltransferase-mgmt-expression-by-immunochemistry-may-help-predict-response-to-streptozotocin-based-chemotherapy-in-pancreatic-neuroendocrine-tumours.html https://www.enets.org/abstract/neuroendocrine-tumours-of-the-thymus-a-report-of-four-cases.html https://www.enets.org/abstract/clinicopathological-features-and-prognosis-of-neuroendocrine-tumors-analysis-from-a-single-institution-in-brazil.html https://www.enets.org/abstract/ectopic-cushing-syndrome-in-a-patient-with-metastatic-medullary-thyroid-carcinoma.html https://www.enets.org/abstract/very-early-response-to-sunitinib-in-vhl-patient-with-pancreatic-neuroendocrine-tumor.html https://www.enets.org/abstract/establishment-and-characterization-of-three-gep-nec-cell-lines-for-in-vitro-and-in-vivo-studies.html https://www.enets.org/abstract/liver-transplantation-for-gastroenteropancreatic-neuroendocrine-tumors.html https://www.enets.org/abstract/a-novel-in-vitro-model-of-a-highly-proliferative-pancreatic-neuroendocrine-neoplasia.html https://www.enets.org/abstract/combination-of-lanreotide-autogel-and-temozolomide-in-patients-with-progressive-gastro-entero-pancreatic-neuroendocrine-tumours-gep-net-a-pilot-study.html https://www.enets.org/abstract/antitumor-activity-of-desmopressin-ddavp-and-the-new-analog-v4q5-ddavp-in-human-small-cell-lung-cancer.html https://www.enets.org/abstract/staging-in-small-bowel-neuroendocrine-tumours-roles-and-shortcomings.html https://www.enets.org/abstract/dual-high-throughput-proteomic-and-transcriptomic-screen-for-predictive-biomarkers-of-everolimus-sensitivity-in-pancreatic-net.html https://www.enets.org/abstract/multivisceral-transplantation-and-vascularised-sentinel-forearm-flap-for-a-metastatic-gut-derived-neuroendocrine-tumour-follow-up.html https://www.enets.org/abstract/mtor-controls-an-epigenetic-program-leading-to-autophagy-and-cell-growth-control.html https://www.enets.org/abstract/cannabinoids-as-inhibitor-of-tumour-growth-and-invasiveness-in-small-intestine-neuroendocrine-cancer.html https://www.enets.org/abstract/pd1-and-pdl1-expression-in-midgut-neuroendocrine-tumors.html https://www.enets.org/abstract/endoscopic-ultrasound-guided-radiofrequency-ablation-for-pancreatic-neoplasms.html https://www.enets.org/abstract/impact-of-early-surgery-on-prognosis-in-advanced-gastro-entero-pancreatic-neuroendocrine-tumours-gep-net.html https://www.enets.org/abstract/well-differentiated-pancreatic-neuroendocrine-tumors-wdpnet-g3-does-the-ki67-really-do-it-allr.html https://www.enets.org/abstract/molecular-imaging-of-late-somatostatin-receptorrpositive-metastases-of-renal-cell-carcinoma-in-the-pancreas-by-radiolabeled-111in-srs-octreotide-scan-a-rare-differential-diagnosis-to-multiple-primary-pancreatic-neuroendocrine-tumors.html https://www.enets.org/abstract/splicing-dysregulation-impacts-on-neuroendocrine-tumors-evidence-from-altered-spliceosoma-components-and-somatostatin-and-ghrelin-systems.html https://www.enets.org/abstract/pancreatic-neuroendocrine-tumors-experience-from-a-single-institute.html https://www.enets.org/abstract/neuroendocrine-neoplasm-of-the-colon-and-rectum-pathological-and-clinical-characteristics-based-on-ptnm-who-2010-classification.html https://www.enets.org/abstract/blood-measurement-of-net-transcripts-netest-predicts-well-differentiated-gastroenteropancreatic-net-disease-status-and-is-prognostic-for-disease-progression.html https://www.enets.org/abstract/peptide-receptor-radionuclide-therapy-prolongs-survival-in-neuroendocrine-neoplasms-a-single-centre-study-in-1048-patients-over-10-years.html https://www.enets.org/abstract/blood-gene-transcript-analysis-diagnoses-bronchopulmonary-nets-and-identifies-progressive-disease.html https://www.enets.org/abstract/study-of-the-biological-significance-of-the-igf-iec-mgf-in-well-and-poorly-differentiated-neuroendocrine-neoplasms.html https://www.enets.org/abstract/regulation-of-neuroendocrine-differentiation-by-growth-factor-induced-proliferation-in-a-well-differentiated-pancreatic-neuroendocrine-tumor-cell-line.html https://www.enets.org/abstract/somatostatin-receptors-profile-in-pulmonary-nets-associated-with-dipnech.html https://www.enets.org/abstract/ultrasound-guided-radiofrequency-ablation-of-liver-metastasis-in-two-cases-with-neuroendocrine-tumors.html https://www.enets.org/abstract/neuroendocrine-tumours-a-retrospective-analysis-in-a-single-irish-institution.html https://www.enets.org/abstract/peritoneal-carcinomatosis-in-digestive-neuroendocrine-neoplasms-complications-and-response-to-therapy.html https://www.enets.org/abstract/everolimus-cumulative-dose-and-dose-intensity-in-pancreatic-neuroendocrine-tumors.html https://www.enets.org/abstract/establishment-and-characterization-of-a-continuous-cell-line-from-a-human-familial-medullary-thyroid-carcinoma.html https://www.enets.org/abstract/the-impact-of-the-pathologic-differentiation-well-or-poorly-and-the-degree-of-ki-67-index-in-patients-with-metastatic-who-grade-3-gep-nets.html https://www.enets.org/abstract/evaluation-of-somatostatin-and-dopamine-receptor-subtype-2-expression-in-pancreatic-neuroendocrine-neoplasms.html https://www.enets.org/abstract/utility-of-serum-chromogranin-b-compared-with-chromogranin-a-as-a-biomarker-in-japanese-patients-with-pancreatic-neuroendocrine-tumors.html https://www.enets.org/abstract/the-clinical-pathological-characteristics-and-prognostic-factors-of-rectal-neuroendocrine-tumors-a-retrospective-analysis-based-on-multi-center-data.html https://www.enets.org/abstract/subtype-classification-and-clinicopathological-features-of-gastric-neuroendocrine-neoplasms-an-analysis-of-241-cases.html https://www.enets.org/abstract/incidence-and-characteristics-of-ileo-colonic-neuroendocrine-tumours-identified-in-the-uk-bowel-cancer-screening-programme.html https://www.enets.org/abstract/biomarkers-for-carcinoid-heart-disease.html https://www.enets.org/abstract/lrig1-was-down-regulated-in-medullary-thyroid-cancer-but-no-significant-effect-of-lrig1-was-found-in-ret2b-transgenic-mice-and-human-differentiated-thyroid-cancer.html https://www.enets.org/abstract/response-prediction-for-vandetanib-treatment-in-recurrent-medullary-thyroid-carcinoma-using-f18-fdg-pet.html https://www.enets.org/abstract/clinicopathologic-characteristics-and-survival-of-patients-with-gastro-enteropancreatic-neuroendocrine-neoplasm-gep-nen-in-a-multi-ethnic-asian-institution.html https://www.enets.org/abstract/treatment-of-metastatic-pancreatic-neuroendocrine-tumors-relevance-of-enets-2016-guidelines.html https://www.enets.org/abstract/patient-reported-preferences-in-treatments-approved-in-neuroendocrine-tumors-a-national-survey-from-the-french-group-of-endocrine-tumors.html https://www.enets.org/abstract/primary-neuroendocrine-carcinoma-of-the-breast-a-diagnostic-approach-to-the-special-type-of-breast-malignancy.html https://www.enets.org/abstract/role-of-ssa-in-the-management-of-multiple-type-1-gastric-neuroendocrine-neoplasms.html https://www.enets.org/abstract/the-epidemiological-study-of-neuroendocrine-neoplasmsr-a-single-center-retrospective-analysis-of-710-patients-in-china.html https://www.enets.org/abstract/pathological-features-of-high-proliferative-activity-neuroendocrine-tumor.html https://www.enets.org/abstract/triple-tracer-imaging-approach-for-the-non-invasive-assessment-of-chemokine-receptor-4-expression-in-gastroenteropancreatic-neuroendocrine-tumors.html https://www.enets.org/abstract/the-diagnostic-and-prognostic-value-of-plasma-cga-in-nonfunctional-pancreatic-neuroendocrine-neoplasms.html https://www.enets.org/abstract/the-exploration-of-the-clinical-value-of-plasma-cga-in-nonfunctional-gastroenteropancreatic-neuroendocrine-neoplasms.html https://www.enets.org/abstract/the-value-of-plasma-cga-combined-with-nse-performed-as-the-real-time-monitor-of-clinical-characteristics-in-gastroenteropancreatic-neuroendocrine-neoplasms-after-the-resection-of-primary-lesions.html https://www.enets.org/abstract/should-surgery-be-conducted-for-small-nonfunctioning-pancreatic-neuroendocrine-tumors-a-systemic-review.html https://www.enets.org/abstract/systematic-review-of-resecting-primary-tumor-in-mnets-patients-with-unresectable-liver-metastases.html https://www.enets.org/abstract/resection-of-liver-metastases-in-patients-with-high-grade-gastroenteropancreatic-neuroendocrine-carcinomas-a-nordic-multicenter-study.html https://www.enets.org/abstract/tumor-growth-rate-to-assess-tumor-activity-in-patients-with-lung-neuroendocrine-tumors-on-lanreotide-autogel-a-case-series-analysis.html https://www.enets.org/abstract/perioperative-carcinoid-crisis-during-surgery-who-benefits-from-octreotider.html https://www.enets.org/abstract/improving-outcomes-for-patients-with-resectable-small-bowel-net-tumours-five-year-experience-from-a-tertiary-centre.html https://www.enets.org/abstract/prognostic-relevance-of-pancreatic-neuroendocrine-tumors-grading-on-eus-fna.html https://www.enets.org/abstract/clinical-significance-of-incidental-detection-of-appendicular-neuroendocrine-tumours-in-sri-lanka.html https://www.enets.org/abstract/a-study-of-s1-temozolomide-stem-regimen-in-patients-with-metastatic-neuroendocrine-tumors.html https://www.enets.org/abstract/different-long-term-oncologic-outcomes-after-radical-surgical-resection-for-neuroendocrine-carcinoma-and-adenocarcinomas-of-stomachra-propensity-score-case-match-approach.html https://www.enets.org/abstract/what-matters-mostr-an-exploration-of-decision-criteria-considered-by-patients-with-gep-net-and-physicians-using-holistic-multi-criteria-decision-analysis.html https://www.enets.org/abstract/to-treat-or-watchr-identifying-drivers-of-decisions-for-patients-with-gep-net-using-reflective-multi-criteria-decision-analysis.html https://www.enets.org/abstract/the-positive-expression-of-pd-l1-pd-1-in-gastroenteropancreatic-neuroendocrine-neoplasias-correlates-with-prognosis.html https://www.enets.org/abstract/pure-alpha-fetoprotein-producing-pancreatic-neuroendocrine-tumors-a-case-report.html https://www.enets.org/abstract/the-role-of-hepatic-trans-arterial-chemoembolization-in-metastatic-medullary-thyroid-carcinoma-a-specialist-center-experience-and-review-of-the-literature.html https://www.enets.org/abstract/the-preoperative-blood-lymphocyte-to-monocyte-ratio-acts-as-a-superior-prognostic-factor-and-predicts-tumor-metastasis-in-gastric-neuroendocrine-neoplasms-after-surgery.html https://www.enets.org/abstract/trends-of-incidence-and-survivals-for-gastric-neuroendocrine-neoplasms-an-analysis-of-3523-patients-in-the-seer-database.html https://www.enets.org/abstract/preoperative-blood-neutrophil-to-lymphocyte-ratio-based-nomogram-predicts-lymph-node-metastasis-in-patients-of-resectable-pancreatic-neuroendocrine-tumors.html https://www.enets.org/abstract/the-effect-of-the-autophagy-inhibitor-chloroquine-cq-alone-or-in-combination-with-mtor-inhibitors-on-neuroendocrine-tumor-net-growth-and-metastatic-spread-in-mouse-models.html https://www.enets.org/abstract/3d-primary-cell-culture-a-new-promising-preclinical-model-for-pancreatic-neuro-endocrine-tumors-pnets.html https://www.enets.org/abstract/endoscopic-ultrasound-appearance-of-pancreatic-serotonin-staining-neuroendocrine-neoplasms-a-case-series.html https://www.enets.org/abstract/sdhb-mutation-in-a-young-patient-with-a-metastatic-paraganglioma-of-the-urinary-bladder.html https://www.enets.org/abstract/somatostatin-receptor-expression-in-adrenocortical-carcinoma.html https://www.enets.org/abstract/angiogenic-circulating-biomarkers-in-patients-with-advanced-pancreatic-neuroendocrine-tumors-treated-with-everolimus.html https://www.enets.org/abstract/pitfalls-in-the-response-evaluation-after-peptide-receptor-radionuclide-therapy-with-177lu-dota0-tyr3-octreotate.html https://www.enets.org/abstract/a-role-of-tets-and-5-hydroxymethylcytosine-in-si-nets.html https://www.enets.org/abstract/patient-satisfaction-regarding-home-injection-service-for-somatostatin-analogues-a-survey-among-patients-with-a-neuroendocrine-tumour.html https://www.enets.org/abstract/treatment-patterns-and-survival-among-patients-with-metastatic-gastroenteropancreatic-neuroendocrine-tumours-in-sweden-r-a-population-based-register-linkage-and-medical-chart-review-study.html https://www.enets.org/abstract/clinicopathological-features-and-survival-analysis-of-98-patients-with-gastroenteropancreatic-neuroendocrine-neoplasms.html https://www.enets.org/abstract/lung-carcinoid-role-of-nse-and-imaging-techniques-in-long-term-follow-up-of-malignancy-recurrence.html https://www.enets.org/abstract/renal-neuroendocrine-tumors-rnets-a-single-center-experience.html https://www.enets.org/abstract/national-cancer-intelligence-network-data-for-net-in-england-accuracy-by-comparison-to-a-large-clinical-database.html https://www.enets.org/abstract/expression-and-clinical-significance-of-somatostatin-receptor-subtype-2a-in-small-cell-lung-carcinoma.html https://www.enets.org/abstract/a-single-centre-analysis-of-the-management-of-appendiceal-neuroendocrine-neoplasms-nens-including-goblet-cell-carcinoids-gcc.html https://www.enets.org/abstract/a-case-report-of-bicaval-stents-and-inferior-vena-cava-valve-implantation-to-control-carcinoid-symptoms-in-order-to-safely-allow-surgical-valve-replacement.html https://www.enets.org/abstract/a-role-for-vitamin-d-in-the-gastro-entero-pancreatic-neuroendocrine-neoplasms-outcome-report-on-a-series-from-a-single-institute.html https://www.enets.org/abstract/establishment-of-japan-neuroendocrine-tumor-society-and-its-registration-system.html https://www.enets.org/abstract/the-clinical-significance-of-elevated-serum-procalcitonin-in-patients-with-gastroenteropancreatic-neuroendocrine-neoplasms.html https://www.enets.org/abstract/multicenter-analysis-of-the-clinicopathological-characteristics-and-prognosis-of-colonic-neuroendocrine-neoplasms.html https://www.enets.org/abstract/the-clinicopathological-characteristics-of-small-intestinal-neuroendocrine-neoplasms-a-multicenter-retrospective-study-from-china.html https://www.enets.org/abstract/investigating-the-increasing-incidence-of-neuroendocrine-tumors-in-pakistan-as-a-result-of-increased-awareness.html https://www.enets.org/abstract/two-separate-modified-enets-staging-classifications-are-needed-for-duodenal-and-jejunoileal-neuroendocrine-neoplasms.html https://www.enets.org/abstract/development-of-neuroendocrine-tumors-in-patients-with-a-family-history-of-net-or-any-other-cancer.html https://www.enets.org/abstract/the-clinicopathological-characteristics-and-prognosis-of-rectal-neuroendocrine-neoplasms-a-multicenter-retrospective-study-from-china.html https://www.enets.org/abstract/exploring-the-pathological-and-clinical-characteristics-of-neuroendocrine-tumors-located-in-pancreas.html https://www.enets.org/abstract/prognosis-and-incidence-in-pancreatic-and-gastrointestinal-neuroendocrine-neoplasms-with-emphasis-on-rnet-g3r-an-analysis-of-198-cases-from-japan.html https://www.enets.org/abstract/a-qualitative-exploration-into-the-experience-of-neuroendocrine-pancreatic-cancer-patients-receiving-molecular-targeted-therapies.html https://www.enets.org/abstract/classification-of-lung-neuroendocrine-neoplasms-lung-nens-according-to-who-2010-for-gastroenteropancreatic-nens-gep-nens-has-prognostic-relevance-and-includes-lung-nets-g3.html https://www.enets.org/abstract/presentation-of-a-neuroendocrine-tumor-of-breast-in-a-pakistani-%27iparous-woman.html https://www.enets.org/abstract/a-successful-case-of-controlling-the-multiple-distant-metastasis-of-pancreatic-g2-net-with-local-therapy-combined-with-systemic-pharmacotherapy.html https://www.enets.org/abstract/gallbladder-neuroendocrine-carcinoma-is-it-different-from-adenocarcinomar.html https://www.enets.org/abstract/pd-l1-expression-and-quantitative-assessment-of-tumor-infiltrating-t-cell-subsets-in-carcinoid-tumors-and-large-cell-neuroendocrine-carcinomas-of-the-lung.html https://www.enets.org/abstract/hsa-microrna-202-3p-up-regulated-in-type-1-gastric-neuroendocrine-neoplasms.html https://www.enets.org/abstract/meta-analysis-of-recurrence-after-curative-surgery-of-pancreatic-neuroendocrine-tumors.html https://www.enets.org/abstract/abdominal-obesity-fasting-glucose-and-metabolic-syndrome-are-risk-factors-for-well-differentiated-digestive-neuroendocrine-tumors.html https://www.enets.org/abstract/netter-1-phase-iii-trial-recent-findings-on-quality-of-life-in-patients-with-midgut-neuroendocrine-tumors.html https://www.enets.org/abstract/a-new-scoring-system-to-predict-recurrent-disease-in-grade-1-and-2-non-functional-pancreatic-neuroendocrine-tumors.html https://www.enets.org/abstract/multicenter-retrospective-analysis-of-clinical-and-pathological-features-of-gastroesophageal-junction-neuroendocrine-neoplasm-gej-nen.html https://www.enets.org/abstract/management-of-neuroendocrine-tumors-in-the-netherlands.html https://www.enets.org/abstract/pd-1-pd-l1-and-pd-l2-expression-in-well-differentiated-small-bowel-gastrointestinal-neuroendocrine-tumours-wd-sb-nets.html https://www.enets.org/abstract/primary-hyperparathyroidism-in-pregnancy-a-case-report.html https://www.enets.org/abstract/clinicohistopathological-features-and-treatment-outcomes-of-neuroendocrine-tumors-a-single-center-experience.html https://www.enets.org/abstract/international-multicenter-retrospective-study-on-the-efficacy-and-toxicity-of-radioembolization-in-neuroendocrine-tumours-with-yttrium-90-resin-microspheres.html https://www.enets.org/abstract/an-exploratory-patient-centric-analysis-of-the-elect-trial-a-phase-3-study-of-efficacy-and-safety-of-lanreotide-autogel-depot-lan-treatment-for-patients-pts-with-carcinoid-syndrome-cs.html https://www.enets.org/abstract/intraoperative-carcinoid-syndrome-during-small-bowel-net-surgery-description-prevalence-and-risk-factors.html https://www.enets.org/abstract/shear-wave-elastography-imaging-in-neuroendocrine-liver-metastases-preliminary-data-from-a-single-center.html https://www.enets.org/abstract/pancreatic-well-differentiated-neuroendocrine-tumor-with-grade-3-does-not-respond-to-platinum-based-chemotherapy-a-multicenter-study-of-neuroendocrine-carcinomas.html https://www.enets.org/abstract/pancreatic-net-g3-does-not-respond-to-platinum-based-chemotherapy-a-multicenter-study-of-neuroendocrine-carcinomas.html https://www.enets.org/abstract/the-prognostic-value-of-the-expression-of-cytokeratin-7-and-19-in-lungs-and-pancreas-neuroendocrine-tumors.html https://www.enets.org/abstract/18f-fdg-pet-to-discriminate-biologically-malignant-pancreatic-neuroendocrine-tumors.html https://www.enets.org/abstract/clinicopathological-features-and-prognosis-of-35-patients-with-gastric-neuroendocrine-carcinomas-a-single-center-experience.html https://www.enets.org/abstract/a-case-report-of-net-g1-of-the-gallbladder.html https://www.enets.org/abstract/a-better-ki-67-index-cutoff-to-redefine-low-grade-net-and-high-grade-nec-in-grade-3-gastroenteropancreatic-neuroendocrine-neoplasms.html https://www.enets.org/abstract/plasma-protein-fingerprinting-for-the-diagnosis-of-small-intestinal-neuroendocrine-tumors-sinets.html https://www.enets.org/abstract/a-multicenter-10-year-clinical-epidemiological-study-of-rectal-neuroendocrine-tumors-in-china.html https://www.enets.org/abstract/on-going-evaluation-of-the-clinical-utility-of-the-health-related-quality-of-life-hrqol-qlq-ginet21-questionnaire-qnr-in-the-treatment-of-patients-pts-with-gastrointestinal-gi-neuroendocrine-tumours-nets-qualinets-study.html https://www.enets.org/abstract/an-open-label-phase-ib-ii-study-of-sulfatinib-in-patients-with-advanced-neuroendocrine-tumors-nct02267967.html https://www.enets.org/abstract/assessment-of-small-intestinal-bacterial-overgrowth-sibo-in-net-patients.html https://www.enets.org/abstract/should-the-selective-arterial-secretagogue-injection-test-for-insulinoma-localization-be-evaluated-at-60-seconds-or-at-120-secondsr.html https://www.enets.org/abstract/distribution-of-68ga-ha-dotatate-and-68ga-dotatate-in-343-patients-not-the-same-after-all.html https://www.enets.org/abstract/characteristics-of-bronchopulmonary-carcinoids-in-cancer-centre-database-in-moscow.html https://www.enets.org/abstract/comparative-retrospective-analysis-of-pnets-treatment-with-everolimus-e-and-sunitinib-s.html https://www.enets.org/abstract/neuroendocrine-tumors-of-the-ampullary-region-a-rare-challenging-entity.html https://www.enets.org/abstract/diffusion-weighted-imaging-as-a-screening-tool-in-the-detection-and-monitoring-of-pancreatic-neuroendocrine-tumours-in-patients-with-familial-cancer-syndromes.html https://www.enets.org/abstract/prostate-specific-membrane-antigen-psma-uptake-in-a-pancreatic-neuroendocrine-tumor-pnet-bearing-patient.html https://www.enets.org/abstract/effectiveness-of-chemoterapy-in-advanced-pannets-with-ki67-55-monocentric-experience.html https://www.enets.org/abstract/implication-of-neuropilin-2-in-the-progression-of-small-intestinal-neuroendocrine-tumors-towards-a-promising-therapeutic-targetr.html https://www.enets.org/abstract/street-somatostatin-treatment-experience-trial.html https://www.enets.org/abstract/68ga-nodaga-exendin-4-pet-ct-for-the-localization-of-insulinomas-preliminary-data-from-a-prospective-multicenter-imaging-study.html https://www.enets.org/abstract/observational-study-of-small-pancreatic-neuroendocrine-incidentalomas-a-tertiary-referral-center-experience.html https://www.enets.org/abstract/survival-analysis-of-combined-therapy-with-177lu-octreotate-and-somatostatin-analogues-in-advanced-metastatic-neuroendocrine-tumours.html https://www.enets.org/abstract/epidemiological-factors-at-diagnosis-in-a-large-cohort-of-patients-with-pancreatic-neuroendocrine-tumours.html https://www.enets.org/abstract/predictive-factors-for-survival-in-patients-with-pancreatic-neuroendocrine-tumours.html https://www.enets.org/abstract/calm-net-a-multicentre-exploratory-study-to-assess-the-clinical-value-of-circulating-tumour-cells-ctcs-enumeration-in-patients-pts-with-functioning-midgut-nets-receiving-lanreotide-autogel-lan.html https://www.enets.org/abstract/recurrence-of-6mm-rectal-neuroendocrine-tumor-14-years-after-excision.html https://www.enets.org/abstract/trans-anal-minimally-invasive-surgery-tamis-for-completion-local-excision-of-well-differentiated-rectal-neuroendocrine-tumours.html https://www.enets.org/abstract/yttrium-90-radioembolization-for-progressive-medullary-thyroid-carcinoma-with-exclusive-liver-metastasis.html https://www.enets.org/abstract/enhanced-prognostication-of-grade-1-small-bowel-neuroendocrine-tumours-with-multi-parametric-clinicopathological-assessment.html https://www.enets.org/abstract/escalated-dose-somatostatin-analogues-for-anti-proliferative-effect-in-gastroenteropancreatic-neuroendocrine-tumours-gepnets-a-systematic-review.html https://www.enets.org/abstract/yttrium90-radioembolization-for-progressive-medullary-thyroid-carcinoma-with-exclusive-liver-metastasis.html https://www.enets.org/abstract/optimisation-of-the-size-variation-threshold-for-ct-evaluation-of-response-in-advanced-gastroenteropancreatic-neuroendocrine-tumors-treated-with-octreotide-lar.html https://www.enets.org/abstract/new-men-1-gene-mutation-implicated-in-familiar-men-1-syndrome-onset.html https://www.enets.org/abstract/evaluation-of-the-somatostatin-and-cxcr4-chemokine-receptor-expression-in-gastroenteropancreatic-neuroendocrine-neoplasms-gep-nen-of-different-origin.html https://www.enets.org/abstract/outcomes-of-hepatobiliary-neuroendocrine-neoplasms-treated-with-systemic-therapy-a-retrospective-analysis.html https://www.enets.org/abstract/safety-of-lanreotide-120-mg-atg-lan-in-combination-with-metformin-met-in-patients-pts-with-progressive-advanced-well-differentiated-wd-gastro-intestinal-gi-or-lung-carcinoids-a-pilot-one-arm-open-label-prospective-study-the-metnet-2-trial.html https://www.enets.org/abstract/a-long-term-complete-response-cr-of-avelumab-in-patient-pt-with-advanced-merkel-cell-carcinoma-mcc.html https://www.enets.org/abstract/ultrasonography-characteristics-of-hepatic-neuroendocrine-neoplasm.html https://www.enets.org/abstract/comparative-analysis-of-computed-tomography-features-in-pancreatic-neuroendocrine-neoplasms-pnens-with-different-pathological-grade-g1-and-g2.html https://www.enets.org/abstract/outstanding-response-to-sunitinib-in-a-patient-with-unresectable-retroperitoneal-paraganglioma.html https://www.enets.org/abstract/neuroendocrine-neoplasm-trends-over-32-years-in-queensland-australia.html https://www.enets.org/abstract/comparative-analysis-of-ct-features-in-pnens-with-different-pathological-grade-g1-and-g2.html https://www.enets.org/abstract/efficacy-of-lanreotide-lan-both-alone-and-in-combination-with-targeted-therapies-in-a-preclinical-model-of-pancreatic-neuroendocrine-tumors-pnets.html https://www.enets.org/abstract/follow-up-in-neuroendocrine-neoplasms-can-chromogranin-a-be-the-cofounderr.html https://www.enets.org/abstract/slit2-robo1-signaling-activates-ras-to-suppress-metastasis-and-is-associated-with-time-to-progression-in-pancreatic-neuroendocrine-tumors.html https://www.enets.org/abstract/the-role-of-mapk-signalling-in-pancreatic-neuroendocrine-cancer.html https://www.enets.org/abstract/sinonasal-neuroendocrine-small-blue-cell-tumour-snbct-presenting-with-bone-marrow-failure-r-a-very-rare-diagnostic-and-therapeutic-challenge.html https://www.enets.org/abstract/a-kinomic-approach-to-identify-signaling-proteins-involved-in-drug-resistance-in-gastroenteropancreatic-neuroendocrine-tumors.html https://www.enets.org/abstract/a-nomogram-consisted-of-routine-biochemical-tests-may-increase-the-diagnostic-accuracy-of-chromogranin-a-in-detecting-patients-with-neuroendocrine-tumors.html https://www.enets.org/abstract/complete-remission-of-hepatic-metastasis-after-total-gastrectomy-for-a-gastric-carcinoid-tumor-type-1-a-case-report.html https://www.enets.org/abstract/nucleolin-ncl-regulates-aerobic-glycolysis-in-pancreatic-neuroendocrine-tumor-p-net-bon-1-cells.html https://www.enets.org/abstract/folfiri-regimen-with-or-without-bevacizumab-as-second-line-therapy-showed-activity-in-patients-with-metastatic-gastroenteropancreatic-neuroendocrine-carcinoma.html https://www.enets.org/abstract/predictors-of-survival-in-patients-with-small-intestinal-neuroendocrine-tumours-sinets-associated-with-mesenteric-desmoplasia.html https://www.enets.org/abstract/high-rate-of-second-neoplasms-in-patients-with-a-bronchial-neuroendocrine-tumor.html https://www.enets.org/abstract/clinical-outcomes-in-small-neuroendocrine-tumours-treated-with-intestinal-surgery-in-tertiary-centre.html https://www.enets.org/abstract/clinical-characterization-of-patients-with-neuroendocrine-neoplasm-of-the-appendix-in-ireland-and-in-italy-a-retrospective-study-from-two-tertiary-institutions.html https://www.enets.org/abstract/external-validation-of-prognostic-classification-score-for-predicting-overall-survival-os-of-patients-pts-with-advanced-well-differentiated-neuroendocrine-tumour-wdnet-neuroendocrine-european-prognostic-score-nep-score-working-group.html https://www.enets.org/abstract/changes-in-the-frequency-and-epidemiology-of-the-gastroenteropancreatic-neuroendocrine-tumors-diagnosed-in-the-university-hospital-of-pleven-bulgaria-from-the-period-2010-to-november-2016.html https://www.enets.org/abstract/sunitinib-as-first-line-therapy-in-patients-with-advanced-pancreatic-neuroendocrine-tumors-experience-of-a-single-algerian-center.html https://www.enets.org/abstract/a-case-with-multiple-neuroendocrine-tumors.html https://www.enets.org/abstract/neuroendocrine-tumors-a-retrospective-analysis-in-a-single-algerien-institution.html https://www.enets.org/abstract/ki67-is-able-to-predict-pancreatic-nens-prognosis-irrespective-of-their-size.html https://www.enets.org/abstract/high-grade-gastroenteropancreatic-neuroendocrine-tumors-compare-to-neuroendocrine-carcinomas-in-276-patients.html https://www.enets.org/abstract/immune-related-factors-analysis-enhances-the-stratification-of-gep-nens-patients-into-distinct-prognostic-subsets.html https://www.enets.org/abstract/somatostatin-analogs-in-patients-with-multiple-endocrine-neoplasia-type-1-and-zollinger-ellison-syndrome-efficacy-and-safety.html https://www.enets.org/abstract/therapeutic-strategies-in-patients-with-neuroendocrine-neoplasm-30-month-follow-up-pf-long-survivors-from-eph-mostaganem-and-ehu-oran-medical-oncology.html https://www.enets.org/abstract/efficacy-and-safety-of-low-dose-vandetanib-in-metastatic-medullary-thyroid-cancer.html https://www.enets.org/abstract/safety-and-tolerability-of-ready-to-use-somakit-toc-68ga-dota0-tyr3-octreotide-68ga-dotatoc-for-injection-in-patients-with-proven-gastro-entero-pancreatic-neuroendocrine-tumours-gep-nets.html https://www.enets.org/abstract/the-efficacy-and-safety-of-sunitinib-in-patients-with-advanced-well-differentiated-pancreatic-neuroendocrine-tumors-focus-on-response-rate.html https://www.enets.org/abstract/incidentally-detected-pancreatic-neuroendocrine-microadenoma-with-lymph-node-metastasis.html https://www.enets.org/abstract/prevalence-of-carcinoid-heart-disease-in-patients-with-disseminated-small-intestinal-net.html https://www.enets.org/abstract/reminet-a-european-multicenter-phase-ii-iii-randomized-double-blind-placebo-controlled-study-evaluating-lanreotide-as-maintenance-therapy-after-first-line-treatment-in-patients-with-non-resectable-duodeno-pancreatic-neuroendocrine-tumors.html https://www.enets.org/abstract/use-of-tyrosine-kinase-inhibitors-in-medullary-thyroid-carcinoma-an-institutional-experience.html https://www.enets.org/abstract/management-of-men1-related-non-functioning-pancreatic-nets-a-shifting-paradigm-results-from-the-dutch-men1-study-group.html https://www.enets.org/abstract/videoconsultation-during-follow-up-care-of-patients-with-a-neuroendocrine-tumor.html https://www.enets.org/abstract/international-patient-survey-of-physical-emotional-and-informational-challenges-when-living-with-nets-understanding-the-unmet-needs.html https://www.enets.org/abstract/patterns-of-treatment-and-prognosis-of-gastroenteropancreatic-neuroendocrine-neoplasms-gep-nens-results-from-multicenter-database-of-china.html https://www.enets.org/abstract/minimal-risk-of-persistent-or-recurrent-hypoglycemia-after-men1-related-insulinoma-surgery-a-large-international-cohort-study.html https://www.enets.org/abstract/cytokines-as-predictive-factors-of-response-to-somatostatin-analogues-in-patients-with-neuroendocrine-tumour.html https://www.enets.org/abstract/nomogram-individually-predicts-the-overall-survival-of-patients-with-gastroenteropancreatic-neuroendocrine-neoplasms.html https://www.enets.org/abstract/expression-of-truncated-functional-subtype-5-somatostatin-receptor-variant-sst5tmd4-in-gep-nets-and-association-with-relevant-pathways-involved-in-net-tumorigenesis.html https://www.enets.org/abstract/clinical-outcomes-of-systemic-chemotherapy-in-patients-with-high-grade-neuroendocrine-carcinoma-of-biliary-tract.html https://www.enets.org/abstract/report-on-the-clinicopathological-characteristics-of-548-romanian-patients-with-neuroendocrine-tumors-treated-with-somatostatin-analogs.html https://www.enets.org/abstract/potential-therapeutic-targets-for-gastric-poorly-differentiated-neuroendocrine-carcinoma.html https://www.enets.org/abstract/external-beam-radiotherapy-ebrt-in-the-treatment-of-gastroenteropancreatic-neuroendocrine-tumors-a-systematic-review.html https://www.enets.org/abstract/tumour-size-is-not-a-reliable-criterion-for-resection-of-patients-with-non-secreting-pancreatic-neuroendocrine-tumours-results-of-an-international-multi-centre-operative-cohort.html https://www.enets.org/abstract/chemotherapy-for-pulmonary-large-cell-neuroendocrine-carcinomas-does-the-regimen-matterr.html https://www.enets.org/abstract/large-cell-metastatic-pancreatic-neuroendocrine-carcinoma-treated-with-somatostatin-analogues.html https://www.enets.org/abstract/pd-l1-is-expressed-in-a-subset-of-pancreatic-neuroendocrine-tumors-pnet.html https://www.enets.org/abstract/clinical-characteristics-and-treatment-outcome-of-advanced-g3-gastroenteropancreatic-neuroendocrine-carcinoma-gep-nec-a-retrospective-analysis.html https://www.enets.org/abstract/small-cell-metastatic-ascending-colon-neuroendocrine-carcinoma.html https://www.enets.org/abstract/gastroenteropancreatic-high-grade-neuroendocrine-carcinomas-a-seer-database-analysis-of-6291-cases.html https://www.enets.org/abstract/peptide-receptor-radionuclide-therapy-prrt-for-treatment-of-functional-and-metastatic-phaeochromocytoma-pcc-and-paraganglioma-pgl.html https://www.enets.org/abstract/eterogeneity-of-duodenal-neuroendocrine-tumors-a-multi-centre-experience-in-italy.html https://www.enets.org/abstract/targeted-therapies-tt-sunitinib-and-everolimus-for-advanced-gastroenteropancreatic-neuroendocrine-tumors-gep-net-a-case-series.html https://www.enets.org/abstract/towards-personalizing-prrt-with-177lu-dotatate-to-minimise-renal-toxicity-in-neuroendocrine-tumour-patients.html https://www.enets.org/abstract/prospective-observational-study-1-on-the-prognosis-of-patients-with-unresectable-advanced-gastrointestinal-and-pancreatic-neuroendocrine-tumors-prop-up-1-study-in-japan.html https://www.enets.org/abstract/fdg-pet-is-superior-to-who-grading-in-predicting-overall-survival-of-patients-with-neuroendocrine-tumors-a-prospective-study-of-172-patients.html https://www.enets.org/abstract/lanreotide-autogel-depot-lan-in-lung-neuroendocrine-tumours-nets-the-randomized-double-blind-placebo-pbo-controlled-international-phase-3-spinet-study.html https://www.enets.org/abstract/treatment-and-survival-of-351-patients-diagnosed-with-merkel-cell-carcinoma-in-2-melanoma-and-neuroendocrine-tumor-expert-centers-in-the-netherlands.html https://www.enets.org/abstract/results-from-a-phase-2-open-label-multicenter-randomized-study-of-the-novel-octreotide-oct-subcutaneous-sc-depot-formulation-in-patients-with-functioning-neuroendocrine-tumors-nets-and-acromegaly-previously-treated-with-long-acting-octreotide.html https://www.enets.org/abstract/typical-bronchial-neuroendocrine-tumours-with-advanced-disease-a-misleading-biology.html https://www.enets.org/abstract/an-open-label-phase-ii-study-to-evaluate-the-efficacy-and-safety-of-pdr001-in-patients-with-advanced-well-differentiated-non-functional-net-of-pancreatic-gastrointestinal-gi-or-thoracic-origin-who-have-progressed-on-prior-treatment.html https://www.enets.org/abstract/safety-and-efficacy-of-14-day-dosing-interval-of-lanreotide-autogel-depot-lan-for-patients-wth-pancreatic-or-midgut-neuroendocrine-tumours-nets-progressing-on-lan-every-28-days-the-prospective-open-label-international-phase-2-clarinet-forte-study.html https://www.enets.org/abstract/pilot-electronic-survey-to-locate-nurses-caring-for-net-patients-in-europe.html https://www.enets.org/abstract/validation-and-comparison-between-current-prognostication-systems-for-pancreatic-neuroendocrine-neoplasms-single-institution-experience-with-176-patients.html https://www.enets.org/abstract/peptide-receptor-radionuclide-therapy-prrt-with-a-somatostatin-receptor-sstr-antagonist-in-patients-with-sstr-positive-progressive-neuroendocrine-tumours-nets-a-phase-i-ii-open-label-trial-to-evaluate-the-safety-and-preliminary-efficacy-of-177lu-o.html https://www.enets.org/abstract/sensitivity-of-glucagon-like-peptide-1-receptor-glp1-r-spect-ct-pet-ct-and-mri-for-the-localization-of-benign-insulinomas-interim-analysis-of-a-prospective-imaging-efficacy-study.html https://www.enets.org/abstract/type-3-gastric-neuroendocrine-neoplasms-relationship-between-tumor-size-ki67-and-clinical-outcome.html https://www.enets.org/abstract/open-label-multicentre-single-arm-phase-2-trial-of-lanreotide-autogel-lan-in-combination-with-temozolomide-tmz-in-patients-with-advanced-well-moderately-differentiated-neuroendocrine-tumours-nets-of-lung-and-thymus-atlant.html https://www.enets.org/abstract/application-of-parametric-contrast-enhanced-ultrasound-for-early-treatment-response-evaluation-in-metastatic-hepatic-neuroendocrine-neoplasm.html https://www.enets.org/abstract/epidemiology-of-carcinoid-heart-disease-chd-in-patients-pts-with-carcinoid-syndrome-cs-a-systematic-literature-review.html https://www.enets.org/abstract/adherence-to-who2010-guideline-for-diagnosis-of-neuroendocrine-carcinoma-and-prognostic-significance.html https://www.enets.org/abstract/lanreotide-autogel-depot-lan-in-combination-with-peptide-receptor-radionuclide-therapy-prrt-in-progressive-digestive-and-lung-neuroendocrine-tumours-nets-design-of-the-prelude-study.html https://www.enets.org/abstract/what-do-we-know-about-carcinoid-heart-diseaser-a-systematic-literature-review.html https://www.enets.org/abstract/foxm1-is-strongly-associated-with-cell-proliferation-and-is-not-influenced-by-metabolic-syndrome-in-gep-nets.html https://www.enets.org/abstract/safety-and-tolerability-of-lanreotide-autogel-depot-lan-in-patients-pts-with-neuroendocrine-tumours-nets-pooled-analysis-of-clinical-studies.html https://www.enets.org/abstract/correlation-of-plasma-p-and-urine-u-5-hiaa-levels-in-patients-pts-with-carcinoid-syndrome-cs-r-post-hoc-analyses-from-the-telestar-study.html https://www.enets.org/abstract/determination-of-an-optimal-response-cut-off-to-predict-progression-free-survival-pfs-in-patients-pts-with-well-differentiated-advanced-pancreatic-neuroendocrine-tumours-pnets-treated-with-sunitinib-s-an-alternative-to-the-current-recist-response.html https://www.enets.org/abstract/predictors-of-outcome-in-patients-treated-with-peptide-radio-labelled-receptor-target-therapy-prrt.html https://www.enets.org/abstract/micrornas-associated-with-small-bowel-neuroendocrine-tumours-and-their-metastases.html https://www.enets.org/abstract/multivisceral-transplantation-and-vascularised-sentinel-forearm-flap-for-a-metastatic-small-bowel-neuroendocrine-tumour-update-on-follow-up.html https://www.enets.org/abstract/dosimetric-analyses-of-patients-with-metastatic-gastrointestinal-neuroendocrine-tumors-treated-with-prcrt-using-177-lu-dotatate-with-capecitabine-as-radiosensitizer.html https://www.enets.org/abstract/patient-outcomes-after-cardiac-surgery-for-carcinoid-heart-disease-are-dependant-upon-successful-cytoreductive-multimodal-treatment-and-control-of-metastatic-neuroendocrine-disease.html https://www.enets.org/abstract/initial-experience-of-a-novel-endoscopic-full-thickness-resection-device-ftrd-for-the-treatment-of-rectal-neuroendocrine-tumours.html https://www.enets.org/abstract/a-nuclear-combination-in-heterogeneous-metastatic-neuroendocrine-tumors.html https://www.enets.org/abstract/long-term-efficacy-and-safety-with-lanreotide-autogel-depot-lan-from-clarinet-and-open-label-extension-ole-studies.html https://www.enets.org/abstract/heterogeneity-of-type-1-gastric-neuroendocrine-neoplasms.html https://www.enets.org/abstract/effects-of-low-doses-aspirin-on-clinical-outcome-and-disease-progression-in-patients-with-gastro-entero-pancreatic-neuroendocrine-tumors-results-of-a-multicentric-retrospective-study.html https://www.enets.org/abstract/a-comparison-of-68ga-dota-tate-and-18f-fdg-pet-ct-imaging-on-patients-with-pancreatic-neuroendocrine-neoplasm-pnen.html https://www.enets.org/abstract/the-effect-of-prrt-on-health-related-quality-of-life-in-net-patients-a-prospective-study.html https://www.enets.org/abstract/an-intrapatient-comparison-of-18fdg-and-68ga-dota-tate-pet-ct-imaging-in-patients-with-gastrointestinal-neuroendocrine-neoplasm.html https://www.enets.org/abstract/primary-tumor-resection-results-in-superior-overall-survival-after-peptide-receptor-radionuclide-therapy-in-advanced-neuroendocrine-neoplasms.html https://www.enets.org/abstract/5-fluorouracile-plus-dacarbazine-in-metastatic-digestive-neuroendoendocrine-tumors-efficacy-and-potential-biomarkers.html https://www.enets.org/abstract/genome-wide-analysis-of-long-non-coding-rnas-in-pancreatic-neuroendocrine-tumors-by-microarray.html https://www.enets.org/abstract/increase-of-the-ki67-proliferation-index-over-time-in-patients-with-neuroendocrine-neoplasms.html https://www.enets.org/abstract/genome-wide-analysis-of-lncrnas-in-pancreatic-neuroendocrine-tumors-by-microarray.html https://www.enets.org/abstract/are-cystic-pancreatic-neuroendocrine-tumors-an-indolent-entityr-results-for-a-single-institutional-surgical-series.html https://www.enets.org/abstract/peptide-receptor-radionuclide-therapy-in-a-patient-with-sdhb-related-grade-3-paraganglioma-pgl-of-urinary-bladder.html https://www.enets.org/abstract/sporadic-panglandular-non-functioning-pnet-new-entitiesr-a-case-series.html https://www.enets.org/abstract/a-prospective-service-evaluation-of-systematic-gastroenterological-assessment-and-management-on-patients-with-neuroendocrine-tumours-in-south-east-wales.html https://www.enets.org/abstract/sporadic-gastric-neuroendocrine-neoplasm-include-two-different-subtype-two-histologically-and-clinicopathologically-distinct-entity.html https://www.enets.org/abstract/evaluation-of-faecal-elastase-1-in-symptomatic-patients-with-neuroendocrine-tumours.html https://www.enets.org/abstract/a-rare-case-of-ectopic-cushing-s-syndrome.html https://www.enets.org/abstract/laparoscopic-and-robotic-resection-for-pancreatic-neuroendocrine-tumors-pnet-less-is-morer.html https://www.enets.org/abstract/genetic-features-and-immunoprofile-of-sporadic-well-differentiated-neuroendocrine-tumors-of-gastric.html https://www.enets.org/abstract/the-characteristics-and-survivals-of-gastrointestinal-neuroendocrine-tumors-a-single-center-experience-from-developing-country.html https://www.enets.org/abstract/opaline-study-observational-study-in-a-real-world-setting-of-the-systemic-treatment-of-progressive-unresectable-or-well-differentiated-metastatic-pancreatic-neuroendocrine-tumors-pnet.html https://www.enets.org/abstract/infrastructural-alterations-in-insulinoma.html https://www.enets.org/abstract/selective-approach-in-surgical-treatment-of-pancreatic-neuroendocrine-tumors.html https://www.enets.org/abstract/mismatch-repair-mmr-protein-expression-is-uncommon-in-poorly-differentiated-neuroendocrine-carcinoma.html https://www.enets.org/abstract/metachronous-pancreatic-neuroendocrine-tumors-an-unusual-interesting-case-report.html https://www.enets.org/abstract/cxcr4-inhibition-by-ulocuplumab-prevents-emt-of-pnet-cells-in-vitro.html https://www.enets.org/abstract/liver-metastatic-disease-lmd-in-gastroenteropancreatic-neuroendocrine-tumors-gep-net-incidence-treatment-and-survival-in-a-multicenter-study-in-argentina-preliminary-report-argentum-group.html https://www.enets.org/abstract/mixed-adeno-neuroendocrine-carcinoma-manec-of-the-gastrointestinal-gi-tract-experience-of-a-european-neuroendocrine-tumour-society-enets-centre-of-excellence.html https://www.enets.org/abstract/influence-of-vegf-splicing-on-microvessel-density-and-architecture-in-pancreatic-neuroendocrine-tumours.html https://www.enets.org/abstract/ecological-study-to-assess-the-management-of-gastroenteropancreatic-neuroendocrine-tumors-in-spain.html https://www.enets.org/abstract/is-ki67-index-in-biopsy-tissue-truly-reflect-grading-of-pancreatic-neuroendocrine-neoplasmr.html https://www.enets.org/abstract/24-hour-urinary-5-hydroxyindoleacetic-acid-5hiaa-and-vasoactive-intestinal-peptide-vip-doubling-times-dts-predict-disease-specific-mortality-dsm-in-patients-with-neuroendocrine-tumors-nets.html https://www.enets.org/abstract/vhl-genotype-is-associated-with-pancreatic-neuroendocrine-tumors-pnets-phenotype-in-patients-with-von-hippel-lindau-disease-vhld.html https://www.enets.org/abstract/total-68ga-dotatate-avid-tumor-volume-tv-predicts-progression-free-survival-pfs-and-disease-specific-mortality-dsm-in-patients-with-neuroendocrine-tumors-nets.html https://www.enets.org/abstract/relationship-between-symptoms-and-hrqol-benefits-in-patients-pts-with-carcinoid-syndrome-cs-a-post-hoc-analysis-of-telotristat-ethyl-te-telestar-trial.html https://www.enets.org/abstract/association-between-neuroendocrine-tumors-nets-biomarkers-and-tumor-burden-based-on-total-68ga-dotatate-avid-tumor-volume-tv-measurements.html https://www.enets.org/abstract/quality-of-life-in-patients-with-multiple-endocrine-neoplasia-type-i-men1-results-from-the-dutch-men1-study-group.html https://www.enets.org/abstract/the-prevalence-of-intestinal-metaplasia-in-patients-with-gastric-neuroendocrine-neoplasms-type-1.html https://www.enets.org/abstract/carcinoid-heart-disease-chd-prognostic-value-of-5-hiaa-and-impact-on-survival-r-a-systematic-literature-review.html https://www.enets.org/abstract/surgical-strategies-and-selection-criteria-for-patients-with-liver-metastasis-from-neuroendocrine-tumors-personal-experience.html https://www.enets.org/abstract/biphosphonates-in-metastatic-bone-disease-of-neuroendocrine-neoplasms.html https://www.enets.org/abstract/outcome-of-surgical-resection-after-neoadjuvant-peptide-receptor-radionuclide-therapy-prrt-for-pancreatic-neuroendocrine-neoplasms-a-case-matched-analysis.html https://www.enets.org/abstract/analysis-of-mtor-cxcr4-and-pd-1-checkpoint-pathways-in-merkel-cell-neuroendocrine-carcinomas-correlations-with-prognosis-and-viral-status.html https://www.enets.org/abstract/evolution-of-gastroenteropancreatic-neuroendocrine-tumors-r-experiene-of-a-romanian-endocrine-clinic.html https://www.enets.org/abstract/net-r-incidental-findings-small-silent-and-innocentr.html https://www.enets.org/abstract/establishment-of-the-first-well-differentiated-in-vivo-human-pancreatic-neuroendocrine-tumor-model.html https://www.enets.org/abstract/study-protocol-prospective-randomized-controlled-trial-on-the-effect-of-primary-resection-in-advanced-metastatic-nen-of-pancreas-and-midgut-presnenas.html https://www.enets.org/abstract/synergistic-effects-of-combining-hsp90-and-pi3k-inhibitors-with-everolimus-in-pancreatic-neuroendocrine-tumors.html https://www.enets.org/abstract/detection-of-metastatic-insulinoma-with-68ga-nodaga-exendin-4-pet-ct-in-a-young-child-r-a-case-report.html https://www.enets.org/abstract/sunitinib-su-in-progressive-pancreatic-neuroendocrine-tumor-pnet-administered-in-different-treatment-lines.html https://www.enets.org/abstract/whole-exome-sequencing-wes-of-samples-from-patients-pts-classified-as-exceptional-responders-er-vs-poor-responders-po-to-targeted-therapies-in-pancreatic-neuroendocrine-tumours-pnets.html https://www.enets.org/abstract/meta-analysis-of-liver-resection-versus-nonsurgical-treatments-for-pancreatic-neuroendocrine-tumors-with-liver-metastases.html https://www.enets.org/abstract/value-of-somatostatin-receptor-imaging-sri-in-patients-with-appendiceal-neuroendocrine-neoplasms-anen-base-on-clinical-follow-up.html https://www.enets.org/abstract/potential-anti-tumor-activity-of-biguanides-and-statins-in-neuroendocrine-tumor-cells.html https://www.enets.org/abstract/multiple-endocrine-neoplasia-type-1-men1-the-experience-of-a-referral-center-in-greece.html https://www.enets.org/abstract/tsc22d1-expression-and-association-with-clinic-pathological-features-in-bronchial-carcinoids.html https://www.enets.org/abstract/measurement-in-blood-of-a-circulating-net-mrna-gene-to-predict-surgical-efficacy.html https://www.enets.org/abstract/a-hybrid-clinical-molecular-nomogram-accurately-predicts-survival-in-prrt-treated-gep-nets.html https://www.enets.org/abstract/dedifferentiation-of-metastatic-pancreatic-neuroendocrine-neoplasms.html https://www.enets.org/abstract/a-gene-expression-based-nomogram-predicts-progression-free-survival-in-small-bowel-nets.html https://www.enets.org/abstract/clinical-nomogram-development-and-predictive-utility-for-appendiceal-and-colorectal-nets.html https://www.enets.org/abstract/utility-of-a-circulating-net-mrna-gene-signature-for-defining-bronchopulmonary-neuroendocrine-neoplasia-and-evaluating-disease-progression.html https://www.enets.org/abstract/towards-optimal-personalized-diet-and-vitamin-supplementation-in-net-patients-a-feasibility-study.html https://www.enets.org/abstract/web-based-tailored-information-and-support-for-patients-with-a-neuroendocrine-tumor.html https://www.enets.org/abstract/effect-of-treatment-with-prolonged-release-somatostatin-analogues-on-the-concentration-of-serum-fibrosis-markers-in-patients-with-carcinoid-syndrome.html https://www.enets.org/abstract/neuroendocrine-neoplasm-registry-single-centre-experience-and-outcomes.html https://www.enets.org/abstract/selective-transarterial-embolization-of-gastro-entero-pancreatic-gep-neuroendocrine-tumors-net-with-advanced-locoregional-disease-and-or-liver-metastases.html https://www.enets.org/abstract/fna-under-percutaneous-ultrasound-or-endoscopic-ultrasound-for-pre-operative-diagnosis-and-grading-determination-in-pannet-are-they-reliable-to-define-a-tailored-therapyr.html https://www.enets.org/abstract/natural-history-of-type-1-gastric-carcinoid-gnens-and-risk-of-adenoma-adenocarcinoma-in-endoscopic-surveillance-programme.html https://www.enets.org/abstract/gsk3-a-novel-therapeutic-target-in-netsr.html https://www.enets.org/abstract/feasibility-and-implication-of-routine-ngs-analysis-in-neuroendocrine-carcinomas.html https://www.enets.org/abstract/peripheral-blood-biomarkers-of-systemic-inflammation-may-be-prognostic-in-metastatic-gastroenteropancreatic-neuroendocrine-tumour-gepnet-patients-following-177lu-dotatate-lutate.html https://www.enets.org/abstract/survival-analysis-after-i-a-90y-dotatate-prrt-in-patients-with-non-resectable-advanced-progressive-liver-dominant-neuroendocrine-neoplasms.html https://www.enets.org/abstract/prospective-study-on-the-impact-of-a-multi-institutional-net-specific-multidisciplinary-tumor-board-on-individual-treatment-plans.html https://www.enets.org/abstract/launching-netwerk-diagnosis-and-treatment-of-neuroendocrine-tumors-within-a-multi-institutional-collaboration-in-the-region-of-antwerp-waasland-in-belgium.html https://www.enets.org/abstract/prognosis-of-sporadic-resected-small-r-2-cm-nonfunctional-pancreatic-neuroendocrine-neoplasms-a-multi-institutional-study.html https://www.enets.org/abstract/over-treatment-radionuclide-therapy-prrt-of-metastatic-neuroendocrine-neoplasm-nen-r-a-case-report.html https://www.enets.org/abstract/sequence-of-therapy-and-survival-among-advanced-pancreatic-neuroendocrine-tumors-pnets.html https://www.enets.org/abstract/well-differentiated-g1-g2-pancreatic-nets-can-evolve-towards-g3-tumors.html https://www.enets.org/abstract/portal-hypertension-related-digestive-hemorrhage-in-patients-with-pancreatic-neuroendocrine-tumors.html https://www.enets.org/abstract/18f-fdg-positron-emission-tomography-computed-tomography-positivity-in-small-incidentally-found-pancreatic-neuroendocrine-tumors-could-it-be-considered-a-predictor-of-malignancyr.html https://www.enets.org/abstract/hypoglycemias-appearing-in-a-patient-suffering-from-poorly-differentiated-neuroendocrine-tumor-for-three-years.html https://www.enets.org/abstract/treatment-of-paragangliomas-with-lutetium-177-octreotate-based-peptide-receptor-radionuclide-therapy.html https://www.enets.org/abstract/pancreatic-neuroendocrine-tumors-pnets-a-population-based-analysis-of-epidemiology-and-outcomes.html https://www.enets.org/abstract/high-prevalence-of-the-c-1546delc-germline-mutation-in-men1-pancreatic-neuroendocrine-tumors.html https://www.enets.org/abstract/pancreatic-neuroendocrine-tumors-in-men1-disease-a-monocentrice-longitudinal-and-prognostic-study.html https://www.enets.org/abstract/staging-classification-comparison-of-resected-pancreatic-neuroendocrine-tumors-pnets-utilizing-the-national-cancer-database-ncdb.html https://www.enets.org/abstract/68ga-dota-toc-and-18f-fdg-pet-ct-in-the-follow-up-of-net-patients-treated-with-first-full-prrt.html https://www.enets.org/abstract/acute-somatostatin-analog-suppression-test-in-a-patient-with-thyrotropin-secreting-pituitary-macroadenoma.html https://www.enets.org/abstract/histological-differentiation-provides-useful-additive-and-independent-prognostic-information-to-proliferation-index-in-g2-and-g3-gastroenteropancreatic-neuroendocrine-neoplasms-gep-nens.html https://www.enets.org/abstract/skeletal-related-events-sres-and-use-of-antiresorptive-therapy-art-in-patients-with-bone-metastases-of-neuroendocrine-neoplasms.html https://www.enets.org/abstract/un-unusual-tumor-association-in-acromegaly.html https://www.enets.org/abstract/prognostic-factors-for-long-term-survival-in-102-consecutive-pancreatic-resections-for-primary-neuroendocrine-tumor.html https://www.enets.org/abstract/interactions-between-sstr-modulation-via-lanreotide-and-molecular-targeted-therapies-in-sequential-and-combination-approaches-in-vitro.html https://www.enets.org/abstract/circulating-neuroendocrine-transcripts-and-gene-cluster-analysis-predict-the-efficacy-of-prrt.html https://www.enets.org/abstract/clinical-correlates-of-discrepant-results-of-chromogranin-a-versus-serotonin-markers-in-patients-with-neuroendocrine-tumors.html https://www.enets.org/abstract/case-study-immunotherapy-in-a-young-adult-with-atypical-neuroendocrine-tumour.html https://www.enets.org/abstract/prognosis-and-treatment-outcomes-of-patients-with-mixed-adenoneuroendocrine-carcinoma-manec-r-a-single-cancer-center-experience.html https://www.enets.org/abstract/optimising-followup-after-complete-surgical-resection-of-gastrointestinal-neuroendocrine-tumours-a-delphi-process-to-produce-expert-consensus-in-an-area-lacking-clinical-evidence.html https://www.enets.org/abstract/prognostic-factors-that-mandate-long-term-follow-up-following-surgery-for-appendiceal-neuroendocrine-tumours-anets.html https://www.enets.org/abstract/comparison-of-long-terms-outcomes-after-resection-of-hepatic-and-or-peritoneal-metastasis-from-neuroendocrine-tumors.html https://www.enets.org/abstract/metastatic-pancreatic-neuroendocrine-tumors-pnets-and-primary-tumor-resection-a-ncdb-survival-evaluation.html https://www.enets.org/abstract/multimodal-treatment-of-a-metastatic-pancreatic-neuroendocrine-tumor-in-von-hippel-lindau-disease.html https://www.enets.org/abstract/ssa-h1-h2-and-leukotriene-receptor-blockade-eliminates-handicapping-symptoms-from-atypical-carcinoid-syndrome.html https://www.enets.org/abstract/long-term-outcomes-and-prognostic-factors-of-gastroenteropancreatic-neuroendocrine-neoplasms-gep-nens-an-update-of-a-large-national-registry-rgetne.html https://www.enets.org/abstract/conditional-survival-cs-analysis-of-liver-resection-lr-for-gastro-entero-pancreatic-neuroendocrine-tumor-gep-net.html https://www.enets.org/abstract/pancreatic-involvement-in-vhl-disease-the-turin-experience.html https://www.enets.org/abstract/safety-and-efficacy-of-high-doses-lanreotide-treatment-in-patients-with-progressive-neuroendocrine-tumors-results-from-a-prospective-phase-ii-trial.html https://www.enets.org/abstract/concomitant-intraductal-papillary-mucinous-neoplasms-and-neuroendocrine-tumors-of-the-pancreas-more-than-just-a-coincidencer.html https://www.enets.org/abstract/quality-of-life-anxiety-and-depression-in-patients-with-nen-after-surgery.html https://www.enets.org/abstract/radiological-changes-in-the-treatment-of-pancreatic-neuroendocrine-tumors-pnet-with-sunitinib-recist-vs-choi-criteria-cripnet-getne-study.html https://www.enets.org/abstract/unusual-presentation-of-carcinoid-syndrome-in-chronic-pancreatitis.html https://www.enets.org/abstract/neuroendocrine-carcinomas-pancreatic-origin-polish-experience.html https://www.enets.org/abstract/prevalence-of-pancreatic-neuroendocrine-neoplasms-with-serotonin-secretion.html https://www.enets.org/abstract/the-expression-of-igf-signaling-pathway-genes-is-frequently-elevated-in-pancreatic-neuroendocrine-tumors-but-is-downregulated-in-metastases.html https://www.enets.org/abstract/clinical-features-and-outcomes-of-advanced-pnets-treated-with-sunitinib-data-from-cripnet-getne-study.html https://www.enets.org/abstract/eleven-years-survival-after-combined-treatment-of-surgery-ultrasound-guided-radiofrequency-ablation-of-liver-metastasis-ct-embolization-plus-somatostatin-lar-in-a-case-with-atypical-carcinoid-of-the-lung.html https://www.enets.org/abstract/antiproliferative-effects-of-lanreotide-in-neuroendocrine-tumors.html https://www.enets.org/abstract/impact-of-concomitant-medication-on-efficacy-of-telotristat-ethyl-r-a-post-hoc-subgroup-analysis-of-the-phase-3-telestar-study-in-carcinoid-syndrome.html https://www.enets.org/abstract/integrated-safety-analysis-of-telotristat-ethyl-in-patients-with-carcinoid-heart-disease.html https://www.enets.org/abstract/telotristat-ethyl-in-carcinoid-syndrome-safety-and-efficacy-results-of-an-open-label-extension-of-the-telecast-phase-3-clinical-trial.html https://www.enets.org/abstract/neuroendocrine-tumors-committee-of-reference-hospital-evaluation-of-health-care-and-research-indicators.html https://www.enets.org/abstract/predictive-value-of-baseline-hematology-parameters-on-outcome-of-177lu-dotatoc-prrt.html https://www.enets.org/abstract/metabolic-adaptation-to-anti-angiogenic-therapy.html https://www.enets.org/abstract/carcinoid-heart-disease-diagnostic-usefulness-of-cardiac-computed-tomography-r-a-pilot-study.html https://www.enets.org/abstract/vitamin-d-bone-mineral-density-and-fracture-risk-assessment-in-patients-with-neuroendocrine-tumors.html https://www.enets.org/abstract/study-of-cell-cycle-protein-expression-pattern-in-bronchial-carcinoids-a-new-potential-target-for-medical-therapyr.html https://www.enets.org/abstract/a-case-of-multiple-endocrine-neoplasia-type-2brmen2br.html https://www.enets.org/abstract/the-anticancer-mechanism-of-metformin-in-pancreatic-neuroendocrine-tumor-cells.html https://www.enets.org/abstract/pulmonary-function-test-physiology-and-progression-in-diffuse-idiopathic-pulmonary-neuroendocrine-cell-hyperplasia.html https://www.enets.org/abstract/comparison-of-glucagon-like-peptide-1-glp-1-receptor-pet-ct-spect-ct-and-3t-mri-for-the-localisation-of-insulinomas-evaluation-of-accuracy-in-a-prospective-crossover-imaging-study.html https://www.enets.org/abstract/opaline-study-observational-study-in-a-real-world-setting-of-the-systemic-treatment-of-progressive-unresectable-or-well-differentiated-metastatic-pancreatic-neuroendocrine-tumors-pnet.html https://www.enets.org/abstract/incidence-and-prevalence-of-neuroendocrine-tumors-in-england.html https://www.enets.org/abstract/the-frequency-of-patients-with-giant-pituitary-tumors-from-retrospective-data.html https://www.enets.org/abstract/the-exact-prognostic-significance-of-lymphatic-metastasis-of-jejunoileal-neuroendocrine-tumors.html https://www.enets.org/abstract/preliminary-evaluation-of-influence-of-different-targeted-drugs-of-vascular-endothelial-growth-factor-signaling-pathway-on-the-proliferation-of-neuroendocrine-neoplasm-cell-lines.html https://www.enets.org/abstract/retrospective-epidemiologic-study-of-medullary-cancer-of-thyroid-gland-in-hospital-r-based-registry-in-moscow-cancer-centre.html https://www.enets.org/abstract/a-case-of-carcinoid-crisis-despite-high-dose-somatostatin-analogue-therapy-peri-operatively.html https://www.enets.org/abstract/expression-and-clinical-significance-of-vascular-endothelial-growth-factor-receptor-3-vegfr3-and-phospho-vegfr3-in-gastroenteropancreatic-neuroendocrine-neoplasms.html https://www.enets.org/abstract/expression-and-clinical-significance-of-vascular-endothelial-growth-factor-d-in-gastroenteropancreatic-neuroendocrine-neoplasms.html https://www.enets.org/abstract/optimizing-reconstruction-algorithm-to-improve-quality-of-post-prrt-yittrium-90-pet-scan.html https://www.enets.org/abstract/imaging-of-advanced-medullary-thyroid-carcinoma-with-the-cck-2-receptor-agonist-177lu-pp-f11n-r-preliminary-proof-of-the-principle-within-the-rlumedr-study.html https://www.enets.org/abstract/single-institutional-review-of-non-pancreatic-gi-neuroendocrine-tumors.html https://www.enets.org/abstract/a-single-center-retrospective-analysis-of-clinicopathological-characteristics-of-gastroenteropancreatic-large-cell-neuroendocrine-neoplasms-gep-lcnec.html https://www.enets.org/abstract/data-on-healthcare-resource-utilization-hcru-and-treatment-modalities-in-patients-pts-with-advanced-adv-well-differentiated-wd-neuroendocrine-tumors-nets-of-gastrointestinal-gi-or-lung-origin-in-finland.html https://www.enets.org/abstract/ex-vivo-activity-of-cytotoxic-drugs-and-targeted-agents-in-small-intestinal-neuroendocrine-tumors.html https://www.enets.org/abstract/gastroenteropancreatic-neuroendocrine-neoplasms-gep-nens-in-the-czech-nen-registry-2009-2016-histologic-spectrum-and-clinicopathological-features.html https://www.enets.org/abstract/expression-of-somatostatin-receptors-in-neuroendocrine-tumors-of-the-lungs-with-various-degrees-of-malignancy.html https://www.enets.org/abstract/1-year-survival-rates-for-neuroendocrine-tumor-patients-in-england.html https://www.enets.org/abstract/cxcr4-expression-on-circulating-tumor-cells-ctcs-and-their-association-with-bone-metastases-in-patients-with-neuroendocrine-tumors-net.html https://www.enets.org/abstract/international-multicentre-retrospective-study-on-the-safety-of-radioembolization-with-yttrium-90-resin-microspheres-after-systemic-radionuclide-therapy-in-neuroendocrine-tumors.html https://www.enets.org/abstract/metachronous-primary-cancers-in-neuroendocrine-tumor-patients.html https://www.enets.org/abstract/health-related-quality-of-life-determinants-in-swedish-patients-after-surgery-for-small-intestinal-neuroendocrine-tumors.html https://www.enets.org/abstract/frequency-the-characteristic-of-diseases-of-thyroid-gland-at-children-and-teenagers-according-to-negotiability-during-5-years.html https://www.enets.org/abstract/predictors-of-antiproliferative-effect-of-lanreotide-autogel-la-as-first-line-therapy-for-advanced-neuroendocrine-tumors-nets.html https://www.enets.org/abstract/education-and-preparation-for-nuclear-medicine-procedures-in-neuroendocrine-tumor-patients.html https://www.enets.org/abstract/prognostic-factors-of-pulmonary-carcinoid-tumors.html https://www.enets.org/abstract/autophagy-process-in-pancreatic-neuroendocrine-tumor-cells.html https://www.enets.org/abstract/screening-of-differentially-expressed-genes-in-gastric-neuroendocrine-neoplasms-based-on-human-transcriptome-array.html https://www.enets.org/abstract/current-educational-strategies-used-by-nurses-caring-for-net-patients-electronic-survey-across-25-countries.html https://www.enets.org/abstract/ki-67-and-presence-of-liver-metastases-predicts-progression-in-pancreatic-neuroendocrine-neoplasms-pnens.html https://www.enets.org/abstract/international-survey-of-clinical-practice-exploring-use-of-platinum-etoposide-chemotherapy-for-extra-pulmonary-high-grade-neuroendocrine-carcinoma-ep-g3-nec.html https://www.enets.org/abstract/prevalence-of-carcinoid-syndrome-cs-in-the-european-union-eu.html https://www.enets.org/abstract/extra-pulmonary-colonic-tuberculosis-presenting-as-intestinal-obstruction-in-a-patient-with-disseminated-carcinoid-tumour.html https://www.enets.org/abstract/stromal-immune-contexture-predicts-disease-free-survival-in-gastro-entero-pancreatic-neuroendocrine-neoplasms-gep-nens.html https://www.enets.org/abstract/overall-survival-progression-free-survival-and-quality-of-life-updates-from-the-netter-1-study-177lu-dotatate-vs-high-dose-octreotide-in-progressive-midgut-neuroendocrine-tumors.html https://www.enets.org/abstract/short-term-change-in-symptoms-and-adverse-events-evaluation-after-prrt-r-first-experience-after-56-patients.html https://www.enets.org/abstract/hepatic-tumor-burden-can-be-reduced-rapidly-and-effectively-by-trans-arterial-embolization-combined-with-systemic-therapy-in-patients-with-neuroendocrine-tumor-liver-metastasis-netlm.html https://www.enets.org/abstract/hepatic-tumor-burden-can-be-reduced-rapidly-and-effectively-by-trans-arterial-embolization-combined-with-systemic-therapy-in-patients-with-neuroendocrine-tumor-liver-metastasis-netlm.html https://www.enets.org/abstract/the-laparoscopic-approach-in-the-surgical-treatment-of-the-gastric-neuroendocrine-tumors.html https://www.enets.org/abstract/combination-of-surgery-and-ethanol-ablation-in-a-men-2a-patient.html https://www.enets.org/abstract/are-current-enets-guidelines-for-surgery-of-small-2cm-pancreatic-neuroendocrine-neoplasms-implemented-in-german-surgical-communityr.html https://www.enets.org/abstract/perioperative-outcomes-of-surgery-for-pancreatic-neuroendocrine-neoplasms-in-germany.html https://www.enets.org/abstract/histopathological-revision-for-gastroenteropancreatic-neuroendocrine-neoplasms-in-expert-centers-does-it-make-the-differencer.html https://www.enets.org/abstract/immuneoct-study-the-role-of-octreotide-lar-in-modulating-the-immune-response-in-patient-with-neuroendocrine-tumors-eudract-number-2017-001613-83.html https://www.enets.org/abstract/the-correlation-between-68ga-dotatate-pet-ct-results-and-tumor-proliferation-in-patients-with-gastroenteropancreatic-neuroendocrine-neoplasms-gep-nens.html https://www.enets.org/abstract/identifying-the-severity-of-psychosocial-symptoms-among-patients-diagnosed-with-pancreatic-neuroendocrine-tumor-do-we-really-need-emotional-support-groupsr.html https://www.enets.org/abstract/finding-the-ways-to-determine-the-prognosis-of-pulmonary-carcinoids-with-certain-genes-markers-in-pakistan.html https://www.enets.org/abstract/do-we-need-hormonal-therapy-for-pancreatic-neuroendocrine-tumorsr-an-effort-to-reduce-the-size-of-pannets.html https://www.enets.org/abstract/oral-carcinoid-mimicking-as-non-healing-ulcer-a-case-report.html https://www.enets.org/abstract/value-of-tumor-growth-rate-tgr-as-an-early-predictor-of-patientsr-outcome-in-patients-diagnosed-with-well-differentiated-neuroendocrine-tumors-nets-the-greponet-study.html https://www.enets.org/abstract/mediastinal-paraganglioma-a-challenge-from-the-surgical-point-of-view.html https://www.enets.org/abstract/antiproliferative-effect-of-above-label-doses-of-somatostatin-analogues-ssa-for-the-management-of-neuroendocrine-tumors-nets.html https://www.enets.org/abstract/morphological-factors-related-to-nodal-metastases-in-neuroendocrine-neoplasms-of-the-appendix-a-multicenter-retrospective-study.html https://www.enets.org/abstract/on-going-evaluation-of-the-use-of-resources-and-the-costs-ur-c-associated-with-controlled-or-uncontrolled-carcinoid-syndrome-cs-in-patients-pts-with-neuroendocrine-tumours-nets-recosy-study-design.html https://www.enets.org/abstract/finding-the-options-of-good-prognosis-for-ampullary-neuroendocrine-tumors.html https://www.enets.org/abstract/peptide-receptor-radionuclide-therapy-prrt-in-35-patients-with-metastatic-neuroendocrine-neoplasms-nens-overall-response-and-toxicity.html https://www.enets.org/abstract/midgut-carcinoids-presenting-as-subacute-intestinal-obstruction-a-case-report-of-territory-care-hospital.html https://www.enets.org/abstract/interim-analyses-lanrel07484-quality-of-life-in-patients-with-symptomatic-gastroenteropancreatic-neuroendocrine-tumors-treated-with-lanreotide-autogel-in-south-africa.html https://www.enets.org/abstract/interim-analyses-lanrel07484-response-to-treatment-and-self-reported-satisfaction-in-symtoms-in-patients-with-gastroenteropancreatic-neuroendocrine-tumors-treated-with-lanreotide-autogel-in-south-africa.html https://www.enets.org/abstract/the-difficulties-in-managing-metastatic-pancreatic-neuroendocrine-tumours-pnets-causing-cushingrs-syndrome-cs.html https://www.enets.org/abstract/sunitinib-in-patients-with-pre-treated-pancreatic-neuroendocrine-tumors-a-real-world-study.html https://www.enets.org/abstract/pretherapeutic-predictors-of-tumor-absorbed-dosimetry-in-radionuclide-therapy-for-metastatic-neuroendocrine-tumors.html https://www.enets.org/abstract/recognition-of-primary-neuroendocrine-tumors-a-challenge.html https://www.enets.org/abstract/durvalumab-plus-tremelimumab-for-the-treatment-of-patients-pts-with-advanced-neuroendocrine-neoplasms-nens-of-lung-or-gastroenteropancreatic-gep-origin-a-phase-ii-multicohort-trial-dune-trial-getne-1601.html https://www.enets.org/abstract/tumor-absorbed-dosimetry-and-response-of-radionuclide-therapy-in-metastatic-neuroendocrine-tumor.html https://www.enets.org/abstract/the-impact-of-netwerk-on-the-multidisciplinary-tumor-boards.html https://www.enets.org/abstract/elevation-net-201-a-phase-ii-study-to-evaluate-the-efficacy-and-safety-of-pdr001-in-patients-with-metastatic-well-differentiated-net-of-pancreatic-gi-thoracic-origin-or-poorly-differentiated-gep-nec-who-have-progressed-on-prior-treatment.html https://www.enets.org/abstract/peptide-receptor-radionuclide-therapy-prrt-in-gastroenteropancreatic-grade-3-neuroendocrine-neoplasms-a-retrospective-international-multicenter-study.html https://www.enets.org/abstract/epigenetic-modulation-of-autophagy-in-pancreatic-spheroid-cells.html https://www.enets.org/abstract/the-risk-of-secondary-primary-colorectal-adenocarcinomas-is-not-increased-among-patients-with-gastroenteropancreatic-neuroendocrine-tumors-r-a-nationwide-population-based-study.html https://www.enets.org/abstract/phase-1-pharmacokinetic-and-pharmacodynamic-study-of-apoc-a-new-controlled-release-formulation-crf-of-15mg-octreotide-acetate-in-healthy-male-volunteers.html https://www.enets.org/abstract/pancreatic-neuroendocrine-tumor-in-polish-population-with-men-1-syndrome.html https://www.enets.org/abstract/linked-colour-imaging-increases-the-diagnostic-yield-of-type-1-gastric-carcinoids.html https://www.enets.org/abstract/self-reported-side-effects-in-neuroendocrine-tumor-net-patients-prescribed-somatostatin-analogues-r-the-role-for-specialist-dietitians-and-nurses.html https://www.enets.org/abstract/excellent-survival-outcomes-for-net-patients-treated-within-netwerk-a-collaborative-enets-center-of-excellence.html https://www.enets.org/abstract/linked-colour-imaging-increases-the-diagnostic-yield-of-type-1-gastric-carcinoid.html https://www.enets.org/abstract/preclinical-testing-of-ssa-compounds-in-a-model-of-pancreatic-neuroendocrine-tumors-to-optimize-scheduling-and-drug-exposition.html https://www.enets.org/abstract/evaluation-of-everolimus-eve-in-patients-with-metastatic-lung-neuroendocrine-tumors.html https://www.enets.org/abstract/plasma-protein-kallikrein-14-strongly-predicts-pronounced-chromogranin-a-cga-response-in-small-intestinal-neuroendocrine-tumor-net-patients-after-somatostatin-analog-ssa-treatment-the-nordic-explain-biomarker-study.html https://www.enets.org/abstract/a-comparison-of-diagnostic-and-management-pathways-for-patients-with-lung-neuroendocrine-tumors-in-enets-centres-of-excellence-vs-non-accredited-centres-in-the-uk-results-from-the-national-lung-net-pathway-project-rleapr.html https://www.enets.org/abstract/alpha-fetoprotein-in-gastro-entero-pancreatic-neuroendocrine-neoplasms-a-single-centre-study.html https://www.enets.org/abstract/mirna-expression-defines-novel-subgroups-of-small-intestinal-neuroendocrine-tumors.html https://www.enets.org/abstract/prospective-multi-center-open-label-phase-study-ii-of-apoc-a-new-controlled-release-15mg-octreotide-acetate-for-the-treatment-of-advanced-nets.html https://www.enets.org/abstract/study-to-evaluate-the-optimal-dose-of-68ga-ops202-as-a-pet-imaging-agent-in-patients-with-gep-nets.html https://www.enets.org/abstract/financial-toxicity-in-patients-with-neuroendocrine-tumor-disease-a-so-far-underestimated-side-effect-of-cancer-in-germanyr.html https://www.enets.org/abstract/differential-signalling-pathways-drive-therapeutic-resistance-in-neuroendocrine-tumors.html https://www.enets.org/abstract/palliative-surgery-in-advanced-small-intestinal-neuroendocrine-tumors.html https://www.enets.org/abstract/genetic-analysis-identifies-subgroups-of-small-well-differentiated-pancreatic-neuroendocrine-tumors-with-different-risk-for-liver-metastases.html https://www.enets.org/abstract/disease-control-in-progressive-pancreatic-and-intestinal-neuroendocrine-tumors-by-combined-treatment-with-lanreotide-autogel-and-temozolomide-the-sonnet-study.html https://www.enets.org/abstract/progression-of-mesenteric-metastasis-in-small-intestinal-neuroendocrine-tumors.html https://www.enets.org/abstract/the-number-of-positive-nodes-accurately-predicts-recurrence-after-pancreaticoduodenectomy-for-nonfunctioning-neuroendocrine-neoplasms.html https://www.enets.org/abstract/oral-ondansetron-offers-effective-symptomatic-bridging-for-carcinoid-syndrome-refractory-to-somatostatin-analogues.html https://www.enets.org/abstract/systemic-anti-cancer-therapies-in-neuroendocrine-tumor-patients-impair-nutritional-status.html https://www.enets.org/abstract/opera-observational-study-of-perception-of-information-and-quality-of-life-in-patients-with-neuroendocrine-tumors-starting-lanreotide-r-study-design.html https://www.enets.org/abstract/the-effect-of-temozolomide-on-pancreatic-neuroendocrine-tumors-in-vitro-and-role-of-mgmt-and-mmr-system-in-temozolomide-resistance.html https://www.enets.org/abstract/pre-treatment-tumor-growth-rate-tgr0-in-patients-diagnosed-with-well-differentiated-neuroendocrine-tumors-nets-treated-with-systemic-therapies-subgroup-analysis-of-the-greponet-study.html https://www.enets.org/abstract/neuroendocrine-tumors-in-the-chilean-population.html https://www.enets.org/abstract/direct-cost-of-metastatic-gastroenteropancreatic-neuroendocrine-tumors-gep-net-grade-1-or-2-g1-g2-in-relation-to-time-since-diagnosis-shows-growing-importance-of-somatostatin-analogues-ssa.html https://www.enets.org/abstract/long-acting-somatostatin-analogue-la-ssa-treatment-durations-in-patients-diagnosed-with-metastatic-gastroenteropancreatic-neuroendocrine-tumors-gep-net-grade-1-or-2-g1-g2-in-sweden.html https://www.enets.org/abstract/long-acting-somatostatin-analogue-la-ssa-treatment-patterns-in-patients-diagnosed-with-metastatic-gastroenteropancreatic-neuroendocrine-tumors-gep-net-grade-1-or-2-g1-g2-in-sweden.html https://www.enets.org/abstract/carboplatin-etoposide-chemotherapy-cb-et-for-patients-diagnosed-with-advanced-extra-pulmonary-ep-poorly-differentiated-pd-neuroendocrine-carcinoma-nec-findings-from-a-european-neuroendocrine-tumour-society-centre-of-excellence.html https://www.enets.org/abstract/molecular-characterization-of-primary-and-metastatic-pancreatic-neuroendocrine-tumors.html https://www.enets.org/abstract/intravenous-versus-oral-etoposide-efficacy-and-correlation-to-clinical-outcome-in-patients-with-high-grade-gastroenteropancreatic-neuroendocrine-neoplasms-who-g3.html https://www.enets.org/abstract/pancreatic-vipomas-reported-cases-from-china-since-1980.html https://www.enets.org/abstract/biliary-neuroendocrine-tumors-a-retrospective-analysis-of-28-patients-since-1991.html https://www.enets.org/abstract/relationship-between-metabolic-toxicity-and-efficacy-of-everolimus-in-patients-with-neuroendocrine-tumors-nets-a-pooled-analysis-from-the-randomized-phase-3-radiant-3-and-radiant-4-trials.html https://www.enets.org/abstract/how-to-perform-contrast-enhanced-oncologic-staging-mri-of-abdomen-and-pelvis-with-a-hepatocyte-specific-agent-in-a-large-bore-mr-scanner-optimizing-extrahepatic-tumor-evaluation-in-neuroendocrine-neoplasms.html https://www.enets.org/abstract/significance-of-biochemical-testing-in-pancreatic-neuroendocrine-tumors.html https://www.enets.org/abstract/systemic-markers-of-inflammation-in-neuroendocrine-tumors-nets-and-outcomes-with-everolimus-a-pooled-analysis-from-the-randomized-phase-3-radiant-3-and-radiant-4-trials.html https://www.enets.org/abstract/ghrelin-o-acyltransferase-goat-enzyme-and-ghrelin-receptor-ghsr1a-as-putative-prognosis-markers-and-therapeutic-targets-in-gastroenteropancreatic-neuroendocrine-tumors.html https://www.enets.org/abstract/neuroendocrine-tumors-an-australian-experience.html https://www.enets.org/abstract/reassessment-of-risk-factors-associated-with-locoregional-lymph-nodal-metastases-in-well-differentiated-appendiceal-neuroendocrine-neoplasms.html https://www.enets.org/abstract/positron-emission-tomography-pet-predictors-of-tumor-response-to-peptide-receptor-radionuclide-therapy-prrt-in-metastatic-neuroendocrine-tumors-net.html https://www.enets.org/abstract/one-year-experience-with-lutetium-dotatate-for-disseminated-nets-in-the-gregorio-maranon-hospital.html https://www.enets.org/abstract/phase-ii-study-of-temozolomide-monotherapy-in-patients-of-neuroendocrine-carcinoma-with-resistant-to-platinum-based-chemotherapy.html https://www.enets.org/abstract/is-the-eortc-qlq-qnet21-optimal-for-patients-with-neuroendocrine-tumorsr.html https://www.enets.org/abstract/large-cell-neuroendocrine-carcinoma-lcnec-associated-with-a-dysplastic-sessile-serrated-lesion-ssl-and-deficient-mismatch-repair-mmr-protein-a-case-report.html https://www.enets.org/abstract/a-case-report-of-a-malignant-insulinoma.html https://www.enets.org/abstract/subtype-classification-and-clinicopathological-features-of-gastric-neuroendocrine-neoplasms-400-cases-of-multicenter-retrospective-analysis.html https://www.enets.org/abstract/histone-replacement-in-cancer-dissecting-the-role-of-h3-3-chaperones-in-pancreatic-tumorigenesis.html https://www.enets.org/abstract/detection-of-bone-metastases-at-fdopa-pet-in-small-intestine-si-net-prevalence-and-associated-factors.html https://www.enets.org/abstract/epigenetic-changes-in-daxx-and-or-atrx-negative-pancreatic-neuro-endocrine-tumors.html https://www.enets.org/abstract/phosphohistone-h3-phh3-immunohistochemical-staining-outperforms-conventional-h-e-mitotic-count-in-classifying-pulmonary-carcinoids.html https://www.enets.org/abstract/remote-tracking-of-symptoms-qol-and-wellbeing-within-the-new-wales-net-service.html https://www.enets.org/abstract/clinical-analysis-of-15-cases-of-gallbladder-neuroendocrine-carcinoma.html https://www.enets.org/abstract/survival-and-prognosis-in-patients-with-duodeno-pancreatic-neuroendocrine-tumors-in-multiple-endocrine-neoplasia-type-1-syndrome.html https://www.enets.org/abstract/clinicopathological-features-of-the-high-grade-pancreatic-neuroendocrine-neoplasms.html https://www.enets.org/abstract/clinicopathological-features-of-63-cases-with-type-3-gastric-neuroendocrine-tumors.html https://www.enets.org/abstract/is-the-classification-of-functioning-pannet-non-functioning-pannet-properlyr-insulinoma-non-insulinoma-is-more-suitable-to-distinguish-the-clinicopathological-and-prognosis-difference-of-localized-insulinoma.html https://www.enets.org/abstract/combination-of-capecitabine-and-temozolomide-for-advanced-thymic-neuroendocrine-tumors.html https://www.enets.org/abstract/evaluation-of-multidisciplinary-tumor-board-decisions-in-the-management-of-neuroendocrine-tumors-impact-of-expert-centers.html https://www.enets.org/abstract/eterogeneity-of-duodenal-neuroendocrine-tumors-a-multi-centre-experience-in-italy.html https://www.enets.org/abstract/genome-wide-dna-methylation-profiling-of-pancreatic-neuroendocrine-tumors.html https://www.enets.org/abstract/neuroendocrine-neoplasms-of-the-appendix-characterization-of-251-patients-referred-to-the-copenhagen-net-centre-of-excellence.html https://www.enets.org/abstract/potential-role-of-sst5tmd4-derived-peptides-in-the-malignancy-of-neuroendocrine-tumors-and-other-endocrine-related-cancer-cells.html https://www.enets.org/abstract/preliminary-safety-and-efficacy-of-rovalpituzumab-tesirine-in-patients-with-delta-like-protein-3-expressing-advanced-solid-tumors.html https://www.enets.org/abstract/efficacy-and-safety-of-anti-pd-1-antibody-ibi308-in-treating-advanced-neuroendocrine-neoplams.html https://www.enets.org/abstract/analysis-of-the-proteomics-of-serum-circulating-exosomes-in-gastro-entero-pancreatic-neuroendocrine-neoplasms.html https://www.enets.org/abstract/thrombotic-risk-in-gastroenteropancreatic-neuroendocrine-tumors-a-single-centre-experience.html https://www.enets.org/abstract/clinical-utility-cu-evaluation-of-the-health-related-quality-of-life-hrqol-qlq-ginet21-questionnaire-qnr-in-the-treatment-of-patients-pts-with-gastrointestinal-gi-neuroendocrine-tumors-nets-qualinets-study.html https://www.enets.org/abstract/nutritional-assessment-and-vitamin-deficiencies-in-patients-with-nets.html https://www.enets.org/abstract/tumor-microenvironment-in-merkel-cell-carcinoma-association-with-merkel-cell-polyomavirus-and-clinico-pathological-features-in-a-retrospective-cohort-study.html https://www.enets.org/abstract/symptomatic-hypothalamic-pituitary-metastases-disclosing-malignant-paraganglioma.html https://www.enets.org/abstract/prognostic-value-of-immunohistochemical-expression-of-somatostatin-receptors-ss-r2-and-ss-r5-in-the-gastroenteropancreatic-neuroendocrine-tumors-diagnosed-in-the-university-hospital-of-pleven-bulgaria-from-the-period-2010-to-november-2017.html https://www.enets.org/abstract/therapeutic-efficacy-of-platinum-etoposide-regimens-in-the-treatment-of-advanced-poor-differentiated-neuroendocrine-carcinomas-of-the-lung-a-retrospective-analysis.html https://www.enets.org/abstract/sequential-therapies-in-well-differentiated-gastrointestinal-neuroendocrine-tumors-g3-net-g3-platinum-based-vs-platinum-free-regimens.html https://www.enets.org/abstract/brain-metastasis-disclosing-neuroendocrine-tumor.html https://www.enets.org/abstract/clinical-and-morphological-features-of-extrapulmonary-small-cell-cancer.html https://www.enets.org/abstract/menstrual-dysfunction-in-women-with-prolactinomas.html https://www.enets.org/abstract/two-cases-synchronous-atypical-parathyroid-adenomas-and-papillary-thyroid-carcinoma.html https://www.enets.org/abstract/a-case-report-of-a-well-differentiated-neuroendocrine-tumor-in-which-sunitinib-treatment-resulted-an-effective-response-of-disease.html https://www.enets.org/abstract/alpps-as-a-technique-to-minimize-small-for-size-syndrome-after-major-hepatectomy-for-neuroendocrine-tumour-metastases.html https://www.enets.org/abstract/hepatic-steatosis-secondary-to-peptide-receptor-radionuclide-therapy-with-somatostatin-analogue.html https://www.enets.org/abstract/a-comparison-of-retrospective-database-analysis-with-chart-review-in-patients-receiving-somatostatin-analog-ssa-in-neuroendocrine-tumors-nets.html https://www.enets.org/abstract/outcomes-of-locoregional-treatment-for-unifocal-progression-in-widespread-metastatic-gastroenteropancreatic-neuroendocrine-tumors.html https://www.enets.org/abstract/single-cell-copy-number-variation-analysis-cnv-of-circulating-tumor-cells-ctcs-in-neuroendocrine-tumor-net-patients.html https://www.enets.org/abstract/peptide-receptor-radionuclide-therapy-in-patients-with-metastatic-neuroendocrine-carcinomas-case-series.html https://www.enets.org/abstract/a-case-of-carcinoid-induced-heart-disease.html https://www.enets.org/abstract/a-pilot-study-of-the-cyclin-dependent-kinases-4-6-inhibitor-ribociclib-in-patients-with-foregut-neuroendocrine-tumors.html https://www.enets.org/abstract/a-family-bronchial-carcinoid-tumor.html https://www.enets.org/abstract/evaluation-of-streptozocin-based-chemotherapeutic-regimens-for-advanced-pancreatic-neuroendocrine-tumors-a-multi-center-clinical-study-in-japan.html https://www.enets.org/abstract/phase-ii-trial-of-cabozantinib-in-patients-with-carcinoid-and-pancreatic-neuroendocrine-tumors.html https://www.enets.org/abstract/patient-and-clinician-perspectives-on-symptom-priorities-across-the-spectrum-of-neuroendocrine-tumors-nets.html https://www.enets.org/abstract/clinical-characteristics-and-prognostic-analysis-of-14-patients-with-gastric-mixed-adenoneuroendocrine-carcinoma.html https://www.enets.org/abstract/a-matched-pair-analysis-of-conventional-surgical-methods-versus-enucleation-for-pancreatic-neuroendocrine-tumors.html https://www.enets.org/abstract/well-differentiated-neuroendocrine-lesions-in-inflammatory-bowel-disease.html https://www.enets.org/abstract/decreased-serum-amyloid-a1-as-potential-diagnostic-marker-for-gastro-entero-pancreatic-neuroendocrine-neoplasms.html https://www.enets.org/abstract/clinicopathologic-features-and-treatment-outcome-of-225-newly-diagnosed-pulmonary-carcinoids-a-single-center-experience-of-28-years.html https://www.enets.org/abstract/a-retrospective-analysis-of-344-cases-with-neuroendocrine-neoplasms.html https://www.enets.org/abstract/new-menin-mutation-associated-with-familial-isolated-hyperparathyroidism-clinical-case-of-three-young-sisters.html https://www.enets.org/abstract/assessment-of-quality-of-life-in-chinese-patients-with-gastroenteropancreatic-neuroendocrine-tumors.html https://www.enets.org/abstract/nutritional-status-and-considerations-for-patients-diagnosed-with-a-gastroenteropancreatic-neuroendocrine-tumor-preliminary-baseline-characteristics-from-the-nutrition-in-nets-study.html https://www.enets.org/abstract/exploring-nutrition-screening-and-management-practices-amongst-health-professionals-managing-patients-with-neuroendocrine-tumors.html https://www.enets.org/abstract/braf-v600e-driven-mutations-in-grade-3-neuroendocrine-carcinomas-of-colon-origin-results-from-genomic-epigenomic-profilings-and-patient-derived-mouse-model.html https://www.enets.org/abstract/using-adult-stem-cell-derived-organoids-to-model-neuroendocrine-tumor-growth.html https://www.enets.org/abstract/favourable-outcomes-of-peptide-receptor-radionuclide-therapy-prrt-for-treatment-of-metastatic-rectal-neuroendocrine-neoplasia-nen.html https://www.enets.org/abstract/4d-ultrasound-high-definition-flow-with-spatio-temporal-image-correlation-in-evaluation-of-neuroendocrine-liver-metastases-r-preliminary-study.html https://www.enets.org/abstract/nonfunctional-pancreatic-neuroendocrine-tumor-nf-pnet-imaging-and-evaluation-using-18f-fdg-and-68ga-dotanoc-pet-ct-initial-data-of-a-prospective-study1.html https://www.enets.org/abstract/management-of-aggressive-medullary-thyroid-cancer.html https://www.enets.org/abstract/typical-and-atypical-bronchial-nets-with-advanced-disease-incidence-management-and-survival.html https://www.enets.org/abstract/predictive-markers-of-gastroenteropancreatic-neuroendocrine-tumors-gep-nets.html https://www.enets.org/abstract/perioperative-chemotherapy-in-resectable-neuroendocrine-carcinomas-of-the-digestive-tract.html https://www.enets.org/abstract/a-prospective-nordic-study-on-the-use-of-chromogranin-a-for-the-prediction-of-progression-in-patients-with-pancreatic-and-small-intestinal-neuroendocrine-tumors.html https://www.enets.org/abstract/endocrine-paraneoplastic-syndromes-in-patients-with-neuroendocrine-neoplasms.html https://www.enets.org/abstract/immunohistochemical-profiles-in-81-patients-with-resected-insulinomas.html https://www.enets.org/abstract/advanced-gastric-neuroendocrine-carcinoma-a-diagnostic-and-management-conundrum.html https://www.enets.org/abstract/therapeutic-sequences-in-patients-with-g1-g2-neuroendocrine-tumors-nets-an-observational-multicentre-prospective-retrospective-study.html https://www.enets.org/abstract/audit-of-a-new-nurse-led-non-medical-prescribing-nmp-clinic-for-systemic-anti-cancer-agents-sacts.html https://www.enets.org/abstract/the-neuroendocrine-phenotype-genomic-profile-and-therapeutic-sensitivity-of-gepnet-cell-lines.html https://www.enets.org/abstract/tumor-necrosis-of-primary-malignancy-affects-survival-and-outcome-in-patients-with-liver-metastases-from-neuroendocrine-tumors.html https://www.enets.org/abstract/pd-l1-expression-and-its-clinical-relevance-in-neuroendocrine-tumors-of-the-lung.html https://www.enets.org/abstract/systematic-evaluation-of-the-immune-microenvironment-of-neuroendocrine-tumors-net.html https://www.enets.org/abstract/tumor-size-correlates-with-grading-in-nonfunctioning-pancreatic-neuroendocrine-tumors-and-is-not-age-dependent.html https://www.enets.org/abstract/early-prognostic-factors-in-medullary-thyroid-carcinoma.html https://www.enets.org/abstract/assessment-of-the-clinical-utility-of-the-netest-in-a-us-registry-based-study.html https://www.enets.org/abstract/a-case-of-rectal-abscess-emerged-immediately-after-starting-chemotherapy-with-everolimus-and-required-surgical-drainage.html https://www.enets.org/abstract/pancreatic-neuroendocrine-tumors-analysis-of-prognostic-factors-after-surgical-resection-in-a-single-centre.html https://www.enets.org/abstract/analysis-of-met-and-ret-expression-in-patients-with-pancreatic-neuroendocrine-tumors-receiving-everolimus.html https://www.enets.org/abstract/metastatic-neuroendocrine-tumor-with-unknown-primary-site-presenting-simultaneously-with-prostate-adenocarcinoma.html https://www.enets.org/abstract/circulating-neuroendocrine-gene-transcripts-netest-decrease-early-after-radical-surgery-preliminary-results-of-a-prospective-study.html https://www.enets.org/abstract/high-hepatic-tumor-burden-and-history-of-cardiovascular-comorbidities-are-associated-with-carcinoid-heart-disease-a-multicenter-and-multinational-study.html https://www.enets.org/abstract/the-enets-registry-first-results-of-a-collaborative-effort-including-over-12-000-patients-with-neuroendocrine-neoplasms-nens-from-7-european-countries.html https://www.enets.org/abstract/213-bi-and-ac-225-dotatoc-receptor-labeled-targeted-alpha-radionuclide-therapy-in-neuroendocrine-tumors-refractory-to-beta-radiation-early-experience.html https://www.enets.org/abstract/clinicopathologic-characteristics-of-chinese-patients-with-gastroenteropancreatic-neuroendocrine-neoplasms-results-of-a-nation-wide-retrospective-epidemiology-study.html https://www.enets.org/abstract/a-rare-case-of-paraneoplastic-hypercalcemia-secondary-to-a-neuroendocrine-pancreatic-tumour-pnet.html https://www.enets.org/abstract/imaging-modality-depending-on-the-levels-of-tumor-markers.html https://www.enets.org/abstract/the-trend-of-using-ct-to-diagnose-the-gastroenteropancreatic-neuroendocrine-neoplasms-results-of-a-nation-wide-retrospective-epidemiology-study-in-china.html https://www.enets.org/abstract/development-of-multiplex-biomarker-assay-to-subtype-pancreatic-neuroendocrine-tumors-pannets-with-distinct-prognosis-and-mutations.html https://www.enets.org/abstract/predicting-response-to-prrt-development-and-validation-of-a-blood-based-predictive-biomarker.html https://www.enets.org/abstract/prognostic-impact-of-choi-response-criteria-compared-to-recist-in-grade-1-2-advanced-pancreatic-neuroendocrine-tumors-cripnet-getne-study-nct02841865.html https://www.enets.org/abstract/more-than-rare-pheochromocytomas-bilateral-and-hemorrhagic-giant-and-metastatic.html https://www.enets.org/abstract/24-hour-urinary-5-hydroxyindoleacetic-acid-levels-in-patients-with-non-functioning-pancreatic-neuroendocrine-tumors.html https://www.enets.org/abstract/validation-of-a-blood-based-biomarker-test-for-the-diagnosis-and-management-of-bronchopulmonary-neuroendocrine-tumors.html https://www.enets.org/abstract/trends-in-diagnosis-of-gastroenteropancreatic-neuroendocrine-tumors-gep-nets-in-india-a-report-of-multicentre-data-from-a-web-based-registry.html https://www.enets.org/abstract/biliary-mixed-neuroendocrine-nonneuroendocrine-neoplasms-a-series-of-four-cases-with-review-of-literature.html https://www.enets.org/abstract/diagnostic-dilemma-in-a-patient-with-recurrent-hypoglycaemia-an-unusual-case.html https://www.enets.org/abstract/neuroendocrine-tumours-in-tailgut-cysts-a-report-of-3-cases-and-review-of-literature.html https://www.enets.org/abstract/long-term-survival-after-transplant-for-neuroendocrine-liver-metastases-a-case-report-and-literature-review.html https://www.enets.org/abstract/approaching-nets-from-many-angles-a-medical-research-paradigm-to-challenge-new-zealandrs-research-traditions.html https://www.enets.org/abstract/screening-benefits-in-men1-associated-pituitary-adenomas.html https://www.enets.org/abstract/prognostic-value-of-lymph-node-status-and-extent-of-lymphadenectomy-in-non-functioning-pancreatic-neuroendocrine-tumors-outcome-analysis-from-378-consecutive-resections-in-a-high-volume-institution.html https://www.enets.org/abstract/the-network-registry-suggests-increasing-incidence-in-a-national-study-of-neuroendocrine-cancer-in-new-zealand-nz.html https://www.enets.org/abstract/does-somatostatin-receptor-ssr-positive-tumor-volume-determined-on-ga68-dotanoc-pet-ct-in-patients-with-paraganglioma-pgl-pheochromocytoma-pcc-correlate-with-biomarkersr-an-explorative-study.html https://www.enets.org/abstract/diagnostic-and-clinical-management-of-pancreatic-neuroendocrine-in-men1-syndrome.html https://www.enets.org/abstract/role-of-interval-reduction-of-somatostatin-analogs-in-patients-with-progressive-neuroendocrine-tumors-our-experience.html https://www.enets.org/abstract/potential-effects-of-ketoconazole-on-acth-producing-and-non-acth-producing-neuroendocrine-tumors.html https://www.enets.org/abstract/high-rate-of-copy-number-alterations-in-gastrointestinal-and-pancreatic-neuroendocrine-tumors-with-unidentified-driver-mutations.html https://www.enets.org/abstract/efficacy-of-sunitinib-correlated-with-clinical-radiological-variables-dose-intensity-and-treatment-time-in-advanced-grade-1-2-pancreatic-neuroendocrine-tumors-cripnet-getne-study-nct02841865.html https://www.enets.org/abstract/carcinoid-syndrome-open-questions-r-evaluations-from-a-real-life-setting.html https://www.enets.org/abstract/99mtc-colloid-scintigraphy-in-the-differential-diagnosis-of-pancreatic-net.html https://www.enets.org/abstract/pnet-g3-tumor-stabilization-achieved-by-an-individualized-molecular-therapy-based-on-tumor-genome-sequencing-results.html https://www.enets.org/abstract/ct-guided-hdr-brachyterapy-in-patients-with-advanced-non-resectable-and-progressive-nen-with-liver-bulky-disease-pilot-study.html https://www.enets.org/abstract/patterns-of-recurrence-after-resection-for-pancreatic-neuroendocrine-tumors-who-when-and-howr.html https://www.enets.org/abstract/diagnostic-utility-of-ki-67-as-a-mean-to-predict-the-uptake-of-functional-imaging-modalities-in-patients-with-neuroendocrine-neoplasms.html https://www.enets.org/abstract/somatostatin-analogs-ssas-as-effective-treatment-of-resectable-non-metastatic-non-functioning-pancreatic-neuroendocrine-tumors-nf-pnets-in-patients-unfit-for-surgery-a-case-series.html https://www.enets.org/abstract/late-metastasis-of-pancreatic-gastrinoma.html https://www.enets.org/abstract/metastatic-vipoma-co-secreting-insulin-with-complete-response-to-lanreotide-combined-with-capecitabine-and-temozolamide.html https://www.enets.org/abstract/diffuse-idiopathic-pulmonary-neuroendocrine-cell-hyperplasia-dipnech-characterisation-of-prevalence-and-prognosis-in-the-pulmonary-carcinoid-population.html https://www.enets.org/abstract/efficacy-of-oral-chemotherapy-with-capecitabine-and-temozolomide-captem-in-patients-with-metastatic-neuroendocrine-tumors-nets-a-single-institution-experience.html https://www.enets.org/abstract/high-grade-g3-gastro-entero-pancreatic-neuroendocrine-neoplasms-should-the-new-who-classification-apply-to-allr.html https://www.enets.org/abstract/pasireotide-as-a-possible-tool-for-the-control-of-refractory-hyperinsulinemic-hypoglycemia-from-malignant-insulinoma.html https://www.enets.org/abstract/treatment-outcomes-of-patients-with-mixed-neuroendocrine-non-neuroendocrine-neoplasms-minen.html https://www.enets.org/abstract/neuroendocrine-testicular-tumour-an-unusual-issue.html https://www.enets.org/abstract/safety-and-efficacy-of-tae-and-sirt-in-net-patients.html https://www.enets.org/abstract/the-evolution-of-surgical-strategies-for-pancreatic-neuroendocrine-tumors-pan-nens-time-trend-and-outcome-analysis-from-587-consecutive-resections-at-a-high-volume-institution.html https://www.enets.org/abstract/development-of-a-patient-centred-service-for-neuroendocrine-tumors-nets-in-wales-population-based-national-commissioning.html https://www.enets.org/abstract/when-is-right-hemicolectomy-really-indicated-for-pediatric-appendiceal-netsr.html https://www.enets.org/abstract/assessment-of-the-serum-levels-of-the-soluble-vascular-cellular-adhesion-molecule-1-svcam-1-in-patients-with-neuroendocrine-neoplasms.html https://www.enets.org/abstract/poorly-differentiated-neuroendocrine-carcinomas-of-the-colon-a-clinicopathological-study.html https://www.enets.org/abstract/cystic-duct-gastrinoma-in-a-patient-with-men1-a-case-report.html https://www.enets.org/abstract/clinical-characteristics-treatment-outcomes-and-potential-novel-therapeutic-options-for-patients-with-prostatic-neuroendocrine-carcinoma.html https://www.enets.org/abstract/carcinoid-heart-failure-in-a-metastatic-duodenal-neuroendocrine-tumor-a-challenging-case-report.html https://www.enets.org/abstract/mechanisms-of-main-pancreatic-duct-dilatation-in-pancreatic-neuroendocrine-tumors-pannets-radiopathologic-correlation.html https://www.enets.org/abstract/time-to-sustained-improvement-in-bowel-movement-frequency-with-telotristat-ethyl-analyses-of-two-phase-3-studies-in-carcinoid-syndrome.html https://www.enets.org/abstract/patient-survey-devoted-to-characterizing-experience-and-expectations-of-patients-with-neuroendocrine-tumors-net.html https://www.enets.org/abstract/metastatic-insulinoma-a-case-report-of-complete-response-to-peptide-receptor-radionuclide-therapy.html https://www.enets.org/abstract/activity-of-bevacizumab-in-neuroendocrine-neoplasms.html https://www.enets.org/abstract/prognostic-value-of-the-different-pre-treatment-biomarkers-for-patients-with-neuroendocrine-tumors.html https://www.enets.org/abstract/large-cell-neuroendocrine-carcinoma-of-the-lung-single-centre-retrospective-cohort-study.html https://www.enets.org/abstract/efficacy-of-octreotide-lar-in-treatment-of-naive-patients-with-advanced-non-resectable-well-and-moderate-differentiated-pancreatic-neuroendocrine-neoplasms-p-nens.html https://www.enets.org/abstract/can-insulin-like-growth-factor-1-igf-1-igf-1-receptor-connective-tissue-growth-factor-and-ki-67-labelling-index-have-a-prognostic-role-in-pulmonary-carcinoidsr.html https://www.enets.org/abstract/development-of-pre-clinical-nen-models-r-limitations-and-opportunities.html https://www.enets.org/abstract/effects-of-multi-receptor-targeting-drugs-in-neuroendocrine-tumors-using-3d-cell-culture.html https://www.enets.org/abstract/enhancing-diagnostic-precision-through-combined-genomic-and-histopathological-analysis-of-pancreatic-neuroendocrine-tumors.html https://www.enets.org/abstract/the-clinical-value-of-circulating-transcript-analysis-netest-during-follow-up-of-resected-well-differentiated-pancreatic-neuroendocrine-tumors.html https://www.enets.org/abstract/liver-resection-for-neuroendocrine-tumors-liver-metastases-in-transplantable-patients-within-the-milan-criteria.html https://www.enets.org/abstract/analysis-of-gene-expression-patterns-of-rectum-neuroendocrine-tumors-net-versus-healthy-tissue-reveals-alterations-in-the-mapk-and-wnt-signaling-pathways.html https://www.enets.org/abstract/ki-67-to-predict-recurrence-and-survival-of-pancreatic-neuroendocrine-tumors.html https://www.enets.org/abstract/neuroendocrine-tumors-committee-of-reference-hospital-decision-making-process-on-the-diagnostic-and-therapeutic-approach-to-patients-with-neuroendocrine-tumors.html https://www.enets.org/abstract/incidental-histological-diagnosis-of-small-pancreatic-neuroendocrine-tumors-are-we-underestimating-their-incidencer.html https://www.enets.org/abstract/expression-of-foxm1-in-g3-neuroendocrine-tumors-net-g3-and-g3-neuroendocrine-carcinomas-nec-g3-of-the-pancreas-and-the-intestine.html https://www.enets.org/abstract/the-bon-sstr2-chicken-chorioallantoic-membrane-cam-model-for-the-analysis-of-lu-17-dotatoc-sensitizing-agents.html https://www.enets.org/abstract/a-novel-classification-of-pancreatic-neuroendocrine-tumors-pnets-guided-by-genomics.html https://www.enets.org/abstract/value-of-somatostatin-receptor-scintigraphy-srs-in-patients-with-appendiceal-neuroendocrine-neoplasms-anen-based-on-clinical-follow-up-and-results-of-netest.html https://www.enets.org/abstract/ultra-deep-targeted-resequencing-reveals-recurrent-daxx-and-cyfip2-mutations-and-implicates-novel-pathways-in-pancreatic-neuroendocrine-tumors.html https://www.enets.org/abstract/the-association-between-gastrin-and-glucose-serum-concentration-in-hypergastrinemic-patients-with-gastric-neuroendocrine-tumors-type-1-and-ecl-cells-hyperplasia.html https://www.enets.org/abstract/the-role-of-magnetic-resonance-imaging-and-endoscopic-ultrasound-imaging-in-the-diagnosis-and-management-of-pancreatic-neuroendocrine-tumors-pnet-in-patients-with-multiple-endocrine-neoplasia-type-1-men1.html https://www.enets.org/abstract/a-randomized-controlled-study-comparing-treatment-of-gastro-entero-pancreatic-neuroendocrine-tumors-gepnet-with-177lu-dotatate-alone-and-in-combination-with-capecitabine.html https://www.enets.org/abstract/mitochondrial-or-aerobic-glycolysis-oriented-metabolism-may-define-pancreatic-neuroendocrine-tumors-pannet-resistance-to-mtor-targeting-therapies.html https://www.enets.org/abstract/predicting-resectability-of-primary-tumor-and-mesenteric-lumps-in-patients-with-small-intestine-neuroendocrine-tumors.html https://www.enets.org/abstract/tumor-necrosis-factor-related-apoptosis-inducing-ligand-trail-receptor-expression-in-patients-with-neuroendocrine-neoplasia.html https://www.enets.org/abstract/prrt-in-hindgut-and-cancer-of-unknown-primary-nen.html https://www.enets.org/abstract/somatostatin-analogs-and-mtor-inhibitors-as-radioprotectors-or-radiosensitizers-in-neuroendocrine-tumor-cells.html https://www.enets.org/abstract/pfs-and-os-after-salvage-peptide-receptor-radionuclide-therapy-prrt-with-177lu-dotatate-in-patients-with-gastroenteropancreatic-or-bronchial-neuroendocrine-tumors-gep-nets-r-the-rotterdam-cohort.html https://www.enets.org/abstract/genomic-and-transcriptomic-characterization-of-aggressive-well-differentiated-pancreatic-neuroendocrine-tumors-wd-pannet.html https://www.enets.org/abstract/identification-and-validation-of-the-angiotensin-ii-receptor-type-1-as-a-possible-anti-cancer-target-in-neuroendocrine-tumors.html https://www.enets.org/abstract/results-of-liver-transplantation-in-patients-with-neuroendocrine-tumors.html https://www.enets.org/abstract/first-patient-survey-about-tumor-associated-fatigue-in-nen.html https://www.enets.org/abstract/merkel-cell-carcinomas-in-new-zealand-virus-or-ultra-violetr.html https://www.enets.org/abstract/large-cell-neuroendocrine-carcinoma-of-the-lung-with-atypical-evolution-and-great-response-to-innovative-treatments.html https://www.enets.org/abstract/expanding-the-who-2017-classification-to-gastrointestinal-tumors-real-world-data-from-the-r-getne-registry.html https://www.enets.org/abstract/clinical-use-of-lanreotide-ag-as-initial-therapy-in-patients-with-advanced-non-resectable-well-g1-and-moderate-g2-differentiated-pancreatic-neuroendocrine-neoplasms-p-nen.html https://www.enets.org/abstract/trends-in-management-of-gastro-intestinal-neuroendocrine-tumors-in-inflammatory-bowel-diseases-the-contribute-of-a-case-series.html https://www.enets.org/abstract/pak4-nampt-dual-inhibition-as-a-novel-strategy-for-therapy-resistant-pancreatic-neuroendocrine-tumors.html https://www.enets.org/abstract/clinicopathological-features-and-prognostic-analysis-of-227-cases-with-well-differentiated-gastric-neuroendocrine-tumors.html https://www.enets.org/abstract/tumour-infiltrating-neutrophils-predict-poor-survival-of-non-functional-pancreatic-neuroendocrine-tumour-patients-after-curative-resection.html https://www.enets.org/abstract/apatinib-inhibits-tumor-growth-and-angiogenesis-in-pnet-models.html https://www.enets.org/abstract/survivorship-care-model-for-patients-with-metastatic-neuroendocrine-tumors.html https://www.enets.org/abstract/correlation-between-immunohistochemical-markers-expression-and-lymph-node-metastasis-in-gastroenteropancreatic-neuroendocrine-neoplasms-a-nation-wide-10-year-retrospective-clinical-epidemiological-study-in-china.html https://www.enets.org/abstract/marked-response-to-nab-paclitaxel-in-advanced-neuroendocrine-carcinoma-of-nasal-sinuses-a-case-report.html https://www.enets.org/abstract/somatostatin-analogs-in-patients-with-zollinger-ellison-syndrome-zes-an-observational-study.html https://www.enets.org/abstract/development-of-ex-vivo-models-of-metastatic-neuroendocrine-neoplasms.html https://www.enets.org/abstract/the-distinctive-character-of-micro-vasculature-and-immune-cell-infiltration-in-cystic-pancreatic-neuroendocrine-tumors.html https://www.enets.org/abstract/the-incidence-of-gastrointestinal-neuroendocrine-tumors-in-the-russian-population.html https://www.enets.org/abstract/different-treatment-options-for-patients-with-advanced-gastrointestinal-neuroendocrine-tumors.html https://www.enets.org/abstract/difficulties-in-providing-palliative-care-in-rural-india-west-bengal-experience-of-an-ngo.html https://www.enets.org/abstract/telephonic-communication-in-palliative-care-for-better-management-of-terminal-cancer-patients-in-rural-india-a-ngo-based-approach.html https://www.enets.org/abstract/safety-and-efficacy-of-salvage-prrt-with-177lu-dota-octreotate-in-patients-with-well-differentiated-metastatic-neuroendocrine-tumours-net.html https://www.enets.org/abstract/dacarbazine-or-temozolomide-based-chemotherapy-in-metastatic-digestive-neuroendocrine-carcinomas-in-post-first-line-chemotherapy-a-retrospective-multicentric-study-of-the-french-group-of-endocrine-tumours-gte.html https://www.enets.org/abstract/pancreatic-neuroendocrine-neoplasms-and-liver-metastases-when-size-matters.html https://www.enets.org/abstract/assessing-the-gaps-in-experience-and-knowledge-of-australian-primary-health-care-professionals-gps-in-treating-and-caring-for-the-increasing-number-of-australian-neuroendocrine-tumour-net-patients.html https://www.enets.org/abstract/carcinoid-heart-disease-a-retrospective-study-and-a-multidisciplinary-proposal-of-a-new-algorithm.html https://www.enets.org/abstract/increased-autophagy-mitophagy-levels-in-pancreatic-neuroendocrine-neoplasms.html https://www.enets.org/abstract/a-new-possibility-in-si-net-surgery-by-using-a-new-probe-and-90y-dotatoc-a-pilot-study.html https://www.enets.org/abstract/investigating-the-crosstalk-between-men1-p53-and-notch-reveals-biomarkers-of-formation-of-primary-pancreatic-neuroendocrine-tumors.html https://www.enets.org/abstract/patient-reported-symptoms-coping-and-quality-of-life-during-somatostatin-analogue-treatment-for-metastatic-small-intestinal-neuroendocrine-tumours.html https://www.enets.org/abstract/endoscopic-management-and-outcomes-of-gastro-duodenal-neuroendocrine-tumours.html https://www.enets.org/abstract/ultrasonography-detects-most-pnet.html https://www.enets.org/abstract/gastric-neuroendocrine-neoplasms-clinical-management-and-outcomes-in-a-cohort-of-54-patients.html https://www.enets.org/abstract/hormonet-study-of-tamoxifen-in-well-differentiated-neuroendocrine-tumors-net-and-hormone-receptor-positive-expression.html https://www.enets.org/abstract/the-economic-impact-to-patients-with-neuroendocrine-tumours.html https://www.enets.org/abstract/the-clinical-outcome-of-non-curative-resection-of-small-rectal-neuroendocrine-tumours.html https://www.enets.org/abstract/the-role-of-serum-concentration-ratio-of-neuron-specific-enolase-in-the-evaluation-of-therapeutic-effect-of-neuroendocrine-tumor.html https://www.enets.org/abstract/neuroendocrine-carcinoma-of-the-upper-urinary-tract-a-case-report.html https://www.enets.org/abstract/64cu-dotatate-pet-ct-predicts-progression-free-survival-in-patients-with-neuroendocrine-neoplasms.html https://www.enets.org/abstract/achieving-objective-response-in-treatment-of-non-resectable-neuroendocrine-tumors-does-not-predict-longer-time-to-progression-compared-to-achieving-stable-disease.html https://www.enets.org/abstract/overall-survival-and-progression-free-survival-of-patients-with-large-cell-neuroendocrine-lung-cancer-and-combined-large-cell-neuroendocrine-lung-cancer-treated-in-clinical-stage-i-iv.html https://www.enets.org/abstract/upfront-surgery-in-patients-with-high-grade-gep-nen-and-minen-a-nordic-multicenter-study-of-201-patients.html https://www.enets.org/abstract/clinicopathological-characterization-of-gastroenteropancreatic-neuroendocrine-tumors-in-a-single-institute-of-north-africa-a-retrospective-study-of-80-cases.html https://www.enets.org/abstract/gastroenteropancreatic-neuroendocrine-tumours-versus-gastroenteropancreatic-neuroendocrine-carcinoma-presentation-in-tunisian-patients.html https://www.enets.org/abstract/survival-of-patients-with-gastroenteropancreatic-neuroendocrine-tumors-gep-nets-in-a-single-institute-in-north-africa-over-the-last-16-years.html https://www.enets.org/abstract/folfirinec-a-multi-center-randomized-comparative-phase-ii-study-of-folfirinox-vs-platinum-etoposide-as-first-line-treatment-for-metastatic-neuroendocrine-carcinoma-of-gastroenteropancreatic-or-unknown-origin-associated-with-molecular-profiling.html https://www.enets.org/abstract/177lu-dotatate-plus-166ho-radioembolization-in-patients-with-neuroendocrine-tumours-a-single-center-prospective-interventional-non-comparative-open-label-phase-ii-study-hepar-plus-study.html https://www.enets.org/abstract/prostate-metastasis-of-medullary-thyroid-carcinoma-in-a-young-patient-with-men2b-syndrome.html https://www.enets.org/abstract/pancreatic-metastases-originating-from-intestinal-neuroendocrine-tumours.html https://www.enets.org/abstract/therapy-related-myeloid-neoplasms-in-patients-with-neuroendocrine-neoplasms-after-peptide-receptor-radionuclide-therapy-a-systematic-review.html https://www.enets.org/abstract/second-primary-neoplasms-in-patients-with-neuroendocrine-neoplasms-nen-data-from-a-retrospective-multicentric-study1.html https://www.enets.org/abstract/identification-of-a-novel-mafa-missense-mutation-causing-familial-insulinomatosis.html https://www.enets.org/abstract/patient-derived-organoid-models-of-human-neuroendocrine-carcinoma.html https://www.enets.org/abstract/epigenetic-landscape-of-pancreatic-neuro-endocrine-tumors-reveals-distinct-cells-of-origin-and-means-of-tumor-progression.html https://www.enets.org/abstract/long-term-complete-response-in-metastatic-poorly-differentiated-neuroendocrine-rectal-carcinoma-with-multimodal-approach-a-case-report.html https://www.enets.org/abstract/histologic-grading-of-neuroendocrine-tumors-and-its-relationship-of-survival.html https://www.enets.org/abstract/anti-tumor-effects-of-semaphorin-4d-blockade-unravel-a-novel-pro-invasive-mechanism-of-vascular-targeting-agents.html https://www.enets.org/abstract/mimics-of-neuroendocrine-neoplasms-identified-in-a-single-consultation-center-between-2009-and-2019.html https://www.enets.org/abstract/immediate-adverse-effects-of-peptide-receptor-radionuclide-therapy-prrt-administration-in-patients-with-neuroendocrine-tumors-nets-a-single-institution-review.html https://www.enets.org/abstract/integrative-genomic-characterization-identifies-molecular-subtypes-of-lung-carcinoids.html https://www.enets.org/abstract/immunohistochemical-biomarker-expression-in-gastro-entero-pancreatic-neuroendocrine-tumors-at-enets-centre-of-excellence-university-hospital-zurich-switzerland.html https://www.enets.org/abstract/ct-based-radiomics-for-prediction-of-outcome-after-somatostatin-analogues-in-patients-with-liver-metastases-of-a-neuroendocrine-tumor-an-exploratory-study.html https://www.enets.org/abstract/impact-of-next-generation-sequencing-analyses-on-treatment-management-of-patients-with-advanced-neuroendocrine-neoplasms.html https://www.enets.org/abstract/progression-free-survival-and-clinical-outcomes-with-long-term-use-of-telotristat-ethyl-in-us-clinical-practice.html https://www.enets.org/abstract/cross-sectional-study-assessing-the-feasibility-of-using-net-vitals-communication-tool-among-patients-with-neuroendocrine-tumors.html https://www.enets.org/abstract/risk-of-prrt-associated-bowel-obstruction-in-patients-with-mesenteric-peritoneal-disease-and-potential-role-of-corticosteroids-in-treatment1.html https://www.enets.org/abstract/somatostatin-analogs-ssa-in-patients-with-symptomatic-diffuse-idiopathic-pulmonary-neuroendocrine-cell-hyperplasia-dipnech.html https://www.enets.org/abstract/theranostic-implication-of-molecular-imaging-phenotype-of-well-differentiated-lung-carcinoid-by-68ga-dotatate-pet-ct-and-18f-fdg-pet-ct1.html https://www.enets.org/abstract/effectiveness-of-lanreotide-120-mg-lan-in-patients-with-locally-advanced-or-metastatic-pancreatic-neuroendocrine-tumours-pannet-in-routine-clinical-practice.html https://www.enets.org/abstract/survival-according-to-therapy-regimen-for-sinet-data-from-145-patients-from-a-german-tertiary-referral-centre-preliminary-results.html https://www.enets.org/abstract/management-and-outcomes-of-duodenal-neuroendocrine-tumours.html https://www.enets.org/abstract/diagnosis-and-management-of-insulinomas-the-use-of-current-practices-in-pakistan.html https://www.enets.org/abstract/finding-the-risk-factors-associated-with-neuroendocrine-tumors-of-rectum.html https://www.enets.org/abstract/incidence-and-outcome-of-brain-metastasis-in-patients-diagnosed-with-neuroendocrine-neoplasm.html https://www.enets.org/abstract/cystic-pancreatic-neuroendocrine-tumors-can-we-diagnose-them-preoperatively.html https://www.enets.org/abstract/role-of-biomarkers-in-disease-progression-of-net.html https://www.enets.org/abstract/neuroendocrine-neoplasms-arising-in-inflammatory-bowel-disease-clinical-features-of-69-cases-and-literature-review.html https://www.enets.org/abstract/rectal-nets-and-rectosigmoid-junction-nets-may-need-to-be-treated-differently.html https://www.enets.org/abstract/risk-factors-of-the-distant-metastasis-in-gastric-neuroendocrine-neoplasms-a-10-year-retrospective-study-in-china.html https://www.enets.org/abstract/treatment-outcomes-of-patients-with-g3-neuroendocrine-neoplasms.html https://www.enets.org/abstract/evaluation-of-early-predictors-of-metabolic-syndrome-in-patients-with-gastroenteropancreatic-neuroendocrine-tumors-gep-net.html https://www.enets.org/abstract/vitamin-supplementation-and-a-personalized-diet-in-patients-with-neuroendocrine-tumors-the-divit-study.html https://www.enets.org/abstract/impact-on-outcome-in-patients-pts-with-advanced-neuroendocrine-neoplasms-nens-included-in-prospective-clinical-trials-ct.html https://www.enets.org/abstract/metastatic-merkel-cell-carcinoma-associated-paraneoplastic-hyponatraemia-response-to-avelumab.html https://www.enets.org/abstract/glucagonoma-still-a-misleading-disease-and-the-importance-of-multidisciplinary-neuroendocrine-tumor-board.html https://www.enets.org/abstract/the-effects-of-somatostatin-analogues-on-hba1c-and-bmi-in-the-treatment-of-neuroendocrine-tumours.html https://www.enets.org/abstract/tumor-to-liver-ratio-of-ga-68-dotatoc-pet-ct-as-a-prognostic-parameter-in-metastatic-well-differentiated-gastroenteropancreatic-neuroendocrine-tumor-patients-who-received-lanreotide-therapy.html https://www.enets.org/abstract/intracardiac-paragangliomas-pgls-a-single-institution-experience.html https://www.enets.org/abstract/case-report-whole-exon-sequencing-of-primary-lesion-and-metastatic-liver-lesion-in-pancreatic-neuroendocrine-tumor.html https://www.enets.org/abstract/clinical-efficacy-of-peptide-receptor-radionuclide-therapy-in-patients-with-neuroendocrine-neoplasm.html https://www.enets.org/abstract/use-of-plasma-proteins-to-predict-progressive-disease-in-patients-with-small-intestinal-neuroendocrine-tumours.html https://www.enets.org/abstract/predictive-factors-of-tumor-recurrence-after-radical-surgery-for-gastro-entero-pancreatic-neuroendocrine-neoplasms-gep-nens-identification-of-high-risk-subgroups.html https://www.enets.org/abstract/inhibition-of-cyclin-dependent-kinases-overcomes-myc-driven-secondary-resistance-to-everolimus-in-digestive-nets.html https://www.enets.org/abstract/outcome-of-net-liver-metastases-treated-by-tae-using-microspheres.html https://www.enets.org/abstract/64cu-dotatate-pet-ct-imaging-of-patients-with-neuroendocrine-neoplasms-can-be-performed-between-1-and-3-hours-after-radiotracer-injection-comparison-of-lesion-detection-ability-and-contrast.html https://www.enets.org/abstract/favourable-outcome-in-patients-with-metastatic-pheochromocytomas-and-paragangliomas-treated-with-177lu-dotatate.html https://www.enets.org/abstract/the-patient-journey-experience-from-symptoms-to-diagnosis-among-patients-with-small-intestinal-neuroendocrine-tumours-sinet.html https://www.enets.org/abstract/trends-of-incidence-and-prognosis-of-gastric-neuroendocrine-neoplasms-a-study-based-on-seer-and-our-multicenter-research.html https://www.enets.org/abstract/nen-skeletal-metastasis-performance-and-the-correlation-with-cell-proliferation-112-cases-of-68ga-dota-tate-results-analysis.html https://www.enets.org/abstract/post-transplant-recurrence-of-neuroendocrine-tumors.html https://www.enets.org/abstract/a-phase-ii-open-label-multicenter-trial-of-avelumab-in-patients-with-advanced-metastatic-high-grade-neuroendocrine-carcinomas-nec-g3-who-2010-progressive-after-first-line-chemotherapy-avenec.html https://www.enets.org/abstract/pancreatic-neuroendocrine-tumor-pnet-showing-remission-after-tuberculostatic-treatment-an-unusual-case-report-suggesting-anti-proliferative-effects-of-antibiotics-in-pnets.html https://www.enets.org/abstract/molecular-correlation-of-the-activity-of-evofosfamide-evo-in-combination-with-sunitinib-sun-in-pancreatic-neuroendocrine-tumors-pnets-in-the-sunevo-getne-trial.html https://www.enets.org/abstract/avelumab-for-advanced-merkel-cell-carcinoma-in-the-netherlands-a-nationwide-survey.html https://www.enets.org/abstract/assessment-of-quality-of-life-in-patients-with-neuroendocrine-tumours-results-of-a-systematic-literature-review.html https://www.enets.org/abstract/risk-of-pre-operative-understaging-of-duodenal-neuroendocrine-tumors-at-conventional-imaging-when-surgery-becomes-the-first-choice.html https://www.enets.org/abstract/thymosin-beta-4-is-an-autocrine-mitogen-for-neuroendocrine-tumour-cells1.html https://www.enets.org/abstract/immuneoct-oct-lar-in-the-induction-of-immunologic-response-in-patients-with-neuroendocrine-neoplasms-nens-a-perspective-observational-and-translational-study-eudract2017-001613-83.html https://www.enets.org/abstract/evaluation-de-satisfaction-infirmiere-nurse-satisfaction-evaluation-observational-study-of-the-preparation-and-intramuscular-administration-of-the-previous-and-new-long-acting-release-octreotide-lar-formulation-easi.html https://www.enets.org/abstract/chromogranin-a-as-a-tumoral-marker-for-neuroendocrine-tumors-in-chilean-patients-a-case-control-study.html https://www.enets.org/abstract/claudin-18-is-a-sensitive-and-a-specific-marker-for-gastric-neuroendocrine-tumors.html https://www.enets.org/abstract/small-bowel-neuroendocrine-tumor-metastases-comparison-of-contrast-enhanced-computed-tomography-and-68ga-dotatate-pet-ct.html https://www.enets.org/abstract/sarcopenia-don-t-judge-a-book-by-it-s-cover.html https://www.enets.org/abstract/clinical-features-and-quality-of-life-in-patients-with-gastroenteropancreatic-neuroendocrine-tumors-from-chile1.html https://www.enets.org/abstract/sporadic-neuroendocrine-neoplasms-in-young-adult-patients-natural-history-prognosis-and-management.html https://www.enets.org/abstract/development-of-a-personalized-human-immunocompetent-ex-vivo-model-of-neuroendocrine-liver-metastasis-using-precision-cut-tissue-slice-technology.html https://www.enets.org/abstract/improving-diagnosis-times-as-part-of-the-transformation-of-the-south-wales-net-service.html https://www.enets.org/abstract/silvelul-project-development-of-an-new-potential-predictive-immunohistochemical-score-spi-in-patients-pts-with-pancreatic-neuroendocrine-tumors-pannet-treated-with-captem-or-everolimus.html https://www.enets.org/abstract/clinical-presentation-and-prognosis-of-patients-with-medullary-thyroid-cancer.html https://www.enets.org/abstract/unexpected-high-rate-of-metastases-in-type-1-gastric-neuroendocrine-neoplasia1.html https://www.enets.org/abstract/germline-variants-in-cancer-predisposing-genes-in-young-adults-with-neuroendocrine-tumors.html https://www.enets.org/abstract/metnet-a-phase-ii-trial-of-metformin-in-patients-with-well-differentiated-neuroendocrine-tumors.html https://www.enets.org/abstract/is-it-that-rare.html https://www.enets.org/abstract/occurrence-of-pancreatic-exocrine-insufficiency-in-patients-with-advanced-neuroendocrine-tumours-treated-with-somatostatin-analogue.html https://www.enets.org/abstract/efficacy-of-peptide-receptor-radionuclide-therapy-for-esthesioneuroblastoma.html https://www.enets.org/abstract/nucleophosmin-expression-and-relocation-in-pancreatic-neuroendocrine-tumors-preliminary-data.html https://www.enets.org/abstract/outcome-of-systemic-therapy-in-secondary-high-grade-pancreatic-neuroendocrine-tumors.html https://www.enets.org/abstract/peptide-receptor-radionuclide-therapy-in-rectal-neuroendocrine-tumours.html https://www.enets.org/abstract/patient-and-nurse-satisfaction-with-the-new-lanreotide-autogel-pre-filled-syringe-in-neuroendocrine-tumors-net-a-prospective-study-sonate.html https://www.enets.org/abstract/interest-of-pet-mri-in-the-management-of-git-nets.html https://www.enets.org/abstract/net-02-a-phase-ii-trial-of-liposomal-irinotecan-nal-iri-and-5-fluorouracil-5-fu-folinic-acid-or-docetaxel-as-second-line-therapy-in-patients-pts-with-progressive-poorly-differentiated-extra-pulmonary-neuroendocrine-carcinoma-pd-ep-nec.html https://www.enets.org/abstract/characterization-of-epigenetic-modulation-in-pancreatic-neuroendocrine-neoplasms.html https://www.enets.org/abstract/g3-neuroendocrine-tumours-and-carcinomas-clinicopathological-features-for-distinct-entities.html https://www.enets.org/abstract/everolimus-induced-pneumonitis-in-patients-with-neuroendocrine-neoplasms-multinational-study-on-risk-factors-and-outcomes.html https://www.enets.org/abstract/immunohistochemical-profile-of-digestive-neuroendocrine-neoplasms-a-retrospective-analysis-in-a-single-algerian-institution.html https://www.enets.org/abstract/lymph-node-merkel-cell-carcinoma-without-primary-long-term-survival.html https://www.enets.org/abstract/surgical-correction-of-carcinoid-heart-disease-improves-liver-function-and-5-hydroxyindoleacetic-acid-levels.html https://www.enets.org/abstract/tumor-promoting-effects-of-the-transcriptional-regulator-cux1-in-pannet.html https://www.enets.org/abstract/primary-hepatic-neuroendocrine-carcinoma-case-report-and-literature-review.html https://www.enets.org/abstract/prospective-evaluation-of-the-netest-as-a-liquid-biopsy-for-gastroenteropancreatic-and-bronchopulmonary-neuroendocrine-neoplasms-enets-center-of-excellence-experience.html https://www.enets.org/abstract/development-and-initial-validation-of-a-brief-questionnaire-to-assess-patient-satisfaction-with-self-injection-of-lanreotide-autogel-results-during-a-home-training-programme.html https://www.enets.org/abstract/accidental-injection-of-unlabeled-lu-177-caused-catastrophic-consequences-in-patients-with-neuroendocrine-tumor.html https://www.enets.org/abstract/the-second-revision-of-clinical-practice-guidelines-in-gep-nen-in-japan.html https://www.enets.org/abstract/a-real-world-study-of-patients-with-carcinoid-syndrome-at-king-s-college-hospital-on-long-term-telotristat-therapy.html https://www.enets.org/abstract/novelties-in-primary-and-metastatic-gep-nens-clinical-outcome-investigation.html https://www.enets.org/abstract/transformation-to-high-grade-3-g3-neuroendocrine-neoplasia-nen-molecular-imaging-pathologic-features-and-patient-outcomes.html https://www.enets.org/abstract/metastatic-risk-in-pancreatic-neuroendocrine-tumors-a-16-year-experience-from-bogota-colombia-a-series-cases.html https://www.enets.org/abstract/rectal-neuroendocrine-tumor-with-chromogranin-expression-is-associated-with-aggressive-clinical-behavior-and-worse-prognosis.html https://www.enets.org/abstract/primary-tumour-resection-and-prrt-of-nen-stage-iv-are-there-differences-in-grading.html https://www.enets.org/abstract/whole-genome-dna-methylation-profiling-identifies-neuroendocrine-tumor-origin.html https://www.enets.org/abstract/surgical-and-survival-outcomes-of-early-peptide-receptor-radionuclide-therapy-for-downstaging-locally-advanced-or-oligometastatic-pancreatic-neuroendocrine-neoplasms.html https://www.enets.org/abstract/correlation-between-clinicopathological-features-and-distant-metastases-in-pancreatic-neuroendocrine-neoplasm-a-national-multicenter-10-year-retrospective-study.html https://www.enets.org/abstract/prrt-neuroendocrine-tumor-response-assessment-using-circulating-transcript-analysis-the-netest.html https://www.enets.org/abstract/a-clinical-controlled-observation-of-chinese-herbal-decoction-smlj01-for-type-1-gastric-neuroendocrine-neoplasms.html https://www.enets.org/abstract/diagnostic-accuracy-of-endoscopic-ultrasound-fine-needle-aspiration-eus-fna-in-the-evaluation-of-pancreatic-neuroendocrine-neoplasms-pnen-grading.html https://www.enets.org/abstract/succinate-dehydrogenase-b-sdhb-immunohistochemical-expression-in-pancreatic-neuroendocrine-tumours-and-correlation-with-somatostatin-receptor-immunohistochemistry.html https://www.enets.org/abstract/a-meta-analysis-of-the-accuracy-of-a-neuroendocrine-tumor-mrna-genomic-biomarker-netest-in-blood.html https://www.enets.org/abstract/whole-exome-sequencing-reveals-the-monoclonal-origin-of-gastric-mixed-adenoneuroendocrine-carcinomas.html https://www.enets.org/abstract/pattern-of-disease-recurrence-and-treatment-after-radical-surgery-for-nonfunctioning-pancreatic-neuroendocrine-tumors-nf-pannet.html https://www.enets.org/abstract/clinical-epidemiology-study-of-rectal-neuroendocrine-neoplasms-in-china-a-national-multicenter-10-year-retrospective-study.html https://www.enets.org/abstract/targeted-next-generation-sequencing-analysis-reveals-the-genetic-characteristics-of-gastric-neuroendocrine-neoplasmas3.html https://www.enets.org/abstract/concurrent-metastatic-pulmonary-neuroendocrine-tumor-and-pituitary-macroadenoma.html https://www.enets.org/abstract/introduction-of-dosimetry-on-prrt-practice-a-useful-tool-to-detect-responders-and-evaluate-treatment-safety.html https://www.enets.org/abstract/irinotecan-based-regimens-for-the-second-line-treatment-of-extrapulmonary-poorly-differentiated-neuroendocrine-carcinomas-a-monocentric-experience.html https://www.enets.org/abstract/can-the-efficacy-of-etoposide-platinum-chemotherapy-be-predicted-by-p53-prb-status-in-grade-3-neuroendocrine-neoplasms-g3-nen.html https://www.enets.org/abstract/extrahepatic-68ga-dotatate-avid-tumor-volume-and-serum-chromogranin-a-predict-short-term-outcome-of-177lu-dotatate-in-late-stage-metastatic-gastroenteropancreatic-neuroendocrine-tumors.html https://www.enets.org/abstract/experience-of-treatment-with-everolimus-in-patients-with-well-differentiated-neuroendocrine-tumors-net-of-various-localizations-at-the-nn-blokhin-nmrco-moscow-russia.html https://www.enets.org/abstract/differential-gene-expression-may-predict-response-to-somatostatin-analogues-ssas-in-gastrointestinal-gi-neuroendocrine-tumors-nets.html https://www.enets.org/abstract/sunitinib-in-combination-with-lanreotide-for-the-treatment-of-pancreatic-neuroendocrine-tumors.html https://www.enets.org/abstract/when-it-comes-to-the-diagnostic-of-neuroendocrine-neoplasms-nen-not-all-markers-and-clones-were-made-equal-assessment-of-5-makers-in-466-nen-from-10-anatomical-sites.html https://www.enets.org/abstract/increase-of-ki-67-index-over-time-and-influence-on-all-cause-mortality-in-patients-with-neuroendocrine-neoplasms-nen.html https://www.enets.org/abstract/characteristics-of-the-immunophenotype-and-the-status-of-receptors-for-somatostatin-type-2-and-5-of-typical-and-atypical-carcinoids-of-the-lung.html https://www.enets.org/abstract/role-of-foxm1-in-aggressive-pancreatic-pulmonary-neuroendocrine-carcinomas-and-anti-tumor-effect-of-the-foxm1-inhibitor-thiostrepton.html https://www.enets.org/abstract/immunotherapy-as-second-line-treatment-in-grade-3-neuroendocrine-carcinomas-a-prospective-case-series-from-an-enets-center-of-excellence.html https://www.enets.org/abstract/efficacy-of-surufatinib-in-western-patients-pts-with-pancreatic-neuroendocrine-tumors-pannets.html https://www.enets.org/abstract/comparison-of-digestive-and-non-digestive-neuroendocrine-neoplasm-patient-characteristics-and-survival-in-an-enets-center-of-excellence.html https://www.enets.org/abstract/surgical-management-of-neuroendocrine-tumor-associated-liver-metastases.html https://www.enets.org/abstract/lung-neuroendocrine-tumors-experience-of-medical-oncology-department-of-hospital-1st-november-1954-oran.html https://www.enets.org/abstract/177-lu-dotatate-in-200-patients-with-neuroendocrine-tumors-real-world-data-from-the-septralu-registry.html https://www.enets.org/abstract/patient-derived-tumor-xenograft-combined-with-chemotherapy-drug-sensitivity-test-in-a-patient-with-pancreatic-neuroendocrine-carcinoma.html https://www.enets.org/abstract/impact-of-ga68-dotatoc-pet-mri-on-therapy-management-in-patients-with-neuroendocrine-neoplasia-nen-preliminary-results.html https://www.enets.org/abstract/comparison-of-somatostatin-analogues-in-metastatic-gastroenteropancreatic-neuroendocrine-tumors-from-a-bayesian-perspective-the-getne-trasgu-study.html https://www.enets.org/abstract/an-infectious-diseases-specialist-net-patient-looks-at-management-of-nets.html https://www.enets.org/abstract/ectopic-neuroendocrine-carcinoma-an-occult-source-of-acth.html https://www.enets.org/abstract/risk-factors-for-short-recurrence-free-survivals-after-resection-of-pannet-liver-metastasis-single-institutional-analysis.html https://www.enets.org/abstract/choi-criteria-are-more-accurate-than-recist-in-advanced-pancreatic-neuroendocrine-tumors-treated-with-sunitinib-data-from-the-cripnet-getne1504-study.html https://www.enets.org/abstract/progression-free-survival-as-a-surrogate-endpoint-in-gastroenteropancreatic-neuroendocrine-tumors-treated-with-somatostatin-analogues.html https://www.enets.org/abstract/transcatheter-arterial-embolization-tae-of-nen-metastases-efficacy-and-predictors-of-response.html https://www.enets.org/abstract/evaluation-of-toxicity-in-peptide-receptor-radionuclide-therapy-prrt-for-neuroendocrine-tumors-net.html https://www.enets.org/abstract/bone-metastases-and-skeletal-related-events-in-patients-with-neuroendocrine-neoplasms-nen-the-role-of-zoledronic-acid.html https://www.enets.org/abstract/prediction-of-survival-for-gastrointestinal-neuroendocrine-tumors-a-systematic-review-of-clinical-tools1.html https://www.enets.org/abstract/single-institution-experience-with-peptide-receptor-radionuclide-therapy-prrt-in-neuroendocrine-tumors-net.html https://www.enets.org/abstract/survival-related-to-treatment-of-patients-with-metastatic-neuroendocrine-lung-tumors-treated-in-a-brazilian-center.html https://www.enets.org/abstract/comparative-genomic-analysis-of-high-grade-neuroendocrine-neoplasms-across-diverse-organs.html https://www.enets.org/abstract/comparison-of-68ga-dotatate-pet-ct-for-assessment-of-response-to-peptide-receptor-radionuclide-therapy-after-2-and-4-cycles-of-177lu-dotatate-preliminary-single-academic-center-experience.html https://www.enets.org/abstract/novel-preclinical-models-of-small-bowel-neuroendocrine-tumors-for-drug-screening.html https://www.enets.org/abstract/using-long-acting-somatostatin-analogue-as-adjuvant-therapy-for-post-resection-grade-2-pancreatic-neuroendocrine-tumor-interim-results-from-an-ongoing-multicenter-real-world-study-in-china.html https://www.enets.org/abstract/radionuclide-therapy-in-the-continuum-of-care-of-neuroendocrine-tumors-results-of-the-septralu-study.html https://www.enets.org/abstract/data-is-power-registry-experience-at-an-enets-coe.html https://www.enets.org/abstract/dna-methylation-analysis-of-the-pdx1-gene-can-be-used-for-pnet-subtyping-and-has-a-possible-prognostic-value.html https://www.enets.org/abstract/bone-metastases-bm-in-neuroendocrine-tumors-net-imaging-characteristics-and-clinical-implications-a-single-institution-experience.html https://www.enets.org/abstract/prognosis-and-management-of-advanced-digestive-well-differentiated-grade-3-neuroendocrine-tumors-g3-nets-a-net-connect-study-performed-in-four-expert-centers.html https://www.enets.org/abstract/dna-methyltransferase-inhibitor-hydralazine-induces-upregulation-of-somatostatin-type-2-receptors-in-human-neuroendocrine-tumor-cells.html https://www.enets.org/abstract/change-of-lactate-transporter-mct4-expression-in-pancreatic-microadenomas-and-stages-of-pancreatic-neuroendocrine-tumors.html https://www.enets.org/abstract/re-cellularised-human-pancreas-3d-scaffolds-as-a-novel-model-for-biomarker-discovery-in-pancreatic-neuroendocrine-tumours-pnets1.html https://www.enets.org/abstract/serotonin-secreting-neuroendocrine-neoplasms-of-the-pancreas-which-are-the-primary-pancreatic-carcinoids.html https://www.enets.org/abstract/virotherapy-shows-promising-efficacy-in-neuroendocrine-cancers.html https://www.enets.org/abstract/pancreatic-neuroendocrine-neoplasms-and-gastrointestinal-stromal-tumours-a-single-institution-experience-of-a-rare-association-and-review-of-the-literature.html https://www.enets.org/abstract/the-predictive-value-of-neuroendocrine-transcript-analysis-in-daily-practice-an-independent-real-world-validation-study1.html https://www.enets.org/abstract/safety-profile-and-adverse-events-of-special-interest-for-surufatinib-in-chinese-patients-with-advanced-extra-pancreatic-neuroendocrine-tumors-analysis-of-the-phase-3-sanet-ep-trial.html https://www.enets.org/abstract/pretherapeutic-heterogeneity-of-somatostatin-receptor-expression-in-neuroendocrine-neoplasia-an-innovative-predictor-of-response-to-everolimus.html https://www.enets.org/abstract/quantification-of-intratherapeutic-spect-ct-for-lutetium-177-dotatoc-prrt-in-neuroendocrine-tumors.html https://www.enets.org/abstract/australasian-gastrointestinal-trials-group-agitg-control-net-study-phase-ii-studies-of-lu-octreotate-peptide-receptor-radionuclide-therapy-lutate-prrt-capecitabine-temozolomide-captem-or-captem-alone-for-neuroendocrine-tumours-nets1.html https://www.enets.org/abstract/mutation-spectrums-analysis-of-colorectal-adenocarcinoma-and-neuroendocrine-neoplasm-based-on-same-genetic-background-to-reveal-tumorigenesis1.html https://www.enets.org/abstract/clinicopathological-characteristics-of-borderline-pulmonary-neuroendocrine-neoplasms1.html https://www.enets.org/abstract/interim-analysis-of-prospective-evaluation-of-the-management-of-sporadic-nonfunctioning-asymptomatic-pancreatic-neuroendocrine-neoplasms-2-cm-aspen-study.html https://www.enets.org/abstract/everolimus-in-patients-with-advanced-neuroendocrine-neoplasia-a-real-world-study-and-analysis-of-long-responders.html https://www.enets.org/abstract/a-single-centre-experience-of-open-surgery-for-pancreatic-insulinomas-on-88-patients.html https://www.enets.org/abstract/o-positive-blood-group-is-associated-with-prolonged-recurrence-free-survival-following-pancreatic-neuroendocrine-tumor-pannet-curative-intent-surgical-resection.html https://www.enets.org/abstract/systemic-chemotherapy-for-inoperable-goblet-cell-adenocarcinomas-gcas-and-the-role-of-anti-egfr-antibodies.html https://www.enets.org/abstract/survey-of-challenges-in-access-to-diagnostics-and-treatment-for-neuroendocrine-tumour-net-patients-scan-assessment-of-early-diagnosis.html https://www.enets.org/abstract/type-iii-gastric-neuroendocrine-neoplasms-is-local-excision-sufficient-in-selected-cases.html https://www.enets.org/abstract/treatment-of-the-pinealoma-experience-from-a-rare-case.html https://www.enets.org/abstract/one-stage-middle-preserving-pancreatectomy-indications-and-outcomes.html https://www.enets.org/abstract/evaluation-of-nurse-preferences-between-the-lanreotide-autogel-new-syringe-and-octreotide-long-acting-release-syringe-an-international-simulated-use-study-presto.html https://www.enets.org/abstract/the-clinicopathological-characteristics-of-gastrinoma-a-single-center-retrospective-study.html https://www.enets.org/abstract/vasostatin-1-predicts-recurrence-in-patients-submitted-to-surgery-for-nonfunctioning-pancreatic-neuroendocrine-tumors-nf-pannet.html https://www.enets.org/abstract/prior-surgical-resection-and-ga-68-dotanoc-pet-ct-imaging-based-parameters-do-these-impact-outcomes-in-grade-ii-gastroentero-pancreatic-neuroendocrine-tumors-gep-nets.html https://www.enets.org/abstract/mutational-landscape-of-109-high-grade-gastroenteropancreatic-neuroendocrine-neoplasms-g3.html https://www.enets.org/abstract/brain-metastasis-in-patients-with-neuroendocrine-neoplasia-of-gastroenteropancreatic-origin-a-single-centre-experience.html https://www.enets.org/abstract/rectal-neuroendocrine-tumor-with-concomitant-erdheim-chester-disease-a-rare-case-report.html https://www.enets.org/abstract/prognostic-evaluation-for-gastroenteropancreatic-nec-ajcc-or-enets-staging-classification-or-others.html https://www.enets.org/abstract/avelumab-in-unresectable-metastatic-progressive-poorly-differentiated-grade-3-neuroendocrine-carcinomas-necs.html https://www.enets.org/abstract/mixed-urothelial-and-neuroendocrine-carcinoma-of-the-urinary-bladder-case-report-and-literature-review.html https://www.enets.org/abstract/risk-stratification-of-well-differentiated-rectal-neuroendocrine-tumors.html https://www.enets.org/abstract/soluble-st2-sst2-levels-in-the-management-of-carcinoid-heart-disease-in-patients-with-neuroendocrine-cancer.html https://www.enets.org/abstract/misdiagnosis-of-pancreatic-neuroendocrine-carcinoma-a-potential-threat.html https://www.enets.org/abstract/analysis-of-factors-related-to-gallstones-in-patients-with-neuroendocrine-tumors-treated-with-long-acting-somatostatin-analogues.html https://www.enets.org/abstract/al18f-nota-octreotide-pet-imaging-of-the-somatostatin-receptor-first-comparison-with-68ga-dotatate-in-neuroendocrine-tumor-patients.html https://www.enets.org/abstract/efficacy-prediction-using-computed-tomography-for-patients-with-pancreatic-neuroendocrine-tumors-receiving-sunitinib.html https://www.enets.org/abstract/sunitinib-may-be-an-effective-treatment-for-hypercalcemia-due-to-a-metastatic-pancreatic-neuroendocrine-tumor.html https://www.enets.org/abstract/hemicolectomy-for-neuroendocrine-neoplasms-of-the-appendix-is-it-really-necessary.html https://www.enets.org/abstract/analysis-of-discordance-between-biopsy-grade-and-surgical-pathology-grade-in-resected-pannen-patients.html https://www.enets.org/abstract/genomic-landscape-of-neuroendocrine-neoplasms-from-gastrointestinal-tract-pancreas-lung-rare-and-unknown-primary-locations.html https://www.enets.org/abstract/temporal-trends-in-incidence-presentation-and-work-up-of-neuroendocrine-neoplasms-of-the-appendix.html https://www.enets.org/abstract/aggressive-resection-a-treatment-option-in-patients-with-advanced-neuroendocrine-tumors.html https://www.enets.org/abstract/development-of-an-eortc-quality-of-life-questionnaire-for-patients-with-pancreatic-neuroendocrine-tumours-phases-1-3.html https://www.enets.org/abstract/somatostatin-analogs-the-economic-value-of-lanreotide-autogel-delivery-attributes-in-the-treatment-of-gep-net-versus-octreotide-lar-a-uk-budget-impact-analysis.html https://www.enets.org/abstract/new-evidence-of-emerging-nodal-metastasis-in-staging-system-after-surgical-pnet-resection-as-predictive-factor-for-recurrence-result-from-monocentric-retrospective-series.html https://www.enets.org/abstract/the-blood-based-multigenomic-netest-accurately-identifies-neuroendocrine-transformed-prostate-cancer.html https://www.enets.org/abstract/synergic-value-of-68ga-dotatoc-pet-and-mri-in-net-patients-undergoing-simultaneous-68ga-dotatoc-pet-mri-scan.html https://www.enets.org/abstract/epidemiological-characteristics-of-neuroendocrine-tumors-a-retrospective-analysis-of-a-single-centre.html https://www.enets.org/abstract/our-experience-using-a-new-scoring-system-to-detect-disease-recurrence-after-curative-surgical-resection-of-well-differentiated-pancreatic-neuroendocrine-tumors.html https://www.enets.org/abstract/90y-and-or-177lu-dotatoc-re-challenge-in-patients-with-progressive-neuroendocrine-tumors.html https://www.enets.org/abstract/intrinsic-gene-programs-in-metastasis-like-primary-subtype-is-associated-with-early-metastatic-evolution-in-pancreatic-neuroendocrine-tumours.html https://www.enets.org/abstract/personalized-therapy-in-a-case-of-esophageal-nec-based-on-tumor-genome-sequencing.html https://www.enets.org/abstract/molecular-signature-of-rectal-neuroendocrine-neoplasia.html https://www.enets.org/abstract/longitudinal-changes-in-plasma-5-hydroxyindoleacetic-acid-5-hiaa-and-other-biomarkers-during-treatment-of-functional-midgut-neuroendocrine-tumours-nets-with-lanreotide-autogel-calm-net-study-results.html https://www.enets.org/abstract/incidence-of-rectal-nen-and-adherence-to-pathology-classification-rules-and-treatment-guidelines-results-of-the-population-based-cancer-registry-in-belgium1.html https://www.enets.org/abstract/lanreotide-autogel-and-octreotide-lar-treatment-patterns-results-from-a-nationwide-french-retrospective-study.html https://www.enets.org/abstract/characteristics-treatments-and-inflammatory-biomarkers-in-patients-pts-with-g3-gastroenteropancreatic-gep-neuroendocrine-neoplasms-nens.html https://www.enets.org/abstract/a-retrospective-multicentre-evaluation-of-the-outcomes-and-management-of-carcinoid-heart-disease-in-patients-with-advanced-midgut-nets-a-net-connect-descriptive-study.html https://www.enets.org/abstract/characteristics-and-management-of-paragangliomas-10-years-experience.html https://www.enets.org/abstract/robustness-of-radiomic-features-in-68ga-dotatoc-pet-ct-a-monocentric-experience-for-neuroendocrine-tumors.html https://www.enets.org/abstract/mek-raf-and-parp-as-novel-targets-in-neuroendocrine-neoplasms-first-results-from-a-molecular-in-vitro-tumor-board.html https://www.enets.org/abstract/next-generation-sequencing-of-pancreatic-neuroendocrine-tumors-in-russian-cohort.html https://www.enets.org/abstract/incidence-of-appendiceal-nen-and-adherence-to-pathological-classification-rules-and-treatment-guidelines-results-of-the-population-based-cancer-registry-in-belgium.html https://www.enets.org/abstract/predicting-survival-in-patients-with-a-neuroendocrine-tumor-of-the-small-intestine-si-net.html https://www.enets.org/abstract/policy-barriers-to-increasing-access-to-radioligand-therapy-for-neuroendocrine-cancers.html https://www.enets.org/abstract/metabolic-dysregulation-and-circadian-clock-in-cellular-models-of-neuroendocrine-tumors1.html https://www.enets.org/abstract/the-distance-from-pathology-to-molecular-imaging-sstr-expression-comparison-in-100-gastroenteropancreatic-neuroendocrine-neoplasms.html https://www.enets.org/abstract/comprehensive-molecular-analysis-identifies-driver-mutations-in-metastases-of-sporadic-well-differentiated-neuroendocrine-tumours-of-the-small-intestine.html https://www.enets.org/abstract/differential-tgf-signalling-in-typical-and-atypical-bronchial-carcinoids.html https://www.enets.org/abstract/agtr1-is-overexpressed-in-neuroendocrine-neoplasms-regulates-secretion-and-may-serve-as-a-target-for-molecular-imaging-and-therapy.html https://www.enets.org/abstract/peptide-receptor-radionuclide-therapy-prrt-outcome-prediction-in-neuroendocrine-tumors-net-could-radiomic-features-analysis-of-68ga-dotatoc-pet-ct-have-a-roll.html https://www.enets.org/abstract/characterization-of-142-human-pancreatic-neuroendocrine-tumors-atrx-and-daxx-correlation-with-clinical-pathological-data.html https://www.enets.org/abstract/68ga-dotatoc-pet-ct-as-tool-for-diagnosis-and-decision-making-process-of-neuroendocrine-tumors.html https://www.enets.org/abstract/epigenetic-treatment-with-histone-deacetylase-inhibitor-enhances-uptake-of-111in-in-dota-tate-by-increased-sst2-expression-on-neuroendocrine-tumor-cells.html https://www.enets.org/abstract/different-social-media-neuroendocrine-tumor-indexing-strategies-used-by-physicians-and-advocacy-groups.html https://www.enets.org/abstract/pitfalls-in-glucagon-like-peptide-1-receptor-imaging.html https://www.enets.org/abstract/gastroenteropancreatic-gep-neuroendocrine-neoplasia-g3-nen-g3-according-to-2019-who-classification-a-comprehensive-clinicopathological-characterization-including-mismatch-repair-mmr-proteins-pdl1-expression-and-kras-braf-status.html https://www.enets.org/abstract/the-pannenomics-project-a-call-for-an-international-collaborative-effort-built-on-the-success-of-the-lungnenomics-project.html https://www.enets.org/abstract/proposal-of-new-imaging-criteria-for-evaluating-the-response-of-liver-metastases-to-systemic-treatments-in-digestive-neuroendocrine-tumors-net-as-an-alternative-to-recist-1-1.html https://www.enets.org/abstract/prediction-of-symptomatic-mesenteric-mass-in-patients-with-small-intestinal-neuroendocrine-tumors-using-a-ct-radiomics-approach1.html https://www.enets.org/abstract/a-head-to-head-comparison-between-two-software-packages-for-hybrid-dosimetry-after-prrt.html https://www.enets.org/abstract/benefits-of-177lu-dotatate-in-patients-with-advanced-neuroendocrine-tumours-case-reports-from-two-patients-with-high-disease-burden.html https://www.enets.org/abstract/inter-and-intrapatient-mean-absorbed-dose-variation-and-simplification-of-dosimetric-workflow-after-prrt.html https://www.enets.org/abstract/aberrant-tryptophan-metabolism-in-stromal-cells-is-associated-with-mesenteric-fibrosis-in-small-intestinal-neuroendocrine-tumours.html https://www.enets.org/abstract/patients-with-somatostatin-receptor-type-2-negative-neuroendocrine-tumors-have-sustained-inferior-survival-rates-in-a-propensity-score-matched-analysis.html https://www.enets.org/abstract/early-response-assessment-for-prediction-of-overall-survival-after-peptide-receptor-radionuclide-therapy.html https://www.enets.org/abstract/quality-of-life-tumour-heterogeneity-and-biomarker-levels-in-patients-with-progressive-pancreatic-or-midgut-neuroendocrine-tumours-baseline-data-from-clarinet-forte.html https://www.enets.org/abstract/the-proinflammatory-molecule-vap-1-is-enriched-in-the-stroma-of-midgut-nets-and-plaques-of-carcinoid-heart-disease-valves.html https://www.enets.org/abstract/development-of-anti-sstr-car-t-cells-for-future-treatment-of-nets.html https://www.enets.org/abstract/comparison-between-tang-and-who-5th-edition-grade-classification-for-goblet-cell-adenocarcinomas.html https://www.enets.org/abstract/teratoma-with-malignant-transformation-a-case-report-of-a-neuroendocrine-tumor-that-arises-from-the-bronchial-mucosa-in-a-mature-cystic-teratoma.html https://www.enets.org/abstract/an-mrna-based-classifier-identifies-pannets-with-different-clinicopathological-characteristics.html https://www.enets.org/abstract/a-single-center-retrospective-analysis-of-thymic-neuroendocrine-tumor.html https://www.enets.org/abstract/opera-observational-study-of-perception-of-information-and-quality-of-life-in-patients-with-gastroenteropancreatic-neuroendocrine-tumors-starting-lanreotide-autogel-baseline-characteristics.html https://www.enets.org/abstract/international-validation-of-a-nomogram-to-predict-recurrence-after-resection-of-grade-1-and-2-pancreatic-neuroendocrine-tumors.html https://www.enets.org/abstract/added-prognostic-value-of-molecular-imaging-biomarkers-over-proliferation-index-in-typical-lung-carcinoid-an-fdg-pet-and-sstr-imaging-study.html https://www.enets.org/abstract/causes-of-death-following-neuroendocrine-tumors-diagnosis-a-united-states-population-based-analysis.html https://www.enets.org/abstract/structurally-optimized-peptide-vmt-alpha-net-enhances-the-efficacy-of-sstr2-targeted-alpha-particle-therapy-for-neuroendocrine-tumors.html https://www.enets.org/abstract/the-number-of-positive-nodes-accurately-predicts-recurrence-after-distal-pancreatectomy-for-nonfunctioning-neuroendocrine-neoplasms.html https://www.enets.org/abstract/biopsy-specimen-diagnosis-in-pulmonary-carcinoids-a-shot-in-the-dark.html https://www.enets.org/abstract/dll3-is-expressed-in-gep-neuroendocrine-neoplasms-with-loss-of-rb1-and-has-prognostic-significance.html https://www.enets.org/abstract/patient-and-healthcare-practitioner-perspectives-of-somatostatin-analogs-in-the-management-of-neuroendocrine-tumors-and-acromegaly-a-systematic-literature-review.html https://www.enets.org/abstract/real-life-data-for-telotristat-ethyl-in-resistant-to-treatment-carcinoid-syndrome-is-it-efficacious-in-carcinoid-flushing-as-well.html https://www.enets.org/abstract/incomplete-peptide-receptor-radionuclide-therapy-courses-are-we-selecting-our-patients-appropriately.html https://www.enets.org/abstract/outcomes-following-surgical-management-of-pulmonary-carcinoids-a-tertiary-center-experience.html https://www.enets.org/abstract/homecare-service-for-administration-of-lanreotide-autogel-injections-assessment-of-patients-experience.html https://www.enets.org/abstract/diagnostic-accuracy-of-68gallium-positron-emission-tomography-68ga-pet-endoscopic-ultrasound-eus-and-computed-tomography-in-the-assessment-of-lymphnode-metastases-by-nonfunctioning-pancreatic-neuroendocrine-neoplasms.html https://www.enets.org/abstract/the-major-role-of-neuroendocrine-tumor-net-specialist-nurse-in-improving-net-patients-disease-related-qol-preliminary-data.html https://www.enets.org/abstract/phase-ii-trials-of-pazopanib-in-metastatic-neuroendocrine-neoplasia-nen-a-systematic-review-and-meta-analysis1.html https://www.enets.org/abstract/imp3-and-ki-67-factors-of-poor-clinical-outcome-in-neuroendocrine-tumors-of-the-lung.html https://www.enets.org/abstract/impact-of-small-cell-sc-versus-vs-non-small-cell-nsc-morphology-on-outcomes-of-patients-pts-with-extra-pulmonary-poorly-differentiated-neuroendocrine-carcinoma-ep-pd-nec.html https://www.enets.org/abstract/pancreatic-neuroendocrine-neoplasms-dissecting-the-molecular-heterogeneity.html https://www.enets.org/abstract/adrenocortical-carcinoma-metastasic-in-adult-on-complete-response-with-edp-m-and-local-therapy-a-single-case-report.html https://www.enets.org/abstract/targeting-cxcr4-and-thioredoxin-reductase-in-theranostics-of-atypical-carcinoid-and-neuroendocrine-carcinoma.html https://www.enets.org/abstract/primitive-peripheral-neuroectodermal-tumor-case-report.html https://www.enets.org/abstract/lung-side-and-site-the-importance-of-location-and-the-prognostic-implication-in-lung-neuroendocrine-tumors.html https://www.enets.org/abstract/first-in-korea-clinical-trial-of-lu-177-dotatate-in-patients-with-inoperable-progressive-somatostatin-receptor-positive-metastatic-or-locally-advanced-neuroendocrine-tumor-snu-kb-01.html https://www.enets.org/abstract/somatostatin-analogs-for-pancreatic-neuroendocrine-tumors-is-there-any-benefit-when-ki-67-is-10.html https://www.enets.org/abstract/large-cell-neuroendocrine-carcinoma-of-the-lung-in-elderly-patient-case-report-and-review-of-literature.html https://www.enets.org/abstract/can-ki-67-with-5-5-be-better-in-predicting-prognosis-for-well-differentiated-pancreatic-neuroendocrine-tumors.html https://www.enets.org/abstract/effects-of-debulking-surgery-transarterial-embolisation-tae-and-transarterial-chemoembolisation-tace-on-quality-of-life-in-patients-with-metastatic-ileal-and-pancreatic-neuroendocrine-tumours-nets.html https://www.enets.org/abstract/managing-neuroendocrine-neoplasms-nen-in-association-with-hiv-infection-a-single-institution-experience.html https://www.enets.org/abstract/evaluation-of-overall-survival-os-in-patients-with-netg1-g2-neuroendocrine-neoplasms-of-the-small-intestine-si-nens.html https://www.enets.org/abstract/palliative-ct-brachytherapy-in-hepatic-metastatic-net.html https://www.enets.org/abstract/resource-use-in-patients-with-carcinoid-syndrome-a-retrospective-analysis-using-the-french-health-insurance-national-snds-database.html https://www.enets.org/abstract/the-use-of-total-parenteral-nutrition-in-a-series-of-patients-with-neuroendocrine-tumours-in-united-kingdom-and-the-netherlands.html https://www.enets.org/abstract/angiogenetic-markers-as-prognostic-predictors-in-neuroendocrine-neoplasms.html https://www.enets.org/abstract/efficacy-of-alkylating-agent-re-challenge-after-therapeutic-pause-in-metastatic-pancreatic-neuroendocrine-tumors-pannet.html https://www.enets.org/abstract/reliability-and-agreement-of-radiological-and-pathological-tumor-size-in-patients-with-men1-related-pancreatic-neuroendocrine-tumors-results-from-a-population-based-cohort.html https://www.enets.org/abstract/incidence-of-neuroendocrine-neoplasms-reported-in-england-2015-2017.html https://www.enets.org/abstract/functional-consequence-of-arrestin-1-gene-knock-out-in-pancreatic-neuroendocrine-tumor-cell-line-bon-1.html https://www.enets.org/abstract/somatostatin-analogs-or-active-surveillance-in-sporadic-non-functioning-pancreatic-neuroendocrine-tumors.html https://www.enets.org/abstract/organoid-models-of-neuroendocrine-cell-growth-and-tumorigenesis.html https://www.enets.org/abstract/radioembolization-for-neuroendocrine-liver-metastases-an-institutional-case-series-systematic-review-and-meta-analysis.html https://www.enets.org/abstract/epidemiology-pathological-and-clinical-features-of-4307-patients-with-gastroenteropancreatic-neuroendocrine-neoplasms-gep-nen-of-the-spanish-neuroendocrine-cancer-registry-r-getne.html https://www.enets.org/abstract/unique-metastatic-patterns-in-neuroendocrine-neoplasms-of-different-primary-origin.html https://www.enets.org/abstract/the-splicing-machinery-is-dysregulated-in-low-grade-pulmonary-neuroendocrine-tumors.html https://www.enets.org/abstract/nutritional-status-and-considerations-for-patients-diagnosed-with-a-gastroenteropancreatic-neuroendocrine-tumour-nutrition-in-nets-study.html https://www.enets.org/abstract/dynamics-of-changes-in-chromogranin-a-concentration-as-a-prognostic-factor-radiopeptide-therapy-in-neuroendocrine-tumours.html https://www.enets.org/abstract/multi-omic-characterization-and-evolution-of-neuroendocrine-neoplasm-organoids.html https://www.enets.org/abstract/epidemiological-features-of-patients-with-neuroendocrine-neoplasms-nens-preliminary-results-of-an-observational-study-by-the-hellenic-society-of-medical-oncology-hesmo.html https://www.enets.org/abstract/diagnosis-and-assessment-of-effectiveness-of-surgical-resection-of-small-bowel-neuroendocrine-tumours-the-roles-of-circulating-micrornas.html https://www.enets.org/abstract/the-splicing-factor-celf4-is-dysregulated-in-neuroendocrine-tumors-where-it-can-enhance-aggressiveness-features3.html https://www.enets.org/abstract/alpps-for-neuroendocrine-liver-metastases-not-suitable-for-conventional-hepatic-resection-interim-analysis-of-the-international-alpps-registry.html https://www.enets.org/abstract/intensive-personalized-program-for-daily-living-with-neuroendocrine-neoplasms-as-a-chronic-disease-preliminary-results.html https://www.enets.org/abstract/somatostatin-analogs-in-real-world-practice-for-patients-with-metastatic-neuroendocrine-tumors-a-single-institution-experience-in-the-ouest-of-algeria-chu-oran1.html https://www.enets.org/abstract/who-grade-3-gastroenteropancreatic-neuroendocrine-neoplasm-gep-nen-data-from-358-patients-of-the-spanish-group-of-neuroendocrine-and-endocrine-tumors-registry-r-getne.html https://www.enets.org/abstract/functioning-pancreatic-neuroendocrine-tumors-f-pnets-the-experience-of-a-tertiary-care-center-of-pancreatic-surgery.html https://www.enets.org/abstract/activity-and-safety-of-avelumab-in-merkel-cell-carcinoma-our-experience.html https://www.enets.org/abstract/hormonal-ectopic-secretion-syndromes-associated-to-neuroendocine-neoplasia.html https://www.enets.org/abstract/rb-and-p53-status-determination-by-immunochemistry-is-complementary-in-routine-practice-to-genetic-testing-of-neuroendocrine-neoplasms.html https://www.enets.org/abstract/the-role-of-rb-as-a-prognostic-factor-in-grade-3-poorly-differentiated-neuroendocrine-carcinoma-g3nec-treated-by-first-line-platinum-etoposide-combination-a-retrospective-study.html https://www.enets.org/abstract/medullary-thyroid-carcinoma-and-dipnech-an-unexpected-association.html https://www.enets.org/abstract/telotristat-makes-significant-difference-on-symptoms-and-serotonin-levels-in-a-population-with-widespread-gi-net-and-severe-carcinoid-syndrome.html https://www.enets.org/abstract/endometrial-small-cell-neuroendocrine-carcinoma-case-report-and-literature-review.html https://www.enets.org/abstract/insights-into-the-practice-patterns-challenges-and-the-role-of-a-shared-care-model-in-the-management-of-neuroendocrine-net-patients-in-the-community.html https://www.enets.org/abstract/gastroenteropancreatic-neuroendocrine-tumor-experience-of-an-algerian-centre.html https://www.enets.org/abstract/novel-symptoms-and-therapy-of-multiple-endocrine-neoplasia-type-1.html https://www.enets.org/abstract/impact-of-multimodal-perioperative-treatment-in-patients-with-resected-non-metastatic-grade-3-neuroendocrine-neoplasms-nen-g3.html https://www.enets.org/abstract/an-atypical-presentation-of-a-neuroendocrine-carcinoma-of-unknown-origin.html https://www.enets.org/abstract/men1-associated-pnets-a-case-series-from-two-centres-of-excellence-in-the-united-kingdom.html https://www.enets.org/abstract/diffuse-idiopathic-pulmonary-neuroendocrine-cell-hyperplasia-dipnech-a-case-report-and-review-of-literature1.html https://www.enets.org/abstract/mixed-large-and-small-cell-neuroendocrine-carcinoma-of-the-endometrium-a-case-report-and-literature-review4.html https://www.enets.org/abstract/retrospective-experience-with-pherochromocytoma-ph-and-paraganglioma-pg-in-a-single-argentinian-institution.html https://www.enets.org/abstract/a-review-of-outcomes-of-two-sets-of-100-consecutive-cases-of-cutaneous-basal-cell-carcinomas-of-the-head-and-neck-managed-in-an-oral-and-maxillofacial-unit-at-a-district-general-hospital.html https://www.enets.org/abstract/mismatch-repair-protein-and-pd-1-pd-l1-expression-in-pancreatic-neuroendocrine-neoplasm.html https://www.enets.org/abstract/risk-analysis-of-distant-metastases-and-age-at-onset-of-patients-with-rectal-neuroendocrine-neoplasm.html https://www.enets.org/abstract/clinical-observation-of-pd-1-inhibitor-combined-with-anlotinib-in-the-treatment-of-advanced-neuroendocrine-carcinoma.html https://www.enets.org/abstract/a-novel-risk-factor-panel-predicts-early-recurrence-of-pancreatic-neuroendocrine-tumors-after-curative-resection.html https://www.enets.org/abstract/infiltrating-pattern-and-prognostic-value-of-tertiary-lymphoid-structures-in-pancreatic-neuroendocrine-tumors.html https://www.enets.org/abstract/the-incidence-rate-and-clinical-characteristics-of-autoimmune-metaplastic-atrophic-gastritis-and-associated-neoplasia-in-chinese-patients.html https://www.enets.org/abstract/evaluating-nationwide-application-of-minimally-invasive-surgery-for-small-bowel-neuroendocrine-neoplasms-and-the-impact-on-survival.html https://www.enets.org/abstract/update-on-incidence-prevalence-treatment-and-survival-of-patients-with-small-bowel-neuroendocrine-neoplasms-in-the-netherlands.html https://www.enets.org/abstract/value-of-laparoscopy-for-resection-of-small-bowel-neuroendocrine-neoplasms-including-central-mesenteric-lymphadenectomy.html https://www.enets.org/abstract/fluorescence-angiography-guided-resection-of-small-bowel-neuroendocrine-neoplasms-with-mesenteric-lymph-node-metastases.html https://www.enets.org/abstract/comparison-of-18f-dopa-versus-68ga-dota-toc-as-preferred-pet-imaging-tracer-in-well-differentiated-neuroendocrine-neoplasms.html https://www.enets.org/abstract/molecular-profiling-of-well-differentiated-neuroendocrine-tumors-role-of-ctdna.html https://www.enets.org/abstract/hematotoxicity-of-holmium-166-radioembolization-in-liver-dominant-metastatic-neuroendocrine-tumors-after-initial-prrt.html https://www.enets.org/abstract/advanced-small-intestine-well-differentiated-neuroendocrine-tumors-wd-sinet-a-survey-of-practice-on-3rd-line-treatment.html https://www.enets.org/abstract/predicting-response-after-166ho-radioembolization-in-patients-with-neuroendocrine-tumor-liver-metastases-using-neutrophil-to-lymphocyte-and-thrombocyte-to-lymphocyte-ratios.html https://www.enets.org/abstract/challenges-in-primary-neuroendocrine-tumor-identification.html https://www.enets.org/abstract/trends-of-incidence-and-prognosis-of-thymic-neuroendocrine-neoplasms-a-survival-analysis-on-320-patients.html https://www.enets.org/abstract/patient-travel-challenges-in-the-rra-of-pprt.html https://www.enets.org/abstract/response-prediction-to-prrt-in-progressing-and-metastatic-gep-net-undergoing-restaging-68ga-dota-pet-ct-a-preliminary-multicenter-radiomics-study.html https://www.enets.org/abstract/small-cell-neuroendocrine-carcinoma-of-vagina-rare-aggressive-but-curable.html https://www.enets.org/abstract/burden-associated-with-multiple-endocrine-neoplasia-type-1-men1.html https://www.enets.org/abstract/assessing-the-management-of-bone-metastases-in-patients-diagnosed-with-neuroendocrine-neoplasms-re-audit-of-clinical-practice.html https://www.enets.org/abstract/the-psychology-of-nets-exploring-anxiety-depression-and-emotional-thermometers.html https://www.enets.org/abstract/clinicopathological-observation-of-gastric-amphicrine-carcinoma.html https://www.enets.org/abstract/location-and-primary-tumor-resection-affect-liver-metastatic-colon-neuroendocrine-carcinoma-patients-survival.html https://www.enets.org/abstract/artificial-intelligence-applications-in-68ga-dota-pet-ct-images-prediction-of-response-assessment-in-gep-nets-undergoing-prrt-with-177lu-dotatoc.html https://www.enets.org/abstract/thinking-and-confusion-about-a-well-differentiated-grade-3-pancreatic-neuroendocrine-tumor.html https://www.enets.org/abstract/prognosis-of-patients-with-rectal-neuroendocrine-neoplasms-and-liver-metastasis-an-analysis-based-on-seer-database.html https://www.enets.org/abstract/plasma-protein-biomarkers-for-the-detection-of-pancreatic-neuroendocrine-tumors-pan-net-and-differentiation-from-small-intestinal-si-net.html https://www.enets.org/abstract/arterial-calcium-stimulated-venous-sampling-to-reveal-insulinoma-in-case-of-pancreatic-multiple-neuroendocrine-neoplasms.html https://www.enets.org/abstract/surgery-for-zollinger-ellison-syndrome-in-multiple-endocrine-neoplasia-type-1-a-afce-and-gte-cohort-study-association-francophone-de-chirurgie-endocrinienne-et-groupe-d-etude-des-tumeurs-endocrines.html https://www.enets.org/abstract/pancreatic-proinsulinomas-single-center-experience.html https://www.enets.org/abstract/the-potential-role-of-circulating-dna-in-the-management-of-neuroendocrine-tumors-net-sanguis-study.html https://www.enets.org/abstract/the-role-of-somatostatin-receptor-scintigraphy-in-predicting-treatment-response-of-somatostatin-analogues-in-pancreatic-neuroendocrine-tumors.html https://www.enets.org/abstract/an-unexpected-effect-of-chronic-treatment-with-temozolomide-in-patients-with-metastatic-well-differentiated-neuroendocrine-tumors.html https://www.enets.org/abstract/colorectal-necs-and-manecs-a-monocenter-pilot-retrospective-analysis.html https://www.enets.org/abstract/metastatic-grade-3-gastric-neuroendocrine-tumor-expressing-somatostatin-receptor-in-multiple-endocrine-neoplasia-type-1-men1-syndrome.html https://www.enets.org/abstract/68ga-ga-dotanoc-pet-ct-radiomics-potential-role-in-discriminating-tumor-grade-in-well-differentiated-primary-pancreatic-neuroendocrine-tumors.html https://www.enets.org/abstract/plasmatic-and-urinary-5-hydroxyindolacetic-acid-measurements-in-patients-with-midgut-neuroendocrine-tumors-a-gte-study.html https://www.enets.org/abstract/establishment-of-neuroendocrine-neoplasms-organoid-biobank-enables-genotype-phenotype-mapping.html https://www.enets.org/abstract/ipilimumab-and-nivolumab-in-patients-with-neuroendocrine-carcinomas-two-case-reports.html https://www.enets.org/abstract/endoscopic-resection-of-type-i-gastric-neuroendocrine-neoplasia-nen-a-systematic-review.html https://www.enets.org/abstract/prognosis-and-the-role-of-rb-expression-in-metastatic-grade-3-neuroendocrine-carcinoma-g3nec-results-from-the-multicenter-retrospective-rbnec-study.html https://www.enets.org/abstract/empowerment-survey-for-patients-with-neuroendocrine-tumors-a-pilot-study-in-spanish-population.html https://www.enets.org/abstract/prognostic-value-of-expression-sox2-in-neuroendocrine-tumors-of-different-localization-and-degree-of-malignancy.html https://www.enets.org/abstract/clinical-and-pathological-characterization-of-renal-neuroendocrine-tumor-rnet-a-national-retrospective-study-from-the-french-group-of-endocrine-tumors-gte.html https://www.enets.org/abstract/prognostic-value-of-whole-body-pet-volumetric-parameters-extracted-from-68ga-dotatoc-pet-ct-in-well-differentiated-neuroendocrine-tumors.html https://www.enets.org/abstract/incidence-of-psychiatric-illness-in-patients-with-neuroendocrine-tumors-net-a-comparative-population-based-analysis.html https://www.enets.org/abstract/patient-reported-cognitive-and-psychological-screening-in-neuroendocrine-tumors-nets-a-prospective-cohort-study.html https://www.enets.org/abstract/20-years-experience-of-metastatic-g2-pnet-in-chinese-population-a-single-center-real-world-study.html https://www.enets.org/abstract/the-value-of-biomarkers-in-gastroenterology-neuroendocrine-neoplasms.html https://www.enets.org/abstract/reduction-of-serum-insulin-levels-and-diazoxide-doses-as-an-effect-of-prrt-in-patients-with-severe-hypoglycemia-due-to-primary-non-operative-insulinoma.html https://www.enets.org/abstract/transcriptomic-deconvolution-of-neuroendocrine-neoplasms-predicts-clinically-relevant-characteristics.html https://www.enets.org/abstract/synthesis-preclinical-evaluation-and-a-pilot-clinical-imaging-study-of-18f-alf-noda-jr11-for-neuroendocrine-neoplasms-compared-with-68ga-ga-dota-tate.html https://www.enets.org/abstract/resection-of-primary-tumor-improves-survival-rate-in-rectal-neuroendocrine-neoplasms-with-liver-metastasis.html https://www.enets.org/abstract/nutritional-assessment-for-predicting-clinical-evolution-in-gastro-enteropancreatic-neuroendocrine-tumors.html https://www.enets.org/abstract/a-case-report-of-familial-paraganglioma-syndrome-type-4-caused-by-the-sdhb-mutation-gene.html https://www.enets.org/abstract/immunohistochemical-evaluation-of-vimentin-aberrant-expression-in-lung-carcinoid-tumors.html https://www.enets.org/abstract/vasostatin-1-as-pancreatic-neuroendocrine-tumor-pannet-biomarker-a-comparison-between-preoperative-and-postoperative-measurements.html https://www.enets.org/abstract/prognostic-and-predictive-value-of-baseline-neutrophil-lymphocyte-ratio-and-its-variations-after-adjuvant-radiotherapy-in-locally-advanced-merkel-cell-carcinoma-mcc.html https://www.enets.org/abstract/diagnostic-work-up-and-surgical-management-of-insulinoma-a-single-center-retrospective-analysis-of-74-cases.html https://www.enets.org/abstract/intensive-international-registry-on-sars-cov-2-positive-neuroendocrine-neoplasm-patients.html https://www.enets.org/abstract/to-determine-the-true-incidence-of-brain-metastases-in-atypical-lung-neuroendocrine-tumors-and-explore-factors-that-increase-the-risk-of-intracranial-disease.html https://www.enets.org/abstract/bronchial-neuroendocrine-tumor.html https://www.enets.org/abstract/incidence-of-brain-metastases-bms-and-outcomes-in-patients-pts-with-extrapulmonary-neuroendocrine-neoplasms-ep-nens.html https://www.enets.org/abstract/wearables-in-metastatic-gastroenteropancreatic-neuroendocrine-tumors-netfit.html https://www.enets.org/abstract/efficacy-and-safety-of-pd-1-inhibitor-combined-with-anlotinib-in-the-treatment-of-advanced-neuroendocrine-cancer-a-single-center-retrospective-study.html https://www.enets.org/abstract/phase-1-trial-of-parp-inhibitor-combined-with-177lu-dota-octreotate-peptide-receptor-radionuclide-therapy-prrt-in-patients-with-metastatic-neuroendocrine-tumor-parlunet.html https://www.enets.org/abstract/the-clinicopathological-characteristics-of-gastro-enteropancreatic-neuroendocrine-tumors-a-single-center-experience-from-pakistan.html https://www.enets.org/abstract/comparison-of-whole-body-mri-and-68ga-dotatate-pet-ct-findings-in-patients-with-suspected-peritoneal-metastases-from-neuroendocrine-tumors.html https://www.enets.org/abstract/automatized-hepatic-tumor-volume-analysis-of-neuroendocrine-liver-metastases-by-gd-eob-mri-a-deep-learning-model-to-support-multidisciplinary-cancer-conference-decision-making.html https://www.enets.org/abstract/clinical-characteristics-and-long-term-follow-up-of-rectal-neuroendocrine-neoplasms-a-single-center-study.html https://www.enets.org/abstract/aberrant-expression-pattern-of-circadian-clock-genes-in-type-1-gastric-neuroendocrine-neoplasms-compared-to-ecl-cell-hyperplasia.html https://www.enets.org/abstract/safety-of-irinotecan-based-chemotherapy-as-second-line-treatment-in-extrapulmonary-poorly-differentiated-neuroendocrine-carcinomas-necs.html https://www.enets.org/abstract/endocrine-neoplasias-and-non-endocrine-neoplasias-associated-with-primary-aldosteronism.html https://www.enets.org/abstract/transarterial-chemoembolization-for-neuroendocrine-tumor-liver-metastases-a-15-years-monocentric-experience.html https://www.enets.org/abstract/endoscopic-resectability-and-clinical-outcome-of-patients-with-rectal-neuroendocrine-neoplasms.html https://www.enets.org/abstract/prognostic-and-diagnostic-value-of-serum-5-hiaa-in-well-differentiated-neuroendocrine-neoplasms.html https://www.enets.org/abstract/peptide-receptor-radionuclide-therapy-prrt-with-lu-dotatate-following-liver-directed-therapy-ldt-in-neuroendocrine-tumors-nets-hepatotoxicity-and-impact-on-progression-free-survival-pfs.html https://www.enets.org/abstract/intestinal-obstruction-io-in-patients-receiving-peptide-receptor-radionuclide-therapy-prrt-for-gastro-enteropancreatic-neuroendocrine-tumors-gep-nets-potential-predictors-and-association-with-overall-survival-os.html https://www.enets.org/abstract/utility-and-timing-of-technetium-99m-diethylene-triamine-penta-acetic-acid-measurement-of-glomerular-filtration-rate-in-patients-undergoing-peptide-receptor-radionuclide-therapy.html https://www.enets.org/abstract/secondary-primary-cancers-and-survival-among-neuroendocrine-tumor-patients.html https://www.enets.org/abstract/tissue-sample-collection-from-patients-with-neuroendocrine-tumor-net-treated-with-peptide-receptor-radionuclide-therapy-prrt-for-future-blood-disease-research.html https://www.enets.org/abstract/is-surgery-the-only-answer-to-g1-nf-pnets-superior-than-2-cm-our-experience.html https://www.enets.org/abstract/dual-68ga-dotatate-and-18f-fdg-pet-ct-in-patients-with-gastroenteropancreatic-neuroendocrine-neoplasms-a-multicentre-validation-study-of-the-netpet-score-in-239-patients.html https://www.enets.org/abstract/type-2-gastric-neuroendocrine-tumors-almost-all-occur-in-patients-with-men1.html https://www.enets.org/abstract/clinical-characteristics-of-patients-with-renal-neuroendocrine-neoplasms.html https://www.enets.org/abstract/clinical-features-of-8-cases-of-neuroendocrine-tumor-with-multi-hormone-secretion.html https://www.enets.org/abstract/cost-of-carcinoid-syndrome-cs-in-france-analysis-of-the-national-health-insurance-database.html https://www.enets.org/abstract/clinical-stratification-of-pancreatic-neuroendocrine-tumors-by-systematically-integrating-multimodal-and-clinical-data.html https://www.enets.org/abstract/immune-heterogeneity-and-cascade-of-changes-in-subtypes-of-pancreatic-neuroendocrine-tumors.html https://www.enets.org/abstract/targeted-and-photodynamic-therapeutic-effect-of-octreotide-nano-micelles-loaded-with-chlorin-e6-on-neuroendocrine-tumors.html https://www.enets.org/abstract/bronchopulmonary-neuroendocrine-tumors-bpnet-a-comparison-of-three-subgroups.html https://www.enets.org/abstract/primary-insulinoma-of-the-liver.html https://www.enets.org/abstract/mtor-pathway-inhibitors-differently-effect-proliferation-and-gene-expression-in-pancreatic-and-pulmonary-net-cell-lines.html https://www.enets.org/abstract/real-world-outcomes-of-patients-with-neuroendocrine-liver-metastases-treated-with-trans-arterial-radioembolization-results-from-cirt-a-large-european-prospective-multi-centre-observational-study.html https://www.enets.org/abstract/getting-results-patient-experiences-and-preferences-for-communicating-scan-results-in-australia.html https://www.enets.org/abstract/determination-of-somatostatin-receptors-types-2a-and-5-sstr-2a-sstr-5-expression-in-neuroendocrine-tumors-nets-and-neuroendocrine-carcinoma-necs-of-various-localizations-and-grade.html https://www.enets.org/abstract/clinical-epidemiology-of-patients-with-neuroendocrine-tumors-nets-in-spain-using-electronic-health-records-ehrs-and-big-data-techniques.html https://www.enets.org/abstract/an-audit-of-psychological-distress-in-the-neuroendocrine-neoplasia-clinic.html https://www.enets.org/abstract/mir-223-a-potential-diagnostic-biomarker-in-gastroenteropancreatic-neuroendocrine-tumors.html https://www.enets.org/abstract/peptide-radio-receptor-therapy-sensitizes-to-immunotherapy-by-increasing-expression-of-checkpoint-molecules-in-in-patients-with-neuroendocrine-tumors.html https://www.enets.org/abstract/phase-2-study-of-cisplatin-and-everolimus-in-patients-with-metastatic-extrapulmonary-neuroendocrine-carcinoma-nec.html https://www.enets.org/abstract/the-role-of-palliative-resection-of-primary-tumor-in-metastatic-lung-neuroendocrine-tumors.html https://www.enets.org/abstract/clinical-epidemiology-study-of-gastroenteropancreatic-neuroendocrine-tumors-gep-nets-a-10-year-retrospective-study-in-china.html https://www.enets.org/abstract/risk-factors-for-gastroenteropancreatic-neuroendocrine-neoplasms-gep-nens-a-multicentre-case-control-study.html https://www.enets.org/abstract/diagnostic-effectiveness-of-chromogranin-a-and-multigene-liquid-biopsy-netest-in-neuroendocrine-neoplasia-a-prospective-comparative-evaluation-of-monoanalyte-and-multianalyte-biomarker-efficacy.html https://www.enets.org/abstract/safety-and-efficacy-of-peptide-receptor-radionuclide-therapy-in-treating-high-risk-patients-with-extensive-neuroendocrine-tumors.html https://www.enets.org/abstract/plasma-cell-free-dna-from-metastatic-gastroenteropancreatic-neuroendocrine-neoplasms-contains-tumor-associated-copy-number-alterations.html https://www.enets.org/abstract/the-efficacy-of-above-label-doses-of-long-acting-somatostatin-analogues-for-the-management-of-patients-with-gastroenteropancreatic-tumors.html https://www.enets.org/abstract/clinical-epidemiology-study-of-pancreatic-neuroendocrine-neoplasms-p-nens-in-different-areas-of-china-a-national-multi-center-10-year-retrospective-study.html https://www.enets.org/abstract/risk-factors-of-the-distant-metastasis-in-rectal-neuroendocrine-neoplasms-a-10-year-retrospective-multi-center-study-in-china.html https://www.enets.org/abstract/efficacy-and-safety-of-peptide-receptor-radionuclide-therapy-prrt-in-patients-with-chronic-kidney-disease-ckd.html https://www.enets.org/abstract/what-role-for-the-interim-pet-ct-with-68ga-dota-peptides-in-the-evaluation-of-the-early-response-to-prrt.html https://www.enets.org/abstract/overall-outcome-of-peptide-receptor-radionuclide-therapy-prrt-in-treatment-metastatic-progressive-neuroendocrine-tumors-nets-survival-toxicity-and-prognostic-factors.html https://www.enets.org/abstract/irinotecan-and-oxaliplatin-based-regimens-of-second-line-treatment-in-gastrointestinal-neuroendocrine-carcinoma-gi-nec-patients-a-retrospective-study.html https://www.enets.org/abstract/lung-side-sites-the-importance-of-localization-and-prognostic-implications-in-pulmonary-neuroendocrine-tumors-an-italian-spanish-multicentric-study-of-139-cases.html https://www.enets.org/abstract/microscopic-resection-margin-status-does-not-predict-long-term-survival-in-small-bowel-neuroendocrine-tumors.html https://www.enets.org/abstract/clarinet-forte-characterization-of-pharmacokinetics-pk-efficacy-and-safety-in-patients-with-progressive-neuroendocrine-tumors-nets-treated-with-lanreotide-autogel-lan-120-mg-every-14-days-q14d.html https://www.enets.org/abstract/hyponatremia-and-hypernatremia-have-an-opposing-effect-on-overall-survival-in-neuroendocrine-tumor-patients-treated-with-peptide-receptor-radionuclide-therapy.html https://www.enets.org/abstract/mixed-neuroendocrine-non-neuroendocrine-neoplasm-of-the-ampulla-of-vater-case-report.html https://www.enets.org/abstract/survey-for-neuroendocrine-tumors-standard-of-care-a-multidisciplinary-pilot-study-in-spanish-specialists.html https://www.enets.org/abstract/survey-of-challenges-in-access-to-diagnostics-and-treatment-for-neuroendocrine-tumor-net-patients-scan-net-experts-net-healthcare.html https://www.enets.org/abstract/efficacy-safety-and-quality-of-life-qol-with-lanreotide-autogel-lan-120-mg-every-14-days-in-progressive-pancreatic-or-midgut-neuroendocrine-tumors-nets-clarinet-forte-study-results.html https://www.enets.org/abstract/opera-observational-study-of-perception-of-information-and-quality-of-life-qol-in-patients-with-gastroenteropancreatic-neuroendocrine-tumors-gep-nets-starting-lanreotide-autogel-lan.html https://www.enets.org/abstract/independent-administration-of-long-acting-somatostatin-analogues-ssas-for-the-treatment-of-gastroenteropancreatic-neuroendocrine-tumors-gep-net-potential-savings-of-increased-uptake-in-the-uk-national-health-service-nhs.html https://www.enets.org/abstract/impact-of-wnt-signalling-on-somatostatin-receptor-sstr-expression-and-function.html https://www.enets.org/abstract/telemedicine-a-good-tool-to-improve-health-care-in-nen-s-patient-during-the-covid19-pandemic-a-multicenter-series-experience-of-a-net-multidisciplinary-team-in-argentina.html https://www.enets.org/abstract/micrornas-193-and-223-alter-net-differentiation-markers-and-shape-inflammatory-response-in-vitro.html https://www.enets.org/abstract/the-netest-a-multigenomic-liquid-biopsy-biomarker-for-neuroendocrine-tumor-disease-is-an-accurate-diagnostic-predicts-surgical-recurrence-stratifies-disease-status.html https://www.enets.org/abstract/immunohistochemical-staining-with-neuroendocrine-markers-is-essential-in-the-diagnosis-of-neuroendocrine-neoplasms-of-the-esophagogastric-junction.html https://www.enets.org/abstract/active-surveillance-as-an-option-for-small-asymptomatic-sporadic-non-functioning-pancreatic-neuroendocrine-tumors-clinical-practice.html https://www.enets.org/abstract/sensitivity-of-68ga-dotatate-pet-in-detecting-primary-tumor-and-nodal-metastases-in-surgically-resected-lung-carcinoids.html https://www.enets.org/abstract/the-use-of-deep-learning-models-to-predict-progression-free-survival-in-patients-with-neuroendocrine-tumors-results-from-phase-3-of-the-raise-project.html https://www.enets.org/abstract/single-institution-real-life-experience-of-177lu-dotatate-treatment-in-progressive-well-differentiated-gep-nets.html https://www.enets.org/abstract/minimally-invasive-cortical-sparing-adrenal-surgery-in-the-treatment-of-pheochromocytomas-in-multiple-endocrine-neoplasia-type-21.html https://www.enets.org/abstract/treatment-outcomes-of-patients-with-g3-neuroendocrine-neoplasms-data-from-the-german-net-registry.html https://www.enets.org/abstract/dissociated-response-as-a-new-biomarker-of-treatment-response-in-neuroendocrine-tumors-results-from-phase-3-of-the-raise-project.html https://www.enets.org/abstract/a-molecular-map-of-lung-neuroendocrine-neoplasms.html https://www.enets.org/abstract/the-role-of-clinical-trials-study-coordinator-sc-in-the-era-of-theragnosis-in-neuroendocrine-tumors-nets-challenges-and-opportunities.html https://www.enets.org/abstract/soluble-urokinase-plasminogen-activator-receptor-supar-serum-levels-are-elevated-in-patients-with-neuroendocrine-neoplasia.html https://www.enets.org/abstract/pheochromocytomas-manifested-as-a-surgical-emergency.html https://www.enets.org/abstract/prevalence-and-presentation-of-cushing-and-carcinoid-syndromes-in-patients-with-non-metastatic-primary-lung-neuroendocrine-tumors-nets.html https://www.enets.org/abstract/mir-29b-serum-levels-are-down-regulated-in-patients-with-neuroendocrine-tumors.html https://www.enets.org/abstract/clinical-features-and-management-of-paragangliomas-in-a-tertiary-university-hospital.html https://www.enets.org/abstract/establishment-and-characterization-of-a-new-neuroendocrine-carcinoma-cell-model.html https://www.enets.org/abstract/the-major-impact-of-progrp-monitoring-in-advanced-atypical-lung-carcinoid-a-case-report.html https://www.enets.org/abstract/efficacy-and-safety-of-immune-checkpoint-inhibitors-in-patients-with-neuroendocrine-neoplasia-report-of-a-case-series-from-a-large-tertiary-centre.html https://www.enets.org/abstract/a-single-institution-experience-with-peptide-receptor-radionuclide-therapy-prrt-in-non-midgut-neuroendocrine-tumors-nets.html https://www.enets.org/abstract/baseline-albumin-and-neutrophil-to-lymphocyte-ratio-as-predictive-biomarkers-of-response-to-platinum-based-therapy-in-patients-with-highly-proliferative-neuroendocrine-carcinomas.html https://www.enets.org/abstract/the-impact-of-covid-19-pandemic-on-oncological-care-in-neuroendocrine-patients-a-single-institution-experience.html https://www.enets.org/abstract/a-single-institution-experience-with-peptide-receptor-radionuclide-therapy-prrt-in-advanced-pheochromocytoma-and-paraganglioma.html https://www.enets.org/abstract/active-surveillance-as-a-treatment-option-for-pancreatic-neuroendocrine-tumors-in-the-context-of-men1.html https://www.enets.org/abstract/high-tmb-and-msi-high-as-independent-predictors-of-survival-in-nens.html https://www.enets.org/abstract/impact-of-wnt-signalling-on-cxcr4-expression-and-function.html https://www.enets.org/abstract/streptozotocin-resistant-pancreatic-neuroendocrine-tumor-cell-lines-as-a-tool-to-understand-chemotherapy-resistance-in-pnet.html https://www.enets.org/abstract/non-curative-radiofrequency-and-microwave-ablation-of-liver-metastasis-to-control-progression-of-advanced-gep-nen.html https://www.enets.org/abstract/covid-19-in-patients-with-neuroendocrine-tumors-nets-the-mayo-clinic-experience.html https://www.enets.org/abstract/the-role-of-intraoperative-ultrasound-in-pancreatic-enucleation-for-pancreatic-neuroendocrine-tumors.html https://www.enets.org/abstract/surgical-outcomes-in-extrapulmonary-g3-neuroendocrine-neoplasms.html https://www.enets.org/abstract/molecular-and-functional-study-of-somatostatin-receptors-in-pheochromocytomas-and-paragangliomas.html https://www.enets.org/abstract/ga68-dotatoc-pet-ct-clinical-impact-in-patients-with-neuroendocrine-tumors-preliminary-results.html https://www.enets.org/abstract/treatment-outcomes-of-patients-with-g3-neuroendocrine-neoplasms1.html https://www.enets.org/abstract/evaluation-of-qol-based-on-eortc-c-30-and-ginet-21-questionaries-in-patients-with-advanced-progressive-net-during-after-combine-prrt-and-captem-therapy.html https://www.enets.org/abstract/splicing-machinery-dysregulation-in-low-grade-pulmonary-carcinoids.html https://www.enets.org/abstract/real-world-effectiveness-and-serotonin-reduction-in-patients-with-progressive-neuroendocrine-tumors-and-carcinoid-syndrome-receiving-telotristat-ethyl.html https://www.enets.org/abstract/prognostic-factors-in-curative-resected-locoregional-small-intestine-neuroendocrine-neoplasms.html https://www.enets.org/abstract/low-rate-of-toxicity-of-combined-prrt-and-captem-therapy-in-patients-with-advanced-non-resectable-progressive-pancreatic-and-midgut-neuroendocrine-tumors-net.html https://www.enets.org/abstract/assessment-of-hormonal-levels-as-prognostic-markers-and-of-their-optimal-cut-offs-in-small-intestinal-neuroendocrine-tumors-grade-2.html https://www.enets.org/abstract/the-psychological-impact-of-covid-19-pandemic-in-patients-with-nets-between-resilience-and-vulnerability.html https://www.enets.org/abstract/high-efficacy-of-combined-prrt-and-captem-therapy-based-on-objective-response-rate-recist-in-patients-with-pancreatic-and-midgut-neuroendocrine-tumors-net.html https://www.enets.org/abstract/management-and-treatment-of-neuroendocrine-tumors-during-the-global-covid-19-pandemic-experience-of-medical-oncology-department-of-hospital-1st-november.html https://www.enets.org/abstract/a-carcinoid-heart-revealing-a-neuroendocrine-tumor.html https://www.enets.org/abstract/exploration-of-ga-68-dota-pet-radiomics-to-predict-the-absorbed-dose-of-lu-177-dotatate-therapy-of-midgut-neuroendocrine-tumors.html https://www.enets.org/abstract/comprehensive-metabolomic-plasma-profiling-identifies-novel-potential-diagnostic-biomarkers-in-patients-with-advanced-neuroendocrine-tumors.html https://www.enets.org/abstract/carcinoid-heart-disease-in-chilean-net-patients-with-malignant-carcinoid-syndrome-long-term-cohort-from-a-developing-country.html https://www.enets.org/abstract/libretto-531-selpercatinib-vs-standard-of-care-in-patients-pts-with-multikinase-inhibitor-naive-advanced-or-metastatic-ret-mutant-mut-medullary-thyroid-cancer-mtc1.html https://www.enets.org/abstract/hpg80-circulating-progastrin-a-novel-blood-based-biomarker-for-detection-of-well-differentiated-neuroendocrine-tumors.html https://www.enets.org/abstract/microrna-prognostic-signature-in-neuroendocrine-neoplasias-nens-of-lung-and-gep-origin-in-silico-analysis-of-target-genes-and-pathways.html https://www.enets.org/abstract/increasing-compliance-of-an-oral-oncolytic-through-a-novel-clinical-nurse-educator-model.html https://www.enets.org/abstract/single-institution-experience-with-18f-dopa-and-68ga-dota-toc-as-a-pet-imaging-tracer-for-peptide-receptor-radionuclide-therapy-in-well-differentiated-neuroendocrine-neoplasms.html https://www.enets.org/abstract/simultaneously-diagnosis-of-neuroendocrine-neoplasm-of-unknown-primary-and-breast-cancer.html https://www.enets.org/abstract/prognostic-role-of-inflammation-index-in-neuroendocrine-neoplasms.html https://www.enets.org/abstract/a-patient-derived-organoid-model-of-neuroendocrine-neoplasms-enables-long-term-growth-in-vitro-of-low-grade-tumors-and-reveals-therapeutic-vulnerabilities.html https://www.enets.org/abstract/prediction-of-progression-free-survival-in-patients-with-neuroendocrine-tumors-received-177lu-dotatate-using-circulating-biomarkers.html https://www.enets.org/abstract/efficacy-of-capecitabine-and-temozolomide-in-small-bowel-midgut-neuroendocrine-tumors.html https://www.enets.org/abstract/tumor-growth-rate-in-well-differentiated-g1-3-gastroenteropancreatic-neuroendocrine-tumors-gep-nets-implications-for-clinical-trials.html https://www.enets.org/abstract/value-of-cga-and-nse-as-predictors-of-tumor-response-after-combined-prrt-and-captem-therapy-in-patients-with-progressive-advanced-gep-net.html https://www.enets.org/abstract/somatostatin-receptor-scintigraphy-in-an-uncommon-neuroendocrine-tumor.html https://www.enets.org/abstract/men1-syndrome-and-neuroendocrine-tumor-of-unknown-primary.html https://www.enets.org/abstract/utilization-of-next-generation-sequencing-in-net-nec-management-and-practice-patterns-a-prospective-survey-of-global-net-specialists.html https://www.enets.org/abstract/not-waving-but-drowning.html https://www.enets.org/abstract/short-interval-low-dose-sild-lu-177-dotaitate-therapy-to-overcome-resistance-to-immunotherapy-with-pd-1-checkpoint-inhibitors-proof-of-concept-to-induce-remission-in-patients-with-metastatic-merkel-cell-carcinoma-and-melanoma.html https://www.enets.org/abstract/intratumoral-serotonin-might-decrease-the-efficacy-of-prrt-in-ileal-neuroendocrine-tumors.html https://www.enets.org/abstract/changes-in-eosinophil-as-potential-marker-for-immune-related-changes-associated-with-prrt-in-net.html https://www.enets.org/abstract/neuroendocrine-differentiation-of-metastasised-castrate-resistant-prostate-cancer-patients-referred-for-radioligand-therapy-with-lu-177-psma.html https://www.enets.org/abstract/clinicopathological-features-and-risk-analysis-of-lymph-node-metastasis-in-type-3-gastric-neuroendocrine-tumor.html https://www.enets.org/abstract/clinicopathological-characteristics-and-prognosis-of-77-cases-with-type-3-gastric-neuroendocrine-tumor.html https://www.enets.org/abstract/network-pharmacology-based-elucidation-of-molecular-biological-mechanisms-of-yiqi-jianpi-decoction-for-treatment-of-neuroendocrine-neoplasms.html https://www.enets.org/abstract/effect-of-different-expression-status-of-mgmt-on-the-efficacy-of-temozolomide-in-gastroenteropancreatic-neuroendocrine-tumors.html https://www.enets.org/abstract/update-on-the-role-of-the-robotic-assisted-surgery-in-the-treatment-of-pancreatic-neuroendocrine-tumors-in-the-context-of-men1.html https://www.enets.org/abstract/adrenocortical-carcinoma-in-the-context-of-men1-patients-with-pnets-from-suspicion-to-diagnosis-management-and-follow-up.html https://www.enets.org/abstract/pheochromocytomas-and-cardiovascular-emergencies-a-need-for-high-index-of-suspicion.html https://www.enets.org/abstract/clinicopathological-characteristics-of-83-lymph-node-negative-rectal-neuroendocrine-tumors.html https://www.enets.org/abstract/telotristat-in-the-management-of-carcinoid-diarrhoea-real-world-experience-of-patients-from-an-enets-centre-of-excellence-in-neuroendocrine-tumors.html https://www.enets.org/abstract/analysis-of-clinicopathological-characteristics-and-prognosis-232-cases-of-gastric-neuroendocrine-carcinoma.html https://www.enets.org/abstract/lanreotide-as-maintenance-therapy-after-first-line-treatment-in-patients-with-non-resectable-duodeno-pancreatic-neuroendocrine-tumors-an-international-double-blind-placebo-controlled-randomized-phase-2-prodige-31-reminet-a-ffcd-study.html https://www.enets.org/abstract/ga-68-lu-177-octreotate-theranostic-paradigm-in-metastatic-merkel-cell-carcinoma.html https://www.enets.org/abstract/177lu-dotatate-efficacy-and-safety-in-functioning-neuroendocrine-tumors-a-joint-analysis-of-phase-2-prospective-clinical-trials.html https://www.enets.org/abstract/secondary-debulking-of-renal-neuroendocrine-tumor.html https://www.enets.org/abstract/heterogenic-clinical-manifestation-of-hypoglycaemia-in-patients-with-insulinoma.html https://www.enets.org/abstract/hypovitaminosis-d-in-patients-with-neuroendocrine-tumors-undergoing-ssa-therapy.html https://www.enets.org/abstract/comprehensive-genetic-analysis-of-tumor-suppressor-genes-men1-pten-rb1-and-p53-in-nets-in-mice.html https://www.enets.org/abstract/ectopic-cushing-s-syndrome-experience-from-a-tertiary-care-center.html https://www.enets.org/abstract/clinical-management-of-neuroendocrine-neoplasms-nens-in-the-time-of-covid-19.html https://www.enets.org/abstract/septralu-registry-of-177-lu-dotatate-in-neuroendocrine-tumors-data-from-321-patients-in-clinical-practice.html https://www.enets.org/abstract/carcinoid-heart-surgery-review-of-outcomes-from-a-single-large-centre.html https://www.enets.org/abstract/characterization-of-28-pancreatic-neuroendocrine-tumors-the-experience-of-a-tertiary-care-center.html https://www.enets.org/abstract/angiosarcoma-is-a-rare-and-aggressive-tumor-of-the-thyroid-case-report.html https://www.enets.org/abstract/evaluation-of-renal-and-hematologic-toxicities-of-212pb-vmt-alpha-net-to-inform-the-safety-of-alpha-particle-therapy-for-neuroendocrine-tumors.html https://www.enets.org/abstract/digital-image-analysis-of-the-ki67-spatial-distribution-improves-classification-and-grading-in-gastroenteropancreatic-neuroendocrine-neoplasms.html https://www.enets.org/abstract/neuroendocrine-tumors-in-young-adult-patients-epidemiological-profile-clinical-aspects-and-prognostic-factors.html https://www.enets.org/abstract/the-rotenone-induced-rat-model-of-parkinson-s-disease-morphological-and-electrophysiological-findings.html https://www.enets.org/abstract/tgf-increase-caspase-activation-and-migration-in-typical-bronchial-carcinoids.html https://www.enets.org/abstract/calcitonin-secreting-neuroendocrine-neoplasms-of-the-lung-a-systematic-review.html https://www.enets.org/abstract/analysis-of-immune-landscape-in-pancreatic-and-ileal-neuroendocrine-tumors-demonstrates-an-immune-cold-tumor-microenvironment.html https://www.enets.org/abstract/anti-immune-defences-involving-down-regulation-of-mhc-i-or-beta-catenin-activation-do-not-explain-immune-coldness-of-pancreatic-or-ileal-neuroendocrine-tumors.html https://www.enets.org/abstract/elastographic-localization-of-insulinoma.html https://www.enets.org/abstract/endoscopic-ultrasound-elastography-in-diagnostics-of-gastroenteropancreatic-neuroendocrine-tumors.html https://www.enets.org/abstract/drug-sensitivity-profiles-of-pnet-sbnet-and-nec-spheroids.html https://www.enets.org/abstract/increased-expression-of-cytochrome-p450-3a4-in-pancreatic-neuroendocrine-tumor-cells-promotes-drug-resistance.html https://www.enets.org/abstract/role-of-neoadjuvant-prrt-in-resectable-borderline-resectable-pannets-clinical-pathological-and-genomic-features.html https://www.enets.org/abstract/the-role-of-68ga-dotatate-pet-ct-in-extensive-igg4-positive-fibrosis-surrounding-a-mesenteric-lymph-node-metastasis-of-a-neuroendocrine-tumor-a-case-report.html https://www.enets.org/abstract/effects-of-transplantation-related-immunosuppression-on-co-existent-neuroendocrine-tumors.html https://www.enets.org/abstract/outcomes-of-upfront-treatment-with-mfolfirinox-regimen-in-g3-gep-nens-a-monocentric-retrospective-experience.html https://www.enets.org/abstract/a-prospective-randomized-double-blind-study-to-evaluate-the-safety-biodistribution-and-dosimetry-of-68ga-nodaga-lm3-and-68ga-dota-lm3-in-patients-with-well-differentiated-neuroendocrine-tumors.html https://www.enets.org/abstract/a-prospective-randomized-double-blind-phase-2-study-to-evaluate-the-diagnostic-efficacy-of-68ga-nodaga-lm3-and-68ga-dota-lm3-in-patients-with-well-differentiated-neuroendocrine-tumors-compared-with-68ga-dotatate.html https://www.enets.org/abstract/utility-of-midpoint-imaging-in-patients-receiving-peptide-receptor-radionuclide-therapy-prrt-for-advanced-progressive-midgut-neuroendocrine-tumors-net.html https://www.enets.org/abstract/efficacy-of-somatostatin-analogue-ssa-monotherapy-for-well-differentiated-grade-3-g3-gastroenteropancreatic-neuroendocrine-tumors-nets.html https://www.enets.org/abstract/management-of-early-stage-lung-carcinoid-analysis-of-ncdb-database.html https://www.enets.org/abstract/somatostatin-analogues-in-the-treatment-of-enteropancreatic-neuroendocrine-tumors.html https://www.enets.org/abstract/utility-of-sstr-radioligands-in-imaging-and-treatment-of-paediatric-gep-nets.html https://www.enets.org/abstract/approval-of-a-programme-to-perform-50-liver-transplants-for-neuroendocrine-tumor-liver-metastases-in-uk-and-ireland-affords-significant-opportunities-for-clinical-study-and-research.html https://www.enets.org/abstract/development-and-launch-of-first-australian-accredited-gp-net-education-course.html https://www.enets.org/abstract/a-rare-case-of-oligometastatic-thymic-carcinoid.html https://www.enets.org/abstract/dosimetry-evaluation-in-177lu-labeled-somatostatin-analogue-therapy.html https://www.enets.org/abstract/somatostatin-receptor-scintigraphy-in-pancreatic-neuroendocrine-tumor.html https://www.enets.org/abstract/integrative-molecular-analysis-of-combined-small-cell-lung-carcinoma-reveals-egfr-and-kras-mutational-analysis-as-the-theragnostic-tools-in-whole-small-cells-lung-carcinoma-landscape.html https://www.enets.org/abstract/molecular-characterization-of-a-multi-institutional-pan-lung-cohort-using-integrative-genomic-and-transcriptomic-analysis.html https://www.enets.org/abstract/broncho-pulmonary-combined-large-cell-neuroendocrine-carcinomas-co-lcnec-more-than-a-hybrid-neoplasm.html https://www.enets.org/abstract/comparable-survival-benefit-of-local-excision-versus-radical-resection-for-10-20mm-rectal-neuroendocrine-tumors.html https://www.enets.org/abstract/nomogram-for-the-prediction-of-lymph-node-metastasis-and-survival-outcomes-in-rectal-neuroendocrine-tumor-patients-undergoing-resection.html https://www.enets.org/abstract/development-and-validation-of-prognostic-nomograms-for-patients-with-periampullary-neuroendocrine-neoplasms.html https://www.enets.org/abstract/safety-and-efficacy-of-peptide-receptor-radionuclide-therapy-with-177-lu-dota-0-tyr-3-octreotate-in-combination-with-amino-acid-solution-infusion-in-japanese-patients-with-somatostatin-receptor-positive-progressive-neuroendocrine-tumors.html https://www.enets.org/abstract/exacerbation-of-necrolytic-migratory-erythema-after-177lu-dotatate-peptide-receptor-radionuclide-therapy.html https://www.enets.org/abstract/severe-gastroduodenal-ulceration-following-radioactive-microspheres-treatment-in-a-woman-with-metastatic-neuroendocrine-tumor-a-case-report-of-paradoxical-microsphere-migration.html https://www.enets.org/abstract/cancer-associated-fibroblasts-induce-proliferation-and-therapeutic-resistance-in-neuroendocrine-tumors-through-stat3-activation.html https://www.enets.org/abstract/clinicopathologic-impact-of-peptide-hormonal-expression-in-rectal-neuroendocrine-tumor.html https://www.enets.org/abstract/association-between-age-of-initial-diagnosis-and-prognosis-of-gastroenteropancreatic-neuroendocrine-neoplasms-a-nation-wide-10-year-retrospective-clinical-epidemiological-study-in-china.html https://www.enets.org/abstract/sars-cov-2-pandemic-and-prrt-the-experience-of-european-institute-of-oncology-ieo-milano-italy.html https://www.enets.org/abstract/evaluation-of-helicobacter-pylori-proteins-in-the-pathogenesis-of-type-1-gastric-neuroendocrine-tumor-and-urticaria-in-silico-approach.html https://www.enets.org/abstract/delayed-gastric-emptying-in-autoimmune-metaplastic-atrophic-gastritis.html https://www.enets.org/abstract/the-risk-factors-of-lymphovascular-invasion-in-rectal-neuroendocrine-tumors.html https://www.enets.org/abstract/folfox-bevacizumab-chemotherapy-in-patients-with-progressive-metastatic-neuroendocrine-tumors.html https://www.enets.org/abstract/need-and-challenges-of-developing-a-comprehensive-neuroendocrine-tumor-dietetic-service.html https://www.enets.org/abstract/neuroendocrine-prostate-cancer-about-4-cases.html https://www.enets.org/abstract/sporadic-and-men1-related-gastrinoma-and-zollinger-ellison-syndrome-differences-in-clinical-manifestation-and-severity.html https://www.enets.org/abstract/clinical-and-epidemiological-features-of-neuroendocrine-tumors-of-the-gastrointestinal-tract-based-on-a-single-center-register.html https://www.enets.org/abstract/long-term-stabilization-in-a-patient-with-neuroendocrine-carcinoma-of-the-laryngopharynx-after-systemic-treatment.html https://www.enets.org/abstract/integrating-saffron-s-metabolomics-on-neuroblastoma-treatment.html https://www.enets.org/abstract/dose-limiting-bone-marrow-toxicities-after-peptide-receptor-radionuclide-therapy-are-sexually-dimorphic.html https://www.enets.org/abstract/evaluating-the-significance-of-chromogranin-a-and-synaptophysin-in-pancreatic-neuroendocrine-tumors-a-road-towards-finding-independent-biomarkers.html https://www.enets.org/abstract/finding-the-outcomes-of-nen-managed-by-high-dose-radiations-in-pakistan.html https://www.enets.org/abstract/utilising-dna-pk-inhibitor-m3814-as-a-radiation-sensitizer.html https://www.enets.org/abstract/finding-the-options-of-managing-duodenal-carcinoids-in-pakistan-a-retrospective-study-in-a-territory-care-setup1.html https://www.enets.org/abstract/educational-learning-investigational-observational-study-elios-a-10-year-italian-network-to-standardize-procedures-and-obtain-multicentric-clinical-research-studies.html https://www.enets.org/abstract/gastric-metaplasia-and-duodenal-neuroendocrine-neoplasms-true-causality-or-simple-coincidence.html https://www.enets.org/abstract/neuroendocrine-tumors-associated-with-ovarian-teratoma-one-centre-experience.html https://www.enets.org/abstract/usefulness-of-corrected-suv-max-change-in-metastatic-net-lesions-before-and-after-prrt-obtained-by-68ga-ga-dota-tate-pet-ct-as-a-prognostic-factor.html https://www.enets.org/abstract/antisecretory-effect-of-oral-targeted-therapies-in-advanced-functioning-neuroendocrine-tumors-the-asset-net-study.html https://www.enets.org/abstract/clinical-impact-of-68-ga-dotanoc-pet-ct-and-18-f-fdg-pet-ct-in-clinical-management-of-who-grade-2-neuroendocrine-tumors.html https://www.enets.org/abstract/survey-of-neuroendocrine-tumor-patients-experience-of-quality-of-care-provided-by-a-dedicated-net-dietitian.html https://www.enets.org/abstract/dose-selection-for-paltusotine-a-once-daily-oral-nonpeptide-somatostatin-receptor-2-ligand-for-the-treatment-of-patients-with-carcinoid-syndrome-cs.html https://www.enets.org/abstract/time-to-reclassify-gastric-carcinomas-of-diffuse-type-to-neuroendocrine-carcinomas.html https://www.enets.org/abstract/agenesis-of-cephalic-pancreas-associated-with-pancreatic-neuroendocrine-tumor-a-case-report-and-review-of-the-literature.html https://www.enets.org/abstract/well-differentiated-grade-3-neuroendocrine-tumors-characteristics-treatments-and-outcomes-from-a-population-based-study.html https://www.enets.org/abstract/rapidly-growing-adenomyomatosis-of-the-gallbladder-to-neuroendocrine-carcinoma-of-the-gallbladder-a-case-report.html https://www.enets.org/abstract/review-of-appendiceal-neuroendocrine-neoplasms-and-pathological-features-that-influence-decision-for-oncological-right-hemicolectomy.html https://www.enets.org/abstract/peptide-radio-receptor-therapy-induces-immune-activation-in-patients-with-neuroendocrine-tumors-and-might-sensitize-to-immunotherapy.html https://www.enets.org/abstract/high-tissue-expression-of-flt3l-is-linked-to-higher-infiltration-of-immune-cells-in-patients-with-high-grade-gep-nen.html https://www.enets.org/abstract/epigenetic-progression-steps-in-alpha-lineage-men1-daxx-atrx-mutated-pancreatic-neuroendocrine-tumors-pannet.html https://www.enets.org/abstract/compose-phase-iii-trial-of-177lu-edotreotide-versus-standard-of-care-in-well-differentiated-wd-aggressive-grade-2-and-grade-3-gastroenteropancreatic-neuroendocrine-tumors-gep-nets.html https://www.enets.org/abstract/complete-regression-of-neuroendocrine-cancer-metastases-after-chemotherapy-with-carboplatin-and-etoposide.html https://www.enets.org/abstract/final-results-from-the-dune-trial-getne-1601-durvalumab-plus-tremelimumab-for-the-treatment-of-advanced-neuroendocrine-neoplasms-nens-of-gastroenteropancreatic-and-lung-origins.html https://www.enets.org/abstract/the-chromosome-18-loss-of-heterozygosity-axis-of-small-intestinal-neuroendocrine-tumors.html https://www.enets.org/abstract/large-cell-neuroendocrine-carcinoma-arising-from-the-mediastinum1.html https://www.enets.org/abstract/changes-in-dna-methylation-are-associated-with-differential-orthopedia-homeobox-otp-expression-in-pulmonary-carcinoids.html https://www.enets.org/abstract/dose-response-relationship-after-yttrium-90-radioembolization-with-glass-microspheres-in-patients-with-neuro-endocrine-tumor-liver-metastases.html https://www.enets.org/abstract/molecular-deciphering-of-primary-liver-neuroendocrine-neoplasms-confirms-its-distinct-existence-with-foregut-like-profile.html https://www.enets.org/abstract/patient-derived-tumoroids-phenocopy-original-gastro-entero-pancreatic-neuroendocrine-neoplasms-and-facilitate-in-vitro-drug-screening.html https://www.enets.org/abstract/prognostic-factors-in-lung-neuroendocrine-neoplasms-the-role-of-bone-metastases.html https://www.enets.org/abstract/addressing-professional-development-needs-in-neuroendocrine-cancer-nursing.html https://www.enets.org/abstract/characterising-aggressive-pulmonary-carcinoids-through-integrative-omics-analysis.html https://www.enets.org/abstract/serial-liquid-biopsies-the-netest-in-gastroenteropancreatic-net-surveillance.html https://www.enets.org/abstract/trends-in-chemotherapy-use-in-neuroendocrine-neoplasms-one-step-beyond-guidelines.html https://www.enets.org/abstract/defining-disease-status-in-gastroenteropancreatic-neuroendocrine-tumors-choi-criteria-or-recist.html https://www.enets.org/abstract/a-phase-2-open-label-study-of-belzutifan-a-hif-2-inhibitor-monotherapy-in-patients-with-advanced-metastatic-pheochromocytoma-paraganglioma-or-pancreatic-neuroendocrine-tumors.html https://www.enets.org/abstract/neoadjuvant-treatment-in-locally-advanced-pancreatic-neuroendocrine-tumor-g3.html https://www.enets.org/abstract/asymptomatic-bradycardia-in-patients-with-net-undergoing-ssa-treatment.html https://www.enets.org/abstract/quality-of-life-in-patients-with-net-undergoing-ssa-treatment.html https://www.enets.org/abstract/ascl1-and-otp-identify-four-prognostic-groups-among-atypical-carcinoids.html https://www.enets.org/abstract/quality-of-life-and-gastrointestinal-symptoms-according-to-phase-of-disease-in-patients-with-nets.html https://www.enets.org/abstract/cannabinoids-and-the-endocannabinoid-system-as-modulatory-targets-in-neuroendocrine-neoplasms-nens-c-possible-mechanisms-and-antitumor-efficacy.html https://www.enets.org/abstract/visceral-obesity-at-diagnosis-is-associated-with-well-differentiated-neuroendocrine-neoplasia-lower-progression-free-survival.html https://www.enets.org/abstract/multifunctional-gold-nanorods-iron-based-metal-organic-framework-for-magnetic-resonance-imaging-guided-photothermal-therapy-in-pancreatic-neuroendocrine-tumor.html https://www.enets.org/abstract/the-pei-q-paradox-qualitative-assessment-of-exocrine-function-in-net-patients-treated-with-ssas.html https://www.enets.org/abstract/men1-gene-sequence-variant-c-527-g-a-p-arg-176-gln-is-it-pathogenic.html https://www.enets.org/abstract/sars-cov-2-vaccination-site-as-possible-pitfall-on-somatostatin-receptor-imaging.html https://www.enets.org/abstract/neuroendocrine-tumor-of-the-kidney-about-an-observation.html https://www.enets.org/abstract/etoposide-based-rechallenge-and-second-third-line-treatments-in-patients-with-metastatic-neuroendocrine-carcinoma-results-from-the-multicenter-rbnec-study-of-the-groupe-d-etude-des-tumeurs-endocrines-gte-and-the-endocan-renaten-network.html https://www.enets.org/abstract/131i-mibg-scintigraphy-in-the-diagnosis-of-pheochromocytoma-retrospective-study-of-50-cases.html https://www.enets.org/abstract/longitudinal-copy-number-alteration-analysis-in-plasma-cell-free-dna-of-neuroendocrine-neoplasms-is-a-novel-specific-biomarker-for-diagnosis-prognosis-and-follow-up.html https://www.enets.org/abstract/mibg-scintigraphy-in-metastatic-neuroblastoma-a-retrospective-study-of-25-cases.html https://www.enets.org/abstract/parietal-cell-selective-slc26a9-deletion-in-mice-results-in-gastric-mucosal-immune-disorders-which-is-the-key-event-to-development-of-autoimmune-gastritis.html https://www.enets.org/abstract/diagnostic-role-and-prognostic-value-of-tumor-markers-in-high-grade-gep-nens.html https://www.enets.org/abstract/neoadjuvant-therapy-in-pancreatic-neuroendocrine-neoplasms-a-systematic-review-and-meta-analysis.html https://www.enets.org/abstract/updated-morphological-and-immunohistochemical-profile-of-neuroendocrine-tumors-developed-in-ovarian-teratomas-a-large-series-of-a-rare-disease.html https://www.enets.org/abstract/indocyanine-green-fluorescence-guided-resection-of-neuroendocrine-liver-metastases-a-proof-of-concept-study.html https://www.enets.org/abstract/international-survey-on-opinions-and-use-of-minimally-invasive-surgery-in-small-bowel-neuroendocrine-neoplasms.html https://www.enets.org/abstract/comprehensive-transcriptomic-and-methylomic-analysis-of-nens-from-multiple-origins-show-subgroups-of-patients-with-clinical-relevance.html https://www.enets.org/abstract/development-and-validation-of-a-nomogram-to-predict-survival-of-colorectal-mixed-neuroendocrine-non-neuroendocrine-neoplasm.html https://www.enets.org/abstract/fibroblast-activation-protein-fap-directed-molecular-imaging-segregates-between-subtypes-of-poorly-differentiated-neuroendocrine-neoplasms.html https://www.enets.org/abstract/role-of-18-f-fdg-pet-ct-in-the-management-of-g1-gastro-entero-pancreatic-neuroendocrine-tumors.html https://www.enets.org/abstract/retrospective-study-on-515-cases-misdiagnosed-as-neuroendocrine-neoplasms-from-a-pathologic-consultation-center.html https://www.enets.org/abstract/comparative-characteristics-of-ttf-1-and-sox2-expression-in-neuroendocrine-tumors-of-the-lungs-and-thymus.html https://www.enets.org/abstract/prognostic-factors-in-382-patients-treated-with-177-lu-dotatate-data-from-the-septralu-registry.html https://www.enets.org/abstract/is-non-operative-management-of-small-asymptomatic-sporadic-nonfunctioning-pancreatic-neuroendocrine-tumors-safe.html https://www.enets.org/abstract/risk-factors-for-complications-after-surgery-for-pancreatic-neuroendocrine-tumors.html https://www.enets.org/abstract/role-of-radiomics-in-the-everolimus-response-prediction-of-metastatic-neuroendocrine-tumors.html https://www.enets.org/abstract/tumor-neoantigens-shape-the-immune-microenvironment-of-pannets-an-in-silico-analysis.html https://www.enets.org/abstract/management-of-type-i-gastric-neuroendocrine-neoplasms-a-single-center-s-real-world-experience.html https://www.enets.org/abstract/surgical-management-of-patients-with-sporadic-zollinger-ellison-syndrome-an-achbt-and-gte-study.html https://www.enets.org/abstract/prospective-phase-ii-trial-of-prognostication-by-68ga-nota-ae105-upar-pet-in-patients-with-neuroendocrine-neoplasms-implications-for-upar-targeted-therapy.html https://www.enets.org/abstract/earlier-diagnosis-of-neuroendocrine-tumors-nets-through-transformation-of-the-south-wales-net-service.html https://www.enets.org/abstract/the-epidemiology-of-gastroenteropancreatic-neuroendocrine-tumors-gep-nets-in-the-north-east-of-england-and-a-systematic-review-of-literature.html https://www.enets.org/abstract/metabolomic-profile-of-extra-pancreatic-net-a-novel-prognostic-tool.html https://www.enets.org/abstract/access-to-diagnosis-and-treatments-for-patients-with-neuroendocrine-tumors-a-survey-by-the-brazilian-gastrointestinal-tumors-group.html https://www.enets.org/abstract/differential-diagnosis-of-diarrhoea-in-patients-with-neuroendocrine-tumors.html https://www.enets.org/abstract/cavum-neuroendocrine-carcinoma.html https://www.enets.org/abstract/re-cellularised-human-pancreas-3d-scaffolds-as-a-novel-disease-model-of-pancreatic-neuroendocrine-tumors-pnets.html https://www.enets.org/abstract/peptide-receptor-radionuclide-therapy-prrt-and-impact-on-quality-of-life-in-patients-with-neuroendocrine-neoplasms-an-international-multi-centre-study.html https://www.enets.org/abstract/comparison-of-lanreotide-and-octreotide-lar-use-and-outcomes-for-gastrointestinal-neuroendocrine-tumors-in-british-columbia-canada.html https://www.enets.org/abstract/thymic-neuroendocrine-tumors-case-series-from-a-colombian-hospital-reference1.html https://www.enets.org/abstract/phase-1-study-of-intralesional-il-rose-bengal-pv-10-an-investigational-autolytic-immunotherapy.html https://www.enets.org/abstract/clinicopathological-characteristics-and-treatment-options-of-the-new-grade-3-neuroendocrine-tumor-subgroup-nets-g3.html https://www.enets.org/abstract/relevant-prognostic-factors-in-patients-with-stage-iv-small-intestine-neuroendocrine-neoplasms.html https://www.enets.org/abstract/post-prrt-imaging-which-scans-to-make-and-what-to-look-for.html https://www.enets.org/abstract/short-term-tolerability-and-dose-toxicity-evaluation-of-177lu-dotatate-for-advanced-neuroendocrine-tumors-net.html https://www.enets.org/abstract/lanreotide-120-mg-every-28-days-lan-in-patients-with-locally-advanced-or-metastatic-pancreatic-neuroendocrine-tumors-pannet-in-routine-clinical-practice-in-iberia.html https://www.enets.org/abstract/gender-specific-differences-in-overall-survival-os-in-patients-with-pulmonary-neuroendocrine-neoplasms-nens-in-a-large-united-kingdom-uk-tertiary-centre.html https://www.enets.org/abstract/development-and-verification-of-a-new-monoclonal-otp-specific-antibody-for-pulmonary-carcinoid-diagnostics.html https://www.enets.org/abstract/jagged-1-restrains-malignant-progression-in-pancreatic-neuroendocrine-neoplasia.html https://www.enets.org/abstract/digital-quantification-of-somatostatin-receptor-subtype-2-immunostaining-in-pancreatic-neuroendocrine-tumors-and-gh-secreting-adenoma-a-validation-study.html https://www.enets.org/abstract/opposite-treatment-approach-in-two-institutes-identifies-primary-tumor-resection-to-be-associated-with-improved-disease-specific-mortality-in-patients-with-stage-iv-small-intestinal-neuroendocrine-tumors-si-net-vs-watch-and-wait-strategy.html https://www.enets.org/abstract/improving-understanding-of-neuroendocrine-tumors-nets-a-key-to-improving-patient-outcomes.html https://www.enets.org/abstract/correlation-study-between-68ga-dotatoc-pet-ct-metrics-and-177lu-dotatate-dosimetry-for-non-pancreatic-neuroendocrine-tumors.html https://www.enets.org/abstract/novel-morphological-tools-in-predicting-pancreatic-neuroendocrine-tumors-pan-net-clinical-outcome.html https://www.enets.org/abstract/hedgehog-pathway-implications-in-gastroenteropancreatic-neuroendocrine-tumors.html https://www.enets.org/abstract/molecular-imaging-tumor-volume-of-somatostatin-receptor-mitvssr-on-68ga-dotatate-pet-ct-dosimetry-and-predictors-of-overall-survival-and-response-in-unresectable-neuroendocrine-neoplasms-treated-with-peptide-receptor-radionuclide-therapy-prrt.html https://www.enets.org/abstract/a-novel-in-vitro-spheroid-model-enables-multi-modality-assessment-of-the-anti-tumoral-immune-response-in-pancreatic-neuroendocrine-neoplasms.html https://www.enets.org/abstract/reduction-of-64cu-dotatate-activity-dose-for-somatostatin-receptor-pet-imaging-of-patients-with-neuroendocrine-neoplasms.html https://www.enets.org/abstract/factors-at-time-of-diagnosis-associated-with-progressive-or-stable-disease-in-patients-with-small-intestinal-neuroendocrine-tumors-si-nets.html https://www.enets.org/abstract/the-prevalence-of-neuroendocrine-neoplasms-in-norway.html https://www.enets.org/abstract/serum-activin-a-is-not-associated-with-carcinoid-heart-disease-chd-in-patients-with-neuroendocrine-tumors-net.html https://www.enets.org/abstract/a-phase-ii-single-arm-trial-evaluating-the-efficacy-and-safety-of-temozolomide-for-second-line-treatment-of-neuroendocrine-carcinomas-progressing-after-first-line-platinum-based-therapy.html https://www.enets.org/abstract/peptide-receptor-radionuclide-therapy-with-177lutethium-or-90yttrium-dota-tate-or-toc-in-malignant-pheochromocytomas-pccs-and-paragangliomas-pgls-results-from-a-single-institutional-retrospective-analysis1.html https://www.enets.org/abstract/mesenteric-fibrosis-in-si-nen-is-characterized-by-strong-dysregulation-of-cxcl9-il6-comp-and-col6a6-genes.html https://www.enets.org/abstract/is-addition-of-netest-to-clinical-parameters-valuable-in-the-prognostication-of-patients-with-small-intestinal-neuroendocrine-tumors-si-net.html https://www.enets.org/abstract/real-world-overall-survival-os-in-patients-with-gastroenteropancreatic-gep-neuroendocrine-neoplasms-nens-in-a-large-united-kingdom-uk-tertiary-centre.html https://www.enets.org/abstract/pandora-2-protocol-intervention-study-to-improve-quality-of-life-in-patients-with-small-2-cm-non-functional-pancreatic-neuroendocrine-tumors.html https://www.enets.org/abstract/a-phase-ii-single-arm-interventional-trial-evaluating-the-activity-and-safety-of-combination-between-cabozantinib-and-temozolomide-tmz-in-lung-and-gep-nens-progressive-after-ssas-everolimus-sunitinib-or-prrt-cabotem.html https://www.enets.org/abstract/a-systematic-review-of-clinical-prediction-models-for-recurrence-in-patients-with-resectable-grade-1-and-2-non-functional-pancreatic-neuroendocrine-tumors.html https://www.enets.org/abstract/small-bowel-net-is-it-better-to-be-diagnosed-after-long-term-symptoms-or-acutely.html https://www.enets.org/abstract/treatment-response-and-survival-according-to-molecular-alterations-in-229-patients-with-high-grade-gastroenteropancreatic-neuroendocrine-neoplasms-hg-gep-nen.html https://www.enets.org/abstract/circulating-cell-free-tumor-dna-as-a-biomarker-in-patients-with-neuroendocrine-neoplasms.html https://www.enets.org/abstract/malignant-insulinomas-are-they-all-alikec.html https://www.enets.org/abstract/texture-analysis-of-liver-net-liver-metastases-on-ga-68-dotatate-pet-candidate-to-prrt-non-invasive-histological-and-prognostic-stratification.html https://www.enets.org/abstract/effects-of-radiation-therapy-for-somatotropic-pituitary-adenomas-depending-on-age.html https://www.enets.org/abstract/renal-uptake-monitoring-during-different-cycles-of-90y-dotatoc-therapy-based-on-111in-and-90y-spect-imaging.html https://www.enets.org/abstract/the-first-circulating-tumor-cell-derived-explant-cdx-model-of-a-merkel-cell-carcinoma.html https://www.enets.org/abstract/molecular-characterization-of-the-splicing-machinery-in-pheochromocytomas-and-paragangliomas-unveils-a-marked-dysregulation-with-instructive-potential.html https://www.enets.org/abstract/real-world-efficacy-of-lutetium-peptide-receptor-radionuclide-therapy-in-patients-with-neuroendocrine-tumors.html https://www.enets.org/abstract/pfs-evaluation-in-patients-with-advanced-non-resectable-progressive-gep-net-treated-using-combine-radioligand-prrt-and-captem-therapy.html https://www.enets.org/abstract/children-with-primary-hyperparathyroidism-after-parathyroidectomy.html https://www.enets.org/abstract/activity-and-safety-of-metformin-met-everolimus-eve-and-octreotide-oct-in-patients-pts-with-advanced-well-differentiated-wd-pancreatic-neuroendocrine-tumors-pnets-the-prospective-phase-ii-metnet-1-trial-nct02294006-interim-analysis.html https://www.enets.org/abstract/challenges-in-the-inclusion-of-patients-with-neuroendocrine-and-endocrine-neoplasms-in-clinical-trials-cts-how-to-minimize-screening-failures-sf.html https://www.enets.org/abstract/epigenetic-ageing-and-metabolic-traits-of-multi-focal-ileal-neuroendocrine-tumors.html https://www.enets.org/abstract/homelan-an-international-online-survey-to-assess-satisfaction-with-injection-experience-of-patients-with-neuroendocrine-tumors-nets-enrolled-in-lanreotide-autogel-lan-patient-support-programmes-psps.html https://www.enets.org/abstract/the-dominant-role-of-pancreatic-and-pulmonary-net-g3-in-a-large-consultation-center-series.html https://www.enets.org/abstract/lifestyle-and-neuroendocrine-tumor-net-development.html https://www.enets.org/abstract/neuroendocrine-neoplasms-of-the-biliary-tract-a-single-enets-centre-of-excellence-case-series.html https://www.enets.org/abstract/telotristat-ethyl-affects-crosstalk-between-tumor-cells-and-stromal-fibroblasts-in-small-intestinal-neuroendocrine-tumors-si-nets.html https://www.enets.org/abstract/drd2-agonist-cabergoline-abolished-the-escape-mechanism-induced-by-mtor-inhibitor-everolimus-in-pituitary-neuroendocrine-tumoral-cells.html https://www.enets.org/abstract/different-patterns-of-recurrence-after-liver-resection-and-transplantation-for-metastatic-neuroendocrine-tumors-single-center-ecperience.html https://www.enets.org/abstract/phase-ii-study-of-everolimus-and-temozolomide-as-1-line-treatment-in-metastatic-high-grade-gastroenteropancreatic-neuroendocrine-neoplasms-net-g3-and-nec.html https://www.enets.org/abstract/liver-transplantation-for-metastatic-neuroendocrine-tumors-time-to-extend-criteria.html https://www.enets.org/abstract/comparative-biocomputational-analysis-of-the-splicing-landscape-across-lung-neuroendocrine-neoplasms-unveils-a-new-actionable-molecular-layer.html https://www.enets.org/abstract/efficacy-of-177-lutetium-dotatate-peptide-receptor-radionuclide-therapy-in-patients-with-metastatic-nens-and-carcinoid-syndrome-refractory-to-somatostatin-analogues.html https://www.enets.org/abstract/predictive-factors-of-adverse-events-onset-in-gep-net-patients-treated-with-lrt.html https://www.enets.org/abstract/genetic-epigenetic-and-or-transcriptional-profiling-of-14q-genes-max-and-meg3-in-pituitary-neuroendocrine-tumors.html https://www.enets.org/abstract/comprehensive-molecular-analysis-of-prognostic-groups-in-neuroendocrine-neoplasms-nens-identifies-key-genes-and-potential-regulatory-mechanisms.html https://www.enets.org/abstract/dll3-expression-and-clinico-pathological-data-in-247-patients-with-nen.html https://www.enets.org/abstract/presto-2-an-international-patient-survey-to-evaluate-impact-of-injection-and-delivery-system-on-local-pain-when-administering-somatostatin-analogue-ssa-therapy.html https://www.enets.org/abstract/177lutetium-peptide-receptor-radionuclide-therapy-prrt-safety-assessment-in-patients-with-refractory-gastro-entero-pancreatic-neuroendocrine-tumors-gep-nets.html https://www.enets.org/abstract/the-role-of-the-net-clinical-nurse-specialist-in-managing-carcinoid-heart-disease-patients-optimising-patient-care.html https://www.enets.org/abstract/effect-of-lanreotide-autogel-depot-lan-on-tumor-growth-rate-tgr-in-patients-with-metastatic-bronchopulmonary-neuroendocrine-tumors-bp-nets-exploratory-data-from-the-phase-3-spinet-study.html https://www.enets.org/abstract/neuroendocrine-neoplasms-of-gall-bladder-peruvian-experience.html https://www.enets.org/abstract/impact-of-a-reduced-dosing-interval-of-lanreotide-autogel-lan-on-tumor-growth-rate-tgr-in-patients-with-progressive-neuroendocrine-tumors-nets-in-the-prospective-single-arm-phase-2-clarinet-forte-trial.html https://www.enets.org/abstract/molecular-histopathological-and-functional-characterization-of-the-dysregulation-of-the-splicing-machinery-in-lung-carcinoids.html https://www.enets.org/abstract/clinical-epidemiology-of-upper-gastrointestinal-neuroendocrine-neoplasms-ugi-nens-a-nationwide-multi-center-10-year-retrospective-study.html https://www.enets.org/abstract/nicenec-phase-2-trial-of-nivolumab-and-platinum-doublet-chemotherapy-in-untreated-advanced-g3-neuroendocrine-neoplasms-nens-of-gastroenteropancreatic-gep-or-unknown-uk-origin-efficacy-by-differentiation-ki67-index-and-primary-tumor-site.html https://www.enets.org/abstract/correlation-of-loss-of-atrx-expression-with-scintigraphic-imaging-studies-in-pancreatic-neuroendocrine-neoplasms.html https://www.enets.org/abstract/prognostic-factors-for-progression-free-survival-pfs-in-patients-with-metastatic-bronchopulmonary-neuroendocrine-tumors-bp-nets-exploratory-data-from-the-phase-3-spinet-study.html https://www.enets.org/abstract/neurofibromatosis-type-1-in-combination-with-pheochromocytoma-clinical-case.html https://www.enets.org/abstract/appendiceal-neuroendocrine-neoplasms-diagnosed-during-pregnancy-a-case-series-and-review-of-the-literature.html https://www.enets.org/abstract/computerized-tomography-ct-based-hepatic-radiomics-phenotypes-associate-with-response-to-anti-angiogenics-in-neuroendocrine-tumors-nets-a-subanalysis-from-the-phase-ii-talent-clinical-trial.html https://www.enets.org/abstract/molecular-profiling-and-target-actionability-for-precision-medicine-in-neuroendocrine-neoplasms-the-gustave-roussy-experience.html https://www.enets.org/abstract/modified-tgr-a-new-strong-radiological-marker-to-accurately-predict-early-response-to-prrt-in-gep-nets.html https://www.enets.org/abstract/bone-loss-and-whole-body-composition-in-patients-with-gastroenteropancreatic-neuroendocrine-neoplasms.html https://www.enets.org/abstract/identification-of-proangiogenic-plasmatic-biomarkers-in-patients-with-advanced-grade-1-2-pancreatic-pan-and-gastrointestinal-gi-neuroendocrine-tumors-nets-treated-with-lenvatinib-a-subanalysis-from-the-talent-phase-ii-clinical-trial.html https://www.enets.org/abstract/avelumab-in-unresectable-metastatic-progressive-grade-2-3-neuroendocrine-neoplasms-nens-translational-results-from-net-001-and-net-002-trials.html https://www.enets.org/abstract/a-case-series-and-literature-review-of-dipnech.html https://www.enets.org/abstract/comparison-of-drug-sensitivity-profiles-of-various-nen-spheroids.html https://www.enets.org/abstract/177lu-dotatate-prrt-in-the-treatment-of-patients-with-gastroenteropancreatic-neuroendocrine-tumors-gepnets-versus-other-tumors.html https://www.enets.org/abstract/a-challenging-diagnosis-of-a-neuroendocrine-tumor-of-unknown-origin-associated-with-primary-aldosteronism.html https://www.enets.org/abstract/a-rare-presentation-of-duodenal-neuroendocrine-carcinoma.html https://www.enets.org/abstract/preoperative-diagnosis-impact-on-surgical-strategies-and-outcomes-in-patients-with-medullary-thyroid-carcinoma.html https://www.enets.org/abstract/surgical-treatment-of-type-1-gastric-neuroendocrine-tumors-a-20-years-single-center-experience.html https://www.enets.org/abstract/essential-role-of-nutritional-support-in-patients-with-advanced-carcinoid-heart-disease.html https://www.enets.org/abstract/safety-of-lanreotide-autogel-lan-120-mg-plus-metformin-met-in-patients-with-advanced-well-differentiated-wd-gastro-intestinal-gi-or-lung-neuroendocrine-tumors-nets-a-pilot-open-label-prospective-study-the-metnet-2-trial-nct02823691.html https://www.enets.org/abstract/incidence-prevalence-and-survival-of-neuroendocrine-neoplasia-1995c2018.html https://www.enets.org/abstract/virchow-s-node-metastasis-from-small-intestinal-neuroendocrine-neoplasms-a-bi-center-cohort-study.html https://www.enets.org/abstract/neuroendocrine-tumors-experience-at-instituto-nacional-de-enfermedades-neoplasicas-in-a-hospital-from-peru.html https://www.enets.org/abstract/a-case-of-night-blindness-from-vitamin-a-deficiency1.html https://www.enets.org/abstract/patient-characteristics-in-metastatic-neuroendocrine-tumors-of-gastric-origin.html https://www.enets.org/abstract/randomized-open-label-phase-iii-study-comparing-the-efficacy-and-safety-of-everolimus-followed-by-chemotherapy-with-streptozotocin-stz-5fu-upon-progression-or-the-reverse-sequence-in-advanced-progressive-pannets-the-seqtor-study-getne-1206.html https://www.enets.org/abstract/endoscopic-ultrasonography-and-elastography-in-pancreatic-and-gastrointestinal-neuroendocrine-tumors-diagnostic.html https://www.enets.org/abstract/fatigue-and-quality-of-life-in-patients-with-neuroendocrine-neoplasia.html https://www.enets.org/abstract/gamma-glutamyltransferase-as-an-indicator-of-hepatic-tumor-burden-in-neuroendocrine-tumors.html https://www.enets.org/abstract/stereotactic-radiosurgery-of-brain-metastases-in-large-cell-neuroendocrine-carcinoma-of-the-lung.html https://www.enets.org/abstract/risk-of-myelodysplastic-syndrome-acute-leukemia-with-sequential-capecitabine-temozolomide-and-177lu-dotatate.html https://www.enets.org/abstract/radioembolization-of-neuroendocrine-neoplasms-liver-metastases-efficacy-and-toxicity.html https://www.enets.org/abstract/final-analysis-of-chromogranin-a-for-neuroendocrine-tumor-diagnosis-in-chilean-patients-an-updated-case-control-study.html https://www.enets.org/abstract/association-of-long-term-ppi-use-with-low-risk-gastric-neuroendocrine-tumor.html https://www.enets.org/abstract/novel-patient-derived-tumor-organoid-models-reveal-growth-factor-dependencies-in-neuroendocrine-tumors-and-serve-as-a-platform-for-neuroendocrine-cancer-research.html https://www.enets.org/abstract/nutritional-status-in-patients-with-neuroendocrine-tumors-a-single-enets-centre-of-excellence-experience.html https://www.enets.org/abstract/minimally-invasive-laparoscopic-and-robotic-versus-open-hepatic-resection-for-nen-liver-metastasis-case-matched-study-with-propensity-score-matching.html https://www.enets.org/abstract/prognostic-factors-in-stage-i-iii-adrenocortical-cancer-acc-data-of-230-patients-from-the-icaro-gethi-seen-registry.html https://www.enets.org/abstract/can-tumor-absorbed-dose-predict-response-to-peptide-receptor-radionuclide-therapy-prrt-in-patients-with-gastroenteropancreatic-neuroendocrine-tumors-gep-nets.html https://www.enets.org/abstract/prevalence-of-other-malignant-cancers-in-patients-with-neuroendocrine-neoplasms.html https://www.enets.org/abstract/grade-3-neuroendocrine-neoplasms-real-life-experience-and-prognostic-biomarkers.html https://www.enets.org/abstract/177-lu-dotatate-in-382-patients-with-somatostatin-receptor-positive-advanced-tumors-real-world-data-from-the-septralu-registry.html https://www.enets.org/abstract/metastatic-mixed-vipoma-ppoma-induced-diarrhoea-causing-renal-failure.html https://www.enets.org/abstract/exploring-the-interplay-between-chromatin-remodeling-genes-and-the-regulation-of-alternative-splicing-and-rna-biology-in-lung-neuroendocrine-neoplasms.html https://www.enets.org/abstract/outcomes-of-streptozotocin-stz-based-chemotherapy-ct-in-patients-with-advanced-pancreatic-neuroendocrine-tumors-pnets-data-from-the-spanish-taskforce-of-neuroendocrine-and-endocrine-tumors-getne-national-registry-r-getne.html https://www.enets.org/abstract/metastatic-middle-ear-neuroendocrine-tumor-treated-with-somatostatin-analogues-and-prrt-a-case-report.html https://www.enets.org/abstract/a-multicentric-randomized-phase-ii-trial-of-captem-ct-or-folfiri-f-as-second-line-therapy-in-neuroendocrine-carcinomas-nec-and-exploratory-analysis-of-predictive-role-of-pet-imaging-and-biological-markers-seneca-study.html https://www.enets.org/abstract/capecitabine-and-temozolomide-in-advanced-neuroendocrine-neoplasms-a-single-center-experience.html https://www.enets.org/abstract/treatment-of-advanced-adrenocortical-cancer-acc-data-from-152-patients-of-the-national-and-multicenter-icaro-gethi-seen-registry.html https://www.enets.org/abstract/multiple-endocrine-neoplasia-type-1-men1-a-series-of-cases-in-an-oncology-department.html https://www.enets.org/abstract/claudin-18-immunohistochemistry-for-determining-site-of-origin-of-metastatic-neuroendocrine-tumor.html https://www.enets.org/abstract/patterns-of-family-history-of-cancer-and-associated-risk-of-developing-neuroendocrine-tumors-a-cross-sectional-study.html https://www.enets.org/abstract/optimal-planning-of-treatment-and-research-of-neuroendocrine-tumors-nets-in-australia-the-planet-registry-and-patient-reported-outcomes-via-planet-app.html https://www.enets.org/abstract/setting-up-of-a-national-liver-transplant-programme-for-neuroendocrine-tumor-liver-metastases-in-uk-and-ireland-opportunities-for-collaborations-in-clinical-study-and-research.html https://www.enets.org/abstract/sex-differences-in-survival-of-neuroendocrine-neoplasia-in-england-1995c2018.html https://www.enets.org/abstract/pancreatic-neuroendocrine-tumors-pannets-vascularization-from-cmicroc-to-cmacroc.html https://www.enets.org/abstract/characterisation-prognosis-and-treatment-of-patients-with-locally-advanced-or-metastatic-thymic-carcinoid-tumor-a-retrospective-study-of-the-french-gte-endocan-renaten-and-rythmic-networks.html https://www.enets.org/abstract/mixed-neuroendocrine-non-neuroendocrine-neoplasms-minen-characterization-of-the-genomic-and-pathological-profile.html https://www.enets.org/abstract/nodal-recurrence-after-curative-surgery-for-non-functioning-pancreatic-neuroendocrine-tumors-a-retrospective-cohort-study.html https://www.enets.org/abstract/belzutifan-an-oral-hypoxia-inducible-factor-2c-inhibitor-for-von-hippel-lindau-diseasecassociated-pancreatic-neuroendocrine-tumors.html https://www.enets.org/abstract/grading-diagnostic-accuracy-of-eus-tissue-acquisition-in-pancreatic-neuroendocrine-tumors-a-systematic-review-and-meta-analysis.html https://www.enets.org/abstract/evaluation-of-pfs-and-os-in-patients-with-sporadic-advanced-unresectable-well-differentiated-pancreatic-neuroendocrine-tumors-pannets-treated-initially-with-octreotide-lar-and-methods-of-further-treatment-after-relapse-real-world-data1.html https://www.enets.org/abstract/evaluation-of-interim-dotatate-pet-after-two-cycles-of-peptide-receptor-radionuclide-therapy-prrt-in-neuroendocrine-tumors-net.html https://www.enets.org/abstract/effects-of-curcumin-on-proliferation-of-pancreatic-neuroendocrine-tumor-cells.html https://www.enets.org/abstract/molecular-mechanism-of-curcumin-inhibiting-proliferation-of-pancreatic-neuroendocrine-tumor-cells.html https://www.enets.org/abstract/clinicopathological-features-and-prognosis-analysis-of-73-patients-with-gastric-neuroendocrine-carcinoma-with-liver-metastasis.html https://www.enets.org/abstract/to-investigate-the-clinicopathological-features-and-prognosis-of-157-patients-with-gastric-neuroendocrine-carcinoma-without-distant-metastasis.html https://www.enets.org/abstract/clinicopathological-features-and-long-term-prognosis-of-purely-cystic-pancreatic-neuroendocrine-tumors-c-a-single-center-experience.html https://www.enets.org/abstract/predictors-of-lymph-node-involvement-in-patients-with-pancreatic-neuroendocrine-tumors.html https://www.enets.org/abstract/genetic-tumor-and-blood-profiling-in-the-randomised-controlled-phase-iii-compose-trial-comparing-177lu-edotreotide-and-best-standard-of-care-for-well-differentiated-aggressive-grade-2-3-gastroenteropancreatic-neuroendocrine-tumors.html https://www.enets.org/abstract/preoperative-acute-pancreatitis-and-hyperenzymemia-are-associated-with-poor-prognosis-in-patients-with-non-functional-pancreatic-neuroendocrine-tumors.html https://www.enets.org/abstract/folfox-in-pancreatic-g1-and-g2-neuroendocrine-tumors.html https://www.enets.org/abstract/artificial-intelligence-and-management-of-gastroenteropancreatic-neuroendocrine-neoplasms.html https://www.enets.org/abstract/endoscopic-ultrasound-fine-needle-biopsy-to-assess-daxx-atrx-expression-and-alternative-lengthening-of-telomeres-status-in-non-functional-pancreatic-neuroendocrine-tumors.html https://www.enets.org/abstract/interest-of-systematic-resection-of-the-visible-scar-after-incomplete-endoscopic-resection-of-rectal-neuroendocrine-tumors.html https://www.enets.org/abstract/c-x-c-receptor-4-cxcr4-directed-imaging-and-therapy-in-nen-patients-with-varying-tumor-aggressiveness-c-diagnostic-performance-and-eligibility-for-cxcr4-targeted-theragnostics.html https://www.enets.org/abstract/surgery-of-primary-lung-carcinoid-tumors-at-metastatic-stage-c-a-national-study-from-the-french-group-of-endocrine-tumors-gte-and-endocan-renaten-network.html https://www.enets.org/abstract/cystatin-c-may-serve-as-a-suitable-blood-based-biomarker-to-monitor-renal-functional-decline-in-patients-scheduled-for-peptide-receptor-radionuclide-therapy.html https://www.enets.org/abstract/plasma-derived-small-extracellular-vesicles-reveal-pancreatic-neuroendocrine-tumors.html https://www.enets.org/abstract/endoscopic-ultrasound-guided-radiofrequency-ablation-versus-surgical-resection-for-the-treatment-of-pancreatic-insulinoma-c-a-multicenter-propensity-score-matched-study.html https://www.enets.org/abstract/clinicopathological-features-treatment-and-prognostic-analysis-of-patients-with-gastrointestinal-neuroendocrine-neoplasms-c-a-nation-wide-clinical-epidemiological-study-in-china.html https://www.enets.org/abstract/somatostatin-analogues-in-the-anti-proliferative-treatment-of-well-differentiated-grade-2-nets-with-ki-67-c-10-c-experience-of-an-algerian-center.html https://www.enets.org/abstract/clinical-and-epidemiological-features-of-intestinal-neuroendocrine-neoplasms-in-china-and-seer-database-2001c2010.html https://www.enets.org/abstract/biliary-neuroendocrine-neoplasms-c-experience-of-an-algerian-center.html https://www.enets.org/abstract/the-mutational-prognostic-and-therapeutic-landscape-of-neuroendocrine-neoplasms.html https://www.enets.org/abstract/real-world-seer-medicare-data-analysis-of-the-evolution-of-tumor-characteristics-first-line-therapies-and-overall-survival-os-in-patients-with-neuroendocrine-tumors-nets.html https://www.enets.org/abstract/comparison-of-radiomics-and-deep-learning-signature-for-the-lymph-node-metastasis-detection-in-pancreatic-neuroendocrine-tumor.html https://www.enets.org/abstract/hypoxia-down-regulates-m6a-methyltransferase-mettl3-and-wtap-promotes-pancreatic-neuroendocrine-tumor-metastasis-via-regulating-tgfbi.html https://www.enets.org/abstract/characteristics-of-clinical-features-of-men1-associated-and-sporadic-insulinomas-c-one-clinical-center-experience.html https://www.enets.org/abstract/clinical-outcomes-of-everolimus-eve-for-patients-with-advanced-rectal-neuroendocrine-tumors-arnets-c-a-single-institutional-retrospective-study.html https://www.enets.org/abstract/characterization-prognosis-and-treatment-of-patients-with-head-neck-well-differentiated-neuroendocrine-tumors-c-a-retrospective-study-of-the-french-gte-endocan-renaten-and-refcor-networks.html https://www.enets.org/abstract/long-term-survival-and-toxicity-in-patients-with-neuroendocrine-tumors-treated-with-177lu-octreotate-peptide-radionuclide-therapy.html https://www.enets.org/abstract/early-prediction-of-the-efficacy-of-177lu-dotatate-in-patients-with-metastatic-neuroendocrine-tumors.html https://www.enets.org/abstract/retrospective-survival-analysis-of-patients-with-small-bowel-neuroendocrine-tumors-nets-and-analysis-of-patient-satisfaction-post-covid-pandemic-in-the-sheffield-european-neuroendocrine-tumor-society-enets-centre-of-excellence-coe.html https://www.enets.org/abstract/evaluating-the-systemic-management-options-in-advanced-pulmonary-carcinoid-tumors-c-a-systematic-review.html https://www.enets.org/abstract/metformin-suppresses-small-intestinal-neuroendocrine-tumor-growth-in-vivo.html https://www.enets.org/abstract/are-hemicolectomies-still-indicated-in-patients-with-neuroendocrine-tumors-of-the-appendix-1-2cmc-a-retrospective-europe-wide-cohort-study.html https://www.enets.org/abstract/medullary-thyroid-carcinoma-and-somatostatin-analogues-a-possible-therapeutic-choice-in-asymptomatic-and-slow-radiological-progression-metastatic-recurrent-disease-after-surgery-c-case-report-of-a-22-years-long-term-survival-patient.html https://www.enets.org/abstract/tumor-mutation-burden-in-gastroenteropancreatic-neuroendocrine-neoplasms.html https://www.enets.org/abstract/imaging-surveillance-in-multiple-endocrine-neoplasia-type-1-c-10-years-of-experience-with-somatostatin-receptor-positron-emission-tomography.html https://www.enets.org/abstract/non-responders-to-peptide-receptor-radionuclide-therapy-prrt-c-a-single-center-retrospective-analysis.html https://www.enets.org/abstract/texture-analysis-in-the-prediction-of-progression-free-survival-pfs-in-patients-with-progressive-neuroendocrine-tumors-nets-treated-with-lanreotide-autogel-lan-in-the-prospective-open-label-non-comparative-phase-2-clarinet-forte-trial.html https://www.enets.org/abstract/incidence-of-neuroendocrine-neoplasms-in-norway.html https://www.enets.org/abstract/tumor-uptake-on-18fdopa-pet-ct-is-a-strong-prognostic-factor-in-patients-with-metastatic-small-intestine-neuroendocrine-tumors-sinets-c-a-gte-study.html https://www.enets.org/abstract/neuroendocrine-tumor-in-a-young-patient.html https://www.enets.org/abstract/a-population-based-analysis-of-the-epidemiology-of-neuroendocrine-tumors-in-newfoundland-and-labrador.html https://www.enets.org/abstract/gp-patient-interactions-and-coding-of-neuroendocrine-tumors-nets-in-primary-care-records.html https://www.enets.org/abstract/effect-of-resection-timing-as-part-of-multidisciplinary-treatment-for-pancreatic-nen-liver-metastases.html https://www.enets.org/abstract/n-terminal-pro-brain-natriuretic-peptide-and-chromogranin-a-as-biomarkers-for-detection-of-carcinoid-heart-disease.html https://www.enets.org/abstract/nab-paclitaxel-plus-bevacizumab-for-patients-with-previously-treated-metastatic-neuroendocrine-carcinomas-nec-c-a-multicenter-open-label-phase-ii-trial.html https://www.enets.org/abstract/thymic-neuroendocrine-neoplasms-c-data-from-the-czech-neuroendocrine-tumor-registry-2008-c-2022.html https://www.enets.org/abstract/autologous-ecm-composed-scaffolds-and-zebrafish-pdxs-for-individualized-theragnostic-in-rare-neuroendocrine-neoplasms.html https://www.enets.org/abstract/treatment-preferences-for-somatostatin-analogues-in-neuroendocrine-tumors-nets-among-patients-clinicians-and-nurses-in-australia.html https://www.enets.org/abstract/influence-of-pathogenic-somatic-mutations-on-the-survival-rates-of-patients-with-neuroendocrine-tumors-of-the-gastrointestinal-tract-net-gi.html https://www.enets.org/abstract/mesenteric-fibrosis-in-small-intestinal-neuroendocrine-tumors-si-nets-c-steps-towards-understanding-its-pathogenesis.html https://www.enets.org/abstract/features-of-the-expression-of-ttf-1-and-cytokeratin-19-as-a-predictor-of-a-less-favourable-prognosis-of-atypical-lung-carcinoids.html https://www.enets.org/abstract/neuroendocrine-urological-tumors-c-experience-of-the-medical-oncology-department-of-the-hospital-november-1st-1954-in-oran-algeria.html https://www.enets.org/abstract/digital-image-analysis-of-ki-67-heterogeneity-of-pancreatic-neuroendocrine-neoplasms-with-or-without-liver-metastasis.html https://www.enets.org/abstract/whole-exome-sequencing-of-rectal-neuroendocrine-tumors.html https://www.enets.org/abstract/glucagonomas-c-characteristics-and-treatment-options-based-on-a-french-multicenter-cohort-study.html https://www.enets.org/abstract/prognostic-and-therapeutic-role-of-a-novel-genomic-subtyping-of-target-gene-sequencing-on-gastroenteropancreatic-neuroendocrine-carcinoma.html https://www.enets.org/abstract/effects-of-curcumin-on-pancreatic-neuroendocrine-neoplasms.html https://www.enets.org/abstract/the-characteristics-of-somatostatin-receptor-pet-ct-in-bone-metastases-of-neuroendocrine-tumors.html https://www.enets.org/abstract/prognostic-value-of-inflammation-related-biomarkers-in-patients-with-gastroenteropancreatic-neuroendocrine-neoplasms-gep-nens-c-a-systematic-review-and-meta-analysis.html https://www.enets.org/abstract/blood-liver-enzyme-levels-correlate-with-hepatic-tumor-burden-in-advanced-neuroendocrine-tumors.html https://www.enets.org/abstract/nothing-but-netc-neuroendocrine-tumors-in-multiple-endocrine-neoplasia-4.html https://www.enets.org/abstract/cannabis-and-endocannabinoid-system-modulation-as-novel-strategies-to-improve-conventional-treatment-outcomes-and-overcome-drug-resistance-in-neuroendocrine-neoplasms-in-vitro-in-vivo-models1.html https://www.enets.org/abstract/endoscopic-submucosal-dissection-for-gastric-neuroendocrine-neoplasms-c-a-multicentre-retrospective-study.html https://www.enets.org/abstract/nomograms-to-predict-the-prognosis-of-pancreatic-neuroendocrine-neoplasms.html https://www.enets.org/abstract/outcome-of-endoscopic-submucosal-dissection-for-rectal-neuroendocrine-neoplasms-c-a-multicentre-study.html https://www.enets.org/abstract/factors-contributing-to-tumor-shrinkage-after-peptide-receptor-radionuclide-therapy-in-patients-with-unresectable-neuroendocrine-tumors.html https://www.enets.org/abstract/can-simple-measurements-on-routine-surveillance-ct-in-metastatic-net-disease-predict-clinically-significant-carcinoid-heart-diseasec-a-retrospective-single-site-study-of-73-patients.html https://www.enets.org/abstract/response-to-peptide-receptor-radionuclide-therapy-in-pheochromocytomas-and-paragangliomas-c-a-systematic-review-and-meta-analysis.html https://www.enets.org/abstract/gep-net-and-early-progression-after-rlt-c-application-of-a-modified-tgr-to-increase-the-accuracy-of-prediction.html https://www.enets.org/abstract/impact-of-everolimus-starting-dose-on-antiproliferative-efficacy-in-patients-with-neuroendocrine-tumors-c-experiences-from-a-tertiary-referral-center.html https://www.enets.org/abstract/neuroendocrine-tumors-of-the-pancreas-c-experience-of-the-general-surgery-department-of-the-ehu-oran-algeria.html https://www.enets.org/abstract/covid-19-in-patients-with-neuroendocrine-neoplasms-c-two-year-results-of-a-worldwide-survey-the-intensive-study.html https://www.enets.org/abstract/care-trajectory-informational-needs-and-challenges-of-patients-with-neuroendocrine-tumors-c-a-mixed-methods-study.html https://www.enets.org/abstract/digestive-neuroendocrine-tumors-c-a-retrospective-study-nine-cases.html https://www.enets.org/abstract/myelophthisis-as-an-end-stage-outcome-of-rare-metastases-in-neuroendocrine-tumors-c-a-dual-case-report.html https://www.enets.org/abstract/complete-remission-of-necrolytic-migratory-erythema-related-to-glucagonoma-under-octreotide-therapy.html https://www.enets.org/abstract/ectopic-cushing-s-syndrome-caused-by-a-well-differentiated-acth-secreting-neuroendocrine-tumor-of-the-ileum.html https://www.enets.org/abstract/18f-fmiso-pet-in-metastatic-neuroendocrine-neoplasms-c-a-pilot-study.html https://www.enets.org/abstract/18f-fdg-pet-ct-avid-discordant-volume-as-a-biomarker-in-patients-with-gastroenteropancreatic-neuroendocrine-neoplasms-c-a-multicentre-study.html https://www.enets.org/abstract/endoscopic-ultrasound-guided-radiofrequency-ablation-of-low-grade-insulinomas.html https://www.enets.org/abstract/distinct-clinico-pathological-features-of-neuroendocrine-liver-metastases-originating-from-the-pancreas-and-rectum.html https://www.enets.org/abstract/clinical-and-epidemiological-features-of-intestinal-neuroendocrine-neoplasms-c-a-hospital-based-multicenter-retrospective-study-in-china-and-the-seer-database.html https://www.enets.org/abstract/somatostatin-receptor-imaging-with-difference-positive-rate-of-mice.html https://www.enets.org/abstract/clinical-and-morphogenetic-features-of-renal-neuroendocrine-tumors.html https://www.enets.org/abstract/lutetium-177-dotatate-prrt-versus-prrt-plus-chemotherapy-in-metastatic-well-differentiated-fdg-avid-gep-nets-c-results-from-a-prospective-cohort.html https://www.enets.org/abstract/novel-von-hippel-lindau-related-pancreatic-neuroendocrine-neoplasms-in-vivo-model.html https://www.enets.org/abstract/claudin18-2-expression-in-gastroenteropancreatic-neuroendocrine-neoplasms-c-a-clinico-pathologic-study.html https://www.enets.org/abstract/development-of-a-novel-net-nutrition-screening-tool-to-identify-patients-requiring-nutrition-related-intervention-and-support.html https://www.enets.org/abstract/efficacy-of-177lu-octreotate-in-biliary-duct-neuroendocrine-tumor.html https://www.enets.org/abstract/improvement-of-lung-net-management-through-standardized-care-c-a-swiss-nationwide-observational-study.html https://www.enets.org/abstract/gallium-68-dotanoc-pet-ct-in-locally-advanced-metastatic-who-grade-2-gastroenteropancreatic-neuroendocrine-tumors-c-clinical-and-prognostic-impact-in-assessing-progression-free-survival.html https://www.enets.org/abstract/enucleation-of-pancreatic-neuroendocrine-neoplasms-c-short-and-long-term-results-in-open-surgery-in-a-single-center.html https://www.enets.org/abstract/pancreatic-steatosis-and-its-correlation-with-clinicopathological-feature-in-patients-with-pancreatic-neuroendocrine-neoplasms.html https://www.enets.org/abstract/the-characteristics-of-serum-lipid-spectrum-in-pannens-and-its-correlation-with-clinicopathological-features-and-prognosis.html https://www.enets.org/abstract/radiological-embolization-of-liver-metastases-in-patients-with-pancreatic-neuroendocrine-neoplasms.html https://www.enets.org/abstract/prrt-for-control-of-hypoglycaemia-and-disease-progression-due-to-metastatic-insulinoma.html https://www.enets.org/abstract/pancreatic-neuroendocrine-neoplasms-c-an-ambispective-study-in-a-surgical-center.html https://www.enets.org/abstract/a-prospective-multicenter-single-arm-open-label-phase-3-study-of-lanreotide-autogel-lan-in-chinese-patients-with-unresectable-locally-advanced-or-metastatic-grade-1-or-2-gastroenteropancreatic-neuroendocrine-tumors-gep-nets.html https://www.enets.org/abstract/primary-tumor-resection-improves-survival-of-gastrointestinal-neuroendocrine-carcinoma-patients-with-non-resected-liver-metastases.html https://www.enets.org/abstract/the-role-of-the-somatostatin-analogues-in-large-cell-neuroendocrine-carcinomas-treatment.html https://www.enets.org/abstract/impact-of-primary-tumor-resection-and-metastasectomy-among-gastroenteropancreatic-neuroendocrine-tumors-with-liver-metastases-only-on-survival.html https://www.enets.org/abstract/impact-of-surgical-approach-on-short-and-long-term-outcomes-in-gastroenteropancreatic-neuroendocrine-carcinomas.html https://www.enets.org/abstract/first-results-from-ieo-676-clinical-study-of-prrt-in-neuroendocrine-tumors-c-is-there-still-a-space-for-y-90-dotatocc.html https://www.enets.org/abstract/long-term-health-related-quality-of-life-after-enucleation-of-pancreatic-neuroendocrine-neoplasms-c-a-single-institution-experience.html https://www.enets.org/abstract/neoadjuvant-prrt-with-y-90-dotatoc-c-preliminary-results-from-a-monocentric-prospective-study.html https://www.enets.org/abstract/a-strange-biodistribution-of-68ga-dotatoc-pet-ct-in-a-net-patient-c-do-you-have-some-advicec.html https://www.enets.org/abstract/surgery-for-pancreatic-neuroendocrine-neoplasms-in-patients-with-age-c-75-years.html https://www.enets.org/abstract/morphological-response-on-mesenteric-mass-of-small-intestinal-neuroendocrine-tumors-treated-by-177lu-dotatate-mesenluth-c-a-gte-endocan-study.html https://www.enets.org/abstract/evaluation-of-unreimbursed-costs-in-the-uk-through-utilisation-of-home-administration-of-lanreotide-autogel-lan-for-the-treatment-of-gastroenteropancreatic-neuroendocrine-tumors-gep-nets.html https://www.enets.org/abstract/germline-pathogenic-variants-in-patients-with-high-grade-gastroenteropancreatic-neuroendocrine-neoplasms.html https://www.enets.org/abstract/methylmalonic-acid-activates-inhba-induced-epithelial-mesenchymal-transition-and-promotes-the-cancer-progression-by-tgf-c-signalling-pathway-in-pancreatic-neuroendocrine-neoplasm.html https://www.enets.org/abstract/ct-derived-body-composition-index-analysis-in-metastatic-net-patients-treated-with-mtor-inhibitor.html https://www.enets.org/abstract/finding-the-frequency-of-bronchial-carcinoid-tumors-associated-with-neuroendocrine-syndrome.html https://www.enets.org/abstract/results-of-netest-liquid-biopsy-in-high-grade-gastroenteropancreatic-neuroendocrine-neoplasms1.html https://www.enets.org/abstract/epidemiology-of-neuroendocrine-neoplasms-nen-in-england-2012-2018-c-home-location-incidence-and-survival-including-access-to-neuroendocrine-centres-of-excellence-coe.html https://www.enets.org/abstract/outcomes-of-surgical-treatment-for-small-bowel-neuroendocrine-neoplasms-c-the-first-preliminary-results-of-the-international-study-group-for-small-bowel-neuroendocrine-neoplasm-surgery-registry.html https://www.enets.org/abstract/efficacy-of-somatostatin-analogues-ssa-in-g3-neuroendocrine-neoplasms-c-a-comprehensive-analysis-among-the-swissnet-cohort.html https://www.enets.org/abstract/no-multiple-endocrine-neoplasia-type-1-men1-patient-died-from-pancreaticoduodenal-neuroendocrine-tumor-c-results-from-long-term-follow-up-of-the-uppsala-model-of-early-diagnosis-and-treatment.html https://www.enets.org/abstract/a-novel-and-potent-pb-212-alpha-particle-therapy-for-nets-c-complete-responses-in-mouse-models-to-global-clinical-translation-for-net-patients.html https://www.enets.org/abstract/tackling-drug-activity-and-resistance-mechanisms-in-neuroendocrine-tumors-treated-with-cabozantinib.html https://www.enets.org/abstract/progression-of-pancreatic-neuroendocrine-tumors-pannets-to-metastatic-disease-is-associated-with-mct4-expression-and-metabolic-heterogeneity.html https://www.enets.org/abstract/inflammation-based-index-and-tumor-heterogeneity-on-pretherapeutic-68ga-dotatoc-pet-ct-predict-outcome-in-midgut-neuroendocrine-tumor-patients-treated-with-177lu-oxodotreotide.html https://www.enets.org/abstract/pref-net-a-patient-preference-and-experience-study-of-lanreotide-autogel-lan-administered-in-the-home-versus-hospital-setting-among-patients-with-gastroenteropancreatic-neuroendocrine-tumors-gep-nets-in-the-uk.html https://www.enets.org/abstract/acth-secreting-pancreatic-neuroendocrine-neoplasms-c-a-case-series.html https://www.enets.org/abstract/phase-ii-study-of-pembrolizumab-and-lenvatinib-in-advanced-well-differentiated-neuroendocrine-tumors.html https://www.enets.org/abstract/somatostatin-receptor-expression-in-lung-neuroendocrine-tumors-c-an-analysis-of-dotatate-pet-scans.html https://www.enets.org/abstract/rare-metastases-diagnosed-on-68ga-dotatoc-pet-ct-in-small-intestinal-and-pancreatic-nets.html https://www.enets.org/abstract/urine-5-hiaa-levels-and-quality-of-life-in-neuroendocrine-neoplasia-c-is-there-an-associationc.html https://www.enets.org/abstract/new-insights-on-the-clinical-role-of-ki-67-and-spindle-cell-and-oncocytic-histological-variants-in-lung-carcinoid-tumors.html https://www.enets.org/abstract/treatment-outcomes-in-patients-with-localized-and-advanced-glucagonomas-c-a-case-series.html https://www.enets.org/abstract/longitudinal-changes-in-ki-67-index-in-a-prospective-cohort-of-pancreatic-neuroendocrine-tumors.html https://www.enets.org/abstract/risk-of-complications-after-biopsy-in-pheochromocytoma-and-paraganglioma.html https://www.enets.org/abstract/the-use-of-somatostatin-analogues-in-a-pregnant-patient-with-gastric-net.html https://www.enets.org/abstract/breast-neuroendocrine-carcinoma-c-a-case-report.html https://www.enets.org/abstract/local-tumor-control-in-patients-with-neuroendocrine-neoplasms-treated-with-stereotactic-ablative-radiotherapy-sbrt.html https://www.enets.org/abstract/pancreatic-neuroendocrine-neoplasms-c-epidemiological-description-clinical-and-pathological-aspects.html https://www.enets.org/abstract/the-need-of-centralisation-for-small-intestinal-neuroendocrine-tumor-surgery-c-a-cohort-study-from-the-gte-endocan-renaten-network-the-centralchirsinet-study.html https://www.enets.org/abstract/germline-whole-exome-sequencing-of-patients-with-neuroendocrine-neoplasms-reveals-pathogenic-or-likely-pathogenic-variants-in-a-large-subset-of-patients.html https://www.enets.org/abstract/prediction-of-disease-recurrence-in-patients-after-complete-pannet-g2-resection.html https://www.enets.org/abstract/characteristics-of-pancreatic-neuroendocrine-tumors-pnet-patients-treated-with-peptide-receptor-radionuclide-therapy-prrt-in-two-canadian-centers-c-a-real-world-evidence-study.html https://www.enets.org/abstract/association-of-minen-with-gist-on-neurofibromatosis-c-a-case-report.html https://www.enets.org/abstract/elevated-inflammatory-markers-are-associated-with-poor-survival-after-surgery-for-pancreatic-and-small-intestine-neuroendocrine-tumors.html https://www.enets.org/abstract/the-obesity-paradox-in-patients-with-bronchial-nens-in-a-single-tertiary-referral-center-in-the-united-kingdom.html https://www.enets.org/abstract/grade-2-gastric-carcinoids-type-1-c-not-always-an-indolent-disease.html https://www.enets.org/abstract/loss-of-protein-expression-of-tumor-suppressor-genes-in-neuroendocrine-tumors-c-a-tissue-microarray-analysis-of-201-tumors-from-various-organ-sites.html https://www.enets.org/abstract/the-additive-value-of-f-18-fluorodeoxyglucose-pet-imaging-in-grade-1-gastroenteropancreatic-neuroendocrine-tumors-gep-nets.html https://www.enets.org/abstract/real-world-data-regarding-the-obesity-paradox-in-patients-with-gastroenteropancreatic-gep-nens-in-a-single-centre-in-the-united-kingdom.html https://www.enets.org/abstract/large-cell-neuroendocrine-carcinoma-of-the-breast.html https://www.enets.org/abstract/the-clinical-utility-of-netest-in-patients-with-small-intestinal-neuroendocrine-neoplasms-si-nens-c-a-real-life-study.html https://www.enets.org/abstract/subtype-specific-landscape-of-splicing-associated-neoantigens-and-mutations-in-pancreatic-neuroendocrine-tumors.html https://www.enets.org/abstract/a-novel-hormone-based-anti-sstr-t-cell-engager-for-the-treatment-of-neuroendocrine-tumors.html https://www.enets.org/abstract/long-term-outcomes-of-surgical-valve-replacement-in-patients-with-severe-carcinoid-heart-disease.html https://www.enets.org/abstract/comprehensive-genomic-and-transcriptomic-analysis-of-lung-carcinoid-reveals-molecular-differences-between-typical-carcinoid-and-atypical-carcinoid.html https://www.enets.org/abstract/tuberous-sclerosis-tsc-mutations-in-patients-with-pancreatic-neuroendocrine-neoplasms-are-associated-with-distinct-pathological-radiological-and-treatment-related-findings.html https://www.enets.org/abstract/cabozantinib-in-high-grade-neuroendocrine-neoplasms-c-interim-results-from-a-phase-ii-trial.html https://www.enets.org/abstract/comparable-survival-benefit-of-surgical-approaches-for-small-grade-1-pancreatic-neuroendocrine-tumors-c-a-propensity-score-matching-study.html https://www.enets.org/abstract/therapeutic-response-of-acth-dependent-ectopic-cushing-s-syndrome-to-low-doses-of-osilodrostat.html https://www.enets.org/abstract/heterogeneity-and-potential-therapeutic-targets-of-rectal-neuroendocrine-tumors-by-single-cell-rna-sequencing-combined-with-spatial-omics.html https://www.enets.org/abstract/nutritional-status-of-patients-with-advanced-gastroenteropancreatic-gep-neuroendocrine-neoplasms-nens-in-spain-c-nutrigetne-study.html https://www.enets.org/abstract/metabolic-alterations-in-patients-with-pheochromocytoma-paragangliomas-and-sdhb-mutations.html https://www.enets.org/abstract/predictive-transcriptomic-signature-of-response-to-axitinib-in-patients-with-advanced-nets-included-in-the-randomized-double-blind-placebo-controlled-axinet-trial-getne-1107.html https://www.enets.org/abstract/adrenal-neuroendocrine-tumors-in-oran-c-epidemiology-and-survival.html https://www.enets.org/abstract/molecular-imaging-molecular-profiling-and-outcomes-in-patients-with-transformation-to-grade-3-neuroendocrine-neoplasia-nen.html https://www.enets.org/abstract/epidemiological-profile-and-survival-of-neuroendocrine-tumors-of-the-ampulla-of-vater.html https://www.enets.org/abstract/r-ache-l-score-c-a-nomogram-model-for-predicting-prognosis-of-lung-neuroendocrine-tumors-according-to-primary-tumor-side.html https://www.enets.org/abstract/pancreatic-neuroendocrine-tumors-in-oran-c-epidemiological-histological-and-therapeutic-aspects.html https://www.enets.org/abstract/the-role-of-the-gut-microbiome-in-patients-with-midgut-neuroendocrine-tumors.html https://www.enets.org/abstract/long-term-effects-of-peptide-receptor-radionuclide-therapy-prrt-used-as-first-line-treatment-of-gep-net-c-a-single-centre-experience.html https://www.enets.org/abstract/the-value-of-the-patient-reported-outcomes-common-terminology-criteria-for-adverse-events-pro-ctcae-in-patients-with-neuroendocrine-tumors-net-treated-with-177lutetium-dotatate-177lu.html https://www.enets.org/abstract/biological-behaviour-and-response-to-treatment-of-neuroendocrine-ovarian-metastases.html https://www.enets.org/abstract/177lu-dotatate-in-advanced-neuroendocrine-neoplasms-of-different-locations-c-data-from-552-cases-in-the-septralu-registry.html https://www.enets.org/abstract/evaluation-of-tumor-tissue-mirnas-for-assessing-the-grade-of-pancreatic-neuroendocrine-tumors-from-ffpe-samples.html https://www.enets.org/abstract/prognostic-factors-in-patients-with-advanced-neuroendocrine-neoplasia-treated-with-radiopeptides-prrt-c-data-from-the-national-registry-septralu.html https://www.enets.org/abstract/somatostatin-analogues-ssa-in-gastroenteropancreatic-neuroendocrine-tumors-gep-net-c-impact-on-glycemia-and-lipid-profile-in-a-monocentric-series.html https://www.enets.org/abstract/impact-on-clinical-management-of-a-novel-blood-derived-liquid-biopsy-netest-in-patients-with-neuroendocrine-tumors.html https://www.enets.org/abstract/high-uptake-of-18f-fdg-in-the-primary-tumor-of-pancreatic-neuroendocrine-tumor-is-an-independent-predictor-for-lymph-nodes-metastasis.html https://www.enets.org/abstract/men1-syndrome-c-data-from-a-single-referral-center.html https://www.enets.org/abstract/overview-of-screening-and-surveillance-practices-for-men1-related-pancreatic-neuroendocrine-neoplasms-in-enets-coes-c-an-enets-men1-task-force-questionnaire-study.html https://www.enets.org/abstract/presto-3-c-an-international-simulated-use-study-to-assess-nursesc-preferences-between-two-lanreotide-injection-syringes-somatuline-autogel-vs-pharmathen-for-patients-with-neuroendocrine-tumors-nets-and-or-acromegaly.html https://www.enets.org/abstract/patient-initiated-follow-up-for-surgically-resected-neuroendocrine-tumor-patients-using-a-digital-system-c-my-medical-record.html https://www.enets.org/abstract/comparison-of-postoperative-textbook-outcome-between-pancreatic-neuroendocrine-tumor-and-pancreatic-ductal-adenocarcinoma-c-a-nationwide-retrospective-cohort-study.html https://www.enets.org/abstract/pancreatic-neuroendocrine-tumors-pnets-in-french-vhl-mutation-carriers-c-a-nationwide-retrospective-study-with-genotype-phenotype-correlations.html https://www.enets.org/abstract/trends-in-neuroendocrine-related-searches-on-google-c-how-famous-cases-impact-on-interest-of-general-population.html https://www.enets.org/abstract/validation-of-a-single-time-point-estimates-of-177lu-prrt-absorbed-doses-and-impact-on-patient-management-for-192-therapies.html https://www.enets.org/abstract/decellularised-pancreas-explants-as-a-novel-3d-model-for-pancreatic-neuroendocrine-tumors-pnets-biomarker-discovery.html https://www.enets.org/abstract/impact-of-gender-on-treatment-decisions-and-outcome-in-patients-with-neuroendocrine-neoplasms.html https://www.enets.org/abstract/sex-differences-on-multikinase-inhibitors-toxicity-in-patients-with-advanced-gastroenteropancreatic-neuroendocrine-tumors-c-a-pooled-analysis-of-five-clinical-trials.html https://www.enets.org/abstract/the-effect-of-pseudohypoxia-on-the-immune-microenvironment-of-pancreatic-neuroendocrine-neoplasms-pannen.html https://www.enets.org/abstract/evaluation-of-neutrophile-to-lymphocyte-and-platelet-to-lymphocyte-ratio-in-patients-with-medullary-thyroid-cancer-mtc.html https://www.enets.org/abstract/intra-arterial-prrt-c-a-prospective-clinical-study-in-net-patients-with-hepatic-metastases.html https://www.enets.org/abstract/high-dose-somatostatin-analoguesc-effects-on-glycolipid-metabolism-in-patients-with-neuroendocrine-tumors.html https://www.enets.org/abstract/correlation-between-early-response-and-lesion-dosimetry-in-patients-with-advanced-neuroendocrine-tumor-net-treated-with-radioligand-therapy-rlt.html https://www.enets.org/abstract/local-treatment-of-neuroendocrine-liver-metastases-c-how-effective-and-safe-is-stereotactic-microwave-ablationc.html https://www.enets.org/abstract/molecular-biological-mechanisms-of-qizhen-yiliu-decoction-qzyl-for-treatment-of-pancreatic-neuroendocrine-tumors-pnets-based-on-liquid-chromatography-mass-spectrometry-lc-ms-integrated-network-pharmacology.html https://www.enets.org/abstract/comprehensive-multidisciplinary-management-of-multiple-endocrine-neoplasia-type-1-men1-with-high-tumor-heterogeneity-c-a-case-report.html https://www.enets.org/abstract/wide-molecular-analysis-of-pannet-revealed-that-only-mgmt-promoter-methylation-seemed-to-correlate-with-temozolomide-response.html https://www.enets.org/abstract/transcriptomic-analyses-of-multifocal-ileal-neuroendocrine-tumors.html https://www.enets.org/abstract/epidemiologic-study-of-neuroendocrine-differentiation-in-different-carcinomas.html https://www.enets.org/abstract/key-device-attributes-for-somatostatin-receptor-ligand-srl-therapy-in-patients-with-neuroendocrine-tumors-nets.html https://www.enets.org/abstract/comparison-of-18f-alf-nota-jr11-with-68ga-dota-jr11-pet-mri-in-models-mice-and-neuroendocrine-tumor-patients.html https://www.enets.org/abstract/metastatic-pattern-and-its-prognostic-value-in-well-differentiated-neuroendocrine-tumors.html https://www.enets.org/abstract/a-patient-with-braf-v600e-mutated-colon-nec-showing-response-to-braf-and-mek-inhibitors.html https://www.enets.org/abstract/multi-omic-factor-analysis-mofa-of-well-differentiated-neuroendocrine-tumors-nets-from-different-tumor-sites.html https://www.enets.org/abstract/validation-of-nep-d-score-as-a-prognostic-index-in-bronchial-carcinoid-tumors.html https://www.enets.org/abstract/first-report-of-the-phase-i-luparp-trial-assessing-177lu-dotatate-in-combination-with-the-parp-inhibitor-olaparib-in-patients-with-somatostatin-positive-tumors.html https://www.enets.org/abstract/intra-individual-comparison-of-68ga-dotatate-pet-ct-and-pet-mr.html https://www.enets.org/abstract/real-world-observational-study-of-somatostatin-analogues-and-rescue-medication-use-for-neuroendocrine-tumors-in-canada.html https://www.enets.org/abstract/met-exon-14-skipping-mutation-c-a-new-potential-therapeutical-target-for-lung-carcinoidsc-results-from-a-next-generation-sequencing-ngs-study.html https://www.enets.org/abstract/mid-treatment-response-to-177lu-dotatate-c-a-possible-estimate-for-final-outcome-in-patients-with-neuroendocrine-neoplasms.html https://www.enets.org/abstract/somatostatin-analogues-or-active-surveillance-in-sporadic-non-functioning-pancreatic-neuroendocrine-tumors.html https://www.enets.org/abstract/dosimetry-evaluation-in-177lu-labeled-somatostatin-receptor-analogue-therapy.html https://www.enets.org/abstract/metabolites-in-the-tryptophan-pathway-as-a-diagnostic-tool-in-neuroendocrine-tumor-patients.html https://www.enets.org/abstract/risk-of-venous-thromboembolism-in-pancreatic-neuroendocrine-neoplasms.html https://www.enets.org/abstract/68ga-dota-peptides-pet-ct-radiomics-in-differentiation-between-pancreatic-net-from-physiologic-uncinate-process-uptake.html https://www.enets.org/abstract/added-value-of-post-177lu-dotatate-and-ga-pet-ct-imaging-in-prediction-and-evaluation-of-treatment-response-for-gep-nets.html https://www.enets.org/abstract/a-rare-clinical-case-of-giant-pituitary-acth-adenoma.html https://www.enets.org/abstract/ga-68-dota-toc-pet-ct-uptake-by-the-parathyroid-glands-in-patients-with-multiple-endocrine-neoplasia-type-1-men1.html https://www.enets.org/abstract/prognostic-value-of-the-neutrophil-lymphocyte-ratio-nlr-in-advanced-non-resectable-progressive-pancreatic-and-midgut-net-after-combine-therapy-using-lu-177-dotatoc-and-captem.html https://www.enets.org/abstract/prevalence-of-clonal-hematopoiesis-ch-in-neuroendocrine-tumor-net-patients-prior-to-lutetium-177-dotatate-therapy-lu177-and-the-risk-of-cytopenia-c-a-prospective-study-of-37-patients.html https://www.enets.org/abstract/role-of-endoscopic-resection-margin-r1-in-the-clinical-outcome-of-patients-with-neuroendocrine-neoplasia.html https://www.enets.org/abstract/mutational-profiling-of-pnets-and-pnecs-indicates-implication-of-chromatin-epigenetic-modification3.html https://www.enets.org/abstract/evaluation-of-pfs-and-os-in-patients-with-sporadic-advanced-unresectable-well-differentiated-pancreatic-neuroendocrine-tumors-net-treated-initially-with-lanreotide-ag-and-methods-of-further-treatment-approaches-after-progression-real-world-data.html https://www.enets.org/abstract/the-prognostic-role-of-radiomics-in-gastroenteropancreatic-neuroendocrine-tumors.html https://www.enets.org/abstract/druggable-growth-dependencies-and-tumor-evolution-analysis-in-patient-derived-organoids-of-neuroendocrine-cancer.html https://www.enets.org/abstract/subgroup-analysis-of-orr-and-pfs-of-the-seqtor-study-getne-1206-c-everolimus-followed-by-streptozotocin-stz-5fu-upon-progression-or-the-reverse-sequence-in-advanced-progressive-pannets.html https://www.enets.org/abstract/the-impact-of-the-covid-19-pandemic-on-neuroendocrine-tumor-net-service-recovery-and-patient-perceptions-in-sheffield-net-centre-uk-c-a-quantitative-and-qualitative-analysis-2017-2021.html https://www.enets.org/abstract/sneak-peek-into-neuroendocrine-tumors-preliminary-study-c-reconsideration-of-histopathological-approach-and-classification.html https://www.enets.org/abstract/diagnostic-work-up-and-surgical-management-of-insulinoma-c-a-retrospective-analysis-from-a-tertiary-referral-center.html https://www.enets.org/abstract/long-response-to-177-lu-dotatate-of-a-long-malignant-metastatic-pheochromocytoma-survivor.html https://www.enets.org/abstract/vipoma-presenting-as-chronic-diarrhea-in-a-30-year-old-filipino-female.html https://www.enets.org/abstract/post-partum-insulinoma-in-a-men1-patient-submitted-to-pancreatic-electroporation.html https://www.enets.org/abstract/the-lungnenomics-project-c-a-comprehensive-multidisciplinary-characterisation-of-pulmonary-carcinoids.html https://www.enets.org/abstract/poorly-differentiated-neuroendocrine-carcinomas-c-characteristics-treatments-and-outcomes-from-a-population-based-cohort-discussed-in-our-enets-coe-institute.html https://www.enets.org/abstract/rna-m6a-methylation-regulators-in-lung-neuroendocrine-neoplasms.html https://www.enets.org/abstract/litespark-015-cohort-b1-c-a-phase-2-open-label-study-of-belzutifan-a-hif-2c-inhibitor-monotherapy-in-patients-with-von-hippel-lindau-vhl-diseasecassociated-tumors.html https://www.enets.org/abstract/is-patient-s-bmi-representative-of-their-body-composition-in-neuroendocrine-tumorsc.html https://www.enets.org/abstract/177lu-oxodotreotide-in-the-treatment-of-gastroenteropancreatic-neuroendocrine-tumors-c-patient-profile-in-the-real-lu-study-prospective-observational-study-to-assess-the-effectiveness-and-outcomes-associated-with-lutathera.html https://www.enets.org/abstract/68ga-dotatoc-pet-radiomics-as-a-novel-preoperative-predictive-tool-for-pannets-aggressiveness.html https://www.enets.org/abstract/novel-insights-to-study-the-potential-of-the-somatostatin-system-in-nets-and-necs.html https://www.enets.org/abstract/determining-the-resistance-to-somatostatin-analogues-in-pheochromocytomas-and-paragangliomas.html https://www.enets.org/abstract/protein-validation-of-multi-omic-classified-pulmonary-carcinoid-c-identification-of-unique-clinical-subtypes-and-potential-therapeutic-vulnerability.html https://www.enets.org/abstract/contrast-enhanced-and-tissue-harmonic-endoscopic-ultrasound-for-pancreatic-neuroendocrine-tumor-diagnostic.html https://www.enets.org/abstract/duodenal-gastric-metaplasia-and-duodenal-neuroendocrine-neoplasms-c-more-than-a-simple-coincidencec.html https://www.enets.org/abstract/the-use-of-quantitative-contrast-enhanced-endoscopic-ultrasound-in-the-evaluation-of-pancreatic-neuroendocrine-tumors-c-can-we-move-from-quality-to-quantityc-a-proof-of-concept-study.html https://www.enets.org/abstract/otp-cd44-and-ki-67-c-a-prognostic-marker-panel-for-relapse-free-survival-in-patients-with-surgically-resected-pulmonary-carcinoid.html https://www.enets.org/abstract/molecular-landscape-of-splicing-dysregulation-in-pheochromocytomas-and-paragangliomas.html https://www.enets.org/abstract/ngs-data-collection-in-high-grade-hg-pancreatic-nens-at-university-hospital-of-verona.html https://www.enets.org/abstract/incidence-and-prevalence-of-gastric-neuroendocrine-tumors-in-patients-with-chronic-atrophic-autoimmune-gastritis.html https://www.enets.org/abstract/dll3-determination-and-immune-milieu-characterization-in-neuroendocrine-neoplasms-nens.html https://www.enets.org/abstract/survival-and-prognostic-factors-in-appendiceal-neuroendocrine-tumors-anet-and-goblet-cell-carcinoma-agcc.html https://www.enets.org/abstract/efficacy-and-safety-of-capecitabine-and-temozolomide-captem-in-advanced-gastroenteropancreatic-neuroendocrine-neoplasms-gep-nen-c-a-systematic-review-and-metanalysis.html https://www.enets.org/abstract/prospective-observational-study-on-third-line-treatments-in-neuroendocrine-carcinoma-c-data-from-the-phase-ii-seneca-trial.html https://www.enets.org/abstract/treatment-efficacy-in-212-metastatic-small-intestinal-neuroendocrine-tumor-grade-2-patients.html https://www.enets.org/abstract/radiological-follow-up-fu-in-resected-pulmonary-typical-carcinoids-ptc-c-do-the-benefits-outweigh-the-risksc.html https://www.enets.org/abstract/real-life-efficacy-and-toxicity-of-lutetium-peptide-receptor-radionuclide-therapy-in-patients-with-progressive-metastatic-neuroendocrine-tumors-who-failed-at-least-one-line-of-systemic-treatment.html https://www.enets.org/abstract/sunitinib-for-the-treatment-of-advanced-pheochromocytomas-paragangliomas-c-a-phase-2-clinical-trial.html https://www.enets.org/abstract/small-bowel-neuroendocrine-tumor-with-carcinoid-heart-disease.html https://www.enets.org/abstract/a-phase-2-randomized-parallel-group-study-to-evaluate-the-safety-pharmacokinetics-and-dose-response-of-paltusotine-treatment-in-patients-with-carcinoid-syndrome.html https://www.enets.org/abstract/mixed-neuroendocrine-non-neuroendocrine-neoplasms-minen-characterization-of-the-genomic-and-pathological-profile1.html https://www.enets.org/abstract/prognostic-significance-of-nodal-micro-metastases-in-patients-with-non-functioning-pancreatic-neuroendocrine-tumors-nf-pannets.html https://www.enets.org/abstract/ileum-net-lost-to-follow-up-due-to-covid-19-pandemic-presents-with-multiple-metastases-and-severe-carcinoid-syndrome.html https://www.enets.org/abstract/investigation-on-dose-toxicity-and-dose-response-relationship-in-neuroendocrine-liver-metastases-treated-with-holmium-166-radioembolization.html https://www.enets.org/abstract/comprehensive-characterization-of-the-net-methylome.html https://www.enets.org/abstract/short-fasting-test-as-a-reliable-and-effective-tool-to-diagnose-insulinoma.html https://www.enets.org/abstract/accuracy-of-intra-operative-beta-probe-in-gep-net-patients-c-preliminary-data-from-a-prospective-study.html https://www.enets.org/abstract/molecular-characterization-of-extrapulmonary-advanced-neuroendocrine-carcinomas-and-mixed-adeno-neuroendocrine-carcinomas-c-the-nirvana-study.html https://www.enets.org/abstract/neoadjuvant-peptide-receptor-radionuclide-therapy-prrt-with-90-yttrium-versus-177-lutetium-c-comparison-of-clinico-pathological-and-survival-outcomes.html https://www.enets.org/abstract/adjuvant-therapy-for-pancreatic-neuroendocrine-tumors-c-expert-consensus-and-recommendations-for-future-research.html https://www.enets.org/abstract/immune-landscape-in-mixed-neuroendocrine-non-neuroendocrine-neoplasms-minen.html https://www.enets.org/abstract/primary-tumor-resection-followed-by-prrt-in-the-treatment-of-patients-with-metastatic-neuroendocrine-ileal-cancer-c-preliminary-data-from-a-retrospective-single-center-study.html https://www.enets.org/abstract/adaptive-immunosuppressive-resistance-mechanisms-towards-antiangiogenic-immunotherapies-revealed-in-a-pancreatic-neuroendocrine-tumor-pnet-model.html https://www.enets.org/abstract/large-cell-neuroendocrine-carcinoma-subtyping-based-on-neurod1-ascl1-pou2f3-and-yap1-expression.html https://www.enets.org/abstract/characteristics-and-management-of-high-grade-gastroenteropancreatic-neuroendocrine-neoplasms-c-a-belgian-retrospective-analysis-from-the-dnet-netwerk-registry.html https://www.enets.org/abstract/outcome-of-typical-and-atypical-carcinoids-after-surgical-resection-c-a-single-center-retrospective-study.html https://www.enets.org/abstract/patterns-of-recurrence-in-patients-with-resected-pulmonary-carcinoid-c-a-dutch-nationwide-study.html https://www.enets.org/abstract/intracardiac-metastasis-in-well-differentiated-ileal-neuroendocrine-tumor.html https://www.enets.org/abstract/exceptional-response-to-everolimus-in-a-pancreatic-net-g3-pnet-c-how-ngs-can-help-in-treatment-choice.html https://www.enets.org/abstract/precision-medicine-in-pancreatic-minen-and-other-rare-pancreatic-histologies-c-a-case-series-from-verona-university-hospital.html https://www.enets.org/abstract/pancreatic-neuroendocrine-tumor-associated-hypophosphatemia-due-to-tumor-induced-osteomalacia-c-a-case-report.html https://www.enets.org/abstract/ngs-in-g1-g2-pancreatic-nets-c-data-collection-at-university-hospital-of-verona.html https://www.enets.org/abstract/diagnostic-utility-of-menin-immunohistochemistry-in-men1-syndrome-patients.html https://www.enets.org/abstract/integrative-molecular-analysis-of-lung-neuroendocrine-neoplasms-with-different-ki-67-indices-identifies-a-molecular-transition-group-between-low-and-high-grade-neoplasms.html https://www.enets.org/abstract/development-and-validation-of-ct-based-radiomics-deep-learning-signatures-to-preoperatively-predict-lymph-node-metastasis-in-non-functional-pancreatic-neuroendocrine-tumor-a-multi-cohort-study.html https://www.enets.org/abstract/development-of-a-mobile-app-for-patients-with-neuroendocrine-neoplasms-a-collaborative-project-between-united-kingdom-net-society-and-neuroendocrine-tumour-patient-foundation.html https://www.enets.org/abstract/clinicopathological-characteristics-and-survival-of-head-and-neck-neuroendocrine-carcinoma.html https://www.enets.org/abstract/mediastinal-neuroendocrine-tumor-with-heart-metastasis-response-to-immunotherapy.html https://www.enets.org/abstract/real-world-data-of-captem-in-metastatic-neuroendocrine-tumors.html https://www.enets.org/abstract/temozolomide-as-second-and-subsequent-lines-of-treatment-in-metastatic-adrenocortical-cancer-prospective-phase-ii-clinical-trial.html https://www.enets.org/abstract/efficiency-of-gemcap-mitotane-in-platinum-and-mitotane-resistant-adrenocortical-carcinoma.html https://www.enets.org/abstract/complete-and-sustained-response-after-peptide-receptor-radionuclide-therapy-in-a-66-year-old-filipino-male-with-metastatic-pancreatic-neuroendocrine-tumor-a-case-report-primary.html https://www.enets.org/abstract/mixed-neuroendocrine-non-neuroendocrine-neoplasms-of-the-rectum-a-case-report.html https://www.enets.org/abstract/national-registry-of-pheochromocytomas-and-paragangliomas-in-the-colombian-territory-epidemiological-insights-and-clinical-profiles.html https://www.enets.org/abstract/telomerase-independence-function-of-dyskerin-is-therapeutic-vulnerability-in-tp53-mutant-pancreatic-neuroendocrine-tumors1.html https://www.enets.org/abstract/epidemiology-and-outcomes-of-net-in-a-portuguese-cancer-center.html https://www.enets.org/abstract/prognostic-role-and-predictors-of-lymph-node-involvement-in-pancreatic-neuroendocrine-tumors.html https://www.enets.org/abstract/men1-deficiency-induced-the-activation-of-c-catenin-mgmt-axis-promotes-pancreatic-neuroendocrine-tumor-growth-and-disrupts-the-response-to-temozolomide.html https://www.enets.org/abstract/gender-role-in-the-authorship-of-italian-academic-medical-literature-on-neuroendocrine-neoplasms-cliche-or-realityc1.html https://www.enets.org/abstract/construction-and-comparison-of-non-functional-pancreatic-neuroendocrine-tumor-models.html https://www.enets.org/abstract/artisan-prospective-phase-ii-trial-of-therasphere-selective-internal-radiation-therapy-sirt-for-liver-metastases-in-neuroendocrine-tumors-nets.html https://www.enets.org/abstract/surufatinib-plus-sintilimab-and-ibi310-in-patients-with-high-grade-advanced-neuroendocrine-neoplasm-hg-nen-a-multicenter-single-arm-phase-2-study.html https://www.enets.org/abstract/the-stromal-microenvironment-endows-pancreatic-neuroendocrine-tumors-with-spatially-specific-invasive-and-metastatic-phenotypes.html https://www.enets.org/abstract/single-cell-sequencing-reveals-the-heterogeneity-of-pancreatic-neuroendocrine-tumors-under-the-pattern-of-genomic-instability-and-histological-grading.html https://www.enets.org/abstract/dissecting-the-intra-and-inter-tumor-heterogeneity-of-adrenocortical-carcinoma-by-single-cell-multi-omics-analyses.html https://www.enets.org/abstract/gender-differences-in-lung-neuroendocrine-tumors-a-single-center-experience.html https://www.enets.org/abstract/brachytherapy-in-craniopharyngiomas-a-systematic-review-and-meta-analysis-of-long-term-follow-up.html https://www.enets.org/abstract/machine-learning-based-identification-of-disulfidptosis-associated-signature-for-improving-outcomes-and-immunotherapy-responses-in-patients-with-adrenocortical-carcinoma.html https://www.enets.org/abstract/heterogenous-uptake-of-68ga-dotatate-and-18f-fdg-in-patients-with-initially-diagnosed-neuroendocrine-tumors-which-patients-are-suitable-for-dual-tracer-pet-imagingc.html https://www.enets.org/abstract/association-of-body-composition-with-survival-in-patients-with-pancreatic-neuroendocrine-tumors-pnet-following-curative-resection.html https://www.enets.org/abstract/a-nomogram-to-preoperatively-predict-the-aggressiveness-of-non-functional-pancreatic-neuroendocrine-tumors-based-on-ct-features.html https://www.enets.org/abstract/a-case-of-conversion-therapy-for-pancreatic-neuroendocrine-tumor-with-liver-metastasis-using-surufatinib-combined-with-captem.html https://www.enets.org/abstract/compare-the-optimal-tnm-staging-of-resectable-functional-and-non-functional-pancreatic-neuroendocrine-tumors.html https://www.enets.org/abstract/8-year-follow-up-reveals-therapeutic-approaches-for-patients-with-neuroendocrine-neoplasms-c-findings-from-the-tne-west-network-2016-2023.html https://www.enets.org/abstract/the-value-of-68ga-dotanoc-and-18f-fdg-pet-ct-for-predicting-the-prognosis-of-patients-with-metastatic-rectal-neuroendocrine-tumor.html https://www.enets.org/abstract/heterogeneity-of-multiple-pancreatic-neuroendocrine-tumors-identified-by-68ga-dotanoc-and-68ga-exendin-4-pet-ct-in-a-patient-with-endogenous-hyperinsulinemic-hypoglycaemia-and-multiple-endocrine-neoplasia-1.html https://www.enets.org/abstract/molecular-typing-and-mutational-characterisation-of-rectal-neuroendocrine-neoplasms.html https://www.enets.org/abstract/real-world-study-of-surufatinib-combined-with-hepatic-artery-infusion-chemotherapy-haic-for-high-grade-neuroendocrine-neoplasm.html https://www.enets.org/abstract/liver-debulking-surgery-affect-the-treatment-efficacy-of-ssas.html https://www.enets.org/abstract/testicular-neuroendocrine-tumors-c-a-retrospective-study-five-cases.html https://www.enets.org/abstract/peptide-receptor-radionuclide-therapy-prrt-in-the-management-of-patients-with-ectopic-cushingcs-syndrome-due-to-metastatic-gastroenteropancreatic-neuroendocrine-neoplasia-gepnen-a-single-centre-experience.html https://www.enets.org/abstract/olaparib-use-in-a-patient-diagnosed-with-brca2-mutated-adrenocortical-carcinoma-a-case-report.html https://www.enets.org/abstract/comparison-of-transarterial-embolisation-tae-or-chemoembolisation-tace-using-streptozotocin-stz-and-biomarker-study-in-patients-with-metastatic-neuroendocrine-tumors-net.html https://www.enets.org/abstract/development-of-clinically-representative-patient-derived-organoid-models-for-diverse-g1-g2-gastroenteropancreatic-neuroendocrine-tumors.html https://www.enets.org/abstract/comparative-efficacy-of-surufatinib-plus-transarterial-embolization-versus-surufatinib-monotherapy-in-neuroendocrine-tumor-with-liver-metastasis-a-prospective-randomised-controlled-trial.html https://www.enets.org/abstract/treatment-strategy-for-pancreatic-nets-smaller-than-2-cm-should-be-based-on-the-diagnosis-of-malignancy-as-well-c-new-treatment-strategy-for-small-pancreatic-nets.html https://www.enets.org/abstract/sortilin-a-novel-marker-and-potential-therapeutic-target-for-functional-neuroendocrine-tumors.html https://www.enets.org/abstract/a-combined-nomogram-to-predict-liver-metastasis-of-pancreatic-neuroendocrine-tumors-integrating-deep-learning-radiomics-and-computational-pathology.html https://www.enets.org/abstract/enhancer-heterogeneity-of-lung-carcinoids-reveals-sensitivity-to-fgf-signaling-inhibition.html https://www.enets.org/abstract/familial-midgut-neuroendocrine-tumors-fm-nets-results-of-the-nationwide-tcf-cohort-from-the-gte-renaten-network.html https://www.enets.org/abstract/infrastructure-for-rare-cancer-in-the-netherlands-towards-a-comprehensive-platform-for-early-detection-and-diagnosis-of-rare-cancers-force-and-especially-neuroendocrine-neoplasms-nen.html https://www.enets.org/abstract/genomic-profiling-in-the-randomised-controlled-phase-iii-compose-trial-of-lu-177-edotreotide-for-well-differentiated-aggressive-grade-2-3-gastroenteropancreatic-neuroendocrine-tumors.html https://www.enets.org/abstract/nordic-nec-2-characteristics-and-treatment-outcome-in-a-prospective-cohort-of-698-patients-with-high-grade-digestive-neuroendocrine-neoplasms-net-g3-and-nec.html https://www.enets.org/abstract/ptk2-protac-unveiled-as-a-selective-inhibitor-of-gastrointestinal-neuroendocrine-cell-proliferation-via-multi-target-drug-screening.html https://www.enets.org/abstract/10-years-experience-of-managing-small-intestinal-neuroendocrine-tumors-at-an-enets-centre-of-excellence.html https://www.enets.org/abstract/a-systematic-review-of-hepatic-transplantation-for-neuroendocrine-liver-metastases-c-focus-on-long-term-outcomes.html https://www.enets.org/abstract/a-case-report-of-a-high-grade-pancreatic-net-patient-with-high-tumor-mutation-burden-who-benefited-from-chemotherapy-combined-with-immunotherapy.html https://www.enets.org/abstract/unveiling-racial-disparities-in-hepatic-neuroendocrine-tumors-a-comprehensive-analysis.html https://www.enets.org/abstract/clinical-manifestation-and-aggressiveness-of-duodenopancreatic-neuroendocrine-tumors-dp-net-in-patients-with-men1-syndrome-a-possible-role-of-exon-2-mutations-in-menin-gene.html https://www.enets.org/abstract/machine-learning-identified-optimised-classification-models-for-the-diagnosis-of-typical-and-atypical-lung-carcinoids-based-on-the-genomic-variance.html https://www.enets.org/abstract/clinical-value-of-endoscopic-submucosal-dissection-combined-with-chemotherapy-for-treatment-of-esophageal-neuroendocrine-carcinoma.html https://www.enets.org/abstract/small-extracellular-vesicles-mir-183-5p-derived-from-highly-invasive-pancreatic-neuroendocrine-tumors-reprogram-macrophages-towards-spp1-macrophages.html https://www.enets.org/abstract/patterns-of-radiotracer-uptake-in-patients-with-resectable-lung-carcinoids-undergoing-preoperative-functional-imaging.html https://www.enets.org/abstract/radiologic-tumor-border-status-can-further-stratify-patients-with-pancreatic-neuroendocrine-tumor.html https://www.enets.org/abstract/serum-b-hcg-as-a-biomarker-in-neuroendocrine-tumors-a-reconsideration-of-single-analyte-approach.html https://www.enets.org/abstract/sdhx-germline-mutation-in-thymic-neuroendocrine-tumors.html https://www.enets.org/abstract/new-insights-into-the-progression-of-net-g3-with-a-focus-of-nets-with-nec-like-transformation.html https://www.enets.org/abstract/interest-of-serum-and-urinary-5hiaa-serotonin-chromogranin-a-and-nt-probnp-assays-as-predictive-factors-for-the-development-of-carcinoid-heart-disease-in-neuroendocrine-tumors.html https://www.enets.org/abstract/identifying-patients-with-undiagnosed-small-intestinal-neuroendocrine-tumors-using-statistical-and-machine-learning-model-development-and-validation-study.html https://www.enets.org/abstract/safety-and-efficacy-of-peptide-radionuclide-therapy-prrt-with-177lu-dotatate-for-japanese-patients-with-neuroendocrine-neoplasm-nen-a-single-center-retrospective-study.html https://www.enets.org/abstract/identification-of-new-biomarkers-associated-with-prognosis-of-pancreatic-neuroendocrine-neoplasms-and-establishment-of-survival-prediction-model.html https://www.enets.org/abstract/the-contribution-of-functional-imaging-in-predicting-the-risk-of-recurrence-after-pancreatic-surgery-for-neuroendocrine-tumors.html https://www.enets.org/abstract/comparison-of-the-diagnostic-value-of-68ga-dotanoc-18f-fdopa-and18f-fdg-pet-ct-for-metastatic-paraganglioma.html https://www.enets.org/abstract/the-application-of-68ga-dotanoc-pet-ct-after-endoscopic-submucosal-dissection-for-patients-with-rectal-net.html https://www.enets.org/abstract/m6a-modifications-promote-the-invasion-and-metastasis-of-pancreatic-neuroendocrine-neoplasms-by-activating-the-integrin-fak-signalling-pathway-via-tgfbi.html https://www.enets.org/abstract/management-and-surveillance-for-rectal-neuroendocrine-tumors-a-single-centre-retrospective-analysis-and-comparison-with-enets-guidelines.html https://www.enets.org/abstract/hypoxia-upregulating-acss2-enhances-lipid-metabolism-reprogramming-through-hmgcs1-mediated-pi3k-akt-mtor-pathway-to-promote-the-progression-of-pancreatic-neuroendocrine-neoplasms.html https://www.enets.org/abstract/digestive-neuroendocine-tumors-dignosis-and-therapeutic-particularities-experience-of-medical-oncology-center-of-annaba-algeria.html https://www.enets.org/abstract/recurrence-free-survival-and-disease-specific-survival-in-patients-with-pancreatic-neuroendocrine-neoplasms-a-single-center-retrospective-study-of-413-patients.html https://www.enets.org/abstract/correlation-between-clinicopathologic-features-and-prognosis-of-196-cases-of-pancreatic-neuroendocrine-tumors.html https://www.enets.org/abstract/outlook-for-615-small-intestinal-neuroendocrine-tumor-patients-recurrence-risk-after-surgery-and-disease-specific-survival-in-advanced-disease.html https://www.enets.org/abstract/pelvic-metastases-in-patients-with-neuroendocrine-tumors-a-rare-site-of-metastases.html https://www.enets.org/abstract/clinical-characteristics-and-prognostic-factors-analysis-of-75-patients-with-neuroendocrine-neoplasms-nens-in-xinjiang-region.html https://www.enets.org/abstract/foxa2-initiated-transcriptional-activation-of-inhba-induced-by-methylmalonic-acid-promotes-pancreatic-neuroendocrine-neoplasm-progression.html https://www.enets.org/abstract/selective-internal-radiation-therapy-for-neuroendocrine-liver-metastases-efficacy-safety-and-prognostic-factors-c-a-retrospective-single-institution-study.html https://www.enets.org/abstract/exploring-the-biological-and-clinical-heterogeneity-of-grade-2-pancreatic-neuroendocrine-tumors-insights-into-diagnosis-prognosis-and-therapeutic-targets.html https://www.enets.org/abstract/prediction-of-survival-for-patients-with-neuroendocrine-neoplasms-nens-using-multivariable-cox-regression-and-survival-nomograms-data-from-national-cancer-registration-and-analysis-service-ncras-uk-database.html https://www.enets.org/abstract/sex-differences-in-survival-of-neuroendocrine-neoplasms-nens-comparative-study-of-patients-from-national-cancer-registration-and-analysis-service-ncras-uk-and-surveillance-epidemiology-and-end-results-seer-us-databases.html https://www.enets.org/abstract/efficacy-and-safety-of-surufatinib-in-combination-with-captem-for-patients-with-advanced-g2-g3-nets-preliminary-results-from-a-single-arm-phase-ii-study.html https://www.enets.org/abstract/neuroendocrine-differentiation-in-gastric-cancer-epidemiological-insights-and-therapeutic-implications.html https://www.enets.org/abstract/prevalence-of-depressive-and-anxiety-symptoms-and-disorders-in-neuroendocrine-neoplasms-a-systematic-review-and-meta-analysis.html https://www.enets.org/abstract/camrelizumab-plus-chemotherapy-as-first-line-treatment-for-advanced-extrapulmonary-neuroendocrine-carcinoma-an-investigator-initiated-phase-2-study-camec-trial.html https://www.enets.org/abstract/efficacy-safety-and-prognostic-factors-of-capecitabine-plus-temozolomide-regimen-in-patients-with-thymic-neuroendocrine-neoplasms.html https://www.enets.org/abstract/inactivation-of-phlda3-gene-leading-to-tumorigenesis-of-pancreatic-neuroendocrine-tumors-and-its-molecular-mechanisms.html https://www.enets.org/abstract/mapping-of-lymph-node-metastasis-in-non-functional-pancreatic-neuroendocrine-tumors-a-retrospective-analysis-of-455-patients.html https://www.enets.org/abstract/hepatic-metastatic-model-establishment-of-pancreatic-neuroendocrine-tumor-by-hemi-splenectomy.html https://www.enets.org/abstract/differences-in-the-microrna-expression-of-g1-and-g2-pancreatic-neuroendocrine-tumors1.html https://www.enets.org/abstract/14-years-of-the-czech-neuroendocrine-tumors-registry.html https://www.enets.org/abstract/a-phase-3-randomised-study-of-177lu-edotreotide-or-everolimus-in-patients-with-advanced-neuroendocrine-tumors-of-lung-or-thymic-origin-level-getne-t2217.html https://www.enets.org/abstract/network-pharmacology-reveal-the-mechanism-of-cordycepin-and-neuroendocrine-tumors.html https://www.enets.org/abstract/responses-to-cabozantinib-plus-atezolizumab-in-a-wide-population-of-advanced-and-progressive-neuroendocrine-neoplasms-nens-a-prospective-multi-cohort-basket-phase-ii-trial-cabaten-getne-t1914.html https://www.enets.org/abstract/factors-influencing-emergency-admissions-in-patients-with-neuroendocrine-neoplasms-nen-in-england-2016-2017.html https://www.enets.org/abstract/serum-5-hydroxyindoleacetic-acid-is-equivalent-to-24-hour-urinary-5-hydroxyindoleacetic-acid-for-the-diagnosis-of-carcinoid-syndrome.html https://www.enets.org/abstract/exploring-the-expression-of-dll3-in-gastroenteropancreatic-neuroendocrine-carcinomas-and-its-potential-diagnostic-value.html https://www.enets.org/abstract/updated-data-from-a-phase-i-trial-of-the-dll3-cd3-igg-like-t-cell-engager-bi-764532-in-patients-pts-with-dll3-positive-tumors-focus-on-extrapulmonary-neuroendocrine-carcinomas-epnecs.html https://www.enets.org/abstract/ovarian-neuroendocrine-tumor-metastases-can-induce-estrogen-production-in-postmenopausal-patients.html https://www.enets.org/abstract/what-is-the-carcinoid-syndromec-a-critical-appraisal-of-its-proposed-mediators.html https://www.enets.org/abstract/immediate-and-sustained-response-of-hypoglycaemia-to-streptozotocin-based-chemotherapy-in-metastatic-insulinoma-a-case-report.html https://www.enets.org/abstract/empowering-patients-with-neuroendocrine-tumors-through-a-mobile-app-netcare.html https://www.enets.org/abstract/management-of-unresectable-insulinoma-using-cloud-based-continuous-glucose-monitoring-a-case-report.html https://www.enets.org/abstract/neuroendocrine-tumors-in-the-stomach-an-epidemiological-analysis-of-belgian-cancer-registry-data.html https://www.enets.org/abstract/prognostic-impact-of-molecular-signatures-in-pancreatic-metastatic-neuroendocrine-tumors-prodeten.html https://www.enets.org/abstract/clinical-application-of-digital-pathology-proposal-of-a-new-g0-category-useful-in-small-intestinal-net-si-net.html https://www.enets.org/abstract/an-italian-multicenter-phase-ii-trial-of-metronomic-temozolomide-in-unfit-patients-with-advanced-neuroendocrine-neoplasms-mete-study.html https://www.enets.org/abstract/neuroendocrine-tumors-in-pediatrics-and-young-adults.html https://www.enets.org/abstract/68-gallium-dotanoc-pet-ct-pitfall-in-adnexal-tumor.html https://www.enets.org/abstract/routine-early-68ga-dotatate-pet-ct-has-low-diagnostic-yield-after-resection-of-pancreatic-neuroendocrine-neoplasms.html https://www.enets.org/abstract/clinical-and-pathological-characteristics-of-77-cases-of-extra-adrenal-paraganglioma.html https://www.enets.org/abstract/the-safety-and-efficacy-of-surufatinib-for-the-treatment-of-advanced-neuroendocrine-tumors-a-prospective-multicenter-real-world-study.html https://www.enets.org/abstract/metformin-inhibits-small-intestinal-neuroendocrine-tumor-proliferation-in-vivo.html https://www.enets.org/abstract/identification-of-gastroenteropancreatic-neuroendocrine-tumor-with-high-liver-tumor-burden-based-on-clinicopathological-features1.html https://www.enets.org/abstract/long-term-natural-history-of-enterochromaffin-like-cell-ecl-hyperplasia.html https://www.enets.org/abstract/surgery-of-small-bowel-neuroendocrine-tumors-10-yearsc-experience-at-a-tertiary-centre.html https://www.enets.org/abstract/mesenteric-fibrosis-in-small-intestinal-neuroendocrine-tumors-si-nets-pathogenesis-and-therapeutic-targets.html https://www.enets.org/abstract/177lu-dotatate-as-salvage-therapy-in-bronchial-and-gep-net-patients-the-irst-dino-amadori-experience.html https://www.enets.org/abstract/treatments-clinicopathological-characteristics-and-prognosis-in-thymic-neuroendocrine-tumors-tnets-with-especial-reference-to-temozolomide-tmz-based-chemotherapy.html https://www.enets.org/abstract/18-f-dopa-pet-ct-leading-to-diagnosis-of-micro-pheochromocytoma.html https://www.enets.org/abstract/radio-guided-surgery-with-a-new-generation-c-probe-for-radiolabelled-somatostatin-analogue-in-patients-with-small-intestinal-neuroendocrine-tumors-c-a-phase-ii-surgical-trial.html https://www.enets.org/abstract/a-single-institution-experience-of-clinic-molecular-characterisation-and-correlation-with-treatment-outcomes-in-patients-with-advanced-extrapulmonary-high-grade-neuroendocrine-carcinomas-the-nirvana-study.html https://www.enets.org/abstract/the-role-of-adipocytes-in-neuroendocrine-neoplasms-molecular-and-metabolic-adaptations.html https://www.enets.org/abstract/single-cell-transcriptomic-analysis-of-small-intestinal-neuroendocrine-tumors-revealed-potential-mechanisms-of-mesenteric-fibrosis.html https://www.enets.org/abstract/a-prospective-open-label-study-evaluating-the-efficacy-and-safety-of-surufatinib-s-in-combination-with-captem-as-conversion-therapy-in-patients-with-unresectable-pancreatic-neuroendocrine-tumors-pnet.html https://www.enets.org/abstract/pet-ct-imaging-of-the-somatostatin-receptor-with-18f-alf-nota-octreotide-pet-ct-analysis-of-impact-on-tumor-staging-and-therapeutic-management.html https://www.enets.org/abstract/tecant-era-permed-study-c-somatostatin-receptor-antagonists-as-a-new-sensitive-diagnostic-tool-for-reliable-assessment-of-the-sstr-status-in-neuroendocrine-neoplasms.html https://www.enets.org/abstract/transarterial-embolisation-for-liver-metastasis-in-patients-with-well-differentiated-grade-3-gastroenteropancreatic-neuroendocrine-tumors.html https://www.enets.org/abstract/risk-factors-of-clinically-relevant-pancreatic-fistula-after-pancreaticoduodenectomy-for-pancreatic-neuroendocrine-tumors-c-single-center-retrospective-study.html https://www.enets.org/abstract/predictive-factors-of-persistent-thrombocytopenia-after-177lu-dotatate-in-patients-with-neuroendocrine-tumors.html https://www.enets.org/abstract/incidental-endoscopic-removal-of-a-rectal-neuroendocrine-tumor-what-to-doc.html https://www.enets.org/abstract/high-expression-of-adam15-in-non-functional-pancreatic-neuroendocrine-tumors-is-associated-with-high-density-tumor-infiltrating-neutrophils-and-predicts-poor-outcome.html https://www.enets.org/abstract/neuroendocrine-neoplasms-in-the-young-the-experience-of-a-single-centre-study.html https://www.enets.org/abstract/carcinoid-syndrome-caused-by-pulmonary-neuroendocrine-tumor-liver-metastases-a-case-report.html https://www.enets.org/abstract/evaluation-of-neutrophil-to-lymphocyte-ratio-nlr-platelet-to-lymphocyte-ratio-plr-and-systemic-immunecinflammation-index-sii-as-potential-biomarkers-in-patients-with-sporadic-pancreatic-neuroendocrine-tumors-pnet.html https://www.enets.org/abstract/interim-safety-and-exploratory-efficacy-results-of-a-phase-2-randomised-parallel-group-study-of-oral-paltusotine-treatment-in-subjects-with-carcinoid-syndrome.html https://www.enets.org/abstract/dissecting-the-single-cell-transcriptome-network-underlying-thymic-neuroendocrine-tumor-and-thymus-non-malignant-tissues.html https://www.enets.org/abstract/incidence-patterns-and-clinical-implications-of-venous-thromboembolism-vte-in-patients-pts-with-neuroendocrine-neoplasms-nen.html https://www.enets.org/abstract/analysis-of-the-net-g3-of-lungs.html https://www.enets.org/abstract/dareonc-7-a-phase-i-open-label-dose-escalation-and-expansion-cohort-trial-of-the-delta-like-ligand-dll3-targeting-t-cell-engager-bi-764532-plus-first-line-platinum-based-chemotherapy-in-patients-with-dll3-positive-neuroendocrine-carcinomas1.html https://www.enets.org/abstract/immune-landscape-of-small-intestinal-neuroendocrine-tumor-at-single-cell-level.html https://www.enets.org/abstract/malignancy-of-gastric-neuroendocrine-tumors-is-higher-than-pancreatic-neuroendocrine-tumors-in-chinese-population-c-characterisation-and-analysis-of-factors.html https://www.enets.org/abstract/yap-1-as-prognostic-marker-for-immunochemotherapy-response-in-sclc-patients.html https://www.enets.org/abstract/impact-of-nutritional-status-in-the-quality-of-life-qol-of-patients-with-advanced-gastroenteropancreatic-gep-neuroendocrine-neoplasms-nens-in-spain-nutrigetne-study.html https://www.enets.org/abstract/ordinary-colorectal-cancers-expressing-synaptophysin-myth-or-realityc.html https://www.enets.org/abstract/hospital-record-data-on-the-clinical-presentation-and-diagnostic-investigations-of-small-intestinal-neuroendocrine-tumors-si-nets.html https://www.enets.org/abstract/just-a-matter-of-weightc-final-results-from-nutrigetne-study-in-patients-with-gastroenteropancreatic-gep-neuroendocrine-neoplasms-nens.html https://www.enets.org/abstract/comparative-targeted-ngs-analysis-between-solid-and-liquid-biopsies-in-gep-net-a-pilot-study.html https://www.enets.org/abstract/clinical-genetic-and-histopathological-characterisation-of-patients-with-multiple-endocrine-neoplasia-type-1-in-two-high-complexity-hospitals-in-medellin-colombia.html https://www.enets.org/abstract/a-phase-ii-study-of-lenvatinib-and-everolimus-in-advanced-well-differentiated-extra-pancreatic-neuroendocrine-tumors.html https://www.enets.org/abstract/machine-learning-model-predicting-prognosis-in-neuroendocrine-tumors.html https://www.enets.org/abstract/the-importance-of-pathological-sample-review-in-the-initial-workup-study-in-reference-centers-the-experience-of-an-enets-center-of-excellence.html https://www.enets.org/abstract/prostate-specific-membrane-antigen-targeting-theranostics-in-neuroendocrine-neoplasms-c-initial-results-from-the-gi-psma-phase-ii-trial.html https://www.enets.org/abstract/temporal-increase-in-ki-67-index-in-patients-with-pancreatic-neuroendocrine-tumors-pannets-frequency-prognostic-impact-and-causal-factors.html https://www.enets.org/abstract/synchronous-case-of-advanced-gastric-her-2-adenocarcinoma-and-metastatic-neuroendocrine-neoplasm-of-unknown-origin-c-a-minen-casec.html https://www.enets.org/abstract/the-risk-of-venous-thromboembolism-in-neuroendocrine-neoplasms-a-single-center-experience.html https://www.enets.org/abstract/proteomic-profiling-reveals-c1qa-and-comp-as-promising-plasma-biomarkers-for-early-detection-of-pancreatic-neuroendocrine-tumors2.html https://www.enets.org/abstract/disease-specific-mortality-in-a-single-center-cohort-of-427-patients-with-carcinoid-syndrome.html https://www.enets.org/abstract/prognostic-significance-of-metabolomics-clusters-in-extra-pancreatic-nets-lung-net-sub-analysis.html https://www.enets.org/abstract/ex-vivo-expansion-of-tils-from-pannet-liver-metastasis-in-search-of-novel-adoptive-transfer-strategies-for-the-treatment-of-nets1.html https://www.enets.org/abstract/peptide-receptor-radionuclide-therapy-is-effective-for-hormonal-control-of-carcinoid-syndrome.html https://www.enets.org/abstract/octreotide-infusion-pump-in-patients-with-functional-neuroendocrine-tumors-and-refractory-hormonal-syndromes.html https://www.enets.org/abstract/grade-2-g2-gastro-entero-pancreatic-gep-neuroendocrine-tumors-nets-risk-stratification-beyond-ki-67c.html https://www.enets.org/abstract/liver-transplantation-for-neuroendocrine-tumor-liver-metastases-uk-and-irelandcs-pioneering-pilot-programme.html https://www.enets.org/abstract/evaluation-of-the-utility-of-group-therapy-as-a-mechanism-of-delivering-facilitated-psychosocial-support-to-those-with-a-neuroendocrine-neoplasm-diagnosis.html https://www.enets.org/abstract/peptide-receptor-radionuclide-therapy-improves-progression-free-and-overall-survival-in-patients-who-progress-after-resection-of-gastroenteropancreatic-nets.html https://www.enets.org/abstract/captem-and-prrt-to-improve-overall-response-for-pancreatic-nets-pnets-c-the-coronet-trial.html https://www.enets.org/abstract/co-production-of-patient-information-a-model-for-todaycs-practice.html https://www.enets.org/abstract/metabolic-tumor-volume-mtv-as-a-biomarker-in-patients-with-gastroenteropancreatic-neuroendocrine-neoplasms-gepnens-a-multicentre-study.html https://www.enets.org/abstract/a-case-of-functional-pancreatic-neuroendocrine-tumor-with-hypercalcemia-as-the-main-manifestation.html https://www.enets.org/abstract/pheochromocytoma-and-paraganglioma-gender-differences-in-lipid-profile.html https://www.enets.org/abstract/pulmonary-neuroendocrine-tumors-c-symptomatology-tumor-characteristics-treatment-strategies-and-long-term-outcomes-in-37-patients.html https://www.enets.org/abstract/the-quantitative-assessment-importance-in-nets-diagnosis.html https://www.enets.org/abstract/the-evolutionary-history-of-metastatic-pancreatic-neuroendocrine-tumors-reveals-a-therapy-driven-route-to-high-grade-transformation.html https://www.enets.org/abstract/promising-outcomes-with-surufatinib-vinorelbine-combination-therapy-in-lung-cancer-with-neuroendocrine-differentiation.html https://www.enets.org/abstract/long-term-outcomes-for-medically-managed-carcinoid-heart-disease-patients-a-retrospective-longitudinal-survey.html https://www.enets.org/abstract/overview-of-609-cases-of-neuroendocrine-neoplasms.html https://www.enets.org/abstract/clinical-and-epidemiological-profile-of-neuroendocrine-differentiation-c-a-hospital-based-retrospective-study.html https://www.enets.org/abstract/digestive-neuroendocrine-tumors-in-the-mostaganemoise-region-western-algeria.html https://www.enets.org/abstract/the-role-of-fibrosis-markers-in-predicting-decline-in-renal-function-in-patients-undergoing-prrt.html https://www.enets.org/abstract/relationship-between-absorbed-dose-and-response-in-neuroendocrine-tumors-treated-with-177lu-lu-dota-tate.html https://www.enets.org/abstract/sexual-dimorphism-in-small-intestinal-nets-any-association-with-development-of-mesenteric-metastasesc.html https://www.enets.org/abstract/establishment-of-a-rat-model-of-diarrhea-induced-by-surufatinib.html https://www.enets.org/abstract/delays-in-the-dosing-administration-of-prrt-in-advanced-neuroendocrine-tumors-c-is-there-an-adverse-impactc.html https://www.enets.org/abstract/neoadjuvant-prrt-with-90y-dotatoc-preliminary-results-from-a-monocentric-perspective-study.html https://www.enets.org/abstract/a-review-of-the-scottish-national-peptide-receptor-radionuclide-therapy-prrt-service-with-focus-on-patients-with-small-bowel-neuroendocrine-tumors-sbnet-treated-between-april-2019-and-march-2021.html https://www.enets.org/abstract/adverse-events-after-endoscopic-ultrasound-guided-fine-needle-aspiration-and-fine-needle-biopsy-in-pancreatic-neuroendocrine-tumors-a-systematic-review1.html https://www.enets.org/abstract/interim-analysis-of-lantana-phase-ib-study-investigating-up-regulation-of-somatostatin-receptor-2-sstr2-with-the-de-methylating-agent-astx727-to-allow-177lu-lu-dota-tate-in-metastatic-neuroendocrine-tumors-nets.html https://www.enets.org/abstract/diffuse-idiopathic-pulmonary-neuroendocrine-cell-hyperplasia-dipnech-an-international-case-series.html https://www.enets.org/abstract/the-efficacy-and-safety-analysis-of-transarterial-embolisation-in-the-treatment-of-cystic-neuroendocrine-neoplasm-liver-metastasis.html https://www.enets.org/abstract/effectiveness-and-safety-of-surufatinib-in-treating-pheochromocytomas-and-paragangliomas.html https://www.enets.org/abstract/evaluating-a-possible-association-between-promoter-methylation-level-of-genes-encoding-catecholamine-metabolizing-enzymes-and-metanephrine-secretion-in-pheochromocytoma-and-paraganglioma1.html https://www.enets.org/abstract/durvalumab-d-plus-tremelimumab-t-for-the-treatment-of-patients-with-progressive-advanced-medullary-thyroid-carcinoma-mtc-c-duthy-getne-t1812-trial.html https://www.enets.org/abstract/a-ct-based-radiomics-and-deep-learning-signature-for-evaluating-the-somatostatin-receptor-2-in-non-functional-pancreatic-neuroendocrine-tumors-a-multicohort-retrospective-study1.html https://www.enets.org/abstract/validation-of-a-3-gene-signature-of-response-to-axitinib-in-patients-with-advanced-nets.html https://www.enets.org/abstract/validation-of-a-radiomics-model-to-predict-symptoms-complications-from-small-intestinal-net-mesenteric-metastases-c-preliminary-report.html https://www.enets.org/abstract/chga-and-daxx-atrx-expression-influence-the-outcome-of-pancreatic-head-neuroendocrine-tumors.html https://www.enets.org/abstract/peptide-receptor-radionuclide-therapy-prrt-in-patients-with-neuroendocrine-neoplasms-a-prospective-multi-site-study-evaluating-quality-of-life-and-objective-response.html https://www.enets.org/abstract/action-1-a-randomised-phase-ib-3-trial-of-ryz101-compared-with-standard-of-care-in-somatostatin-receptor-positive-well-differentiated-gastroenteropancreatic-neuroendocrine-tumors-with-progression-following-177lu-somatostatin-analogue-therapy.html https://www.enets.org/abstract/clinical-impact-and-prognosis-of-patients-with-si-net-and-bone-metastases-c-do-they-matterc.html https://www.enets.org/abstract/assessment-of-the-current-and-emerging-criteria-for-the-histopathological-classification-of-lung-neuroendocrine-tumors-in-the-lungnenomics-project.html https://www.enets.org/abstract/alk-targeted-therapy-in-atypical-carcinoid-of-the-lung-a-case-report.html https://www.enets.org/abstract/peptide-receptor-radionuclide-treatment-in-an-outpatient-setting-c-a-single-center-experience.html https://www.enets.org/abstract/liquid-biopsy-as-a-new-tool-for-the-molecular-profiling-of-neuroendocrine-neoplasms-the-gustave-roussy-experience.html https://www.enets.org/abstract/characterisation-of-new-biomarkers-from-patients-with-neuroendocrine-cancer-using-liquid-biopsy-methods.html https://www.enets.org/abstract/mixed-neuroendocrine-and-non-neuroendocrine-tumors-of-the-digestive-system-minen-a-clinicopathological-observation.html https://www.enets.org/abstract/braf-mek-combination-treatment-in-a-patient-with-braf-mutated-neuroendocrine-carcinoma.html https://www.enets.org/abstract/metastatic-insulinoma-c-a-clinical-conundrum.html https://www.enets.org/abstract/portal-vein-resection-in-pancreatic-neuroendocrine-neoplasms.html https://www.enets.org/abstract/phase-ib-portion-of-the-action-1-phase-ib-3-trial-of-ryz101-in-gastroenteropancreatic-neuroendocrine-tumors-gep-nets-progressing-after-177lu-somatostatin-analogue-ssa-therapy-safety-and-efficacy-findings.html https://www.enets.org/abstract/itanet-national-prospective-database-a-comprehensive-analysis-of-epidemiology-and-clinical-presentation-of-gep-nen-in-italy.html https://www.enets.org/abstract/anticancer-activity-of-cabozantinib-and-temozolomide-in-cell-lines-derived-from-lung-carcinoid-and-pancreatic-neuroendocrine-tumors.html https://www.enets.org/abstract/5-hydroxymethylcytosine-profiling-of-plasma-derived-circulating-free-dna-in-patients-with-pancreatic-neuroendocrine-tumors-treated-with-177lu-lu-dota-tate.html https://www.enets.org/abstract/s-1-temozolomide-versus-s-1-temozolomide-plus-thalidomide-in-advanced-pancreatic-and-non-pancreatic-neuroendocrine-tumors-stem-a-randomised-open-label-multicentre-phase-2-trial.html https://www.enets.org/abstract/a-case-of-multiple-endocrine-neoplasia-type-1-men1-phenotype-caused-by-cdc73-mutation.html https://www.enets.org/abstract/uncovering-the-role-of-netrins-and-dcc-deleted-in-colorectal-cancer-in-pancreatic-neuroendocrine-neoplasms-pnen-tumorigenesis.html https://www.enets.org/abstract/identifying-potential-tumor-drivers-through-integration-of-gene-expression-and-dna-copy-number-in-si-net.html https://www.enets.org/abstract/valvular-surgery-in-carcinoid-heart-disease-c-indications-and-outcome.html https://www.enets.org/abstract/type-1-gastric-neuroendocrine-tumors-g-nets-with-vitamin-b12-deficiency-caused-nerve-function-damage-c-a-case-report.html https://www.enets.org/abstract/gastric-mucosa-conditions-during-atrophic-gastritis-and-gastric-neuroendocrine-neoplasia-type-1-gnen-1.html https://www.enets.org/abstract/177lu-lu-dota-tate-in-newly-diagnosed-patients-with-advanced-grade-2-and-grade-3-well-differentiated-gastroenteropancreatic-neuroendocrine-tumors-primary-analysis-of-the-phase-3-randomised-netter-2-study.html https://www.enets.org/abstract/status-of-the-ongoing-sorento-clinical-trial-assessing-efficacy-and-safety-of-high-exposure-octreotide-subcutaneous-depot-in-patients-with-gep-net.html https://www.enets.org/abstract/decoding-and-targeting-of-metabolic-heterogeneity-in-pancreatic-neuroendocrine-tumors-pannets-mct1-and-mct4-in-the-crosshair-for-precision-therapy.html https://www.enets.org/abstract/transcriptomic-analysis-of-pannet-tumor-progression-from-microtumor-to-metastasis-in-men1-patients.html https://www.enets.org/abstract/thoughts-on-the-results-of-genetic-map-of-a-family.html https://www.enets.org/abstract/pancreatic-neuroendocrine-tumors-mimicking-pancreatic-metastases-from-renal-neoplasms.html https://www.enets.org/abstract/177lu-dotatate-177lu-efficacy-in-metastatic-well-differentiated-neuroendocrine-tumors-wdnet-differences-in-response-according-to-metastases-met-location.html https://www.enets.org/abstract/functioning-neuroendocrine-neoplasms-symptomatic-control-with-177lu-dotatate.html https://www.enets.org/abstract/metabolite-biomarker-discovery-for-pancreatic-neuroendocrine-tumors-using-metabolomic-approach.html https://www.enets.org/abstract/diagnostic-work-up-for-neuroendocrine-tumors-of-occult-primary-at-diagnosis-a-retrospective-monocentric-study-of-60-cases.html https://www.enets.org/abstract/detecting-net-using-methylation-based-biomarkers-and-the-novel-impress-technology.html https://www.enets.org/abstract/characterising-the-tumor-microenvironment-of-multifocal-small-intestinal-nets.html https://www.enets.org/abstract/brca-gene-mutations-and-nen-c-is-it-just-random-or-a-meaningful-coincidencec.html https://www.enets.org/abstract/germline-mutation-spectrum-of-neuroendocrine-tumors.html https://www.enets.org/abstract/analysis-of-the-efficacy-of-stem-chemotherapy-in-patients-with-metastatic-paraganglioma.html https://www.enets.org/abstract/prevalence-of-sarcopenia-in-patients-with-advanced-intestinal-neuroendocrine-neoplasms-at-time-of-diagnosis.html https://www.enets.org/abstract/hormonally-characterised-nf-pannets-and-their-clinicopathological-features.html https://www.enets.org/abstract/the-global-leadership-into-malnutrition-criteria-reveals-a-high-percentage-of-malnutrition-which-negatively-influences-overall-survival-in-patients-with-gastroenteropancreatic-neuroendocrine-tumors-gep-nets-treated-with-somatostatin-analogues.html https://www.enets.org/abstract/uncovering-the-genomic-profiling-of-metastatic-pheochromocytomas-and-paragangliomas-leveraging-plasma-circulating-tumor-dna-for-comprehensive-genetic-characterisation-and-monitoring.html https://www.enets.org/abstract/immunohistochemical-profiling-of-lung-carcinoid-subtypes-and-marker-comparison-of-matched-primary-and-metastatic-tumors.html https://www.enets.org/abstract/a-single-center-experience-of-locoregional-treatments-application-in-neuroendocrine-liver-metastases.html https://www.enets.org/abstract/performance-of-a-prognostic-otp-cd44-ki-67-biomarker-panel-on-paired-biopsies-and-resections-of-lung-carcinoids.html https://www.enets.org/abstract/men1-syndrome-across-four-generations.html https://www.enets.org/abstract/non-functional-alpha-cell-hyperplasia-with-glucagonoma-a-case-report.html https://www.enets.org/abstract/high-prevalence-of-deficiencies-in-fat-soluble-vitamins-minerals-and-trace-elements-but-no-relation-with-malnutrition-in-patients-with-gastroenteropancreatic-neuroendocrine-tumors-using-somatostatin-analogues.html https://www.enets.org/abstract/dna-damage-repair-genes-alterations-in-pancreatic-neuroendocrine-tumor-treated-with-temozolomide.html https://www.enets.org/abstract/establishment-of-novel-patient-derived-preclinical-models-for-neuroendocrine-tumors.html https://www.enets.org/abstract/cystic-pancreatic-neuroendocrine-tumors-rare-but-more-commonc.html https://www.enets.org/abstract/primary-hepatic-neuroendocrine-neoplasms-c-clinical-characteristics-and-treatment-outcomes-of-a-rare-disease.html https://www.enets.org/abstract/the-effect-of-the-covid-19-pandemic-on-the-body-composition-of-patients-with-gastroenteropancreatic-neuroendocrine-tumors-using-a-somatostatin-analogue.html https://www.enets.org/abstract/psychiatric-and-cognitive-function-in-patients-with-serotonin-producing-neuroendocrine-tumors.html https://www.enets.org/abstract/a-case-report-of-metastatic-mediastinal-minen-with-clinical-complete-remission.html https://www.enets.org/abstract/pit-and-pitfalls-of-tumor-mutational-burden-assessment-in-well-differentiated-pancreatic-neuroendocrine-tumors-two-case-reports-from-university-of-verona.html https://www.enets.org/abstract/burden-of-medication-in-patients-with-lung-neuroendocrine-tumors-nets-in-a-us-real-world-setting.html https://www.enets.org/abstract/hypercalcemia-due-to-parathyroid-hormone-related-protein-pthrp-secretion-in-pnets-a-series-of-cases.html https://www.enets.org/abstract/real-world-efficacy-and-safety-of-re-treatment-with-177lu-lu-dota-tate-in-patients-with-neuroendocrine-tumors-nets.html https://www.enets.org/abstract/pivotal-role-of-the-multidisciplinary-tumor-board-on-the-management-of-neuroendocrine-neoplasms-c-impact-of-mtb-decisions-in-an-enets-center-of-excellence.html https://www.enets.org/abstract/temozolomide-treatment-induces-an-mmr-dependent-hypermutator-phenotype-in-well-differentiated-pancreatic-neuroendocrine-tumors.html https://www.enets.org/abstract/metastatic-potential-and-associated-mortality-in-a-greek-cchort-of-123-men1-patients1.html https://www.enets.org/abstract/unravelling-the-rna-landscape-of-small-intestine-neuroendocrine-neoplasms-applying-transcriptomic-and-spliceosomic-perspectives.html https://www.enets.org/abstract/risk-of-venous-thromboembolism-according-to-molecular-profiling-in-patients-with-neuroendocrine-carcinoma.html https://www.enets.org/abstract/prospective-analysis-of-the-risk-of-post-surgical-recurrence-in-lung-typical-carcinoid.html https://www.enets.org/abstract/preliminary-experience-with-a-new-institutional-dedicated-neuroendocrine-team-in-a-tertiary.html https://www.enets.org/abstract/the-diagnostic-role-of-dwi-mri-for-liver-metastases-of-neuroendocrine-neoplasms-nens-in-comparison-with-the-functional-imaging.html https://www.enets.org/abstract/personalised-dosimetry-as-a-key-for-optimising-radioligand-therapy-rlt-with-177lu-lu-dota-tate-or-177lu-lu-dota-tate-and-90y-y-dota-tate-in-patients-with-neuroendocrine-tumors-c-the-duonen-multicenter-study.html https://www.enets.org/abstract/precision-medicine-in-advanced-nens-molecular-profiling-and-target-actionability-real-world-data.html https://www.enets.org/abstract/specific-spliceosomic-landscapes-reveal-a-possible-link-between-rna-processing-and-pannets-behaviour.html https://www.enets.org/abstract/start-net-systemic-targeted-adaptive-radiotherapy-of-neuroendocrine-tumors-c-an-open-label-multi-center-randomised-phase-iii-trial-comparing-safety-and-efficacy-of-personalised-vs-non-personalised-radionuclide-therapy-with-177lu-dotatoc.html https://www.enets.org/abstract/the-somatostatin-system-c-a-silent-messenger-in-pheochromocytomas-and-paragangliomasc.html https://www.enets.org/abstract/transcriptomic-and-spliceosomic-landscapes-of-pancreatic-neuroendocrine-tumors-generated-through-oxford-nanopore-technology-sequencing.html https://www.enets.org/abstract/splenic-metastases-in-the-course-of-neuroendocrine-tumors-c-are-they-really-that-uncommonc.html https://www.enets.org/abstract/breast-neuroendocrine-carcinomas-surgery-a-case-report.html https://www.enets.org/abstract/immunohistochemical-analysis-for-galectin-3-and-outcomes-in-medullary-thyroid-cancer.html https://www.enets.org/abstract/prediction-of-recurrence-for-grade-1-2-small-bowel-neuroendocrine-neoplasms-after-curative-intended-resection.html https://www.enets.org/abstract/primary-hepatic-neuroendocrine-tumor-in-a-series-of-8-cases.html https://www.enets.org/abstract/mapk-and-mtor-pathway-activation-is-associated-with-chemotherapy-resistance-and-a-poor-prognosis-in-g3-advanced-nens.html https://www.enets.org/abstract/risk-of-bowel-ischemia-in-patients-with-mesenteric-neuroendocrine-tumors-after-treatment-with-177lutetium-dotatate.html https://www.enets.org/abstract/assessing-the-frequency-of-type-i-gastric-neuroendocrine-neoplasms-in-autoimmune-atrophic-gastritis-a-multi-center-study-in-italy.html https://www.enets.org/abstract/quali-net-a-prospective-study-on-patient-reported-quality-of-life-in-neuroendocrine-neoplasms.html https://www.enets.org/abstract/us-real-world-study-of-the-burden-of-medication-in-patients-with-gastroenteropancreatic-neuroendocrine-tumors-gep-nets.html https://www.enets.org/abstract/uncommon-manifestations-in-type-4-familial-paraganglioma-syndrome-c-a-large-cohort-of-patients-harbouring-the-sdhb-p-q214ter-variant.html https://www.enets.org/abstract/digestive-neuroendocrine-tumors-c-retrospective-study-and-experience-of-the-general-surgery-department-of-ehu-oran.html https://www.enets.org/abstract/pancreatic-neuroendocrine-tumors-c-epidemiological-profile-and-surgical-aspects.html https://www.enets.org/abstract/evaluation-of-circulating-extracellular-vesicles-as-suitable-prognostic-markers-in-men1-associated-non-functioning-pancreatic-neuroendocrine-neoplasia.html https://www.enets.org/abstract/evaluation-of-the-impact-of-indoleamine-2-3-deoxygenase-ido-enzyme-activity-in-neuroendocrine-tumors-nets.html https://www.enets.org/abstract/bone-health-in-neuroendocrine-neoplasms.html https://www.enets.org/abstract/grade-c3-subacute-haematological-toxicity-with-177lu-dotatate-prrt-c-results-from-lumen-study.html https://www.enets.org/abstract/analysis-of-ai-based-clinical-trial-search-tool-usage-reveals-motivations-of-neuroendocrine-tumors-patients-in-searching-for-trials.html https://www.enets.org/abstract/aurora-kinase-a-inhibition-as-a-promising-therapeutic-strategy-in-arid1a-mutated-neuroendocrine-carcinomas-first-results-of-an-in-vitro-and-in-vivo-study.html https://www.enets.org/abstract/characteristics-of-gastric-neuroendocrine-tumors-type-1.html https://www.enets.org/abstract/association-of-long-term-ppi-use-with-low-risk-gastric-neuroendocrine-tumor1.html https://www.enets.org/abstract/tricuspid-valve-replacement-and-liver-transplantation-in-a-51-year-old-female-patient-with-grade-1-ileum-net-and-refractory-carcinoid-syndrome.html https://www.enets.org/abstract/do-metastatic-appendiceal-nets-ever-develop-metachronously-after-appendectomy-or-right-hemicolectomyc.html https://www.enets.org/abstract/continuing-somatostatin-analogues-upon-progression-in-neuroendocrine-tumor-patients-sauna-trial-c-study-protocol-for-a-bi-national-multi-center-open-label-randomised-pragmatic-clinical-trial.html https://www.enets.org/abstract/implementation-of-a-new-nurse-led-clinic-nlc-for-neuroendocrine-tumor-net-patients.html https://www.enets.org/abstract/plasma-extracellular-vesicles-number-and-size-distinguish-patients-with-neuroendocrine-neoplasms.html https://www.enets.org/abstract/sequential-everolimus-and-sunitinib-treatment-in-progressive-advanced-pancreatic-nens-real-world-data-from-the-belgian-group-of-digestive-oncology-dnet-netwerk1.html https://www.enets.org/abstract/role-of-gastric-mucosa-evaluation-in-diagnostic-of-pancreatic-neuroendocrine-tumors-functional-status.html https://www.enets.org/abstract/cell-free-dna-cfdna-methylation-profiling-for-minimally-invasive-cancer-detection-in-patients-with-extra-pulmonary-neuroendocrine-carcinoma-ep-nec.html https://www.enets.org/abstract/carcinoid-heart-in-neuroendcrine-tumor-c-experience-of-medical-departement-oncology-oran-algeria.html https://www.enets.org/abstract/prevalence-of-germline-mutations-in-pancreatic-neuroendocrine-tumors.html https://www.enets.org/abstract/diffuse-idiopathic-pulmonary-neuroendocrine-cell-hyperplasia-a-case-report.html https://www.enets.org/abstract/tryptophan-pathway-metabolites-as-prognostic-biomarkers-of-recurrent-disease-in-curatively-operated-neuroendocrine-tumor-patients.html https://www.enets.org/abstract/factors-associated-with-post-operative-pancreatic-insufficiency-after-distal-pancreatectomy-for-localised-non-functioning-pancreatic-neuroendocrine-tumors-nf-pannet.html https://www.enets.org/abstract/lutetium-177-dotatate-peptide-receptor-radionuclide-therapy-in-metastatic-pheochromocytoma-and-paraganglioma-experience-in-our-center.html https://www.enets.org/abstract/upfront-oxaliplatincfluoropyrimidine-chemotherapy-and-somatostatin-analogues-ssa-in-advanced-well-differentiated-g2-g3-gastro-entero-pancreatic-neuroendocrine-tumors-gep-nets.html https://www.enets.org/abstract/intra-arterial-peptide-receptor-radionuclide-therapy-in-a-filipino-male-with-predominantly-hepatic-metastasis-in-a-known-primary-pancreatic-neuroendocrine-tumor.html https://www.enets.org/abstract/new-insight-in-the-environment-immunephenotyping-of-gastroenteropancreatic-neuroendocrine-neoplasms-cd-90-expression.html https://www.enets.org/abstract/leak-rates-in-pancreatico-duodenectomy-procedures-in-pancreatic-nets-compared-to-pancreatic-ductal-adenocarcinoma-resections.html https://www.enets.org/abstract/prognostic-significance-of-nodal-micrometastases-in-patients-with-non-functioning-pancreatic-neuroendocrine-tumors-nf-pannets-c-a-survival-analysis-from-a-prospective-observational-study.html https://www.enets.org/abstract/epigenetic-prediction-of-aging-and-metabolic-traits-provides-insight-into-tumor-biology-in-multi-focal-ileal-neuroendocrine-tumors.html https://www.enets.org/abstract/tolerability-and-outcomes-of-neuroendocrine-tumors-treated-with-peptide-receptor-radionuclide-therapy-and-stereotactic-body-radiation-therapy.html https://www.enets.org/abstract/unanticipated-heterogeneity-in-high-grade-large-cell-neuroendocrine-carcinoma-pinpoints-cell-sub-state-specific-therapeutic-targets.html https://www.enets.org/abstract/predictive-and-prognostic-nomogram-models-for-liver-metastasis-in-colorectal-neuroendocrine-neoplasms-a-large-population-study.html https://www.enets.org/abstract/automated-artificial-intelligence-vs-manual-evaluation-of-the-somatostatin-receptor-2a-and-proliferation-marker-ki-67-in-neuroendocrine-neoplasms-a-pilot-study.html https://www.enets.org/abstract/a-first-in-human-phase-i-trial-with-antibody-drug-conjugate-adct-701-in-neuroendocrine-tumours-and-carcinomas.html https://www.enets.org/abstract/long-term-efficacy-and-safety-of-peptide-receptor-radionuclide-therapy-prrt-in-japanese-patients-with-unresectable-neuroendocrine-tumour-japanese-phase-i-and-phase-i-ii-extension-study.html https://www.enets.org/abstract/malignant-gep-net-with-cbd-stricture-and-portal-lymphadenopathy-c-a-rare-case-report-and-review-of-literature.html https://www.enets.org/abstract/predictive-biomarkers-for-immunotherapy-efficacy-in-neuroendocrine-neoplasms.html https://www.enets.org/abstract/clinicopathologic-characteristics-and-survival-outcomes-in-patients-with-gastroenteropancreatic-neuroendocrine-neoplasms-at-a-latin-american-reference-centre.html https://www.enets.org/abstract/challenges-in-access-to-peptide-receptor-radionuclide-therapy-prrt-in-developing-countries-c-insights-from-patient-advocacy-perspective.html https://www.enets.org/abstract/a-virtual-patient-handbook.html https://www.enets.org/abstract/temozolomide-associated-hypermutation-and-response-to-immunotherapy-in-advanced-pulmonary-neuroendocrine-tumours.html https://www.enets.org/abstract/tb-161-dotatate-and-lu-177-dotatate-as-a-tandem-therapy.html https://www.enets.org/abstract/novel-genomic-score-predicts-survival-with-immune-checkpoint-blockade-in-neuroendocrine-neoplasms.html https://www.enets.org/abstract/predictors-based-on-the-radiologic-characteristics-for-aggressiveness-of-small-c20-mm-non-functioning-pancreatic-neuroendocrine-tumours.html https://www.enets.org/abstract/efficacy-of-folfox-chemotherapy-combined-with-anti-angiogenic-targeted-drugs-bevacizumab-surufatinib-in-neuroendocrine-tumours-after-progression-following-multiple-lines-of-therapy-a-retrospective-study.html https://www.enets.org/abstract/measuring-quality-of-life-in-patients-receiving-radionuclide-therapy-using-the-european-organisation-for-research-and-treatment-of-cancer-quality-of-life-questionnaire-eortc-qlq-c30-and-gastro-intestinal-net-ginet-21.html https://www.enets.org/abstract/are-patients-on-somatostatin-analogue-therapy-receiving-high-quality-holistic-cancer-nursing-carec.html https://www.enets.org/abstract/small-bowel-neuroendocrine-neoplasm-c-a-very-intriguing-case.html https://www.enets.org/abstract/clinicopathologic-characteristics-and-prognosis-of-581-cases-of-hepatic-neuroendocrine-tumours.html https://www.enets.org/abstract/defective-dna-repair-promotes-progression-of-small-intestinal-neuroendocrine-tumours-despite-a-lack-of-common-genomic-drivers.html https://www.enets.org/abstract/a-retrospective-comparison-of-preoperative-characteristics-and-surgical-outcomes-in-small-intestine-neuroendocrine-neoplasms-sinens-and-small-intestine-adenocarcinoma.html https://www.enets.org/abstract/case-report-on-the-effectiveness-of-combination-therapy-in-highly-aggressive-resistant-prolactinoma.html https://www.enets.org/abstract/carcinoid-crisis-insights-from-an-enets-center-of-excellence1.html https://www.enets.org/abstract/co-targeting-the-endocannabinoid-system-es-and-mtor-in-nen-potentiates-their-anti-tumour-effect-via-unique-metabolic-changes.html https://www.enets.org/abstract/lower-dose-of-lenvatinib-is-similarly-effective-as-higher-dose-for-patients-pts-with-advanced-neuroendocrine-tumours-nets-a-multinational-retrospective-cohort.html https://www.enets.org/abstract/evenet-randomised-phase-ii-trial-of-everolimus-5mg-vs-10mg-daily-in-patients-with-neuroendocrine-tumours.html https://www.enets.org/abstract/predictive-value-of-pepsinogen-i-and-i-ii-ratio-for-diagnosing-autoimmune-gastritis.html https://www.enets.org/abstract/head-to-head-comparison-of-18f-aif-nota-octreotide-and-68ga-dota-tate-pet-ct-in-patients-with-neuroendocrine-neoplasms1.html https://www.enets.org/abstract/18f-alf-nota-octreotide-as-tracer-for-somatostatin-receptor-pet-ct-retrospective-analysis-of-the-clinical-use-in-288-neuroendocrine-tumour-patients.html https://www.enets.org/abstract/characterisation-of-patients-diagnosed-with-metastatic-head-and-neck-paraganglioma-treated-at-an-oncology-referral-institution-in-colombia.html https://www.enets.org/abstract/developing-innovative-genetically-modified-proliferation-regulated-patient-derived-models-representing-human-well-differentiated-gep-nets-for-drug-screening.html https://www.enets.org/abstract/identification-of-gastroenteropancreatic-neuroendocrine-tumour-patients-with-high-liver-tumour-burden-based-on-clinicopathological-features.html https://www.enets.org/abstract/understanding-neuroendocrine-cancer-a-palliative-care-perspective-in-rural-india.html https://www.enets.org/abstract/the-indolent-nature-of-type-1-gastric-neuroendocrine-tumours-under-1cm-insights-from-a-dual-centre-study.html https://www.enets.org/abstract/combination-of-sorafenib-and-everolimus-regresses-pancreatic-neuroendocrine-tumour-significantly-in-vitro-and-vivo.html https://www.enets.org/abstract/late-diagnosis-of-men2a-syndrome-ten-cases-in-one-family.html https://www.enets.org/abstract/management-of-asymptomatic-sporadic-small-non-functional-pancreatic-neuroendocrine-tumours-active-surveillance-or-surgeryc-a-retrospective-cohort-study-in-the-seer-database.html https://www.enets.org/abstract/everolimus-combined-with-orlistat-inhibits-the-development-of-neuroendocrine-tumours-by-inhibiting-the-mtor-pi3k-akt-signalling-pathway.html https://www.enets.org/abstract/added-value-of-multifrequency-magnetic-resonance-elastography-in-predicting-pathological-grading-of-pancreatic-neuroendocrine-neoplasms.html https://www.enets.org/abstract/insulinoma-c-a-diagnostic-challenge.html https://www.enets.org/abstract/clinical-outcomes-of-patients-with-rectal-neuroendocrine-tumours-smaller-than-10mm-after-endoscopic-resection.html https://www.enets.org/abstract/the-value-of-68ga-exendin-4-pet-ct-for-benign-and-metastatic-insulinoma.html https://www.enets.org/abstract/the-diagnostic-and-prognostic-value-of-68ga-dotanoc-and-18f-fdg-pet-ct-for-thymic-carcinoids.html https://www.enets.org/abstract/resection-strategies-for-pulmonary-typical-carcinoids-do-surgical-extents-impact-survivalc.html https://www.enets.org/abstract/an-evaluation-of-the-methodological-quality-of-published-guidelines-for-the-surgical-treatment-of-pulmonary-carcinoids.html https://www.enets.org/abstract/metastatic-non-functional-pancreatic-neuroendocrine-tumour-with-transformation-to-insulinoma-shown-on-68ga-exendin-4-pet-ct.html https://www.enets.org/abstract/health-related-quality-of-life-hrql-and-supportive-care-needs-scn-of-gastroenteropancreatic-neuroendocrine-tumours-gep-net-in-a-swiss-net-centre.html https://www.enets.org/abstract/multivariate-survival-analyses-of-544-advanced-high-grade-digestive-neuroendocrine-neoplasms-net-g3-and-nec-given-first-line-chemotherapy-nordic-nec-2.html https://www.enets.org/abstract/clinical-and-gut-microbiota-gm-markers-of-aggressive-carcinoid-syndrome-cs.html https://www.enets.org/abstract/amino-acid-induced-hyperkalaemia-during-peptide-receptor-radionuclide-therapy-prrt-a-case-report-and-literature-review.html https://www.enets.org/abstract/efficacy-of-sirt-radioembolisation-of-liver-metastases-of-neuroendocrine-tumours-nets-a-single-institution-experience.html https://www.enets.org/abstract/clinical-efficacy-of-peptide-receptor-radionuclide-therapy-with-radiolabelled-somatostatin-analogues-prrt-of-metastatic-neuroendocrine-tumours-nets-c-a-single-centre-cohort-study.html https://www.enets.org/abstract/late-nephrotoxicity-of-peptide-receptor-radionuclide-therapy-prrt-and-impact-of-selected-factors-c-a-single-centre-cohort-study.html https://www.enets.org/abstract/life-threatening-hypoglycaemia-due-to-insulinoma-successfully-treated-with-prrt.html https://www.enets.org/abstract/differences-in-plasma-concentrations-of-selected-growth-factors-in-endocrine-neoplasms-c-a-pilot-study.html https://www.enets.org/abstract/spot-urine-5-hiaa-creatinine-ratio-is-comparable-to-24hr-urine-collection-for-diagnosis-of-carcinoid-syndrome.html https://www.enets.org/abstract/dual-threshold-contouring-for-68ga-dotatate-pet-and-correlation-with-overall-survival-os-in-patients-with-neuroendocrine-neoplasia-nen.html https://www.enets.org/abstract/predominant-volumetric-phenotype-in-dual-pet-and-overall-survival-in-nens.html https://www.enets.org/abstract/genetic-factors-associated-with-thymic-tumours-in-patients-with-men1-a-nested-case-control-study-in-the-gte-afce-cohort-of-patients-with-men1.html https://www.enets.org/abstract/a-real-world-retrospective-analysis-to-evaluate-the-efficacy-and-safety-of-surufatinib-in-the-treatment-of-unresectable-locally-advanced-or-metastatic-neuroendocrine-neoplasms-in-china.html https://www.enets.org/abstract/ga68-dotatate-imaging-on-a-state-of-the-art-total-body-pet-ct-scanner-with-reducing-administered-activity.html https://www.enets.org/abstract/the-deadly-connection-liver-metastasis-and-prognostic-factors-in-sclc.html https://www.enets.org/abstract/real-life-results-of-the-treatment-with-lutetium-in-advanced-neuroendocrine-tumours.html https://www.enets.org/abstract/efficacy-and-safety-of-surufatinib-in-the-treatment-of-thymic-neuroendocrine-tumours-a-102-case-retrospective-study.html https://www.enets.org/abstract/mixed-neuroendocrine-non-neuroendocrine-neoplasm-associated-with-gastric-autoimmunity-a-clinicopathological-analysis-of-two-cases.html https://www.enets.org/abstract/real-world-clinicopathological-features-and-outcome-of-elderly-patients-with-thymic-neuroendocrine-neoplasms-a-retrospective-single-institution-analysis.html https://www.enets.org/abstract/challenging-management-of-ductal-adenocarcinoma-of-the-prostate-with-neuroendocrine-differentiation-a-case-report.html https://www.enets.org/abstract/cytoendoscopy-for-determining-the-depth-of-invasion-and-metastasis-of-rectal-neuroendocrine-tumours.html https://www.enets.org/abstract/outcomes-of-lobar-and-sub-lobar-resection-for-lung-neuroendocrine-tumours-lnets-carcinoids-c-an-enets-coe-experience.html https://www.enets.org/abstract/what-can-a-reference-centre-offer-to-patientsc-evolution-of-first-visits-for-neuroendocrine-and-endocrine-tumours-and-its-relation-to-clinical-trials-availability.html https://www.enets.org/abstract/familial-inactivating-glucagon-receptor-mutation-resulting-in-pancreatic-neuroendocrine-tumours-with-metastatic-potential-somatic-men1-mutations-and-a-heterozygous-phenotype.html https://www.enets.org/abstract/analysis-of-gastric-nens-in-the-czech-neuroendocrine-tumour-registry-2009-2024.html https://www.enets.org/abstract/emergence-of-dna-damage-repair-clonal-haematopoiesis-after-peptide-receptor-radionuclide-therapy-for-neuroendocrine-tumours.html https://www.enets.org/abstract/assessment-of-medium-and-long-term-side-effects-of-lu-177-treatment-in-patients-with-neuroendocrine-tumours.html https://www.enets.org/abstract/proof-of-concept-and-design-of-an-externally-controlled-trial-for-patients-with-gastroenteropancreatic-neuroendocrine-carcinomas-based-on-the-randomised-phase-ii-bevanec-trial.html https://www.enets.org/abstract/patients-with-neuroendocrine-tumour-after-surgical-treatment-and-therapy-with-somatostatin-analogues-comparison-of-body-mass-index-bmi.html https://www.enets.org/abstract/treatment-response-and-survival-in-163-metastatic-colorectal-neuroendocrine-carcinomas-a-prospective-cohort-from-the-nordic-nec-registry.html https://www.enets.org/abstract/real-world-practice-patterns-of-177lu-dotatate-in-neuroendocrine-tumours-a-gte-national-survey.html https://www.enets.org/abstract/identification-of-irs2-as-a-prognostic-and-therapeutic-target-in-gastrointestinal-neuroendocrine-tumours.html https://www.enets.org/abstract/61cu-nodaga-lm3-for-the-detection-of-neuroendocrine-tumours-preliminary-results-of-the-copper-pet-in-net-trial-a-randomised-crossover-readers-blind-phase-i-ii-non-inferiority-study.html https://www.enets.org/abstract/single-agent-axitinib-in-the-management-of-patients-with-progressive-pheochromocytoma-and-paraganglioma.html https://www.enets.org/abstract/cisplatin-and-etoposide-as-first-line-chemotherapy-for-poorly-differentiated-neuroendocrine-carcinoma-of-the-stomach-a-case-report.html https://www.enets.org/abstract/care-of-neuroendocrine-tumours-the-collaborative-of-surgical-teams-for-neuroendocrine-tumors-cutnets.html https://www.enets.org/abstract/comparative-analysis-of-post-pancreatic-surgical-complications-in-elderly-versus-younger-patients-with-inactive-neuroendocrine-pancreatic-tumours.html https://www.enets.org/abstract/surgical-and-multidisciplinary-management-of-pancreatic-neuroendocrine-tumours-with-liver-metastases-insights-from-a-high-volume-centre.html https://www.enets.org/abstract/the-predictive-value-of-68ga-dotanoc-18f-dopa-and-18f-fdg-pet-ct-in-patients-with-paragangliomas.html https://www.enets.org/abstract/role-of-68ga-dotatoc-pet-ct-in-therapeutic-decision-making-for-well-differentiated-neuroendocrine-tumours.html https://www.enets.org/abstract/clinical-management-of-oesophageal-nec-a-popular-based-study.html https://www.enets.org/abstract/cvm-005-a-multicentre-single-arm-phase-iia-study-of-cvm-1118-a-novel-oral-anti-vasculogenic-mimicry-vm-agent-in-patients-with-treatment-refractory-advanced-neuroendocrine-tumours-net.html https://www.enets.org/abstract/focal-adhesion-kinase-drives-proliferation-and-invasion-in-gastrointestinal-neuroendocrine-tumours-via-modulation-of-transformative-cell-signalling-and-gene-expression.html https://www.enets.org/abstract/efficacy-and-safety-of-immunotherapy-combined-with-antiangiogenesis-agents-and-temozolomide-in-neuroendocrine-carcinoma.html https://www.enets.org/abstract/analysis-of-clinical-features-and-prognosis-of-195-cases-of-gastrointestinal-and-pancreatic-neuroendocrine-tumours.html https://www.enets.org/abstract/characteristics-of-endoscopic-ultrasonography-in-patients-with-gastrointestinal-and-pancreatic-neuroendocrine-tumours.html https://www.enets.org/abstract/hypoxic-signalling-in-pancreatic-nets-pnets.html https://www.enets.org/abstract/fully-automated-segmentation-and-lymph-node-metastasis-prediction-of-non-functional-pancreatic-neuroendocrine-tumours-using-deep-learning.html https://www.enets.org/abstract/cell-free-dna-concentration-correlates-with-copy-number-variant-cnv-count-describes-tumour-progression-and-nuclear-instability-in-gep-nets.html https://www.enets.org/abstract/topk-promotes-tumorigenesis-and-metastasis-of-pancreatic-neuroendocrine-neoplasms-by-enhancing-the-mapk-signalling-pathway.html https://www.enets.org/abstract/sensitivity-of-endoscopic-ultrasound-in-detecting-small-gastrointestinal-neuroendocrine-tumours.html https://www.enets.org/abstract/clinical-and-biological-heterogeneity-of-grade-2-gastroenteropancreatic-neuroendocrine-neoplasms-gep-nens-prognostic-significance-of-the-10-ki-67-index-cutoff-and-implications-for-treatment-strategies.html https://www.enets.org/abstract/the-efficacy-of-combination-of-temozolomide-and-capecitabine-for-neuroendocrine-tumours-a-real-world-comparison-of-outcomes-in-alberta-canada-c-patients-treated-from-2011-2021.html https://www.enets.org/abstract/sdhb-related-metastatic-paragangliomas-treated-with-capecitabine-and-temozolomide-experience-of-a-tertiary-centre.html https://www.enets.org/abstract/streptozotocin-and-temozolomide-based-chemotherapy-treatment-in-neuroendocrine-neoplasms-c-efficacy-in-patients-treated-outside-clinical-trials.html https://www.enets.org/abstract/exenatide-test-for-diagnosing-endogenous-hyperinsulinemic-hypoglycaemia-a-randomised-placebo-controlled-cross-over-proof-of-principle-study-c-fast-study.html https://www.enets.org/abstract/pancreatic-neuroendocrine-tumours-pnet-and-mutyh-germline-gpv-and-somatic-spv-pathogenic-variants-a-multinational-study.html https://www.enets.org/abstract/the-lola-trial-phase-ii-trial-with-combination-of-cabozantinib-plus-lanreotide-in-gastroenteropancreatic-gep-and-thoracic-neuroendocrine-tumours-nets-c-interim-results-of-step-1.html https://www.enets.org/abstract/fdg-uptake-in-lung-neuroendocrine-tumours-and-its-association-with-tumour-characteristics-and-prognosis.html https://www.enets.org/abstract/clinicopathologic-characteristics-therapy-and-outcomes-of-gastroenteropancreatic-neuroendocrine-tumours-a-single-centre-experience.html https://www.enets.org/abstract/updated-results-of-first-line-chemotherapy-combined-with-an-immune-checkpoint-inhibitor-for-advanced-extrapulmonary-neuroendocrine-carcinoma-a-single-arm-phase-ii-study.html https://www.enets.org/abstract/surufatinib-plus-trans-arterial-embolisation-tae-vs-surufatinib-monotherapy-in-neuroendocrine-tumour-with-liver-metastasis-updated-results-from-the-prospective-randomised-controlled-trial.html https://www.enets.org/abstract/application-of-somatostatin-receptor-pet-ct-in-assisting-preoperative-lymph-node-evaluation-and-surgical-decision-making-for-duodenal-and-pancreatic-neuroendocrine-neoplasms.html https://www.enets.org/abstract/mechanisms-of-drug-resistance-in-neuroendocrine-tumours-a-basic-research-study.html https://www.enets.org/abstract/hypoxic-microenvironment-in-neuroendocrine-tumours.html https://www.enets.org/abstract/dna-repair-enzyme-regulation-strategy-for-enhanced-pancreatic-neuroendocrine-tumour-therapy-via-targeting-sirna-lipid-nanoparticles.html https://www.enets.org/abstract/the-role-of-chromogranin-a-as-a-biomarker-in-neuroendocrine-tumours-diagnostic-and-prognostic-implications.html https://www.enets.org/abstract/updated-data-from-a-single-arm-open-label-multicentre-clinical-study-on-the-efficacy-and-safety-of-surufatinib-combined-with-ep-regimen-and-serplulimab-in-first-line-treatment-of-nec.html https://www.enets.org/abstract/analysis-of-clinicopathologic-features-and-prognosis-of-8096-patients-with-gastric-neuroendocrine-neoplasms.html https://www.enets.org/abstract/australasian-gastro-intestinal-trials-group-agitg-stopnet-a-randomised-study-of-cessation-of-somatostatin-analogues-after-peptide-receptor-radionuclide-therapy-prrt-in-mid-hind-gut-and-pancreatic-neuroendocrine-tumours.html https://www.enets.org/abstract/ki-67-index-cut-off-values-and-survival-prognostication-in-neuroendocrine-neoplasms-machine-learning-based-insights.html https://www.enets.org/abstract/a-comparative-study-on-the-progression-of-neuroendocrine-carcinomas-and-mixed-neuroendocrine-non-neuroendocrine-neoplasms.html https://www.enets.org/abstract/fluorescence-labelled-plasma-derived-small-extracellular-vesicle-as-biomarkers-in-metastatic-pancreatic-neuroendocrine-tumour-patients.html https://www.enets.org/abstract/characterisation-of-patients-with-neuroendocrine-tumours-in-a-specialised-care-institution-in-oncological-endocrinology-bogota-colombia.html https://www.enets.org/abstract/metabolic-syndrome-mets-and-metastatic-disease-in-patients-with-sporadic-small-intestine-neuroendocrine-tumour-sinet.html https://www.enets.org/abstract/the-value-of-netest-2-0-in-stratifying-patients-with-suspected-nen-for-formal-diagnostic-evaluation-c-real-world-data.html https://www.enets.org/abstract/netest-can-predict-the-tumour-burden-in-neuroendocrine-tumours.html https://www.enets.org/abstract/25-years-of-experience-with-somatostatin-receptor-based-therapy-in-patients-with-small-intestinal-neuroendocrine-tumours.html https://www.enets.org/abstract/efficacy-and-safety-of-adjuvant-peptide-receptor-radionuclide-therapy-after-curative-surgery-of-locoregional-limited-small-intestine-neuroendocrine-neoplasia-apsin-c-a-multi-centre-prospective-randomised-controlled-phase-iii-study.html https://www.enets.org/abstract/impact-of-chromogranin-a-expression-on-clinicopathological-characteristics-and-prognosis-in-patients-with-gastrointestinal-tumours-exhibiting-neuroendocrine-differentiation.html https://www.enets.org/abstract/mgmt-activated-dub3-stabilises-nrf2-ncoa4-to-modulate-apoptosis-and-ferroptosis-driving-temozolomide-resistance-in-pancreatic-neuroendocrine-tumours.html https://www.enets.org/abstract/medicine-treatment-of-functional-pancreatic-neuroendocrine-tumour-with-hypercalcaemia.html https://www.enets.org/abstract/efficacy-of-immune-checkpoint-inhibitors-ici-in-patients-with-advanced-pancreatic-nets-displaying-high-tmb-and-mmr-alterations-following-treatment-with-alkylating-agents.html https://www.enets.org/abstract/endoscopic-ultrasound-guided-radiofrequency-ablation-is-a-safe-and-efficient-treatment-of-symptomatic-insulinomas-c-a-single-centre-experience-of-14-patients.html https://www.enets.org/abstract/real-world-outcomes-in-patients-with-gastroenteropancreatic-neuroendocrine-neoplasms-at-a-cancer-centre-in-a-middle-income-country.html https://www.enets.org/abstract/nab-paclitaxel-plus-bevacizumab-for-patients-with-previously-treated-metastatic-extrapulmonary-neuroendocrine-carcinomas-ep-necs-a-multicentre-open-label-phase-ii-trial.html https://www.enets.org/abstract/head-to-head-comparison-of-18f-alf-nota-jr11-pet-mr-and-68ga-dotatate-pet-ct-in-patients-with-neuroendocrine-tumours-a-prospective-study.html https://www.enets.org/abstract/a-case-report-of-an-undifferentiated-neuroendocrine-carcinoma-with-an-unknown-primary-site.html https://www.enets.org/abstract/exploring-decorin-in-plasma-derived-small-extracellular-vesicles-sevs-as-a-potential-diagnostic-biomarker-for-pancreatic-neuroendocrine-tumours.html https://www.enets.org/abstract/tumour-derived-apolipoprotein-e-induces-tip-endothelial-cell-to-remodel-tumour-stroma-ratio-and-promote-pancreatic-neuroendocrine-tumour-progression.html https://www.enets.org/abstract/ampullary-composite-gangliocytoma-neuroma-and-neuroendocrine-tumour-management.html https://www.enets.org/abstract/a-case-of-giant-neuroendocrine-tumour-of-unknown-primary-site.html https://www.enets.org/abstract/surufatinib-combined-with-hepatic-artery-infusion-chemotherapy-haic-as-second-line-and-maintenance-therapy-for-neuroendocrine-carcinoma-with-liver-metastases-a-single-arm-open-label-single-centre-phase-ii-clinical-study-suhanec.html https://www.enets.org/abstract/tumour-derived-apolipoprotein-e-drives-temozolomide-chemoresistance-by-reprogramming-lipid-metabolism-and-activating-the-homologous-recombination-repair-pathway-in-pancreatic-neuroendocrine-tumours.html https://www.enets.org/abstract/liver-transplantation-for-pancreatic-neuroendocrine-tumour-a-case-report.html https://www.enets.org/abstract/long-term-prognosis-of-parenchyma-sparing-vs-oncologic-resections-for-distal-pancreatic-non-functional-neuroendocrine-tumours-c-3cm-a-real-world-data-study-cspac-nen-5.html https://www.enets.org/abstract/systemic-treatment-in-metastatic-pheochromocytomas-and-paragangliomas-optimal-moment-for-starting-and-outcomes-of-a-multicentre-spanish-cohort.html https://www.enets.org/abstract/prostatic-small-cells-carcinoma-a-case-report.html https://www.enets.org/abstract/treatment-approaches-for-gastroenteropancreatic-neuroendocrine-neoplasms-a-twelve-year-experience-at-a-single-centre-in-colombia.html https://www.enets.org/abstract/clinicopathological-characteristics-and-prognosis-of-12191-patients-with-pancreatic-neuroendocrine-neoplasms.html https://www.enets.org/abstract/application-of-novel-wound-materials-in-symptom-management-of-patients-with-neuroendocrine-tumours.html https://www.enets.org/abstract/pancreatic-metastases-in-neuroendocrine-neoplasia-a-systematic-review.html https://www.enets.org/abstract/survival-of-10-418-lung-neuroendocrine-tumours-after-surgical-resection-who-needs-follow-up-and-for-how-longc1.html https://www.enets.org/abstract/efficacy-of-octreotide-in-treating-advanced-gastrointestinal-and-pancreatic-neuroendocrine-tumours-a-retrospective-cohort-study.html https://www.enets.org/abstract/gastric-neuroendocrine-neoplasms-in-younger-patients-a-retrospective-single-centre-study.html https://www.enets.org/abstract/prevalence-of-second-primary-malignancies-in-patients-with-neuroendocrine-tumours-c-experience-from-a-tertiary-reference-centre.html https://www.enets.org/abstract/digestive-neuroendocrine-tumour-diagnosis-and-therapeutic-particularities-experience-of-medical-oncology-centre-annaba-algeria.html https://www.enets.org/abstract/pancreatico-duodenal-gastrinomas-surgical-management-and-late-results-c-50-years-experience-in-a-single-centre.html https://www.enets.org/abstract/uncommon-ophthalmic-presentation-of-a-small-bowel-neuroendocrine-tumour-case-report.html https://www.enets.org/abstract/efficacy-and-safety-analysis-of-xelox-plus-bevacizumab-in-the-treatment-of-metastatic-nets.html https://www.enets.org/abstract/statins-and-somatostatin-analogues-in-gastroenteropancreatic-neuroendocrine-tumours-gep-net-impact-on-overall-survival.html https://www.enets.org/abstract/treatment-of-minen-with-peptide-receptor-radionuclide-therapy.html https://www.enets.org/abstract/management-of-grade-i-metastatic-pancreatic-neuroendocrine-tumours-a-case-report-and-literature-review.html https://www.enets.org/abstract/the-management-of-well-differentiated-gastroenteropancreatic-neuroendocrine-tumours-in-a-tertiary-centre-c-the-contribution-of-radionuclide-therapy.html https://www.enets.org/abstract/multiple-sporadic-neuroendocrine-tumours-a-diagnostic-challenge.html https://www.enets.org/abstract/impact-of-pathological-review-of-neuroendocrine-neoplasms-nens-within-the-french-national-endocan-tenpath-network.html https://www.enets.org/abstract/multicentric-enets-morphological-and-molecular-appraisal-of-high-grade-gastroenteropancreatic-neuroendocrine-neoplasms-hg-gep-nen-distinguishing-net-g3-from-nec.html https://www.enets.org/abstract/characteristics-and-clinical-outcomes-after-endoscopic-or-surgical-resection-of-localised-sporadic-type-iii-gastric-nets-a-national-study-from-the-french-group-of-endocrine-tumors-and-endocan-renaten-network.html https://www.enets.org/abstract/primary-mixed-hepatocellular-carcinoma-neuroendocrine-carcinoma-a-case-report.html https://www.enets.org/abstract/survival-and-optimal-follow-up-cut-off-of-lung-neuroendocrine-tumours-after-surgery-experience-of-a-high-volume-centre-over-25-years.html https://www.enets.org/abstract/sequential-alkylating-therapy-and-pembrolizumab-induce-near-complete-response-in-high-tumour-mutational-burden-pancreatic-neuroendocrine-tumour-a-case-report.html https://www.enets.org/abstract/digestive-neuroendocrine-tumours-g1-and-g2-experience-of-the-medical-oncology-department-at-the-oran-university-hospital-establishment-1st-november-1954.html https://www.enets.org/abstract/systemic-anti-cancer-therapy-in-gastroenteropancreatic-neuroendocrine-carcinoma-gep-nec-insights-from-national-cancer-registration-and-analysis-service-ncras.html https://www.enets.org/abstract/clustering-of-gastroenteropancreatic-neuroendocrine-neoplasms-gep-nen-using-machine-learning-ml-and-comparison-with-tumour-node-metastasis-tnm-staging-a-population-based-study-using-surveillance-epidemiology-and-end-results-seer.html https://www.enets.org/abstract/evaluating-multi-visceral-resection-for-locally-advanced-and-metastatic-pancreatic-neuroendocrine-tumours-pnets-feasibility-safety-and-complications.html https://www.enets.org/abstract/ret-lys666asn-has-low-men2-related-tumours-penetrance-but-may-be-associated-with-pheochromocytoma.html https://www.enets.org/abstract/molecular-characterisation-of-extrapulmonary-mixed-adeno-neuroendocrine-neoplasms-minens-the-nirvana-sub-study.html https://www.enets.org/abstract/prevalence-of-familial-pheochromocytoma-and-paraganglioma-syndromes-c-a-large-multicentre-study.html https://www.enets.org/abstract/therapeutic-strategy-for-pancreatic-neuroendocrine-tumours-an-overview-of-the-tne-west-network-2016-2024.html https://www.enets.org/abstract/demystifying-dipnech-updates-from-a-new-longitudinal-patient-registry.html https://www.enets.org/abstract/acromegaly-and-small-intestinal-neuroendocrine-tumours-association-or-coincidencec.html https://www.enets.org/abstract/paraneoplastic-cerebellar-degeneration-relates-to-lung-neuroendocrine-tumour.html https://www.enets.org/abstract/somatostatin-analogue-delayed-the-recrudescence-of-stomach-net-a-real-world-study.html https://www.enets.org/abstract/follow-up-68ga-dotatate-pet-ct-post-resection-of-small-bowel-neuroendocrine-neoplasia.html https://www.enets.org/abstract/retreatment-with-177lu-lu-dotatate-in-neuroendocrine-tumours-outcomes-in-progression-free-survival-and-toxicity-c-our-experience.html https://www.enets.org/abstract/pancreatic-stellate-cells-promote-tumorigenesis-and-progression-of-pancreatic-neuroendocrine-tumours-through-serpine2-and-kcna5.html https://www.enets.org/abstract/stable-tumoural-response-to-stereotactic-body-radiotherapy-in-well-differentiated-metastatic-small-intestine-neuroendocrine-tumour.html https://www.enets.org/abstract/association-between-serum-biomarkers-and-liver-tumour-burden-in-advanced-gastroenteropancreatic-neuroendocrine-tumours.html https://www.enets.org/abstract/bilateral-adrenal-masses-associated-with-arterial-hypertension-with-rare-and-unexpected-definitive-histopathological-diagnosis-a-case-report.html https://www.enets.org/abstract/efficacy-of-regional-and-systemic-therapies-for-refractory-hypoglycaemia-in-malignant-insulinoma.html https://www.enets.org/abstract/predicting-peptide-receptor-radionuclide-therapy-prrt-response-through-the-landscape-of-the-immune-microenvironment-in-neuroendocrine-tumours.html https://www.enets.org/abstract/metabolic-parameters-and-visceral-adiposity-index-in-type-1-gastric-neuroendocrine-tumours-a-single-centre-cross-sectional-study.html https://www.enets.org/abstract/experiences-of-combining-narrative-care-and-case-care-in-the-nursing-of-patients-with-neuroendocrine-tumours.html https://www.enets.org/abstract/inpatient-admissions-for-hormone-secretion-management-in-patients-with-neuroendocrine-neoplasms-nen-treated-with-177lu-lu-dota-octreotate-lutate-therapy-over-a-4-5-year-period-at-a-single-high-volume-treatment-centre.html https://www.enets.org/abstract/fast-pancreatic-cancer-diagnosis-using-lightweight-mamba-framework1.html https://www.enets.org/abstract/parietal-cell-selective-slc26a9-deletion-in-mice-causes-gasdermin-d-mediates-mitochondrial-damage-and-pyroptosis-which-is-the-key-event-to-induce-autoimmune-gastritis2.html https://www.enets.org/abstract/expression-and-clinical-significance-of-igfbp-3-in-pituitary-neuroendocrine-tumours.html https://www.enets.org/abstract/utility-of-netest-2-0-as-a-biomarker-for-neuroendocrine-tumours-the-swiss-experience-c-real-world-data.html https://www.enets.org/abstract/efficacy-and-safety-of-surufatinib-in-combination-with-captem-for-patients-with-advanced-g2-g3-nets-updated-results-from-a-single-arm-phase-ii-study1.html https://www.enets.org/abstract/clinicopathologic-characteristics-and-prognostic-analysis-of-rectal-neuroendocrine-tumours-a-multicentre-clinical-study.html https://www.enets.org/abstract/atrx-daxx-and-menin-immunohistochemistry-identify-prognostic-relevant-non-functioning-neuroendocrine-tumours-subgroups.html https://www.enets.org/abstract/complex-management-of-a-long-term-gastrinoma-survivor-with-multimodal-treatment-approaches.html https://www.enets.org/abstract/quality-of-life-outcome-after-each-cycle-in-net-patients-receiving-peptide-receptor-radionuclide-therapy-prrt.html https://www.enets.org/abstract/impact-of-early-molecular-tumour-board-inclusion-on-treatment-outcomes-in-neuroendocrine-neoplasms-a-retrospective-double-centre-study.html https://www.enets.org/abstract/effectiveness-of-palbociclib-plus-letrozole-as-first-line-therapy-of-metastatic-breast-neuroendocrine-carcinoma-a-case-report.html https://www.enets.org/abstract/efficacy-and-safety-of-surufatinib-in-unresectable-or-metastatic-grade-3-neuroendocrine-tumours-net-g3-a-national-multi-centre-retrospective-study.html https://www.enets.org/abstract/molecular-analysis-of-non-functioning-pannets-of-the-alpha-lineage-reveals-new-subtypes-and-mechanisms-of-progression.html https://www.enets.org/abstract/duodenopancreatic-neuroendocrine-tumour-in-men1-gender-difference-and-survival-rates.html https://www.enets.org/abstract/matching-adjusted-indirect-comparison-maic-of-177lu-lu-dota-tate-177lu-dotatate-vs-captem-as-first-line-1l-treatment-for-advanced-grade-3-g3-gastroenteropancreatic-neuroendocrine-tumours-gep-nets.html https://www.enets.org/abstract/net-impress-a-novel-methylation-based-assay-to-diagnose-and-monitor-net-patients-using-liquid-biopsies.html https://www.enets.org/abstract/matching-adjusted-indirect-comparison-maic-of-177lu-lu-dota-tate-177lu-dotatate-vs-streptozocin-based-chemotherapies-stz-bc-as-first-line-1l-treatment-for-advanced-grade-2-3-g2-g3-pancreatic-nets-pnets.html https://www.enets.org/abstract/biliary-complications-for-metastatic-patients-with-neuroendocrine-tumours-of-the-pancreatic-head-and-their-influence-on-survival-is-it-necessary-to-change-the-current-managementc.html https://www.enets.org/abstract/epidemiological-characteristics-and-prognosis-analysis-of-gastric-cancer-gc-with-neuroendocrine-differentiation-ned1.html https://www.enets.org/abstract/follow-up-analysis-of-group-nutritional-education-in-patients-with-neuroendocrine-neoplasms-gednen-course-a-novel-approach-with-proven-acceptability.html https://www.enets.org/abstract/sequencing-chemotherapy-and-radiotherapy-leading-to-complete-remission-in-a-patient-with-highly-aggressive-advanced-neuroendocrine-cancer-of-unknown-origin.html https://www.enets.org/abstract/a-deep-learning-integrated-multimodal-diagnostic-framework-for-enhanced-early-detection-of-neuroendocrine-tumours.html https://www.enets.org/abstract/predictive-value-of-different-pd-l1-immunohistochemistry-clones-for-immunotherapy-efficacy-in-neuroendocrine-tumours-a-case-series.html https://www.enets.org/abstract/liver-debulking-surgery-is-benefit-to-pfs-in-patients-with-high-tumour-burden-of-neuroendocrine-tumour-liver-metastases.html https://www.enets.org/abstract/prognostic-factors-for-survival-in-patients-with-metastatic-small-intestinal-neuroendocrine-tumours-undergoing-primary-tumour-resection.html https://www.enets.org/abstract/a-methylation-based-classifier-for-neuroendocrine-tumour-detection-using-smmip-technology.html https://www.enets.org/abstract/efficacy-and-safety-of-cabozantinib-cabo-for-advanced-grade-3-g3-neuroendocrine-tumours-nets-after-progression-on-prior-therapy-subgroup-analysis-of-the-phase-iii-cabinet-trial-alliance-a021602.html https://www.enets.org/abstract/anxa1-labelled-cancer-associated-fibroblasts-induces-tumour-invasion-and-immunosuppressive-microenvironment.html https://www.enets.org/abstract/is-late-diagnosis-and-carcinoid-heart-disease-cahd-associated-with-deprivation-indexc-c-an-audit-of-practice-and-assessment-of-deprivation-index-in-sheffield-enets-centre-of-excellence.html https://www.enets.org/abstract/18f-fdg-fdg-pet-ct-metrics-as-prognostic-biomarkers-in-the-agitg-nabnec-trial.html https://www.enets.org/abstract/leveraging-large-language-models-for-enhanced-diagnosis-of-neuroendocrine-tumours.html https://www.enets.org/abstract/preoperative-evaluation-of-tumour-border-using-radiomics-and-its-surgical-guidance-in-pancreatic-neuroendocrine-tumours.html https://www.enets.org/abstract/sirt7-drives-the-radioresistance-of-pancreatic-neuroendocrine-tumours-via-the-dnmt1-men1-axis.html https://www.enets.org/abstract/mri-findings-of-jejunal-mesentery-neuroendocrine-tumour-c-a-case-report.html https://www.enets.org/abstract/the-relationship-between-adherence-to-traditional-chinese-medicine-and-disease-progression-in-type-1-gastric-neuroendocrine-tumours-a-case-report.html https://www.enets.org/abstract/serum-visfatin-concentration-in-metastatic-pancreatic-and-midgut-nets-an-exploratory-study.html https://www.enets.org/abstract/long-term-quality-of-life-after-pancreatic-surgery-for-neuroendocrine-tumours-of-the-pancreas-outcome-of-100-patients-evaluated-with-new-eortc-questionnaires.html https://www.enets.org/abstract/the-role-of-metabolism-in-neuroendocrine-tumour-cell-models-and-patients.html https://www.enets.org/abstract/gender-differences-in-patients-with-medullary-thyroid-cancer-mtc-a-single-centre-experience.html https://www.enets.org/abstract/receptor-radionuclide-therapy-with-177lu-dotatoc-177luedotreotide-or-177lu-octreotide-in-sstr-positive-patients-a-multicentre-prospective-phase-ii-trial.html https://www.enets.org/abstract/development-of-new-3d-in-vitro-models-for-pancreatic-neuroendocrine-tumours-pannets.html https://www.enets.org/abstract/survival-and-toxicity-outcomes-of-somatostatin-analogues-vs-other-systemic-therapies-as-first-line-palliative-treatment-for-patients-with-extrapulmonary-g2-well-differentiated-neuroendocrine-tumours-with-a-ki-67-index-between-10-and-20.html https://www.enets.org/abstract/follow-up-is-not-justified-in-patients-with-typical-lung-carcinoids-treated-with-curative-intent.html https://www.enets.org/abstract/the-usefulness-of-circulating-fibrosis-markers-in-detection-of-carcinoid-heart-disease.html https://www.enets.org/abstract/single-nucleus-profiling-of-the-tumour-microenvironment-in-si-net-patients.html https://www.enets.org/abstract/retrospective-analysis-of-somatostatin-receptors-expression-in-cohort-of-thoracic-neuroendocrine-neoplasms-with-immunohistochemistry-method-or-pet-ct-ga68-dota-tate.html https://www.enets.org/abstract/prognosis-analysis-of-metastatic-rectal-neuroendocrine-tumour-liver-directed-trans-arterial-embolisation-may-play-a-pivotal-role.html https://www.enets.org/abstract/results-of-active-observation-of-pancreatic-non-functioning-neuroendocrine-tumours-c-medical-registry-data.html https://www.enets.org/abstract/single-cell-transcriptomic-landscape-indicates-the-potential-role-of-immunotherapy-in-metastatic-pancreatic-angiosarcoma.html https://www.enets.org/abstract/spatial-and-temporal-intratumour-heterogeneity-of-pancreatic-neuroendocrine-tumours-pannet.html https://www.enets.org/abstract/analysis-of-the-mutational-landscape-of-pancreatic-neuroendocrine-tumours-before-and-after-temozolomide-treatment.html https://www.enets.org/abstract/epigenetic-exploration-of-mesenteric-fibrosis-indicates-epigenetic-disruption-of-daxx-is-driving-metastatic-potential-in-small-intestinal-neuroendocrine-tumours.html https://www.enets.org/abstract/carcinoid-heart-disease-in-patients-with-carcinoid-syndrome-and-metastatic-small-intestinal-neuroendocrine-tumours-a-single-centre-experience.html https://www.enets.org/abstract/alpha-fetoprotein-as-a-valuable-biomarker-in-neuroendocrine-tumours.html https://www.enets.org/abstract/the-relationship-between-men1-germline-mutations-and-sstr2-expression-in-neuroendocrine-tumours.html https://www.enets.org/abstract/characterisation-and-management-of-neuroendocrine-tumours-findings-from-a-prospective-study-in-algeria.html https://www.enets.org/abstract/the-efficacy-of-crechallengec-peptide-receptor-radionuclide-therapy-prrt-may-be-inferior-to-that-of-the-initial-prrt-while-the-safety-profile-remains-comparable1.html https://www.enets.org/abstract/base-on-deep-learning-integrated-multimodal-diagnostic-framework-for-enhanced-early-detection-of-neuroendocrine-tumours.html https://www.enets.org/abstract/assessment-of-gastric-mucosa-conditions-changes-in-patients-with-gastric-neuroendocrine-neoplasia-type-1-during-gastroprotective-therapy.html https://www.enets.org/abstract/optimising-the-establishment-of-patient-derived-models-for-neuroendocrine-neoplasms.html https://www.enets.org/abstract/mir-1290-and-mir-320c-regulate-cell-proliferation-and-predict-patient-prognosis-in-neuroendocrine-carcinomas.html https://www.enets.org/abstract/prognostic-impact-of-primary-tumour-location-after-resection-of-neuroendocrine-liver-metastases-from-gastroenteropancreatic-tumours.html https://www.enets.org/abstract/exploring-the-interplay-between-rna-methylation-and-splicing-dysregulation-in-neuroendocrine-tumours.html https://www.enets.org/abstract/genetic-trajectory-and-clonal-evolution-of-non-functional-pancreatic-neuroendocrine-tumours-with-lymph-node-and-liver-metastasis.html https://www.enets.org/abstract/prognostic-value-of-pre-therapeutic-and-interim-sstr-pet-in-patients-with-gi-net-receiving-peptide-receptor-radionuclide-therapy.html https://www.enets.org/abstract/secondary-endpoint-results-of-the-first-multicentric-randomised-phase-ii-trial-investigating-the-antitumour-efficacy-of-177lutetium-dota-octreotate-oclu-in-advanced-progressive-neuroendocrine-pancreatic-tumour-the-oclurandom-trial.html https://www.enets.org/abstract/clinical-case-of-a-young-woman-with-acromegaly-hyperprolactinemia-and-pituitary-tumour-with-mixed-morphology-of-adenoma-and-gangliocytoma.html https://www.enets.org/abstract/vasculogenic-mimicry-in-neuroendocrine-tumour-across-different-primary-sites.html https://www.enets.org/abstract/evaluation-of-duodenal-neuroendocrine-tumours-according-to-mcsc-register.html https://www.enets.org/abstract/predictive-value-of-high-risk-histopathological-and-molecular-criteria-for-lymph-node-metastasis-in-appendiceal-neuroendocrine-tumours.html https://www.enets.org/abstract/malignant-pheochromocytoma-with-late-distant-metastases-and-secondary-hypercalcaemia.html https://www.enets.org/abstract/investigating-the-dual-role-of-snw1-in-splicing-and-transcription-to-understand-pancreatic-neuroendocrine-tumour-progression.html https://www.enets.org/abstract/dramatic-response-to-tarlatamab-in-a-patient-with-metastatic-primary-small-cell-neuroendocrine-carcinoma-of-the-breast.html https://www.enets.org/abstract/diagnosis-of-carcinoid-heart-disease-continues-to-be-late-delayed.html https://www.enets.org/abstract/characterisation-and-prognostic-impact-of-carcinoid-syndrome-in-bronchial-neuroendocrine-tumours.html https://www.enets.org/abstract/steroid-dosing-to-prevent-tumour-flare-reaction-with-177lu-dotatate.html https://www.enets.org/abstract/digestive-neuroendocrine-tumours-patterns-pathways-and-progress-in-personalised-management.html https://www.enets.org/abstract/long-acting-somatostatin-analogue-injections-for-treating-gastroenteropancreatic-neuroendocrine-tumours-gep-nets-and-acromegaly-backsom-c-a-patient-preference-study.html https://www.enets.org/abstract/once-daily-oral-paltusotine-in-the-treatment-of-patients-with-carcinoid-syndrome-safety-and-exploratory-efficacy-results-from-a-phase-ii-randomised-parallel-group-study.html https://www.enets.org/abstract/economic-evidence-for-pancreatic-and-extra-pancreatic-neuroendocrine-tumours-following-treatment-failure-or-disease-progression-a-systematic-literature-review.html https://www.enets.org/abstract/diagnosis-of-a-cervical-carotid-paraganglioma-a-case-report-and-review-of-diagnostic-imaging-approaches.html https://www.enets.org/abstract/dissecting-the-role-of-collagen-quantitation-via-tissue-tethered-digital-analysis-in-small-bowel-neuroendocrine-tumours-and-related-mesenteric-tumour-deposits.html https://www.enets.org/abstract/real-world-effectiveness-of-lanreotide-autogel-in-patients-with-advanced-gastroenteropancreatic-neuroendocrine-tumours-with-antigen-ki-67-proliferation-index-above-and-below-10-the-kinetics-study.html https://www.enets.org/abstract/improving-diagnosis-of-neuroendocrine-tumours-using-large-language-models.html https://www.enets.org/abstract/clinical-efficacy-and-safety-of-treatments-for-pancreatic-and-extra-pancreatic-neuroendocrine-tumours-following-treatment-failure-or-disease-progression-a-systematic-literature-review.html https://www.enets.org/abstract/potential-significance-of-individual-dosimetry-of-radionuclide-therapy-rlt-using-177lu-lu-dota-tate-or-mixture-of-177lu-90y-dota-tate-in-net-therapy.html https://www.enets.org/abstract/improved-assessment-of-gene-rearrangements-by-targeting-non-coding-dna-regions-in-patients-diagnosed-with-pancreatic-neuroendocrine-neoplasms.html https://www.enets.org/abstract/hepatic-cytoreduction-in-advanced-lung-neuroendocrine-neoplasms-a-single-institutional-case-series.html https://www.enets.org/abstract/short-term-observation-of-liver-transplantation-combined-with-multidisciplinary-integrated-treatment-of-liver-metastases-from-neuroendocrine-tumours-beyond-the-milan-criteria.html https://www.enets.org/abstract/base-on-neuroendocrine-tumour-classification-in-ct-imaging-using-pretrained-vision-transformers-and-data-augmentation.html https://www.enets.org/abstract/exploring-the-splicing-landscape-to-identify-survival-related-biomarkers-in-small-intestine-neuroendocrine-neoplasms.html https://www.enets.org/abstract/spatial-transcriptomics-identifies-wnt-signalling-in-multifocal-ileal-neuroendocrine-tumours.html https://www.enets.org/abstract/clinical-efficacy-of-rlt-to-assess-os-and-pfs-using-177lu-dotatate-90y-dotatate-and-a-mixture-of-both-in-patients-with-advanced-unresectable-progressive-rectal-net-c-a-retrospective-analysis.html https://www.enets.org/abstract/association-of-sst5tmd4-and-sst5tmd5-expression-with-metastasis-and-poor-prognostic-markers-in-gastroenteropancreatic-neuroendocrine-tumours.html https://www.enets.org/abstract/efficacy-of-trabectedin-and-olaparib-in-homologous-repair-deficient-neuroendocrine-neoplasms-c-a-subgroup-analysis-of-the-top-art-pmo-1603-trial.html https://www.enets.org/abstract/uncovering-cell-state-heterogeneity-in-large-cell-pannec-indicates-potentially-targetable-aberrant-brain-type-neuronal-de-differentiation.html https://www.enets.org/abstract/excellent-response-to-ac-225-dotatate-therapy-in-a-patient-with-small-cell-lung-cancer.html https://www.enets.org/abstract/rna-splicing-as-a-key-regulatory-player-with-translational-potential-in-pulmonary-neuroendocrine-neoplasms-lungnets.html https://www.enets.org/abstract/gender-and-metastatic-burden-as-preoperative-predictors-of-disease-progression-in-patients-undergoing-surgery-for-pancreatic-neuroendocrine-tumours-with-liver-metastases.html https://www.enets.org/abstract/fit-nets-assessing-the-effects-of-an-exercise-programme-on-the-physical-and-emotional-well-being-of-patients-with-advanced-g1-2-nets-of-gep-or-unknown-origin.html https://www.enets.org/abstract/i-ainct-missing-you-at-all-c-vanishing-extra-abdominal-small-intestinal-neuroendocrine-carcinoma-metastasis.html https://www.enets.org/abstract/endosonography-guided-coloenterostomy-for-management-of-malignant-small-bowel-ileus.html https://www.enets.org/abstract/artificial-intelligence-in-predicting-neuroendocrine-tumour-net-outcomes-a-model-based-prognostic-approach.html https://www.enets.org/abstract/pembrolizumab-combined-with-cisplatin-or-carboplatin-and-etoposide-in-treatment-naicve-advanced-merkel-cell-carcinoma-mcc-the-phase-ii-pandora-trial.html https://www.enets.org/abstract/the-role-of-microbiome-diversity-in-neuroendocrine-tumour-net-development-and-progression-insights-from-a-cohort-study.html https://www.enets.org/abstract/germline-predisposition-to-neuroendocrine-tumours-of-the-pancreas-pnen-based-on-mutations-in-dna-repair-genes-c-brca1-brca2-palb2-chek2-mlh1-msh2-msh6-pms2-epcam-apc-mutyh-stk11.html https://www.enets.org/abstract/primary-mammary-neuroendocrine-tumour-a-case-report-and-literature-review.html https://www.enets.org/abstract/neuroendocrine-mess-c-ectopic-cushing-syndrome-and-severe-hypokalaemia.html https://www.enets.org/abstract/bh3-mimetic-drugs-elicit-cell-death-of-neuroendocrine-tumours-in-preclinical-models-c-an-emerging-therapeutic-strategy-for-nets.html https://www.enets.org/abstract/a-complex-and-rare-association-of-neuroendocrine-and-endocrine-neoplasms-a-case-report.html https://www.enets.org/abstract/external-validation-of-rachel-score-a-prognostic-tool-for-lung-neuroendocrine-tumours.html https://www.enets.org/abstract/the-last-10-years-c-single-centre-experience-of-gastrointestinal-nen.html https://www.enets.org/abstract/management-strategies-and-outcomes-for-type-1-gastric-neuroendocrine-tumours-measuring-1cm-in-diameter.html https://www.enets.org/abstract/intraoperative-beta-probe-for-pathological-tissue-detection-in-gep-net-patients-a-prospective-phase-ii-trial.html https://www.enets.org/abstract/correlation-of-serum-cytokeratin-18-ferritin-cancer-antigen-125-and-beta-2-microglobulin-with-tumour-grade-and-stage-in-pancreatic-neuroendocrine-tumours.html https://www.enets.org/abstract/rare-diagnosis-of-intrapancreatic-accessory-spleen-mimicking-pannet.html https://www.enets.org/abstract/dosimetry-efficacy-and-safety-of-radiolabelled-somatostatin-receptor-antagonist-in-patients-with-metastatic-pheochromocytoma-or-paraganglioma.html https://www.enets.org/abstract/clinical-characterisation-of-patients-with-familial-midgut-neuroendocrine-tumours-fm-nets-based-on-a-comparison-with-the-large-population-based-gte-renaten-cohort.html https://www.enets.org/abstract/analysis-of-new-immunohistochemical-biomarkers-in-a-cohort-of-pancreatic-nets.html https://www.enets.org/abstract/the-exceptionally-rare-phenomenon-of-well-differentiated-colon-neuroendocrine-tumours.html https://www.enets.org/abstract/targeted-beta-plus-auger-and-conversion-electron-therapy-with-terbium-161-labelled-somatostatin-receptor-antagonist-dota-lm3-c-beta-plus-phase-0-study.html https://www.enets.org/abstract/impact-of-the-extent-of-surgical-resection-on-the-development-of-post-operative-diabetes-in-patients-undergoing-distal-pancreatectomy-for-non-functioning-pancreatic-neuroendocrine-tumours-nf-pannet.html https://www.enets.org/abstract/clinical-presentation-and-outcomes-of-sporadic-neuroendocrine-neoplasms-in-young-adults-international-multicentre-analysis.html https://www.enets.org/abstract/elucidating-the-role-of-high-mobility-group-box-3-hmgb3-during-progression-and-response-to-radiation-therapy-in-pancreatic-neuroendocrine-tumours.html https://www.enets.org/abstract/68ga-ga-dota-exendin-4-pet-ct-for-the-localisation-of-insulinoma-results-of-an-international-dual-centre-retrospective-open-label-real-world-imaging-study.html https://www.enets.org/abstract/efficacy-and-safety-of-capecitabine-temozolomide-captem-regimen-in-patients-with-neuroendocrine-neoplasms-c-a-systematic-review-and-experience-from-netwerk-a-belgian-enets-center-of-excellence1.html https://www.enets.org/abstract/comparison-of-two-prognostic-models-for-the-treatment-of-pancreatic-net-with-prrt.html https://www.enets.org/abstract/triple-negative-breast-neuroendocrine-carcinoma-in-older-patient-a-rare-entity1.html https://www.enets.org/abstract/identification-of-putative-master-regulators-in-pancreatic-neuroendocrine-tumours-using-gene-expression-data-and-network-inference.html https://www.enets.org/abstract/radiolabelled-somatostatin-receptor-sstr-antagonist-vs-agonist-for-peptide-receptor-radionuclide-therapy-pprt-in-patients-with-sstr-positive-neuroendocrine-tumours-c-a-retrospective-basket-study.html https://www.enets.org/abstract/correlations-between-dosimetry-and-imaging-in-patients-with-neuroendocrine-tumour-treated-with-177lu-dotatate.html https://www.enets.org/abstract/men1-associated-pancreatic-neuroendocrine-tumours-re-evaluating-the-2cm-cut-off-for-surgical-resection.html https://www.enets.org/abstract/mini-invasive-pancreatectomy-for-pancreatic-neuroendocrine-tumours-current-state-of-management-in-france.html https://www.enets.org/abstract/management-of-hypercalcaemia-of-malignancy-in-neuroendocrine-tumour-patients-c-a-case-series.html https://www.enets.org/abstract/comparison-of-18f-dopa-pet-ct-and-68ga-dotatoc-pet-ct-and-their-impact-on-response-to-prrt-in-midgut-neuroendocrine-tumours.html https://www.enets.org/abstract/maximising-the-use-of-pancreatic-enzyme-replacement-therapy-pert-among-patients-with-gastroenteropancreatic-neuroendocrine-neoplasms-gepnens-and-exocrine-pancreatic-insufficiency-epi.html https://www.enets.org/abstract/non-functional-retroperitoneal-paraganglioma-in-a-young-patient-a-case-report.html https://www.enets.org/abstract/prognostic-role-of-the-kynurenine-tryptophan-pathway-and-inflammatory-cytokines-in-neuroendocrine-tumour-progression-a-cross-sectional-analysis.html https://www.enets.org/abstract/prevalence-and-characteristics-of-incidental-net-of-the-meckelcs-diverticula-retrospective-cohort-study-at-a-tertiary-centre.html https://www.enets.org/abstract/case-series-tuberous-sclerosis-associated-pancreatic-neuroendocrine-tumours-at-a-tertiary-centre1.html https://www.enets.org/abstract/establishing-a-standardised-histopathological-grading-system-for-mesenteric-fibrosis-in-small-intestinal-neuroendocrine-tumours.html https://www.enets.org/abstract/characterisation-of-patients-with-progressive-digestive-net-during-prrt-luta-chec-a-multicentre-study-from-the-groupe-des-tumeurs-endocrines.html https://www.enets.org/abstract/first-results-of-peptide-receptor-radionuclide-therapy-in-the-russian-population-of-patients-with-neuroendocrine-neoplasms.html https://www.enets.org/abstract/radio-guided-surgery-in-use-for-treatment-of-early-relapse-in-small-intestine-neuroendocrine-tumours.html https://www.enets.org/abstract/dysregulated-mirna-in-patients-with-gep-nen-and-potential-role-as-circulating-biomarker.html https://www.enets.org/abstract/crosstalk-between-cancer-associated-fibroblasts-and-small-intestinal-neuroendocrine-tumour-cells-in-a-3d-spheroid-model.html https://www.enets.org/abstract/analysis-of-presentation-and-outcomes-of-mixed-adenoneuroendocrine-carcinoma-manec-c-a-single-centre-experience.html https://www.enets.org/abstract/claudin-18-2-overexpression-in-gastric-neuroendocrine-tumours.html https://www.enets.org/abstract/whole-exome-sequencing-in-pulmonary-neuroendocrine-neoplasms-findings-from-a-pilot-investigation.html https://www.enets.org/abstract/neuroendocrine-hyperplasia-of-infancy-nehi-vs-diffuse-idiopathic-pulmonary-neuroendocrine-cell-hyperplasia-dipnech-what-is-the-differencec.html https://www.enets.org/abstract/clinical-response-to-somatostatin-analogues-in-patients-with-dipnech-findings-from-a-new-longitudinal-registry.html https://www.enets.org/abstract/usefulness-of-soluble-tumour-necrosis-factor-related-apoptosis-inducing-ligand-trail-and-its-receptors-r2-and-r3-in-progression-assessment-of-gastroenteropancreatic-neuroendocrine-neoplasms-c-a-preliminary-study.html https://www.enets.org/abstract/a-novel-nonpeptide-drug-conjugate-ndc-for-the-treatment-of-somatostatin-receptor-2-expressing-tumours.html https://www.enets.org/abstract/development-of-a-3d-patient-derived-extracellular-matrix-hydrogel-model-of-small-intestinal-neuroendocrine-tumour-and-mesenteric-fibrosis.html https://www.enets.org/abstract/should-we-use-the-growth-modulation-index-gmi-in-response-assessment-in-g2-neuroendocrine-tumours-nets-c.html https://www.enets.org/abstract/the-nutritional-status-worsens-over-5-years-in-patients-with-gastroenteropancreatic-neuroendocrine-tumours-on-treatment-with-somatostatin-analogues.html https://www.enets.org/abstract/current-role-of-systemic-lanreotide-therapy-of-patients-with-advanced-unresectable-non-metastatic-paraganglioma-pheochromocytoma-ppgl-sporadic-and-hereditary.html https://www.enets.org/abstract/clinical-significance-of-interval-imaging-in-patients-with-well-differentiated-neuroendocrine-neoplasms-nens-receiving-peptide-receptor-radionuclide-therapy-prrt.html https://www.enets.org/abstract/comparison-of-preoperative-chemotherapy-and-radio-ligand-therapy-on-prognosis-after-surgical-resection-for-locally-advanced-or-hepatic-metastatic-pancreatic-neuroendocrine-tumours.html https://www.enets.org/abstract/a-novel-hormone-based-anti-sstr-anti-cd3-t-cell-engager-for-the-treatment-of-neuroendocrine-tumours.html https://www.enets.org/abstract/carefndr-a-phase-iii-randomised-parallel-group-placebo-controlled-study-to-evaluate-the-efficacy-and-safety-of-paltusotine-in-adults-with-carcinoid-syndrome-due-to-well-differentiated-neuroendocrine-tumours.html https://www.enets.org/abstract/prognostic-value-of-systemic-inflammatory-parameters-in-neuroendocrine-tumour-patients-treated-with-peptide-receptor-radionuclide-therapy-c-preliminary-results.html https://www.enets.org/abstract/merkel-cell-neuroendocrine-carcinoma-of-the-skin-high-response-rates-to-short-course-palliative-radiotherapy-c-typical-clinical-scenarios.html https://www.enets.org/abstract/clinical-outcomes-in-patients-with-typical-tc-and-atypical-bronchial-carcinoids-ac-a-15-year-retrospective-study-from-an-enets-center-of-excellence.html https://www.enets.org/abstract/predictive-factors-of-postoperative-recurrence-in-patients-with-neuroendocrine-tumour-of-the-lung-prospective-analysis-of-clinicopathologic-features-and-radiomics.html https://www.enets.org/abstract/efficacy-and-safety-of-177lu-lu-edotreotide-vs-everolimus-in-patients-with-grade-1-or-grade-2-gastroenteropancreatic-neuroendocrine-tumours-compete-phase-3-trial.html https://www.enets.org/abstract/the-efficacy-of-first-line-combination-therapy-with-everolimus-plus-lanreotide-for-gastroenteropancreatic-neuroendocrine-tumour-with-a-poor-prognostic-factor-updated-and-subgroup-analysis-of-the-phase-iii-study-starter-net-jcog1901.html https://www.enets.org/webinars/practice-webinar.html https://www.enets.org/webinars/enets-webinar-most-frequent-confusions-in-nen-management.html https://www.enets.org/webinars/enets-webinar-surgical-strategies-for-patients-with-men1.html https://www.enets.org/webinars/enets-nanets-webinar.html https://www.enets.org/webinars/enets-inca-net-cancer-day-2024.html https://www.enets.org/webinars/enets-webinar-what-has-changed-in-the-new-guidance-enets-manuscript-in-2023-characterisation-and-treatment.html https://www.enets.org/webinars/enets-nanets-webinar-new-signals-directions-signals.html https://www.enets.org/webinars/enets-nanets-webinar-post-enets.html https://www.enets.org/webinars/enets-webinar-systemic-therapy-new-advances.html https://www.enets.org/webinars/enets-webinar-local-management-of-bone-metastases-in-advanced-nets-what-do-i-expect-2.html https://www.enets.org/webinars/enets-webinar-local-management-of-bone-metastases-in-advanced-nets-what-do-i-expect.html https://www.enets.org/webinars/enets-webinar-theranostics-in-net-hit-and-miss.html https://www.enets.org/webinars/enets-inca-net-cancer-day-2023.html https://www.enets.org/webinars/enets-webinar-management-of-functioning-syndrome-in-advanced-net-what-can-we-expect.html https://www.enets.org/webinars/synoptic-reporting-of-echocardiography-in-carcinoid-heart-disease.html https://www.enets.org/webinars/enets-webinar-how-to-interpret-imaging-results-in-nets-being-aware-of-false-positive-and-false-negative-results.html https://www.enets.org/webinars/enets-webinar-genetic-syndromes-in-nen-what-is-new.html https://www.enets.org/webinars/enets-webinar-best-supportive-care-the-holistic-approach-to-a-nen-patient.html https://www.enets.org/webinars/enets-webinar-immunotherapy-where-do-we-stand-in-net-nec-pheochromocytomas-and-paragangliomas-ppgl-medullary-thyroid-carcinomas-mtc-and-merkel-cell-carcinomas-mcc.html https://www.enets.org/webinars/enets-webinar-endoscopic-treatment-options-in-localised-digestive-net-when-and-how.html https://www.enets.org/webinars/enets-webinar-functioning-syndromes-in-nen-from-patients-journey-to-clinical-dos-and-don-ts-quantifying-the-severity-of-symptoms-and-preventing-common-mistakes.html https://www.enets.org/webinars/enets-inca-net-cancer-day-educational-webinar-2.html https://www.enets.org/webinars/enets-webinar-appraisal-of-locoregional-treatments-in-net.html https://www.enets.org/webinars/enets-webinar-update-on-the-diagnosis-and-characterisation-of-nen.html https://www.enets.org/webinars/enets-webinar-selection-of-the-most-appropriate-chemotherapy-in-nens.html https://www.enets.org/webinars/enets-webinar-role-of-molecular-testing-for-individualising-therapy-in-gastro-entero-pancreatic-gep-and-thoracic-nens.html https://www.enets.org/webinars/side-effects-toxicity-of-commonly-used-agents-in-neuroendocrine-neoplasms-nen-treatment-identification-management-and-assessment-of-the-risk-of-cumulative-side-effects.html https://www.enets.org/webinars/enets-webinar-best-treatment-sequences-in-advanced-net.html https://www.enets.org/webinars/does-surgery-cure-localised-net-which-level-of-evidence.html https://www.enets.org/webinars/nanets-enets-highlights-program.html https://www.enets.org/webinars/abc-in-nen.html https://www.enets.org/webinars/surgery-of-localised-digestive-net-a-tailored-approach.html https://www.enets.org/webinars/post-omics-landscape-and-agnostic-strategy.html https://www.enets.org/webinars/enets-inca-net-cancer-day-educational-webinar.html https://www.enets.org/webinars/prrt-practical-issues-grey-areas.html https://www.enets.org/webinars/new-tki-results-in-nets.html https://www.enets.org/general-assembly/ga-2023.html https://www.enets.org/general-assembly/ga-2021.html https://www.enets.org/db-faqs/enets-database-support-jourfixe-2.html https://www.enets.org/db-faqs/enets-database-support-jourfixe-3.html